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Abstract 
The human endometrium is a highly regenerative organ undergoing over 400 
cycles of shedding and regeneration over a woman’s life time. Menstrual 
shedding and subsequent repair of the endometrial functionalis layer is a 
process unique to humans and higher-order primates. This massive 
regenerative capacity is thought to have a stem cell basis, with the human 
endometrial stromal stem cells already widely studied. However, studies on 
endometrial epithelial stem cells are sparse, and the current dogma is that 
the endometrial epithelial stem cells reside in the terminal ends of the basalis 
glands at the endometrial/myometrial interface. Consequently, there is a lack 
of information available regarding endometrial epithelial stem cells, and the 
histo-architecture of the endometrial epithelial compartment. Since almost all 
endometrial pathologies are thought to be originating from aberrations in 
stem cells that regularly regenerate the functionalis layer, expansion of our 
current understanding of stem cells is necessary in order for curative 
treatment strategies to be developed. The principal goal of the work 
presented in this thesis was to determine if the human endometrial 
epithelium has a stem cell that is likely to be involved in glandular 
regeneration, and to understand the three-dimensional histo-architecture of 
the endometrial epithelial organisation.  
There are many stem cell markers described in different tissues using 
extensive characterisation and functional confirmatory studies. Evidence 
from work in the intestine, hair follicles and kidneys showed Leucine-rich 
repeat-containing G-protein-coupled receptor 5 (LGR5) to be an epithelial 
stem cell marker. In the initial part of the work in this thesis, the expression of 
LGR5 in the human endometrium was examined to ascertain if it is likely to 
be a marker of endometrial epithelial stem cells. This was accomplished by 
confirming the expression, and subsequently examining the cellular 
localisation of LGR5 in all epithelial compartments of the human 
endometrium, and the Fallopian tube. The hormone regulation of LGR5 in 
the endometrium was also studied in vitro and in vivo. Quantitative reverse 
transcriptase polymerase chain reaction (qRT-PCR) was initially used to 
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determine the presence of LGR5 in the endometrium and Fallopian tube 
across the menstrual cycle, showing higher expression in the oestrogen 
dominant proliferative phase of the cycle. The gold standard method for 
locating LGR5 expression at a cellular level, in situ hybridisation (ISH), was 
in agreement with the qRT-PCR data regarding the differences of LGR5 
expression across the menstrual cycle, but, surprisingly, the location of 
LGR5 expressing cells was not limited to the postulated stem cell niche, the 
basalis glands. Our data demonstrated the luminal epithelium (LE) to have 
significantly higher levels of LGR5 expression than all other epithelial 
compartments in the endometrium; basalis glands also constitutively 
expressed LGR5 albeit at lower levels than LE. When LGR5 expression was 
considered in the context of the expression of the previously known 
progenitor markers SSEA-1 and SOX9, the luminal and basalis epithelia 
shared distinct, region specific, patterns of co-expression. Levels of LGR5, 
SSEA-1 and SOX9 decreased in all 3 endometrial epithelial compartments, 
and also in the tubal epithelium in the secretory phase, when compared with 
the samples from the proliferative phase, suggesting a hormonal 
(progesterone) regulation. To further investigate the possible regulation of 
LGR5 by progesterone, endometrial explants, treated with progesterone in 
vitro (medroxyprogesterone acetate (MPA)) and in vivo (patients on 
exogenous progestagenic treatment), were examined, demonstrating a 
decrease in LGR5 expression. From this work we hypothesised that it is 
possible for the human endometrium to have more than one epithelial 
stem/progenitor cell pool.  
The current consensus had been that the endometrial glandular arrangement 
is similar to the intestinal glandular crypts, assuming a single blunt ended 
ductular design. Utilising a three dimensional (3D) reconstruction technique, 
previously used in the liver and kidney, we created three 3D endometrial 
reconstructions. These reconstructions revealed that the premenopausal 
functionalis glands are non-branching and run a vertical and parallel course 
through the superficial functionalis layer of the human endometrium. The 
basalis glandular arrangement was very different to this, and formed a 
complex branching configuration proceeding in a horizontal course to the 
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myometrium. This novel finding, basalis assuming a root-like “stolon” 
configuration, is likely to provide an effective glandular propagation strategy 
to maintain continuous endometrial covering of the uterine cavity, and if the 
stem cells are residing in them, contribute efficiently to the scar-less 
regeneration of the endometrium. 
With the unexpected findings in the LGR5 study and the newly discovered 
3D histo-architecture of the endometrial epithelium, we required direct 
evidence as to the existence of endometrial epithelial stems cells. Therefore, 
in the final part of this thesis, in vivo lineage tracing, the “gold standard” 
method of stem cell identification, was utilised to prove the existence of 
endometrial epithelial stem cells for the first time. Tracing non-pathogenic 
mitochondrial DNA (mtDNA) mutations using cytochrome C oxidase (CCO)-
deficiency as a marker, is a natural experiment allowing lineages to be 
traced, and stem cell niches to be identified. The amount of CCO-deficient 
clonal patches, were found to be increased in incidence across the 
reproductive years, up to the age of menopause, with the earliest patch seen 
in the basalis of a 25 year old patient. This suggested the long lived epithelial 
cells, (likely stem cells), to be located in the basalis. Using single cell Sanger 
sequencing of the whole mitochondrial genome following laser capture micro 
dissection (LCM), a unique mtDNA mutation was found in all CCO-deficient 
cells, of a partially mutated gland, and absent in all adjacent CCO-proficient 
wild type cells, conclusively confirming the existence of endometrial epithelial 
stem cells in the endometrium. The existence of partially mutated glands, 
suggests that at least some endometrial glands are regenerated by more 
than one epithelial stem cell (polyclonal origin). The clonal patches were 
found to contain markers specific to all three endometrial epithelial 
compartments, suggesting the different cell subtypes comprising the human 
endometrial glandular compartment has a common ancestral origin, i.e. a 
multipotent epithelial stem cell. Using a 3D model of CCO staining, the extent 
of the clonal patches was examined. The clonal population, extending to the 
functionalis glands, suggested that they had risen from stem cells located in 
the basalis glands. The work presented in this thesis therefore describes for 
the first time, that the human endometrium harbours unique mtDNA 
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mutations, proving the existence of endometrial epithelial stem cells, and the 
endometrial glandular regeneration to be polyclonal. Although the method 
only allows for a snapshot in time, the technique does demonstrate the two 
major aspects of stemness, multipotentiality and self-renewal.  
In conclusion, the work described in this thesis presents three novel findings: 
LGR5 expression in the human endometrial epithelium has presented a new 
conundrum regarding the location of the stem cell niche in the human 
endometrial epithelium; the 3D reconstruction of the endometrial epithelium 
has shown non-branching vertical and parallel functionalis glands and 
intricate branching horizontal basalis glands forming a root-like “stolon” 
architecture; utilising non-pathogenic mtDNA mutations, and lineage tracing, 
the existence of endometrial epithelial stem cells has been proven for the 
first time. This work therefore provides a novel basis for further work on the 
exact location, dynamics, and changes in diseased tissue of stem cells, and 
discovering their identity in the future. 
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Chapter 1. General Introduction  
Human endometrium, which lines the uterine cavity, is the main target for 
ovarian steroid hormones. During the reproductive period of a woman’s life, 
the endometrium undergoes up to 400 monthly cycles of proliferation and 
sloughing under the influence of the ovarian hormonal signals. Since tissue 
regeneration is directly dependent on adult stem cell (ASC) function, the 
remarkable regenerative ability of the endometrium, seen during this monthly 
loss and repair cycle, should also have a stem cell basis. The work 
undertaken in this thesis, examines the stem cell involvement in normal 
endometrial epithelial regeneration, and the histo-anatomical architecture of 
the endometrial epithelial compartment. 
1.1 Development of the uterus 
1.1.1 Early fetal development of the human uterus 
The sperm, at fertilisation, determines the genetic sex of an embryo, but 
before 7 weeks, the genital systems are similar in both sexes; the indifferent 
or primitive stage of the reproductive organs (Edgar, Mazor et al. 2013). In 
the female embryo, development of the uterus and tubes occurs, because of 
the absence of a Y chromosome, and lack of testosterone from testicular 
tissue, not because of the presence of an ovary, (Jost, Vigier et al. 1973). 
This is also the case if no gonad is present. In the seventh week, the 
paramesonephric (Müllerian) ducts arise from the mesoderm, lateral to the 
mesonephric ducts, as focal invaginations of the coelomic epithelium, on the 
upper pole of each mesonephros (Healey 2012, Edgar, Mazor et al. 2013). 
The paramesonephric ducts, are the precursors of the uterus, Fallopian 
tubes, cervix, and upper vagina, growing caudally, coursing lateral to the 
urogenital ridges (Healey 2012). The cranial end of the fused ducts yields the 
single median uterovaginal primordium; the future uterus. The epithelium, 
and glands of the uterus (Healey 2012), the endometrial stroma, and 
myometrium, form from adjacent mesenchyme (Edgar, Mazor et al. 2013). 
The unfused cranial ends of the paramesonephric ducts assume a funnel 
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shaped configuration, and remain open to the future peritoneal cavity as the 
fimbrial portions of the Fallopian tubes (Healey 2012, Edgar, Mazor et al. 
2013). The caudal end of the fused ducts will form the upper two thirds of the 
vagina (Healey 2012). Lateral fusion of the paramesonephric ducts occurs 
between the seventh and ninth weeks, when the lower segments of the 
paramesonephric ducts fuse. At this stage, a midline septum is present in the 
uterine cavity, which usually regresses at around 20 weeks, but can persist 
even postnatal (Healey 2012). Simultaneously, the mesonephric (Wolffian) 
ducts regress, and any abnormality that occurs during this phase of 
development may result in a variety of paramesonephric anomalies in 
women. 
1.1.2 Overview of the uterus 
The adult human uterus is a hollow muscular organ, approximately 7.5 cm in 
length (Figure 1.1). It serves to act as a conduit for the migrating sperm, and 
houses the developing embryo and foetus. In terms of tissue remodelling, it 
is arguably the most plastic organ in a woman, expanding up to 1000 times 
in volume and 20 fold in weight during pregnancy, and returning to near pre-
pregnancy size after parturition (Ono and Maruyama 2015).  
14 
 
 
Figure 1.1 – Photograph of a human uterus following hysterectomy and 
bilateral salpingo-ophrectomy. (A) Labelled clinical sample (B) Labelled 
clinical sample following opening of the anterior aspect of the uterus in the 
sagittal plane. 
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Most human women have one uterus; however, sometimes there appears to 
be double uteri because of the incomplete development in utero. This is 
called a Mullerian Anomaly. There are many uterine anomaly variants, 
ranging from a uterine septum, to uterine didelphys (double uterus) (Sosa-
Stanley and Bhimji 2017) (Figure 1.2).  
 
Figure 1.2 – Illustrations of congenital Mullerian anomalies. 
 
The uterus consists of the fundus, the corpus, and the cervix, with three 
openings to the uterine cavity; the two Fallopian tubes and the external os 
(connecting the uterus with the vagina and the outside environment). The 
uterus is covered with peritoneum and the uterine wall contains a thick 
muscular outer layer (myometrium), a criss-cross of involuntary fibres mixed 
with fibro-elastic connective tissue, and an inner lining, the endometrium 
(Figure 1.3). 
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Figure 3 – Figure of the female reproductive organs.  
 
The uterus is typically located, in the female pelvis, posterior to the bladder 
and anterior to the rectum, supported by several ligaments, including the 
utero ovarian ligament, round ligament, broad ligament, cardinal ligament, 
and uterosacral ligaments (Figure 1.4). It is further supported (inferiorly) by 
the pelvic diaphragm, urogenital diaphragm, and perineal body.  
17 
 
 
Figure 1.4 – Schematic of the uterine ligament support network.  
 
The uterus may naturally lie in different positions such as ante-verted/retro-
verted, ante-flexed/retro-flexed, or midline, and it may be rotated (especially 
during pregnancy). In 50% of women, the uterus lies in an ante-flexed and 
ante-verted position (Sosa-Stanley and Bhimji 2017) (Figure 1.5).  
18 
 
 
Figure 1.5 - Illustrations of uterine positions in the pelvis.  
 
The uterus receives a blood supply from the uterine and ovarian arteries, 
which arise from the anterior branch of the internal iliac artery. As the blood 
supply enters the myometrium, it branches into the arcuate arteries, which 
branch into the radial arteries. As they enter the level of the endometrium, 
they branch into the basal and spiral arteries (Sosa-Stanley and Bhimji 
2017). 
Nerves from T11 and T12 innervate the uterus; the sympathetic supply is 
from the hypogastric plexus, and the parasympathetic supply is from S2 to 
S4. 
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1.2 The Endometrium 
Endometrium is the complex, innermost mucosal layer of the uterus. It 
consists of 2 main resident specific cell types; stromal and epithelial cells; it 
also contains blood vessels, leucocytes, nerves and lymphatic vessels.  
 
1.2.1 Endometrial Gland development 
While in utero (as in rodents and ungulates), uterine glands begin to develop 
in the female fetus as invaginations of luminal epithelium (LE), giving rise to 
primordial glandular epithelial buds (Gray, Bartol et al. 2001, Cooke, Spencer 
et al. 2013). By 20–22 weeks of gestation, the myometrium is well 
developed, but adeno-genesis (gland-formation) is superficial (Song 1964). 
Scattered glands that exist are straight, narrow, and consist of a 
pseudostratified appearance to the epithelium (Wang 1989). On the apical 
surface of the LE, microvilli, cilia, and cytoplasmic projections can be seen 
(Wang 1989). As the gestation progresses, by the 7th and 8th months, more 
glands are seen, but the pseudostratified configuration of the epithelium 
persists (Wang 1989). By the 9th gestational month, glands become slightly 
tortuous and dilated, where simple columnar epithelium predominates, and a 
pseudo-stratification arrangement is seen only rarely. The microvilli, cilia, and 
cytoplasmic projections become increasingly common in the LE (Wang 
1989). In addition to this, in the 9th gestational month, scanning electron 
microscopy (SEM) studies have found isolated triangular, or elongated cells, 
containing pale cytoplasm and numerous, highly electron dense, granules 
(approximately 0.3 to 0.8 µm in diameter) at the base of the epithelium, 
together with some less electron dense granules, grouped in the basal 
region, with the same morphology as endocrine cells (Wang 1989). The 
exact function and further characterisation of these cells has not, as yet, 
been determined. At late gestation, the fetal endometrial glands display a 
morphological resemblance to the proliferative phase endometrial glands of a 
sexually mature women (Wang 1989).  
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During the pre-pubertal period, from birth to puberty, the glands 
progressively invade the mesenchyme with extensive tubular coiling and 
branching morphogenesis (Gray, Bartol et al. 2001) resulting in an extensive 
network of epithelial glands throughout the stroma (Cooke, Spencer et al. 
2013) extending to the myometrium. The glands extend half way to the 
myometrium by the age of 6 years (Valdes-Dapena 1973, Gray, Bartol et al. 
2001). 
1.2.2 Overview of the endometrium 
Histologically, the adult human and primate endometrium is divided into two 
functionally different layers. The upper functionalis; which contains glands 
loosely held together by supportive stroma, and the lower basalis; consisting 
of branching glands and dense stroma (Ferenczy and Bergeron 1991, Gray, 
Bartol et al. 2001) (Figure 1.6A).  
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Figure 1.6 – The layers of the human endometrium. (A) All layers of the 
human endometrium stained with Hematoxylin and Eosin (H&E). (B) 
Representative micrograph of the LE (magnification x400). (C) 
Representative micrograph of the functionalis epithelium (magnification 
x400). (D) Representative micrograph of the basalis epithelium 
(magnification x400). 
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1.2.2.1 The luminal epithelium 
The LE is a single layer of cuboidal epithelial cells lining the functionalis 
epithelium. It is supported by stromal fibroblasts (Evans, Martinez-Conejero 
et al. 2014), and invaginates into the underlying cellular stroma to form tube-
like glands (Figure 1.6B). LE cells are less abundant than their glandular 
counterparts and, therefore, could be underrepresented in studies that used 
either whole endometrial tissue, or isolated epithelial cells (Evans, Martinez-
Conejero et al. 2014).  
Ultra-structurally, LE cells have distinctive euchromatic nuclei with prominent 
nucleoli, and relatively loose cell membranes in both cellular poles (apical 
and basal) (Demir, Kayisli et al. 2002). In the follicular phase of the cycle, LE 
possess many ciliated cells (Nilsson, Englund et al. 1980), located near 
gland orifices, at tubal corners, and close to the endo-cervical mucosa 
(Baraggino, Dalla Pria et al. 1980). The number of cilia varies from cell to cell 
and includes an average of 60 branches; each with a length of 8 µm, and 
width of 0.2 µm, with growth in relation to oestrogenic stimulus (Baraggino, 
Dalla Pria et al. 1980). Their role is to remove the secretion products of the 
bordering cells, and take an active part in the kinetics of the spermatozoa, 
and in the capitation of the oocyte. Ciliated to non-ciliated cells are present at 
a ratio of 1:30 during the 5th to 6th day of the cycle, but this gradually 
increases in the pre-ovulatory period (Baraggino, Dalla Pria et al. 1980). The 
non-ciliated cells carry numerous, fairly long microvilli; a number of these 
have an irregular surface with small apical protrusions (Nilsson, Englund et 
al. 1980), (hairy branches) (Baraggino, Dalla Pria et al. 1980). In some 
areas, they are arranged to form what looks like cobbled paving intersected 
by deep grooves, with the presence of a greater number of microvilli in the 
oestrogen driven proliferative phase of the cycle, compared with the 
secretory phase (Baraggino, Dalla Pria et al. 1980). The apocrine secretory 
activity of non-ciliated cells is proved by the presence of round apical 
prominences with a 2-4 µm diameter, wrinkled and umbilicated surface. 
These cells are irregularly distributed and increased in number during the 
20th to 24th day (“window of implantation”) of the menstrual cycle (Baraggino, 
Dalla Pria et al. 1980). The LE and glandular epithelia (GE) are distinct from 
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each other, despite both potentially originating from the basalis. The LE cells 
are cuboidal, unlike the columnar shaped GE (Aplin 2006). This fundamental 
difference in shape, thus creates other variables such as differences in the 
degree of secretions, changes to the internal structure (van Mourik, Macklon 
et al. 2009), variations in location, and also in their threshold of response to 
ovarian steroids (Bartlemez G 1951).  
The LE is the first maternal layer of cells that an embryo communicates with 
during the window of implantation (Gray, Bartol et al. 2001), thus, it is central 
to determining the receptivity of the endometrium (Evans, Martinez-Conejero 
et al. 2014). LE undergoes apical surface specialisation, expressing cell 
adhesion molecules that permit adherence of the blastocyst (Bruce Lessey 
2013), and controls excessive trophoblastic invasion (Tabibzadeh and 
Babaknia 1995). Therefore, molecular expression at the LE determines the 
early steps of embryo attachment and implantation, and if the mRNA and 
protein expression of these cells is not appropriate, implantation may not be 
successful (Evans, Martinez-Conejero et al. 2014). In 2014, laser capture 
micro dissection (LCM) of LE and GE from endometrial tissue (and 
subsequent microarray and immunohistochemistry (IHC) experiments) was 
used to show that, in the same sample, expression of many genes and 
proteins in the LE were different to that of GE. These findings indicate that 
different cellular processes may occur in LE and GE, despite them existing 
as a continuous monolayer (Evans, Martinez-Conejero et al. 2014). Fifty of 
242 down-regulated LE genes were upregulated in the GE, and 34 of 159 
genes were down-regulated in GE, but were up-regulated in LE. Of the 84 
significantly and contradictorily regulated genes, 18 were involved in catalytic 
activity (transferase and hydrolase), and 23 were involved in binding (protein 
and nucleic acid), pathways involved in metabolism. IHC was used to further 
confirm the findings of the gene expression study, demonstrating, in all 
samples examined, stronger staining of the LE than the GE for androgen 
receptor (AR), oestrogen receptor α (ERα), cyclin-dependent kinase Inhibitor 
2A, Mouse double minute 2 homolog, matrix metalloproteinase-7, matrix 
metalloproteinase-11, and oviductal glycoprotein 1. Interestingly, the 
aforementioned stronger LE staining of AR and ERα had a noticeable 
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reduction in staining where the LE monolayer invaginated to form a gland. 
This work reiterates how important it is to treat the LE as a distinct entity to 
the GE (Evans, Martinez-Conejero et al. 2014).  
A recent preliminary study further reported that CK5/6 protein expression, 
and lack of Podocalyxin-like protein 1 (PODXL) marked the LE cells. Further 
identification of cell surface markers, with expression limited to the LE or GE 
such as PODXL, may provide the opportunity to isolate these cells, and to 
further examine the freshly-isolated cells for their phenotypical, as well as 
functional properties, rather than using LCM which only allows phenotypical 
characterisation (Maclean A 2017). However, such isolation methods also 
have drawbacks, since the mechanical and enzymatic digestion that is 
required for releasing cells from the solid organ (endometrium) may affect 
the gene expression, and cells, when they are removed from their natural 
three dimensional (3D) environment, they may demonstrate different 
functional properties to their normal, physiological behaviour. 
1.2.2.2 The functionalis epithelium 
In numerous studies, the endometrial functionalis and basalis were examined 
without splitting into separate entities and they were loosely termed as the 
GE. When the GE ultrastructure is considered, there are mainly two types of 
cells; dark and clear cells (Demir, Kayisli et al. 2002). The functionalis 
epithelia proliferate massively in response to oestrogen and differentiate in 
response to progesterone; changing their features throughout the menstrual 
cycle, ready to assist with conception; accepting the invading trophoblast. 
When compared with the relatively less active basalis layer, most of the 
cyclical changes observed in the cellular phenotype (gene/protein 
expression; changes in cell fate of the endometrium) occur in this layer 
(Bruce Lessey 2013) (Figure 1.6C).  
During the early secretory phase, the glandular cells have a huge 
accumulation of glycogen particles, giant mitochondria, and the occurrence 
of a nucleolar channel system. As the secretory phase proceeds, apocrine 
secretions and giant lysosomes become the striking findings (Cornillie, 
Lauweryns et al. 1985). The glands have been described to be vertically 
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orientated, perpendicular to the LE, with relatively large diameters, 
substantial lumens and irregular outer borders (Garry, Hart et al. 2010). 
The decidual cells in the functionalis, and large granular lymphocytes, 
modulate the trophoblast function, and endometrial angiogenesis, through 
the following secretions: growth factors; growth factor binding proteins; 
angiogenic factors; cytokines (Bruce Lessey 2013, Filant and Spencer 2013). 
The GE and their secretions play a fundamental role during early pregnancy 
by secreting substances that support blastocyst development (Bruce Lessey 
2013); its absence being associated with reduced conceptus survival (Gray, 
Bartol et al. 2001). As maternal circulation to the human placenta is not 
established until 10-12 weeks gestation, GE helps to sustain the trophoblast 
during the first-trimester. Research using a sheep model of uterine gland 
knockout (UGKO) emphasised the importance of GE and secretions for 
conceptus survival and implantation (Gray, Taylor et al. 2001, Gray, 
Burghardt et al. 2002). Deficient glandular activity during the secretory phase 
of the cycle in humans has been correlated with unexplained infertility 
(Dimitriadis, Stoikos et al. 2006, Burton, Jauniaux et al. 2007). Filant et al 
demonstrated the important role of GE in supporting successful mouse 
implantation by utilising the progesterone-induced uterine gland knockout 
(PUGKO) mouse model (neonatal mice are exposed to progesterone from 
postnatal day 2 to 10 which permanently ablates the differentiation of uterine 
glands, the adult mice cycle normally, but are infertile) to test the hypothesis 
that uterine glands and their secretions are essential for blastocyst 
implantation, and stromal cell decidualisation, in the uterus. The PUGKO 
mice do not contain GE but do contain LE, stroma and myometrium, and no 
implantation occurs in the mice but blastocysts are made. Other researchers 
have shown that the lack of Leukaemia Inhibitory factor (LIF) leads to 
implantation, and decidualisation defects, and this is also secreted from the 
GE (Stewart, Kaspar et al. 1992). A further recent study found that 
conditional ablation of Forkhead Box A2 (FOXA2) in the postnatal mouse 
uterus using a PGR-Cre mouse model, resulted in a reduction, and near 
absence of endometrial glands in the adult. Thus indicating, FOXA2 is a 
critical regulator of endometrial adenogenesis in the mouse uterus, and also 
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demonstrating that GE are required for implantation, as these mice 
blastocysts did not implant (Jeong, Kwak et al. 2010). The results from the 
three sets of mouse work (aglandular PUGKO; FOXA2 mutant; LIF null mice) 
support the need for GE, and their secretions, for blastocyst implantation, 
and stromal cell decidualisation, both of which are required for successful 
pregnancy in mice and humans (Filant and Spencer 2013). Accordingly, an 
increased understanding of uterine gland biology is important for diagnosis, 
prevention, and treatment of fertility, and pregnancy problems, in mammals 
(Spencer 2014).  
Furthermore, thin endometrium is a well-recognised factor in subfertility and 
in vitro fertilisation (IVF) failure, and is obviously associated with inadequate 
glandular growth, but its diagnosis and treatment are controversial. The 
current literature does not justify the use of measuring the endometrial 
thickness to decide on IVF cycle cancellation, freezing of embryos, or 
refraining from further IVF (Kasius, Smit et al. 2014). Autologous cell therapy 
with C133+  bone marrow derived stem cells, combined with simultaneous 
hormone replacement therapy for refractory Asherman`s syndrome, and 
endometrial atrophy has been attempted (Santamaria, Cabanillas et al. 
2016). The authors report that in the first three months, the therapy 
increased the volume, and duration, of menses as well as the endometrial 
thickness, and angiogenesis processes of the endometrium, while 
decreasing intrauterine adhesion scores (patients diagnosed with 
Asherman`s syndrome were classified according to the American Fertility 
Society classification of uterine adhesions (Society 1988)) However, the 
apparent benefit was short lived, with patients` scores returning to baseline 
within 6 months post-completion of the therapy (Santamaria, Cabanillas et al. 
2016). Treatment for thin endometrium remains a challenge, and future large 
research studies are required to further elucidate and optimise management 
of these patients (Lebovitz and Orvieto 2014). 
1.2.2.3 The basalis epithelium 
Similar to the functionalis, the endometrial basalis is also dynamic. The 
functionalis and basalis are morphologically similar, both with high nucleus-
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to-cytoplasm ratios and elongated sausage-shaped nuclei, with dense 
chromatin and inconspicuous nucleoli; the nuclei appear pseudostratified, 
especially when proliferating (Hendrickson 2007). However, the basalis is 
also the structurally stable and permanent compartment of the uterus, not 
eroded during menstruation or at parturition (at the end of gestation), this 
tissue is, therefore, postulated to function as the germinal compartment of 
the human endometrium (Gray, Bartol et al. 2001, Valentijn, Palial et al. 
2013). The basalis rests on the myometrium, contains fewer glands and 
denser stroma, and is present throughout a woman’s life (Figure 1.6D). The 
glands respond weakly, at best, to hormones, and the stroma is inactive, 
therefore, the basalis should not be used to morphologically date 
endometrium (Hendrickson 2007). Since this layer is retained after menstrual 
shedding of the functionalis, the stem/progenitor cells are postulated to 
reside in the basalis (Prianishnikov 1978, Gargett, Chan et al. 2007). The 
endometrial ablative procedures that are used to treat excessive 
menstruation, therefore, are designed to destroy this deeper layer, and also 
to abolish the stem cells that reside there, with the expectation that complete 
cessation of menstruation due to lack of subsequent regeneration will 
happen. Nevertheless, this is not the case in a number of women, and even 
after extensive iatrogenic destructive procedures (Tresserra, Grases et al. 
1999) the endometrium regrows in some women (range 25-75% of women 
having endometrial ablation), who will continue to bleed (Gimpelson 2014, 
Muller I 2015). 
The basalis glands are less responsive to hormones than the functionalis 
glands; hence, they do not undergo rapid change throughout the menstrual 
cycle (Slayden and Keator 2007, Bruce Lessey 2013). Surface markers have 
been used to differentiate the basalis epithelium from the functionalis, 
namely nuclear β-catenin, nuclear SRY-Box 9 (SOX9), surface Stage 
specific embryonic antigen -1 (SSEA-1) (Valentijn, Palial et al. 2013) and 
recently, surface marker N-cadherin (Nguyen, Xiao et al. 2017). Both nuclear 
β-catenin and nuclear SOX9 suggest activation of the Wnt signalling pathway 
in these cells, and this is an important pathway for adenogenesis in the 
endometrium and in the intestine (Valentijn, Palial et al. 2013).  
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1.2.2.4 The blood supply of the endometrium  
The endometrial vasculature is supplied by the arcuate arteries of the 
adjacent myometrium, giving rise to radial arteries, which traverse through 
the myometrium to reach the basalis as basal arteries, and spiral arteries 
which supply the functionalis, and are drained by their corresponding veins 
(Ramsey 1989). Uterine blood vessels are comprised of outer layers of 
vascular smooth muscle cells, and extracellular matrix, with an inner 
endothelial cell layer (Biswas Shivhare, Bulmer et al. 2018). Although basal 
arteries are not hormonally responsive, the spiral arteries are exceedingly 
hormonally responsive. Markee showed that in a rhesus monkey model of 
intraocular endometrial menstruation, following hormone withdrawal, the 
coiled arteries constricted, terminating the haemorrhage from them (Markee 
1946).  
Angiogenesis is one of the main features of the endometrium. Normal 
physiological angiogenesis occurs in most organs during fetal growth and 
development, but it is a rare occurrence in adult organs, except during 
episodes of wound healing (regeneration) and in the female reproductive 
tract. Throughout the reproductive life of females, angiogenesis occurs 
regularly in the corpus luteum and the endometrium, as part of the rapid 
growth and regression that occurs in these tissues during the menstrual 
cycle (Gargett and Rogers 2001, Demir, Yaba et al. 2010). 
 During the menstrual cycle, angiogenesis is spatially and temporally 
regulated under the control of oestrogen and progesterone (Rogers, 
Donoghue et al. 2009, Demir, Yaba et al. 2010) with; (A) vascular repair in 
the superficial layers of the remaining basalis in the menstrual phase 
(Maybin and Critchley 2015); (B) angiogenesis throughout the functionalis of 
the proliferative phase, supporting rapid endometrial growth; and (C) growth 
and coiling of the spiral arterioles in the secretory phase (Rogers, Donoghue 
et al. 2009, Biswas Shivhare, Bulmer et al. 2018) in the functionalis (Demir, 
Yaba et al. 2010). The capillary plexus, supplied by arterioles, develops just 
below the LE surface. Vascular endothelial growth factor, messenger RNA 
(mRNA), and protein are present during all phases in the endometrium, but 
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its expression increases during the late secretory phase, and menstruation 
(Chen, Liu et al. 2015).  
Spiral artery remodelling has 2 phases: a decidua-associated, or extravillous 
trophoblast (EVT) independent phase; and an EVT-dependent phase (Lash, 
Pitman et al. 2016). The importance of angiogenesis for endometrial function 
and epithelial growth is demonstrated by many studies (Alfer, Happel et al. 
2017). Remodelling of the spiral arteries is a key maternal adaptation 
required for successful human pregnancy, failure being associated with pre-
eclampsia, fetal growth restriction, and miscarriage (Robson, Harris et al. 
2012, Lash, Pitman et al. 2016). `Sub-fertile` patients with abnormally thin 
endometrium showed adequate serum concentrations of hormones, but a 
severe deficiency of angiogenesis-related marker molecules, leading to a 
defectively thin endometrium, potentially providing an explanation for the 
endometrial factor causing infertility (Alfer, Happel et al. 2017). A major side 
effect of progesterone only contraceptives is also abnormal uterine bleeding; 
this is again caused by problems with the endometrial vasculature. Women 
display abnormally enlarged, fragile blood vessels with decreased 
endometrial blood flow and oxidative stress, this abnormal bleeding leads to 
discontinuation of use of said contraception by many women (Smith and 
Critchley 2005, Hickey, Krikun et al. 2006, Lockwood 2011, Guzeloglu 
Kayisli, Kayisli et al. 2015). Heavy menstrual bleeding is also related to 
aberrant endometrial angiogenesis, with stromal cell-derived factor 1 and 
endothelial cells being disturbed (Kooy, Taylor et al. 1996, Elkilani and 
Soliman 2017), affecting a woman’s quality of life and requiring medications 
and surgery. Potential anti angiogenic medications are being assessed (Rae, 
Mohamad et al. 2009).  
1.2.2.5 The nerves of the endometrium  
The available studies on the endometrial nerve supply are contradictory, 
regarding the depth in the endometrium they reach, their density, and if the 
amount/density changes according to the menstrual cycle, or with disease. 
Studies have reported that nerves vary greatly from patient to patient in both 
their number, and the level to which they penetrate the endometrium, and 
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these variations do not seem to correlate with the phase of the cycle or 
pathology (Dallenbach and Vonderlin 1973). The variation, potentially, seems 
to correlate with the degree of menstrual shedding of a patient (Dallenbach 
and Vonderlin 1973). Straight coursing bundles of nerves of variable sizes 
have been found to reach the endometrium from the myometrium, often 
without following blood vessels. In the basalis, the nerve bundles branch into 
smaller bundles, or into single fibres, with a high density of fine nerve trunks 
and axons (Miller and Fraser 2015), these are normally distributed (Ellett, 
Readman et al. 2015) and often assume a wavy tortuous course. At the 
functionalis they pass near glands and, it could be assumed that, the level at 
which nerve fibres are found in the endometrium, approximates to the level 
at which shedding occurs to at menstruation (Dallenbach and Vonderlin 
1973). Uterine nerve fibres degenerate with the progression of pregnancy 
and regenerate after parturition (Zoubina, Fan et al. 1998). These nerves are 
suggested to be involved in endometriosis associated pain, as well as 
aberrant nerve fibre expression being a diagnostic feature of the disease 
(Tokushige, Markham et al. 2006, Tokushige, Markham et al. 2007). These 
claims, however, were not substantiated by further studies (Ellett, Readman 
et al. 2015).  
1.2.2.6 The lymphatics of the endometrium 
The lymphatic vasculature functions to maintain fluid haemostasis within 
tissues, and to direct and regulate immunological responses in the body 
(Swartz, Hubbell et al. 2008). Lymphatic vessels have been identified in all 
layers of the endometrium, but with a significant reduction of vessels in the 
functionalis, where they are small and sparsely distributed compared with the 
basalis (Donoghue, Lederman et al. 2007), which are larger and closely 
associated with spiral arterioles (Donoghue, Lederman et al. 2007, Rogers, 
Donoghue et al. 2009). The observation that lymph fluid, returning from the 
superficial endometrium, comes into intimate contact with the smooth muscle 
cells in the wall of the spiral arteries, opens up the possibility of a novel 
mechanism of regulation for these specialised vessels. Any factors secreted 
by either the endometrium or the implanting embryo, will have direct access 
to the spiral artery wall via the lymphatic’s (Rogers, Donoghue et al. 2009, 
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Volchek, Girling et al. 2010). Patients with recurrent pregnancy loss, show 
compromised extra villous trophoblast invasion of the venous and lymphatic 
vasculature, highlighting the importance of this access to the lymphatics 
(Windsperger, Dekan et al. 2017). 
1.2.3 The endometrial cycle 
In non-pregnant, pre-menopausal women, oestrogen is primarily released 
from the granulosa cells of the ovary, under the regulation of the 
hypothalamic-pituitary-ovarian axis (Figure 1.7). Oestrogen is a primary sex 
hormone that regulates endometrial regeneration (Kamal, Tempest et al. 
2016). Relatively smaller amounts of oestrogen are also produced by extra-
ovarian tissue, such as adipose tissue, liver, and adrenal glands (Kamal 
2016). There are three forms of endogenous oestrogen: oestradiol (E2, the 
most potent oestrogen) predominates in reproductive life, estrone (E1, the 
weaker oestrogen) predominates after menopause, and the third is oestriol 
(E3, the least potent) produced by the placenta (Kamal 2016, Kamal, 
Tempest et al. 2016). Progesterone is the second major hormone involved in 
the endometrial cycle and is essential for cellular differentiation, it is a steroid 
hormone secreted by the ovarian corpus luteum that develops after ovulation 
in women. Progesterone promotes decidualisation, counteracts oestrogen-
induced proliferation, and, if conception occurs, maintains the pregnancy 
(Kamal, Tempest et al. 2016). Adrenals also produce progesterone, which is 
largely converted into glucocorticoids and androgens, without being released 
in to the circulation. The half-life of progesterone is as short as five minutes, 
being either promptly deactivated in the liver or converted in the kidney to a 
potent mineralocorticoid (Taraborrelli 2015, Kamal, Tempest et al. 2016).  
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Figure 1.7 – The ovarian and endometrial cycle. 
 
1.2.3.1 The menstrual phase of the endometrial cycle 
In the absence of implantation, the degeneration of the corpus luteum lowers 
the amount of circulating oestradiol and progesterone, and this, in turn, 
triggers the cascade of events resulting in the shedding of the endometrial 
functionalis. As menstruation proceeds, and regeneration commences, the 
surface of the endometrium is rapidly re-epithelialised by epithelial cells. This 
is completed within 48 hours post shedding, and a new cycle then 
commences (Sturgis SH 1936, Chan, Schwab et al. 2004). The most 
accepted theory to date suggests that the regenerating surface epithelium 
originates from the residual epithelium of the basal gland stumps 
(Dallenbach-Hellweg 2012). However, others have proposed different 
theories including; the transformation of endometrial stromal cells into 
regenerating surface epithelial cells (Baggish, Pauerstein et al. 1967); 
regeneration of new epithelial cells by the transformation of peritoneal cells 
after their migration through the oviducts (Singer, Reid et al. 1968).  
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Experiments in non-menstruating species, such as rats and rabbits, have 
shown that the earliest signs of repair (as evidenced by the presence of 
flattened epithelial cells covering part of the denuded surfaces) occur 3 hours 
after surgical curettage (Schenker, Sacks et al. 1971). Therefore, a similar, 
rapid repair process is expected to happen in the human endometrium.  
SEM studies have revealed a shared origin for reepithelialisation. Outgrowth 
from exposed basal glands ran alongside ingrowth from the peripheral 
surface membrane; importantly, these studies have shown the stromal 
regeneration to only commence once the denuded endometrium has been 
completely re-epithelialised (Ferenczy 1976). 
Examination of the isthmic and corneal uterine mucosal segments revealed 
foci of stromal haemorrhage and inflammatory exudate, but the endometrial 
architecture, including the surface epithelium, remained intact following 
menstruation (Ferenczy 1976), this may suggest the possibility of the intact 
surface epithelium from these regions contributing to the re-epithelialisation 
of the denuded endometrial surface during the regenerative process. On the 
third menstrual day, there was an irregular ragged surface present because 
of the menstrual shedding; most of the basal zone was denuded, with a few 
foci of the residual spongy layer. The basalis showed no disintegration of 
stroma and glands, merely shrinkage (Dallenbach-Hellweg Gisela 2010). 
SEM studies showed that many basal gland crypts were orientated parallel to 
the long axis of the uterine cavity, with their body and neck arranged 
obliquely or perpendicular to the surface into which opened haphazardly 
spaced gland mouths (Ferenczy 1976). 
Surface epithelium of the isthmic and cornual origin establish anastomosis 
with peripheral portions of the LE, originating in the gland stumps of the zona 
basalis (Ferenczy 1976). Both the basal glands and the peripheral uterine 
regions remain intact during the entire menstrual period (Ferenczy 1976). 
The endometrial surface regeneration is likely a local reaction to injury, 
induced by loss of endometrial mucosa, rather than being mediated by 
ovarian hormones, as morphologic changes known to be associated with 
oestrogenic stimulation, only occur following complete surface re-
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epithelialisation, coinciding with the increase in plasma and tissue receptor 
levels of oestradiol-17 beta (Ferenczy 1976, Ferenczy 1976). The lack of 
ERα receptor, which mediates the classical mitotic effects of oestrogen in 
endometrial primitive cell populations, may also agree with this observation 
(Hapangama, Kamal et al. 2015). The aberrations in endometrial 
regeneration are obviously likely to cause clinical manifestations, such as 
heavy menstrual bleeding, and researchers are actively seeking to enhance 
current knowledge on the endometrial regenerative process, exploring novel 
avenues to treat millions of women worldwide suffering with this common 
gynaecological condition. 
1.2.3.2 The proliferative phase of the endometrial cycle 
The proliferative phase can be of variable length (10-20 days) but the 
suggested ideal duration is 14 days (Deligdisch 2000). Growth of the new 
endometrial functionalis (intensive mitosis in the GE and in the stroma) 
begins in this phase in response to the rising levels of circulating oestrogen 
(Deligdisch 2000). The endometrium at this phase is reported to be thin, with 
sparse, narrow, and straight glands evenly distributed in a loose stroma of 
spindle-shaped cells. The GE cells are low, columnar, and contain small 
rounded or oval shaped chromatin dense nuclei in a scanty cytoplasm. The 
stromal cells are poorly differentiated and of equal size with small, dense 
nuclei in a scanty cytoplasm. Nucleoli are inconspicuous and mitoses are 
rare. The cells are surrounded by a firm reticulin network and the surface 
epithelium is flat and still regenerating (Dallenbach-Hellweg Gisela 2010). 
Endometrial thickness proceeds to increase more than 10 fold (Deligdisch 
2000, Dallenbach-Hellweg Gisela 2010), glands assume a simple tube-like 
shape, with narrow lumens, lined with columnar epithelial cells (Gray, Bartol 
et al. 2001). By the late proliferative phase, they become longer and more 
tortuous (Gray, Bartol et al. 2001); the spiral arteries wind themselves lightly 
into the stroma with the functionalis stroma becoming more oedematous 
(Ferenczy and Bergeron 1991). The oestrogen-induced changes are 
mediated via ER. The presence of nuclear ERs in endometrial cells are 
responsible for the translation of hormonal signals into structural changes 
(Deligdisch 2000).  
35 
 
GE cells, in particular in the proliferative phase, were reported to be tall and 
columnar, and contain slightly enlarged oval-shaped, chromatin-rich nuclei in 
a dense, sparse cytoplasm, rich in RNA (Dallenbach-Hellweg Gisela 2010). 
They were covered with long microvilli demonstrating a well-developed 
glycolcalyx layer (Gray, Bartol et al. 2001). Changes observed at an ultra-
structural level include a marked increase in the number of rough 
endoplasmic reticulum and Golgi apparatus (Cornillie, Lauweryns et al. 
1985), protein synthesis by free ribosomes, and rough endoplasmic 
reticulum, as well as accumulation of intermediate filaments, mitochondria 
(spherical, elongated and irregular (Cornillie, Lauweryns et al. 1985)), and 
lysosomes. The nuclei increased in size; nucleoli became prominent; and 
chromatin became coarse. Individual cell mass and nuclear: cytoplasmic 
ratio also increased, with numerous mitoses seen throughout the glands and 
stroma (Deligdisch 2000, Gray, Bartol et al. 2001, Dallenbach-Hellweg 
Gisela 2010) and lipid droplets observed (Cornillie, Lauweryns et al. 1985, 
Gray, Bartol et al. 2001). The spindle-shaped stromal cells were still poorly 
differentiated, but they were rich in DNA and RNA with occasional mitoses, 
and were separated by interstitial oedema (Dallenbach-Hellweg Gisela 
2010).  
When ovulation is imminent (in the mid-cycle), there are large round 
mitochondria associated with semi-rough endoplasmic reticulum. In non-
dividing glandular cells, the nucleus usually exhibited a euchromatin texture 
suggesting a high level of transcription activity. Massive cellular 
accumulation of glycogen in the GE was a hallmark of the late proliferative, 
and early secretory phases (Cornillie, Lauweryns et al. 1985). 
At the end of the proliferative phase the oestradiol peak (released by the 
growing follicles) triggers a positive feedback mechanism at the level of the 
pituitary, and ovulation commences 35 to 55 hours after the initial luteinising 
hormone (LH) increase (Choi and Smitz 2014).  
1.2.3.3 The secretory phase of the endometrial cycle 
Rising progesterone (from the corpus luteum) during the secretory phase, 
blocks epithelial mitoses, inhibiting proliferative activity (Deligdisch 2000), 
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and cells commence differentiation. Stromal proliferation reduces, and the 
stroma features vacuoles and granulocytes, predecidualisation begins 
around blood vessels and extends to the stroma beneath the surface 
epithelium. Numerous basal glycogen vacuoles appear in the GE (in, at 
least, 50% of the glandular cells), pushing the nucleus towards the lumen 
(Dallenbach-Hellweg Gisela 2010). The glands dilate and are lined by low 
columnar epithelium. By the late secretory phase, they are irregular in shape 
with large lumens, and are lined by tall columnar epithelial cells (Garry, Hart 
et al. 2010), allowing endometrial cells to undergo secretory differentiation 
with the subsequent exposure to progesterone that is released by the post-
ovulatory corpus luteum. The secretory changes only take place in an 
oestrogen-primed endometrium (Deligdisch 2000). 
At an ultrastructure level, in the early secretory phase, glandular cell nuclei 
demonstrated a euchromatin pattern with only chromatin condensation along 
the nuclear membrane. Nucleoli were well developed alongside a fully 
differentiated nuclear channel system (Gray, Bartol et al. 2001). Glycogen 
particles were found in the glandular lumen amidst other amorphous 
secretory material. Mitochondria were numerous and well developed (Gray, 
Bartol et al. 2001). The rough endoplasmic reticulum, Golgi apparatus, and 
glycogen stores of the endometrial stromal cells became well developed. 
These changes contributed to the predecidual transformation of the stromal 
cells, which progressively became separated by accumulation of 
oedematous fluid, while the number of mononuclear phagocytes, 
lymphocytes, and endometrial granulocytes gradually increased towards the 
end of the cycle (Cornillie, Lauweryns et al. 1985).  
In the mid secretory phase, the nucleus retained the basal position with 
larger amounts of heterochromatin. A well-developed labyrinth of rough 
endoplasmic reticulum cisternae remained throughout the cytoplasm, but 
focal dilatation was less pronounced. Glycogen particles were present in 
basal paranuclear, and apical cytoplasm. Glycogen was found in the 
glandular lumen, together with other glycoprotein secretory material (Gray, 
Bartol et al. 2001).  
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Lipid droplets became apparent in the subnuclear cytoplasm in association 
with decreasing stores of glycogen (Gray, Bartol et al. 2001). In the late 
secretory period the nucleoli were less conspicuous and glycogen remained 
to be present in small sub and paranuclear patches, larger amounts were 
found in the supranuclear cytoplasm and in apical blebs protruding into 
glandular lumen, with intraluminal glycogen as an additional feature. The 
mitochondria were numerous and small, and the Golgi system was also very 
prominent (Gray, Bartol et al. 2001). 
If pregnancy does not occur, endometrial glands regress late in the secretory 
phase, commensurate with luteolysis, and break down during menstruation 
(Gray, Bartol et al. 2001). The main function of the endometrium, embryo 
implantation, occurs in the secretory phase, which makes it the most 
important cycle phase. Researchers therefore focus on the changes 
associated with the many endometrial pathologies, in this phase.  
1.2.3.4 Implantation  
The proposed time period of the maximal receptivity for the blastocyst in a 28 
day cycle is between the 20th and 23rd day. This 4 day time frame is termed 
the window of implantation. By day 20, flattened ‘droplet like’ projections 
appear on the luminal surface called pinopodes/uterodomes, and they are 
believed to be ‘landing platforms’ for the potential blastocyst; they disappear 
within 4 days of formation.  
Muc-1, a mucin thought to cause steric hindrance between the blastocyst 
and luminal apical surfaces, is locally down-regulated at implantation sites 
(Surveyor, Gendler et al. 1995, Meseguer, Aplin et al. 2001). With the 
expression of αvβ3 vitronectin receptor integrin on both LE and GE 
coinciding with the time of embryo attachment, aberrant expression of this 
integrin has been found to be associated with infertility (Lessey, Ilesanmi et 
al. 1996). 
Endometrial progesterone receptor (PR) is critical for embryo implantation 
(Mulac-Jericevic and Conneely 2004), yet the loss of PR expression in the 
uterine epithelium is considered as a prerequisite for implantation (Bazer and 
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Slayden 2008). The expression of PR in the LE is sustained when local 
oedema is present at the implantation site and disappears from the LE, not 
before implantation, but in the middle of the implantation process (Diao, 
Paria et al. 2011). 
If implantation occurs, endometrial stromal cells complete their 
decidualisation and will be terminally differentiated; this is thought to apply to 
the epithelium as well. Most fertility researchers focus their studies to this 
phase of the cycle, for obvious reasons.  
1.3  The Fallopian tubes 
The Fallopian tubes develop from the cranial parts of the paramesonephric 
ducts, with their cranial ends remaining open connecting the duct with the 
coelomic (peritoneal) cavity, and the caudal end communicating with the 
uterine cornua (El-Mowafi DM 2017). 
The human Fallopian tubes are paired tubular, sero-muscular organs, 
approximately 10-15 cm long and 6-8 mm in diameter with one end open into 
the peritoneal cavity (near the ovary) (Edgar, Mazor et al. 2013) and the 
other into the superior lateral part of the uterine cavity (El-Mowafi DM 2017). 
The tubes are situated in the upper margins of the broad ligaments, between 
the round and utero ovarian ligaments. The tube conducts the ova, 
discharged from the primordial follicle at ovulation, in to the uterine cavity, 
and can be broken into 4 different regions for descriptive purposes (Figure 
1.8): the infundibulum is funnel shaped and formed of a number of fimbria; 
the ampulla is the largest section and thin walled like the infundibulum; the 
isthmus is short and smaller in diameter but thicker walled than the ampulla; 
the interstitial portion is the segment embedded in the uterine wall with a 
small diameter of 1 mm (El-Mowafi DM 2017).  
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Figure 1.8 - Illustration of the human Fallopian tube.  
The Fallopian tube wall consists of a series of layers, namely: the internal 
mucosa (endosalpinx); the muscularis (myosalpinx); and the serosa. The 
internal mucosa is thrown into longitudinal folds (primary folds) increasing in 
numbers towards the fimbria and lined by columnar epithelium of three types: 
ciliated cells; secretory cells; and peg cells. Ciliated cells are characterised 
by pale stained nuclei and long, slender cilia protruding into the tubal lumen 
(Novak E 1928) with progressively increasing numbers from the proximal to 
distal end of the Fallopian tube (Crow, Amso et al. 1994). These cells can be 
identified by β-tubulin and TUBB4 expression (Paik, Janzen et al. 2012). 
Secretory cells overhang ciliated cells, and are narrower, containing 
secretory granules in their apical regions (Woodruff JD 1969). They are 
found at higher numbers in the ampulla (Paik, Janzen et al. 2012), and are 
marked by PAX8 expression (Paik, Janzen et al. 2012). Peg cells are rarer 
and interspersed between ciliated and secretory cells (Paik, Janzen et al. 
2012), they are usually identified by the expression of EPCAM, CD44 and 
integrin 6 (Paik, Janzen et al. 2012). The three cell types of the Fallopian 
tube have distinct markers, making it possible to identify and examine cell 
specific function. The peg cells, are fivefold enriched for cells capable of 
clonal growth and self-renewal, thus are thought to be the stem cells (Paik, 
Janzen et al. 2012). Unlike the Fallopian tube, similar information is lacking 
for the different epithelial cell types of the endometrium epithelium.  
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In the ampullary and infundibular sections, secondary folds of the tubal 
mucosa exist, increasing the surface area. The internal mucosa secretes 
mucous, in order to maintain the ovums journey through the Fallopian tube, 
and it also undergoes cyclical epithelial changes. The height and proportion 
of ciliated to non-ciliated secretory cells vary; the epithelium is reported to be 
taller in the first half of the follicular phase, and the relative number of non-
ciliated cells increased in the secretory phase. However, in comparison to 
the endometrium, there is no organised and cyclical shedding in this mucosal 
layer. The muscularis was thickest at the isthmus, and thinned toward the 
fimbrial end. It had a well-developed inner circular layer, and thin outer 
longitudinal layer (complete only at the isthmus). The longitudinal muscle 
bundles that are present were discontinuous in the ampulla and may be 
absent in the fimbria (Ernst LM 2011). The outer serosal layer has the 
structure of peritoneum, and is continuous with the peritoneum of the broad 
ligament and uterus, the upper margin of which is the mesosalpinx (El-
Mowafi DM 2017). Although the available literature on the exact hormone 
responsiveness of the Fallopian tube mucosa is sparse, tubal epithelium 
shares the same embryological origin; continues from the endometrium; and 
expresses ovarian hormone receptors. Yet, a cycle of similar growth, 
shedding, and regeneration does not happen in the tube; and why this is so, 
remains to be a mystery. 
1.3.1.1 Blood, nerve and lymphatic supply of the Fallopian tubes 
Blood supply to the Fallopian tube is derived from the tubal branch of the 
uterine artery, and small branches from the ovarian artery. Generally, 
branches of the uterine artery supply the isthmus and proximal ampulla, 
while branches of the ovarian artery supply the remainder of the tube. The 
arteries run in the stroma along the bases of the folds, giving rise to a dense 
capillary stromal network, with the veins coursing a similar way (Eddy and 
Pauerstein 1980). 
The autonomic innervation of the tube is sympathetic and parasympathetic. 
The distribution pattern of extrinsic tubal adrenergic nerves is composed of 
long post ganglionic fibres spreading out distally from the hypogastric, celiac 
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and pelvic ganglia of short neurons, originating in the proximal ganglia 
located in the cervicovaginal region. The afferent innervations carrying pain 
sensation are derived from T11 and T12, and upper lumbar nerves. The 
parasympathetic supply is dual; the distal portion of the tube is supplied by 
vagal fibres and from the ovarian plexus, and the sacral parasympathetic 
fibres are derived from S2,3,4 and are conveyed to the terminal ganglia of 
the pelvic plexuses. Short postganglionic fibres from this plexus supply the 
interstitial portion of the isthmus (Eddy and Pauerstein 1980).  
The lymphatic’s follow the blood vessels and drain into the lumbar (or aortic) 
nodes (Eddy and Pauerstein 1980, Edgar, Mazor et al. 2013). Three 
separate lymphatic networks drain the mucosa, muscularis, and serosa 
(Eddy and Pauerstein 1980). 
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1.4  Stem cells 
1.4.1 History 
Stem cells are undifferentiated cells, without any tissue-specific function, that 
have the potential to differentiate into certain tissues determined by their 
genetic and epigenetic program (Nemeth and Karpati 2014). The term “stem 
cell” first appeared in scientific literature as early as 1868, coming from the 
German “Stammzelle” or “family cell”. Ernst Haeckel, a phylogenist, used the 
term to describe a single cell, from which all multicellular organisms were 
believed to originate. Although controversial at the time, the concept was 
later echoed by Russian histopathologist Alexander Maksimow, and applied 
to the haematopoietic system in 1905. It took another 50 years for the theory 
to be replaced by fact, as a consequence of the pioneering work by Till and 
McCulloch. 
The first scientific research evidence on the existence of ASCs was 
produced more than 60 years ago. In the 1950s, researchers discovered that 
bone marrow contains at least two kinds of stem cells; haematopoietic stem 
cells, which form all the varieties of blood cells in the body, and bone marrow 
stromal stem cells (also called mesenchymal stem cells (MSC)), which were 
discovered a few years later. These non-hematopoietic stem cells make up a 
small proportion of the stromal cell population in the bone marrow, and can 
generate bone, cartilage, and fat cells that support the formation of blood and 
fibrous connective tissue. 
The function of a stem cell in the literature seems to be dependent on the 
tissue, the context, and the groups of scientists who study the cells, thus, 
there is no general consensus amongst scientists as to the exact universally 
acceptable definition for them. Some researchers have proposed that a cell 
should have the following three qualities to qualify as a stem cell: 
clonogenicity (the ability of single cells to form colonies); prolonged self - 
renewal and proliferative potential (the ability to undergo a high number of 
passages before cell death); differentiation potential (the ability of a stem cell 
to produce differentiated progeny) (Eckfeldt, Mendenhall et al. 2005). For 
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simplicity, the different types of stem cells with reference to their 
differentiation potential are described below. 
1.4.2 Types of stem cells according to their 
differentiation potential 
The known hierarchical differentiation potential in stem cells is seen in Figure 
1.9. The most potent of all mammalian stem cells is the zygote, which has 
the ability to differentiate into embryonic and extra-embryonic tissue and, 
therefore, is termed ‘totipotent’. Totipotent cells of the early embryo can build 
a complete organism, as well as extra-embryonal tissues such as the 
placenta (Nemeth and Karpati 2014). 
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Figure 1.9 - The graphical representation of the known hierarchical 
differentiation potential in stem cells, with a table depicting the progeny of all 
three germ layers.  
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Totipotent cells differentiate to produce pluripotent stem cells, which have the 
ability to form tissue from all three germ layers: the endoderm, mesoderm 
and ectoderm. Human Pluripotent stem cells are found within the inner cell 
mass (ICM) of the blastocyst. They are commonly referred to as embryonic 
stem cells (ESCs), and are capable of creating all tissues in the body 
(Nemeth and Karpati 2014). Human ESCs were first grown in the laboratory 
in 1998. ESCs provide enormous possibilities for disease research, and for 
providing new therapies. Unfortunately, transplantation of ESCs in vivo has 
led to teratoma formation, and acquisition of ESCs is associated with obvious 
ethical problems.  
Pluripotent stem cells produce multipotent stem cells that give rise only to 
cell types within a particular germ layer; an example of this would be MSCs. 
Induced pluripotent stem cells (iPSCs) are obtained by reprogramming 
animal and human differentiated cells (Medvedev, Shevchenko et al. 2010). 
They are self-renewable and can differentiate to different types of adult cells 
(Singh, Kumar et al. 2015). The iPSCs are reprogrammed from somatic cells 
through ectopic expression of various transcription factors (Oct4, Sox2, Klf4 
and c-Myc) (Singh, Kumar et al. 2015), and have provided the regenerative 
medicine field with a new tool for cell replacement strategies. The 
advantages over other sources of stem cells include, the generation of 
patient-derived cells, and the lack of embryonic tissue, whilst maintaining a 
versatile differentiation potential. Concerns regarding the delivery and 
expression of the reprogramming factors, the genomic instability, epigenetic 
memory and impact of cell propagation in culture, are ongoing (de Lazaro, 
Yilmazer et al. 2014).  
Multipotent and unipotent stem cells exist in the embryo as well as in 
postnatal adult tissues. Multipotent stem cells can be found in the 
hematopoietic and in the stromal compartment of the bone marrow with the 
former producing blood lineages, and the latter being responsible for creating 
connective tissue cell types, such as adipocytes and osteoblasts (Nemeth 
and Karpati 2014). Unipotent stem cells can differentiate along only one 
lineage and are found in epithelial tissues, replenishing the epithelial cell 
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compartment of the skin, gut, or mucosal layer of the airways (Nemeth and 
Karpati 2014). 
ASCs, synonymous with somatic stem cells (SSCs), are quiescent 
undifferentiated cells, existing in small numbers in most organs after the 
completion of embryonic development. They retain the potential to 
regenerate the entire tissue in which they reside. They differ from ESCs in 
that they are not pluripotent, they lack the ability to produce all cell types 
present in the embryo, and express different markers. This is obviously 
advantageous, since retention of multipotential undifferentiated cells in adult 
somatic organs that require regular regeneration, will increase the risk of 
teratoma formation. Although ASCs still possess high proliferative potential, 
and can persist for the individual’s lifetime in many human tissues, they 
remain committed to a more specific lineage. ASCs are either unipotent, 
bipotent, or multipotent, and are able to reconstitute any part of a tissue by 
producing one or more of the component fully differentiated cells (Chan, 
Schwab et al. 2004). 
ASCs undergo asymmetric cell divisions, which enable them to maintain their 
own population of undifferentiated cells (self-renewal), whilst also producing 
more differentiated, progenitor, daughter cells that are capable of rapid 
proliferation. They are fundamental units for tissue homeostasis, playing a 
critical part in the replenishment of dying cells, and regeneration of damaged 
tissue (Li and Xie 2005). The progenitors and their daughter cells proliferate, 
producing progressively more differentiated and mature progeny, 
characterised by the expression of more surface markers. These more 
mature cells, also known as transit-amplifying (TA) cells, are characterised 
by their limited proliferative potential and inability to self-renew, but are 
readily observed in tissue sections by expression of proliferation markers 
(Chan, Schwab et al. 2004). ASCs are a more attractive alternative to ESCs 
with regards to research and stem cell therapies as, comparatively, their 
acquisition is less controversial (without severe ethical concerns) and in vivo 
transplantation of them does not pose the risk of teratoma formation.  
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1.4.3 The stem cell niche 
It is widely believed that adult tissue-specific stem cells reside within a 
“specialised microenvironment” known as the `niche`, and stem cell 
phenotype/ behaviour is regulated and maintained there (Spradling, 
Drummond-Barbosa et al. 2001). The niche senses the need for tissue 
replacement and compromises the ASC, surrounding niche cell(s), and 
extracellular matrix. It is a protective environment for the stem cell to 
maintain its genetic fidelity (Gargett and Masuda 2010). Furthermore, its 
function includes the balance of stem cell replacement (self-renewal), and 
provision of differentiated cells that are required for organ function (Gargett 
and Masuda 2010). The stem cells receive a unique combination of 
extracellular signals directing them to maintain their “stemness”, and 
preserving their stem cell characteristics (Fuchs and Horsley 2011, Nemeth 
and Karpati 2014). The non-stem cell residents of the niche must also be 
responsive to the needs of the organism/tissue so that they can integrate 
external cues and mobilise the stem cells to exit the niche during 
homeostatic replacement (tissue maintenance), or on injury (Fuchs and 
Horsley 2011). 
A characteristic niche of epidermal stem cells is the bulge region of the hair 
follicle, they can also be found in the interfollicular epidermis. Hematopoietic 
stem cells are located either, in close proximity to osteoblasts, in the 
endosteal niche, or around sinusoidal vessels in the vascular niche within the 
bone marrow (Morrison and Scadden 2014). MSCs reside within the 
basement membrane of capillaries, and postcapillary venules, and form a 
subpopulation of contractile perivascular cells called pericytes (Sacchetti, 
Funari et al. 2007). 
1.4.4 Methods of stem cell identification 
Stem cell researchers often use one or more of the following methods to 
identify / characterise ASCs:  
(1) Label the cells in a living tissue with molecular markers, and then 
determine the specialised cell types they generate. 
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(2) Remove the cells from a living animal, label them in in vitro cell culture, 
and transplant them back into another animal to determine whether the cells 
replace (or "repopulate") their tissue of origin. 
(3) Use potential stem cell surface markers to isolate cells expressing the 
specific marker, and examine their functional stem cell characteristics in vitro 
and in vivo.  
(4) Examine cells in vitro for their functional stem cell characteristics (e.g. 
clonogenicity, SP cells), and subsequently identify markers demarcating 
them. 
The experimental methods follow the principle that it must be demonstrated 
that an ASC can generate a line of genetically identical cells that can give 
rise to all of the appropriate differentiated cell types of the tissue of origin.  
In vitro functional assays used in the identification of putative stem cells are 
described below: 
1.4.4.1 Colony-forming efficiency and holoclone identification 
The colony-forming efficiency assay is an in vitro method that enriches for 
stem cells. Freshly harvested tissues are, initially, mechanically and 
enzymatically digested to release live cells, to produce a single cell 
suspension from the target tissue, followed by a dilution and inoculation of 
two dimensional (2D) culture dishes with a low number of cells (typically 10–
100 cells/cm2). The colonies that form are enriched in stem cells, and the 
number of resulting colonies is presumed to correlate with the initial number 
of stem cells in the single cell suspension, therefore, the initial tissue 
samples. When epidermal stem cells are studied, colonies formed by 
keratinocytes can be further sub cultured, and colonies in this secondary 
culture re-evaluated. Cells with high replicative capacity, and a low level of 
terminal differentiation, will form large colonies with smooth edges called 
holoclones. They represent a further enriched population of epidermal stem 
cells (Barrandon and Green 1987). Prolonged self-renewal requires serial 
passaging of cells before cell death and apoptosis. In vitro differentiation is 
performed by culturing cells in media, supplemented with various growth 
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factors, implicated at inducing differentiation into a specific cell type. 
Histochemical staining, along with gene expression, confirms differentiation. 
There are other authors who are opposed to the use of clonogenicity to 
assign “stemness” to a cell population. They argue that stem cells have been 
assumed to spawn large, and/or diverse colonies, following explantation into 
tissue culture. The ‘logic underlying this expectation is flawed’, and ‘in most 
cases, “stemness” does not appear to be an autonomous cellular property 
that persists in culture, but a labile state maintained by the tissue 
microenvironment’. Without a physiological microenvironment, colony growth 
in culture may bear no relationship to cellular behaviour in vivo (Spradling 
2011). 
1.4.4.2 Side population 
Side population (SP) analysis distinguishes stem and progenitor cells from 
other somatic cells, based on their ability to remove foreign molecules from 
the cells. The SP phenotype could be classified as either in vitro or in vivo, 
and was first described when studying bone marrow (Goodell, Rosenzweig 
et al. 1997). In a mixture of cells, DNA-binding fluorescent dyes (such as 
Hoechst 33342, a fluorescent dye that binds to the minor groove of 
deoxyribonucleic acid) are taken up by cells universally, but only 
stem/undifferentiated cells (expressing special ATP-binding cassette–
containing pumps (ABC transporters - a type of membrane-bound active 
transporter)) will be able to remove the dyes. When excited by ultraviolet 
(UV) light, these fluorescence emitting dyes will remain unstained, or weakly 
stained, and therefore can be analysed, or isolated, by flow cytometry. Due 
to this mechanism, it is postulated that stem cells are able to extrude DNA 
damaging agents from their nucleus, where DNA resides. If stem cells had 
DNA damage, this would mean all progeny would be affected and it is, 
therefore, believed that stem cells have the ability to extrude Hoescht dye as 
a safety mechanism. In several tissues, dye-excluding SP cells represent a 
stem cell–enriched fraction. This method is able to pick up rare events, in a 
heterogeneous cell population. There are limitations with the SP assay: the 
detection of dye-excluding stem cells requires active cellular metabolism, 
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and is largely dependent on cell viability, which is adversely affected by the 
presence of DNA intercalating dyes; Hoescht can be toxic and the effect on 
cell survival can be poor, therefore, cells are counter stained with propodium 
iodide (PI) to ensure viability; there are many other dyes that are extruded 
using the same nuclear membrane pump, with reduced cellular toxicity, that 
have since been developed to aid more efficient isolation of these primitive 
populations (Bertoncello and Williams 2004, Telford, Bradford et al. 2007, 
Gisina, Lupatov et al. 2014, Tomiyasu, Miyamoto et al. 2014), despite this, 
Hoescht dye continues to be used; the isolated SP cells are not always 
suitable for further functional stem cell analysis (Terunuma, Jackson et al. 
2003); fluorescence activated cell sorting (FACS) isolation requires isolation 
of cells in a single cell suspension, and this process is particularly 
detrimental to epithelial cells from a solid organ; it removes a stem cell from 
its niche, a process which may alter the retention of stem cell function, but 
force differentiation, therefore, the subsequent cell function examined in vitro 
of these FACS isolated cells may be different to their functional potential in 
vivo, or in the stem cell niche; there is growing caution that dye efflux ability 
is not ubiquitous, nor a common property, of all stem cell populations 
(Terunuma, Jackson et al. 2003, Triel, Vestergaard et al. 2004, Zeng, Park et 
al. 2009), the SP phenomenon has also been described in certain 
differentiated cells in adult tissues, so is therefore not restricted to the stem 
cell phenotype (Golebiewska, Brons et al. 2011); ABC transporters are 
expressed by specialised cells in several organs, including the small intestine 
(Mayer, Wagenaar et al. 1996), placenta (Lankas, Wise et al. 1998) and 
kidney (Smit, Schinkel et al. 1998), the transporters are thought to play a role 
in protection against the cytotoxic effects of toxins and xenobiotics by limiting 
toxin/drug entry into certain tissues, and promoting their elimination into the 
bile and urine (Fromm 2000). 
Another FACS-based assay measuring mitochondrial membrane potential 
was shown to enrich cells with stem cell characteristics. By adding a 
potentiometric dye to a mixture of cells, followed by FACS analysis, stem 
cells can be separated by their higher mitochondrial membrane potential, 
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compared to more differentiated cells (Schieke, Ma et al. 2008, Charruyer, 
Strachan et al. 2012). 
1.4.5 Isolation of cells using a variety of putative 
“stem cell” markers 
1.4.5.1 Cell surface markers 
Universal stem cell markers, if existed, would be very useful for the scientist 
studying stem cells and their properties, but unfortunately, to date, no such 
marker has been identified. Definitive markers of organ specific ASCs would 
facilitate identification and enrichment of cell populations of interest for 
further study. Cell surface markers have been utilised widely in a number of 
different tissues, but reports suggest different tissues to have many varied 
markers, including panels of markers. For example, the human hair follicle–
derived epidermal stem cells were reported to be negative for CD45 and c-
kit, positive for CD34 and CD200, and have a low expression of CD71, while 
producing α-6-integrin at a high level (Terunuma, Cross et al. 2008). The 
most widely reported markers of an undifferentiated/pluripotent state are 
NANOG, OCT4, and SOX2, but these are transcription factors, and are 
located within the cell nucleus. Cell isolation following their identification 
through a marker, then employing methods such as magnetic cell sorting 
(MACS), or FACS, can be used for functional studies of live cells, but in 
order to do this the marker is required to be on the cell surface, not in the 
nucleus. Permeation of the cell, needed to identify an intracellular marker, 
cannot be done on live cells, thus, no functional studies can be subsequently 
done in them.  
1.4.5.1.1 Leucine-rich repeat-containing G-protein-coupled receptor 5 
Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is a 
transmembrane receptor (Barker, van Es et al. 2007) characterised by a 
large leucine-rich extracellular domain (Barker, van Es et al. 2007), and 
belonging to a family of glycoprotein hormone receptors (Sun, Jackson et al. 
2009). Little was known about mammalian LGR5 before 2007 (Barker and 
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Clevers 2010) when it was discovered by researchers looking to find an 
intestinal stem cell marker (Kumar, Burgess et al. 2014). R-spondins 1-4, a 
group of Wnt agonists, are the ligands of LGR5 (Carmon, Gong et al. 2011, 
Glinka, Dolde et al. 2011). LGR5 is closely related to LGR4 and LGR6 with 
approximately 50% sequence analogy. In comparison, it has 33% analogy to 
glycoprotein hormone receptors such as follicle stimulating hormone (FSH), 
LH, and thyroid stimulating hormone (TSH). LGR5 and LGR4 have 17 
leucine-rich repeats in contrast to 13 in LGR6, and 9 in glycoprotein hormone 
receptors. The C-terminal flanking segment of LGR4 and LGR5 contains a 
cysteine-rich, chemokine-like domain, similar to the consensus CF3 subtype 
domain found in 45 glycoprotein hormone receptors. The core sequences of 
this consensus CF3 domain (CCAF and FK/NPCE sequences) are 
completely conserved, but the number of residues separating the conserved 
cysteines in LGR4 and LGR5 (CC-4X-C-4/54X-C) differs from that in the 
three known human glycoprotein hormone receptors (CC-15/23X-C-31/88X-
C) (Kumar, Burgess et al. 2014). Similarly to FSH, the LGR5 ectodomain 
adopts a horseshoe-shaped architecture with C- and N-terminal caps (Figure 
1.10). The linker between LGR5 repeats 10 and 11 has two phenylalanines 
at positions usually occupied by leucines. The binding site of R-Spondin 1 
(RSPO1) on LGR5 is similar to the FSH binding site on the N-terminal 
leucine-rich repeat region of FSH, despite the ligands being quite distinct 
(Kumar, Burgess et al. 2014). 
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Figure 1.10 – The structure of LGR5. 
 
Much of the understanding of LGR5 function has come from the analysis of 
null or loss-of-function mutants (Kumar, Burgess et al. 2014). Homozygous 
mice, lacking Lgr5, exhibit ankyloglossia and gastrointestinal tract dilation 
resulting in neonatal lethality (Sun, Jackson et al. 2009, Barker and Clevers 
2010, Gil-Sanchis, Cervello et al. 2013). Lgr5 was found to be expressed in 
the epithelium of the tongue, and in the mandible of wild-type embryos. The 
observed phenotype indicated that Lgr5 is an essential gene, yet the lethal 
neonatal phenotype precluded the study of the role of Lgr5 in adult tissues. 
The same Lgr5-null strain also had accelerated maturation of paneth cells in 
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the developing intestine (Garcia, Ghiani et al. 2009). The Wnt pathway is one 
of the pivotal molecular pathways in development, and is particularly involved 
in stem cell function. A role for LGR5 in negatively regulating Wnt signalling 
during neonatal development of the intestine has been proposed (Schuijers 
and Clevers 2012, Kumar, Burgess et al. 2014). LGR5 is considered a Wnt 
target gene (Sun, Jackson et al. 2009, Gil-Sanchis, Cervello et al. 2013), 
playing a key role in the regulation of the canonical Wnt signalling pathway 
and, therefore, in the activation/inhibition of cells occupying the niche (Gil-
Sanchis, Cervello et al. 2013). RSPO protein expression, via LGR5 receptor 
interaction, leads to enhanced Wnt activation (de Lau, Barker et al. 2011, Gil-
Sanchis, Cervello et al. 2013). Understanding the critical molecular 
mechanisms associated with the RSPO:LGR5 regulation of Wnt signalling is 
a key goal in stem cell biology. It is also important to determine whether the 
RSPO-LGR5 complex activates intracellular signalling pathways 
independently of the Wnt-frizzled complex (Kumar, Burgess et al. 2014). 
The role that the Wnt signalling plays in the physiology of the intestine has 
been identified for a long time, and it is suggested that one or more Wnt 
target genes could be stem cell markers (Barker, van Es et al. 2007). In 
2007, Clevers' laboratory performed breakthrough research focused on the 
identification of the genes responsible for self-renewal in the small intestinal 
mucosa. From 80 genes identified as regulated by Wnt signalling, eleven 
demonstrated restricted expression to the intestinal crypt bottoms (Van der 
Flier, Sabates-Bellver et al. 2007). LGR5 was the only gene expressed in the 
crypt in a distinctive manner. LGR5 expression, demonstrated by in situ 
hybridisation (ISH), was restricted to a population of 10-14 proliferating 
slender cells, interspersed between the differentiated Paneth cells at the 
crypt base in the human small intestine, and on scattered cells at the base of 
the colonic crypts (Barker, van Es et al. 2007, Schuijers and Clevers 2012). 
These cells, known as crypt base columnar (CBC) cells, were discovered 
back in the early 1970s using detailed SEM studies (Cheng and Leblond 
1974, Cheng and Leblond 1974). Largely on the basis of morphological 
considerations, Bjerknes and Cheng originally formulated the ‘stem cell zone’ 
model, proposing the CBC cells to represent the adult intestinal stem cell 
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population (Bjerknes and Cheng 1981). Formal proof of this model awaited 
the discovery of a specific marker for the cell population (Leushacke and 
Barker 2012).  
To evaluate the “stemness” of Lgr5+ populations, in vivo lineage tracing was 
used, and a heritable-inducible lacZ reporter gene was introduced into Lgr5-
expressing cells. This, firstly, resulted in the appearance of lacZ+ cells in the 
CBC compartment within the crypt base, over the course of a week the 
progressively expanding lacZ+ progeny were observed extending from the 
crypt base towards the tips of the interstitial villi. Similar observations were 
also made in the colon. Thus, individual lacZ+ tracing units were present in all 
epithelial cell lineages, and persisted throughout the life of the organism, 
identifying Lgr5+  cells as a truly multipotent, self-renewing population of adult 
intestinal stem cells. Morphological and marker expression studies revealed 
that all differentiated cell types in the intestinal epithelium originated from 
Lgr5+  CBC cells, therefore, that includes, enterocytes, paneth cells, goblet 
cells, enteroendocrine cells, tuft cells, and M-cells (Gerbe, van Es et al. 
2011). Lineage tracing demonstrated Lgr5+  CBC cells persisted over the 
lifetime of the animal, thus demonstrating that Lgr5+  stem cells are long-lived 
and multipotent (Schuijers and Clevers 2012).  
In vitro, small numbers of LGR5+  cells are able to generate self-organising, 
self-renewing epithelial organoids with an architecture and cell composition 
that are remarkably similar to in vivo crypt/villus units (Sato, Vries et al. 2009, 
Leushacke and Barker 2012, Schuijers and Clevers 2012, Kumar, Burgess et 
al. 2014). Maintenance of these intestinal organoids is dependent on the 
presence of defined secreted growth factors, including RSPO1, noggin, and 
Epidermal growth factor (EGF) (Sato, Vries et al. 2009, Leushacke and 
Barker 2012).  
It appears likely that generally, LGR5+ stem cells double daily in tissue, and 
that adoption of stem cell or progenitor fate is determined stochastically 
(Kumar, Burgess et al. 2014). Intestinal stem cells divide symmetrically, such 
that every stem cell division gives rise to two equipotent daughters. These 
daughters can remain as stem cells or can become TA cells, depending on 
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their location relative to the Paneth cell niche. This model of ‘neutral 
competition' (that is, stem cells compete, but have equal chances to win) 
implies that longevity is an attribute of the stem cell population, but not of 
individual stem cells. The stem cell population size results directly from the 
size of the niche. Thus, the exact control of Paneth cell numbers at crypt 
bottoms is the central driver of homeostatic self-renewal (Schuijers and 
Clevers 2012). 
The intestinal epithelium survives conditional ablation of the LGR5+ stem cell 
compartment in vivo, but a dramatic reduction in LGR5+ stem cell numbers 
accompanied the ablation of the Paneth cell compartment (Sato, van Es et 
al. 2011, Leushacke and Barker 2012). This finding led to the speculation 
that a dedicated ‘reserve’ LGR5− stem cell population may also exist (Kim, 
Escudero et al. 2012, Barker, Tan et al. 2013). An alternative explanation 
was provided when it was shown that secretory progenitor cells expressing 
the Dll1 marker gene, which encodes the Notch ligand Delta-like 1, re-
acquire a multipotent stem cell identity following damage-induced LGR5+ 
stem cell ablation (van Es, Sato et al. 2012, Barker, Tan et al. 2013). These 
seminal works on LGR5+  cells highlight many aspects of epithelial ASC 
biology as well as the possibility of the existence of more than one stem cell 
type in epithelial organs. The plasticity of the epithelial stem cell 
compartments, and their interaction with the surrounding niche, are under 
intense scrutiny in many human tissue systems at this present time. 
1.4.5.1.2 N-cadherin 
N-cadherin (CDH2 gene) is a calcium dependent cell adhesion molecule of 
the cadherin family; mainly mediating adhesion among the brain, muscle and 
vascular tissues (Xie, Zheng et al. 2017), and playing an important role in 
migration (Nguyen, Xiao et al. 2017). Expresssion of N-cadherin in epithelial 
cells is reported to be rare (Xie, Zheng et al. 2017), and induces changes in 
morphology to a fibroblastic phenotype rendering the cells more motile and 
invasive. N-cadherin can have multiple functions; promoting adhesion, or 
induction of migration, dependent on the cellular context (Derycke and 
Bracke 2004).  
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1.4.5.1.3 SSEA-1 
In 1978, Solter and Knowles produced a monoclonal antibody from 
lymphocytes of a mouse immunised with F9 ECs, the monoclonal antibody, 
MC480, which recognised an antigen expressed by mouse ECs, and by the 
ICM of early embryos, and was down regulated on differentiation (Solter and 
Knowles 1979). The antigen, SSEA-1 was subsequently found to be the 
epitope recognised by the antibody Lewis-X hapten, a carbohydrate structure 
known to be related to the Lewis blood group antigens (Wright and Andrews 
2009). In humans, the Lewis-X structure (also known as CD15) (Xu, Hardin 
et al. 2016) is expressed by some myeloid cells, and a variety of tumours 
unrelated to teratocarcinomas (Valentijn, Palial et al. 2013). Sialylated Lewis-
X was found to be the ligand for E-selectin, one of a family of adhesion 
molecules involved in lymphocyte and macrophage homing to sites of 
inflammation and injury (Wright and Andrews 2009). Its expression on 
human ESCs is associated with differentiation (Valentijn, Palial et al. 2013). 
Lewis-X detecting antibodies are routinely used for cell sorting of 
neural stem- and progenitor cells. Applications include the enrichment of 
neural stem- and progenitors cells after neural differentiation of human 
iPSCs or ESCs, as well as their direct isolation from mouse neural tissue. 
Still, only a small amount is known about the role of Lewis-X in the central 
nervous system (Hennen and Faissner 2012). SSEA-1 may be expressed in 
normal ASCs and cancer stem-like cells (Xu, Hardin et al. 2016). 
1.4.5.1.4 Musashi-1 
The Musashi family is a conserved group of RNA-binding proteins (Potten, 
Booth et al. 2003), which regulates translation of target mRNAs specifically 
(Gotte, Wolf et al. 2008, Horisawa, Imai et al. 2010, Nikpour, Mowla et al. 
2013). Musashi-1 promotes Notch signalling by binding to the mRNA of 
Numb, the negative regulator of Notch signalling, thus preventing its 
translation (Lagadec, Vlashi et al. 2014). The Musashi protein was originally 
identified as a regulator of asymmetrical division of sensory organ precursor 
cells in Drosophila (Nakamura, Okano et al. 1994, Nishimura, Wakabayashi 
et al. 2003, Potten, Booth et al. 2003).  
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Next, its mammalian homologs, Musashi1 (Msi1) and Musashi2 (Msi2), were 
identified in mice, prior to Musashi and Musashi-like proteins being 
discovered in a variety of multicellular animals, and the overall primary 
structure, and expression patterns, were highly conserved among them 
(Horisawa, Imai et al. 2010). Strong expression of Musashi1 protein has 
been identified in the nervous systems of vertebrates, in the central nervous 
system of mice and in undifferentiated neural stem/precursor cells at the 
embryonic and adult stages (Horisawa, Imai et al. 2010). Expression has 
also been observed in many types of somatic stem cells in adult tissues, e.g.: 
eye (Raji, Dansault et al. 2007); intestine (Potten, Booth et al. 2003); 
stomach (Akasaka, Saikawa et al. 2005); mammary gland (Clarke, Spence et 
al. 2005); and hair follicle (Sugiyama-Nakagiri, Akiyama et al. 2006). 
Mushashi-1 is, therefore, regarded as a marker for neural and intestinal 
epithelial stem cells (Murayama, Okamoto et al. 2009, Lan, Yu et al. 2010). 
1.4.6 Tissue reconstitution 
This methodology involves transplantation of donor cells into a recipient 
animal, to examine if the tissue of interest is reconstituted in the host. Most 
commonly, bone marrow derived stem cells are injected intra-venously, after 
labelling with (for example) enhanced green fluorescent protein, into immune 
compromised mice (Liu, Zhang et al. 2014). Alternatively, they can be 
transplanted subcutaneously, or under the kidney capsule. After a defined 
period of time, animals are sacrificed, and the explants can be examined 
(Masuda, Maruyama et al. 2007). These experiments, however, are limited 
by their absence of a stem cell niche, as the tissue of interest is transported 
without the surrounding tissue usually present in the natural location, 
potentially causing the explants not to develop into a functional organ. 
Transplantation studies are important to define the differentiation potential of 
stem cells. These assays mimic a regenerative state that, in certain 
circumstances, forces stem cells to differentiate into lineages for which they 
usually do not contribute to regenerate to under physiological conditions 
(Van Keymeulen, Rocha et al. 2011). 
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1.4.7 Identifying stem cells for their in vivo properties 
1.4.7.1 Label-retaining assays 
In 1975, John Cairns proposed the immortal DNA strand hypothesis: when 
stem cells undergo mitosis, DNA is divided asymmetrically; the parent strand 
is retained by stem cells and the new strand is selectively segregated to a 
daughter cell. This mechanism would prevent accumulation of genetic errors, 
as it would mean that spontaneous mutations only occur in the newly 
synthesised strand, and are passed on to the stem cell progeny. This 
principle forms the basis for the label retaining cell technique (LRC). Parental 
DNA is marked with a DNA label during S phase of the cycle, typically 
bromodeoxyuridine (BrdU). If cells undergo symmetric mitotic division, the 
DNA label would rapidly be chased out of the cell, but if the cell undergoes 
asymmetric DNA division, the BrdU will segregate in the stem cell and would 
be detectable after a number of divisions. BrdU specific antibodies are then 
utilised to identify the LRCs in the tissue. The main drawback of LRCs is that 
BrdU binds to DNA during replication, instead of the usual thymidine, this 
means that mutations invariably occur. Additionally, BrdU is a recognised 
health hazard, therefore, the use of the LRC technique in humans is, 
justifiably, not permitted. Furthermore, more quiescent and non-dividing stem 
cells will not be labelled by this method. A pulse chase method is used to 
determine LRC characteristics, and enrich for stem cells. Firstly, in the “pulse 
phase”, radiolabelled nucleotide, or BrdU, is administered to animals, or cell 
cultures (for 3-5 days), labelling all proliferating cells in the S phase of the 
cell cycle (when DNA replication takes place). Following this, a long-term 
chase of the label (2–10 weeks) is undertaken to allow the highly proliferative 
cells to dilute the label, and the labelled cells that had terminally 
differentiated to be sloughed from the tissue. In this scenario, the amount of 
original label decreases to the point of being practically undetectable. LRCs 
are identified as they retain more label; they are slow-cycling and divide less 
frequently. Although this technique allows the in situ detection of a stem cell 
enriched population, it cannot be used to isolate living cells from tissue. The 
technique has been successful in its mission to identify cells that cycle 
60 
 
infrequently in the skin and the immune system (Punzel and Ho 2001, Potten 
2004, Fuchs 2009), the hair follicle bulge (Cotsarelis, Sun et al. 1990) and 
the limbus of the eye (Cotsarelis, Cheng et al. 1989). The method relies on 
the stem cell population having at least some proliferative activity, entering 
the cell cycle during the period where they are labelled, and then 
subsequently being permeabilised to measure the level of nucleotide 
retention by FACS, rendering the cells non-viable for further assessments. 
Years later these hurdles are being defeated with modifications to the 
method, for example, the usual pulse chase was replaced by using the 
expression of tissue-specific, tetracycline-inducible histone, tagged with 
green fluorescent protein (H2B–GFP) (Tumbar, Guasch et al. 2004). 
Although this would allow isolation of the live green fluorescent protein+ 
LRCs cells for further functional analysis, the technique will still remain 
unsuitable for human in vivo studies.  
1.4.7.2 Methylation patterns 
CpG sequences are unmethylated at birth and become progressively 
methylated, over the years, from random errors that occur during cell division 
(Ahuja, Li et al. 1998, Yatabe, Tavare et al. 2001, Bird 2002). Therefore, 
more errors, or methylations, should be observed in cells with greater 
numbers of divisions since birth, regardless of why they have divided. 
Consequently, the hypothesis postulates that the number of divisions since 
birth (mitotic age) may be inferred by counting somatic errors (Ro and 
Rannala 2001). 
Random replication errors in methlyation patterns are used to reconstruct 
somatic cell lineages (Kim, Tavare et al. 2005). This approach has been 
used to predict the progeny of stem cells, and their location, in lots of 
different systems including blood (Chambers, Shaw et al. 2007), brain 
(Nelson, Kavalali et al. 2008), intestine (Kaaij, van de Wetering et al. 2013), 
and endometrium (Kim, Tavare et al. 2005). This approach relies on 
unverified assumptions that replication errors are stochastic, and average 
error rates are constant. Somatic epigenetic errors are inherited, and 
methylation measurably increases with age in certain CpG-rich sequences 
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(Ahuja, Mohan et al. 1997, Yatabe, Tavare et al. 2001). Methylation can 
modulate transcription and chromatin structure, but some changes may 
reflect random errors, especially at CpG sites of unexpressed genes. Such 
age-related errors can potentially encode binary (methylated vs. 
unmethylated) information strings in adjacent CpG sites, creating tags that 
can be read with bisulfite sequencing (Yatabe, Tavare et al. 2001). 
1.4.7.3 Lineage tracing 
Lineage studies aim to establish which cells, and how many of those cells, 
will give rise to a structure in the early embryo and, as development 
proceeds, which part of a structure is responsible for the development of a 
substructure. Similar interrogations have now extended to the origin of stem 
cells that permit the regeneration of an adult structure, as well as its initial 
formation (Buckingham and Meilhac 2011). 
Lineage analysis is a technique that was originally developed to study early 
embryos, and it represents, by far, the most powerful and reliable tool for 
identifying stem cells, and also for deciphering other aspects of tissue 
behaviour (Fox DT 2009). Lineage tracing can be utilised in both animals and 
humans, but the techniques utilised are very different. In order to follow the 
descendants of a parent cell, the recombinase approach to permanent 
genetic labelling by specific activation of a conditional reporter, is widely 
used in mouse and fly, and is also now available in fish, in addition to being 
used for genetic cell tracing in Xenopus (Satoh, Sakamaki et al. 2005). The 
techniques used to trace lineage in animal models are invasive, with a 
detrimental effect on the organism, thus, not suitable for humans. 
Consequently, a different way of tracking cell lineages had to be developed 
for human in vivo experiments.  
1.4.7.3.1  Lineage tracing in Animal models 
1.4.7.3.1.1 Drosophilia 
Lineage tracing in the Drosophilia can be achieved by activation of a heat-
shock promoter (hsp) regulating Flp (Harrison and Perrimon 1993), due to a 
change in temperature, or by the use of temperature-sensitive versions of the 
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GAL80 repressor (McGuire, Le et al. 2003). These control the activity of 
promoters, and enable cellular descendants of a singly marked cell to be 
monitored. Cell toxicity can also be a problem in Drosophila, therefore, Flp 
recombinases are now the preferred tools, and improved variants of Flp and 
Cre, together with the identification of specific target site variants (FRT, lox), 
have increased the efficiency and scope of these tools (Turan, Galla et al. 
2011).  
 This strategy has been used to identify stem cells within the Drosophila 
ovary and posterior midgut. Using this method, intestinal stem cells were 
found to reside at the basement membrane, and be multipotent, producing 
both enterocytes and enteroendocrine cells. Regulation and differentiation 
systems for the intestinal stem cells were elucidated, and consisted of Notch, 
Janus kinase/signal transducer and activator of transcription, EGF 
receptor/mitogen-activated protein kinase, Hippo, and wingless signalling 
pathways (Singh, Mishra et al. 2012). Although drosophila work aided 
progression of stem cell research in some human organs, there were 
difficulties in translating the strategy to more complex human organs such as 
the endometrium. 
1.4.7.3.1.2 Mice 
In mice, regulation by temperature changes is not possible, and inducible 
systems (which involve antibiotics, such as the Tet system (Gossen and 
Bujard 1992), or hormones) have been developed. The ER, with tamoxifen 
as a ligand, is widely used (Feil, Boyano et al. 1997). Tamoxifen 
administration by injection into the mother usually results in recombination 
within 6–24 hours in the mouse embryo (Hayashi and McMahon 2002). 
Two challenges exist for mouse lineage tracing, firstly, in engineering mice to 
express Cre under the control of a promoter that is only active in the desired 
stem cells, and secondly, titrating down the activation of Cre within the stem 
cell niche such that on average, only one cell per niche is marked. The stem 
cell that is initially labelled will be long-lived and recognisable based on its 
mark and location, if it remains in its niche. When the engineered mice 
express an inducible Cre recombinase in the desired cell type, they are then 
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mated to a different mouse, genetically manipulated to ubiquitously express 
Rosa26 gene. The resulting offspring will have a stop codon (or secondary 
gene) flanked by Cre-recombinogenic loxP sites, followed by a reporter gene 
positioned downstream from the Rosa26 promoter. Once the Rosa26 locus 
has been recombined, reporter activity is faithfully transmitted to all progeny, 
and a small clone of marked cells will develop that will continue to increase in 
size over time. The progeny are expected to be shorter lived, leaving a trail 
of transiently labelled cells, enabling a tracing of where they go, and what 
lineages they differentiate into. This analysis was employed in the hair 
follicle, demonstrating that self-renewal and differentiation are separated 
temporally in follicular stem cells. The problems with this method are related 
to the toxicity of Cre (Naiche and Papaioannou 2007). Most promoters active 
in stem cells are not exclusive to these cells, resulting in a heterogeneous 
group of stem cells, and early progeny, that are marked; and long-term 
quiescent stem cells, or stem cells leaving the niche, that are not revealed 
with this method. 
Clevers lab knocked an EGFP–ires–CreERT2 transgene into the Lgr5 locus. 
Mice carrying this locus were then crossed to Rosa26–fl–stop–fl–lacZ 
reporter mice, and the resulting strains were treated with tamoxifen to 
activate Cre in only a small number of Lgr5-expressing stem cells at the base 
of the intestinal crypts, which resulted in excision of the floxed stop codon in 
the Rosa-lacZ reporter. GFP+ and βgal+ stem cells remained localised, but 
over time entire discrete crypts were found to be βgal+, but did not express 
GFP, suggesting that they were progeny of the Lgr5-expressing cells 
(Barker, van Es et al. 2007). 
In the hair follicle system, lineage tracing using Lrg5-Cre mice to label hair 
follicle stem cell progeny that have moved away from the bulge, showed that 
committed cells that have progressed along the lineage and lost stemness, 
are able to home back to their niche. When back in the niche, these non-
stem cells transmit critical inhibitory signals to the stem cells that keep them 
in a quiescent state, even in the presence of positive stimuli, and raise the 
threshold of activators needed to initiate the next round of stem cell 
activation and hair production (Hsu, Pasolli et al. 2011). This demonstrates 
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the importance of instructing stem cells when to stop tissue regeneration, as 
well as initiating the regenerative process, during tissue homeostasis and 
wound repair. By imposing both stimulatory and inhibitory signals on the 
stem cell niche, the balance between quiescence and activation of its 
residents is placed under the dynamic control of the microenvironment. 
1.4.7.3.1.3 Mosaics: Labeling of several progenitors simultaneously  
Labelling of several progenitor cells may be useful to assess the variability of 
cell fate potential, to recognise differing cell fate choices after asymmetric 
division, or to monitor cell dynamics with genetic manipulations to produce 
mosaics classically used in Drosophila for clonal analysis. This would depict 
the existence of multiple stem cells in a tissue. From pioneering work by 
Sturtevant (1929) on gynandromorphs (an organism that contains both male 
and female characteristics) resulting from spontaneous X-inactivation, to 
current techniques for spatially and temporally controlled activation of cell 
markers, the coherent growth of cells in the Drosophila embryo has 
facilitated clonal analysis. Isolated clusters of labelled cells are generally 
assumed to be clonal. 
The Brainbow system, developed for mouse models, depends on a 
stochastic choice between distinct recombinase target sites flanking a range 
of fluorescent markers in a transgene integrated in multiple copies. This 
technique leads to the generation of a spectacular mosaic of differently 
coloured cells (Livet 2007). With fluorescent proteins targeted to subcellular 
compartments, as well as with recombinase-mediated inversion of reporter 
sequences (Brainbow 2), the possible combinations that can distinguish cells 
are huge. A universal rainbow line, R26R-confetti (Snippert, van der Flier et 
al. 2010), coupled to existing specific Cre lines, increases the range of 
applications. This was used with a Cre-ERT2, under the control of Lgr5, 
which is expressed in stem cells of the crypt of the mouse intestine. 
Tamoxifen induction of Cre at different time points, followed by mathematical 
analysis of cell patterns marked with the four randomly generated reporters, 
led to conclusions about stem cell turnover without asymmetric cell divisions. 
Stochastic adoption of stem, or TA cell fates, depends on neutral competition 
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between cells. Such sophisticated mathematical analysis of clone 
distributions has also been applied to other tissues, and a general theoretical 
framework, which discriminates between patterns of long-term clonal 
evolution for distinguishing three classes of stem cell behaviour, has been 
proposed (Klein and Simons 2011). A limitation to this method is in the 
analysis, the sorting of colours can be limited by the spectral separation of 
different combinations of fluorescent proteins, and by the light microscopy 
resolution of subcellular localisation. Mosaics have, nonetheless, given 
insight into the polyclonal origin of tissues, their architecture, and the cell 
dynamics underlying tissue growth.  
Following the Lgr5 lineage tracing experiments in the small intestine, it was 
thought that Lgr5 marks intestinal stem cells, and that an individual stem cell 
can give rise to an individual crypt unit. To test this hypothesis further, 
Clevers and colleagues employed Brainbow technology. After inducing Cre 
expression in Lgr5-expressing stem cells, the resulting mix of colours 
revealed that intestinal stem cells do indeed generate clonality in the small 
intestine (Snippert, van der Flier et al. 2010). Such experimental work 
highlights the importance of lineage tracing in identifying stem cells and their 
involvement in tissue regeneration. 
1.4.7.3.2  In vivo lineage tracing in humans 
1.4.7.3.2.1 Mitochondrial DNA mutations 
The adaptation of lineage tracing to humans was reported first when Taylor 
and colleagues in Newcastle-upon-Tyne (Taylor, Barron et al. 2003) 
originally used the mitochondrial DNA (mtDNA) mutations method on human 
colon tissue. The method was later generalised for the identification of 
human epithelial stem cell niches in solid organs by Fellous et al (Fellous, 
McDonald et al. 2009) and we have, therefore, employed this well-
established method to prove the existence of human endometrial epithelial 
stem cells for the first time. In this context, the analysis of passenger 
mutations has proven to be more useful than the analysis of driver mutations, 
because maintenance of passenger mutations is presumably not subject to 
selective pressure (Fearon and Bommer 2011). Tracing mtDNA mutations is 
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deemed a natural experiment, genetic changes occur spontaneously, 
allowing lineages to be tracked and, in several instances, the stem cell niche 
to be identified (Wright 2012). The following section explains this 
methodology in detail. 
1.4.7.3.2.2 Mitochondria 
Mitochondria are essential intracellular organelles, required for oxidative 
phosphorylation and found in all nucleated human cells. They contain the 
only non chromosomal DNA in human cells (their own mtDNA) (Taylor and 
Turnbull 2005), and are, therefore, under the dual control of nuclear DNA 
and mtDNA (Taylor, Barron et al. 2003). Each cell in the body can contain 
hundreds, or thousands, of mitochondria, and each mitochondrion contains 
multiple copies of its own mitochondrial genome (Wallace 2005, Fellous, 
McDonald et al. 2009). The mtDNA is a small (16.5 kb in humans), self-
replicating DNA molecule, that encodes 13 essential proteins of the 
mitochondrial respiratory chain, as well as 2 ribosomal RNA and 22 transfer 
RNA genes required for intra-mitochondrial synthesis of proteins (Anderson, 
Bankier et al. 1981). All of the other mitochondrial proteins are nuclear 
encoded and transported into the mitochondria. Unlike nuclear DNA, mtDNA 
is not integrated with the cell cycle (Elson, Samuels et al. 2001).  
The mitochondrial genome is more prone to mutations than nuclear DNA due 
to its high production levels of reactive oxygen species (ROS) (Richter, Park 
et al. 1988), and mitochondria lack the protective histones and DNA repair 
mechanisms that protect the nuclear genome (Taylor, Taylor et al. 2001, He, 
Chinnery et al. 2002, Fellous, McDonald et al. 2009). 
1.4.7.3.2.3 Mitochondrial mutations 
Inherited abnormalities of the mitochondrial genome are recognised as 
important causes of disease (He, Chinnery et al. 2002, Taylor and Turnbull 
2005) and are common, with over 200 pathogenic defects (point mutations, 
deletions, and rearrangements) having been identified (Taylor, Taylor et al. 
2001, He, Chinnery et al. 2002). mtDNA, being prone to mutations, also carry 
spontaneous non-pathogenic passenger mutations. Through these, 
visualisation of the progeny of an individual stem cell in a tissue section has 
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been realised, where these passenger mutations are used as clonal markers 
(Walther and Alison 2016). The passenger mutations are passed on to 
daughter cells during cell division, providing a platform for studying cell 
lineage in human tissues. Although these mutations are generally thought to 
have no functional consequence, there is recent evidence that they may 
contribute to stem cell aging, suggesting tissue aging is driven by stem cell 
dysfunction in response to the accumulation of mtDNA point mutations (Su, 
Turnbull et al. 2018). 
The mitochondrially-encoded cytochrome C oxidase gene (CCO), which 
confers little or no selective growth advantage to normal cells (Nooteboom, 
Johnson et al. 2010), is a spontaneous passenger non-pathogenic mutation, 
which occurs in the enzyme forming the last step of the electron transport 
chain in respiratory complex IV (Mootha, Lepage et al. 2003, Taylor, Barron 
et al. 2003, Greaves, Preston et al. 2006, Li, Park et al. 2006, McDonald, 
Greaves et al. 2008). It is also a major regulatory site for oxidative 
phosphorylation, which is essential for the assembly and respiratory function 
of the enzyme complex (Li, Park et al. 2006).  
When CCO mutations occur, they can affect all copies of the mitochondrial 
genome within a cell, termed homoplasmy (homoplasmic conversion, where 
all copies of the genome in a cell are identical, and a mutation in the mtDNA 
will be present in all copies); or there may be a mixture of mutated and wild-
type genomes in the same cell, termed heteroplasmy (mixed mitochondrial 
genotype where a mutation is present in only some copies of the genome) 
(Lightowlers, Chinnery et al. 1997, Taylor and Turnbull 2005). In the 
presence of heteroplasmy, due to the mitochondria containing multiple 
mtDNA copies, and the cells containing hundreds or thousands of 
mitochondria, at least 80% of the CCO genes in a cell must be mutated 
(Taylor, Barron et al. 2003) for the visualisation of a detectable deficiency in 
CCO enzyme activity. This will allow direct visualisation of cell lineages in a 
renewing tissue ASC system (Sciacco, Bonilla et al. 1994, Taylor, Barron et 
al. 2003).  
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1.4.7.3.2.4 Expansion of mtDNA mutations 
The expansion of a mtDNA mutation within a cell can follow a stochastic 
course, which, over time, can evolve from a heteroplasmic state to a 
homoplasmic, or near homoplasmic, state. This process is termed “genetic 
drift” (Elson, Samuels et al. 2001, Wright 2012). The mutation initially 
spreads within the individual mitochondrial genome, and then in the 
mitochondria of the stem cell, to a level of homoplasmy (80% of CCO genes 
must be mutated for a cell to show as negative). Therefore, due to this 
lengthy process, wholly-mutant crypts are rarely seen before the age of 40 
years (Greaves, Preston et al. 2006), an indication of the time required 
(Greaves, Preston et al. 2006, Wright 2012). Stem cells should be the oldest 
cells in an organ. Due to genetic drift taking many years, we assume that 
only stem cells are sufficiently long lived in a tissue, to acquire the near-
homoplasmic state, enabling detection of a biochemical deficiency in them 
(Fellous, McDonald et al. 2009).  
1.4.7.3.2.5 Using CCO to demonstrate the potency of human stem cells 
In tissues such as the small intestinal crypt and the gastric gland, CCOˉ 
crypts and glands were shown to contain cells of all lineages in the epithelial 
system, showing that all the cells in these glands originated from a parent 
CCOˉ stem cell (Wright 2012).  
This method has been utilised to confirm the existence of epithelial stem 
cells in the colon (Taylor, Barron et al. 2003), pancreas (Fellous, McDonald 
et al. 2009), bladder (Gaisa, Graham et al. 2011) and prostate (Gaisa, 
Graham et al. 2011), but human endometrium has not yet been examined 
with this method.  
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1.5  Evidence for endometrial stem cells 
The human endometrium is a highly regenerative organ undergoing over 400 
cycles of shedding and regeneration over a woman’s life time (Jabbour, Kelly 
et al. 2006, Gargett 2007, Cervello, Gil-Sanchis et al. 2010). Menstrual 
shedding, and subsequent repair of the endometrial functionalis, is a process 
unique to humans, and higher-order primates (Slayden and Brenner 2006, 
Brenner and Slayden 2012). It re-grows from 1-2 mm after menstrual 
shedding to 16 mm in the secretory phase of the menstrual cycle (Fleischer 
1999), and is able to completely regenerate after parturition, and in post-
menopausal (PM) women, when exposed to oestrogen replacement therapy 
(Gargett 2006, Gargett 2007). Even after extensive iatrogenic destructive 
procedures such as ablation (Tresserra, Grases et al. 1999), the 
endometrium regrows in some women, who will continue to bleed (25-75%) 
(Gimpelson 2014, Muller I 2015). This huge regenerative ability suggests that 
the endometrium has a stem cell(s) basis that supports the tissue 
maintenance/regrowth.  
1.5.1 History of endometrial stem cells 
Prianishnikov was the first to consider the existence of endometrial ASCs 
and, in 1978, he proposed ASCs to reside in the deep basalis layer, and their 
differentiation to be marked by functional changes (acquiring) in hormonal 
receptivity (Prianishnikov 1978). He suggested a hierarchical hormone 
receptiveness in the endometrial cells matching their level of maturity, 
therefore, the most primitive, hormone independent ASCs differentiate 
initially into oestrogen dependent cells, then they may further differentiate in 
to both oestrogen and progesterone dependent cells. Terminally-
differentiated cells were expected to be only progesterone dependent, and 
postulated to have a limited lifespan (Prianishnikov 1978) (Figure 1.11). 
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Figure 1.11 – Hormone dependent regulation of the ratio of cell types in the 
endometrium (Abbreviations - ST-cell – stem cell, E2-cell – oestrogen 
sensitive cell, E2P-cell – oestrogen-progesterone sensitive cell, P-cell – 
progesterone sensitive cell). Figure adapted from (Prianishnikov 1978). 
 
This hypothesis, proposing that the human endometrium regenerates from 
the deeper basalis layer (which is the proposed germinal compartment that 
persists after menstruation, and is responsible for the regeneration of the 
new upper/ superficial functionalis layer), has been echoed many times since 
(Chan, Schwab et al. 2004, Valentijn, Palial et al. 2013, Fayazi, Salehnia et 
al. 2016, Gargett, Schwab et al. 2016). 
Identifying human endometrial epithelial stem cells is problematic, due to the 
lack of specific markers for isolating and examining them for functional 
properties (Kim, Tavare et al. 2005). Furthermore, the true, and conclusive, 
confirmation of an endometrial epithelial stem cell requires the demonstration 
that they are able to produce all of the epithelial cell types that exist in all 
regions of the endometrium. The characterisation of different endometrial 
epithelial cell subtypes to ascertain the mature progeny of the putative stem 
cell is not yet complete in the human endometrium. 
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1.5.2 Evidence so far for the existence of endometrial 
stem cells 
1.5.2.1 In vivo evidence 
1.5.2.1.1  Scanning Electron microscope studies 
Early work on endometrial regeneration has been gleaned through SEM 
studies, this includes some evidence for the existence of endometrial 
epithelial stem cells. SEM studies confirmed that the total regeneration time 
for postmenstrual surface re-epithelialisation to be approximately 48 hours 
(Ferenczy 1976) (with the regenerative period beginning between cycle days 
2 and 3, and ending between cycle days 4 and 5). This time interval 
coincides with the maximum area of the denuded basalis (Ferenczy 1976). 
The SEM data also suggests that the surface epithelial repair occurs by a 
simultaneous and progressive outgrowth from the remaining stumps 
(“mouths”) of basal glands, and by out growth from the surface epithelium, 
adjacent to the denuded areas, that has not been lost from the isthmic and 
cornual regions (Ferenczy 1976). A similar observation was reported in rabbit 
endometrium; the newly restored surface lining was derived from the intact 
surface epithelium that remained bordering the artificially (rabbits do not 
menstruate) denuded area (Schenker, Sacks et al. 1971). The other 
important findings of the SEM studies had been the description of 
morphological differences in endometrial epithelial subtypes. For example; 
ciliated and non-ciliated cells have been observed in the LE (Baraggino, 
Dalla Pria et al. 1980). Cells with the same morphology as that of endocrine 
cells were found in the lower layers of the epithelium at late gestation (clear 
cells), and they were positive for anti-serotonin and anti-somatostatin 
antisera (Satake and Matsuyama 1987), and morphologically similar to 
endocrine cells in other tissues (Wang 1989). This further confirms the 
existence of different epithelial subtypes that are yet to be characterised for 
the expression of distinct markers or for their possible functional diversity. 
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1.5.2.1.2 Studies using stem cell markers 
Stem cell marker identification in the endometrium has been undertaken 
according to 3 main hypothesis:  
1. Examining endometrium for the expression of putative stem cell markers 
that were identified to be expressed in the ESCs, or stem cells of different 
tissues (e.g. OCT4, Mushashi-1, LGR5).  
2. Identifying markers that are highly expressed in cells with some in-vitro 
stem cell properties (clonogenic cells, SP cells).  
3. Identifying markers that are expressed by cells located in the postulated 
stem cell niche (basalis and PM glandular epithelium). 
1.5.2.1.2.1 Putative stem cell markers 
1.5.2.1.2.1.1 OCT-4 
OCT-4, a marker of pluripotent human ESCs and some ASCs, was seen in 
some endometrial samples by IHC, and in all endometrial samples by 
reverse transcriptase- polymerase chain reaction (RT-PCR) with variable 
expression in the human endometrium (Matthai, Horvat et al. 2006). Close 
scrutiny of the pictures presented in this manuscript reveal that OCT-4 is not 
expressed in the epithelial cells, but appears to be seen rarely in some 
stromal cells or blood vessels. The presented pictures are not conclusive, 
and there is no further explicit description, or further confirmatory data using 
a different method in the manuscript, about the above findings. The authors 
simply concluded that OCT-4 staining is present, and mostly expressed in 
the stromal compartment (Matthai, Horvat et al. 2006). OCT-4 was found not 
to be differentially expressed during the menstrual cycle in women, therefore, 
proposed to be uninfluenced by hormones (Bentz, Kenning et al. 2010). 
OCT-4 has also been located in some mouse LRCs in the lower region of the 
stroma, co-localising with c-KIT (Cervello, Martinez-Conejero et al. 2007). 
Therefore, further work needs to be done using a reliable antibody, specific 
to human OCT4a antigen, to examine the cell specific expression in the 
human endometrium, since this is the particular antigen associated with an 
undifferentiated phenotype.  
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1.5.2.1.2.1.2 Musashi-1 
Musashi-1, an RNA-binding protein in neural stem cells and an epithelial 
progenitor cell marker that regulates self-renewal signalling pathways, was 
immunolocalised to single epithelial cells, and small clusters of stromal cells 
in human endometrium (Gotte, Wolf et al. 2008). The authors describe the 
staining as nuclear and cytoplasmic, but the representative figures presented 
in the manuscript only demonstrated cytoplasmic staining. 
Immunofluorescence (IF) images showed Musashi-1 to be co-localised with 
its molecular target, Notch-1, and telomerase. Musashi-1 positive cells were 
mainly found, in the basalis, in the proliferative stage of the menstrual cycle 
(when compared to the secretory stage), suggesting their possible 
stem/progenitor cell function. Stromal Musashi-1 positive cells were not found 
in a perivascular location, although some were in a peri-glandular region, a 
similar location to some stromal LRC in mouse endometrium (Chan and 
Gargett 2006).  
More recently, Musashi-1 expression has, been found in the neonatal 
endometrium from the twelfth week of gestation, with the number of positive 
cells decreasing with increasing gestational age. In reproductive 
endometrium Musashi-1 staining was seen in dispersed single cells, and in 
stromal cell groups adjacent to myometrium (Lu, Lin et al. 2011). 
In summary, there is unconvincing cytoplasmic and nuclear staining for 
Musashi-1, without any functional studies, and no further confirmatory follow 
up work has been undertaken since the preliminary work published in 2006. 
Taken together, the above evidence suggests Musashi-1 has not proven 
itself as an endometrial stem cell marker. 
1.5.2.1.2.1.3 SOX9 
SOX9 is a Wnt target transcription factor first discovered in patients with 
campomelic dysplasia (Nguyen, Sprung et al. 2012). SOX9 expression 
differentiates cells derived from all three germ layers into a large variety of 
specialised tissues and organs (Jo, Denduluri et al. 2014), with roles in 
chondrogenesis (Foster, Dominguez-Steglich et al. 1994, Wagner, Wirth et 
al. 1994) , male gonad development (Sudbeck, Schmitz et al. 1996), neural 
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crest development (Spokony, Aoki et al. 2002) and in the lower crypt region 
of the intestinal epithelium (Blache, van de Wetering et al. 2004, Bieczynski, 
Torres et al. 2016). SOX9 expression detected by IHC in normal human 
endometrium was found to be significantly higher in the proliferative phase of 
the menstrual cycle when compared with the secretory phase (Saegusa, 
Hashimura et al. 2012). Following this work, another IHC study, described 
SOX9 expression to be largely confined to the basal epithelial cells 
throughout the cycle, with significantly greater numbers of epithelial cells 
expressing nuclear SOX9 in the basalis (46.2–52.3%) over the functionalis 
(8–12.1%) glands. The PM endometrium demonstrated the highest SOX9 
immunostaining out of the pre/PM endometrial samples, with over 75% of 
PM epithelial cells expressing nuclear SOX9 (Valentijn, Palial et al. 2013). 
This paper concluded that nuclear SOX9, co-localised with SSEA-1 and 
nuclear β-catenin suggesting an activated Wnt pathway, in the basal glands 
of premenopausal endometrium, could function by maintaining the SSEA-1 
cells in a less-differentiated state, representing the endometrial 
stem/progenitor cell compartment of the stem cell niche, playing an important 
role in homing stem cells (Valentijn, Palial et al. 2013). It was also concluded 
that high levels of nuclear SOX9 observed in the PM endometrial epithelial 
cells may function as a checkpoint to prevent hyperplasia, as loss of SOX9 in 
the intestinal epithelium leads to hyperplasia (Bastide, Darido et al. 2007). 
Although nuclear SOX9 may mark a potential primitive cell population in the 
endometrium, due to the nuclear location, SOX9 is obviously not a suitable 
marker to select these cells for further functional studies. The authors further 
concluded that nuclear SOX9, containing basalis endometrial epithelial cells, 
can be isolated for functional studies using the surface marker SSEA-1 
(Valentijn, Palial et al. 2013), and their subsequent in vitro experiments 
demonstrated these epithelial cells to have high telomerase activity and 
superior ability to generate endometrial gland-like organoids in 3D culture 
(Valentijn, Palial et al. 2013).  
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1.5.2.1.2.1.4  LGR5 
By using RT-PCR, LGR5 gene was found to be expressed in 26 full 
thickness, mid proliferative to late secretory, human endometrial samples. 
Substantial differences were discovered in expression levels of individual 
women, but no variation was observed throughout the menstrual cycle, 
therefore suggesting it was not hormonally regulated (Krusche, Kroll et al. 
2007). This study was followed by a mouse study demonstrating that: 
Lgr5 gene is dynamically regulated in endometrial epithelium; expressed only 
in immature and ovariectomised mice; and down-regulated by oestrogen. All 
of this evidence alludes to a hormonal regulation, and Lgr5 to be lost with 
differentiation (such as acquiring hormonal responsiveness) (Sun, Jackson et 
al. 2009). More recently, in a review paper, a group from Valencia proposed 
LGR5 to be a potential stem cell marker in the human endometrium. They 
included original data, using IHC, to show a population of stromal and 
epithelial cells stained by an anti-human LGR5 antibody, mainly to 
perivascular regions (Gil-Sanchis, Cervello et al. 2013). In this review, data 
from telomapping (a type of confocal quantitative fluorescence in situ 
hybridisation that displays the gradient of telomere length in a given adult 
tissue) was also included, it was used to identify cells with the longest 
telomeres. The authors subsequently claimed that LGR5 mRNA signal was 
present in some of the cells containing the longest telomeres, suggesting 
LGR5 expressing cells are associated with a long telomere phenotype. 
However, it must be noted that this statement was made without the data 
being presented in the paper. No menstrual cycle differences were noted 
with regards to expression of LGR5 protein. This work concluded that, 
perhaps, LGR5 could be considered as a universal stem cell marker (Gil-
Sanchis, Cervello et al. 2013). This paper, being a review (and although 
mentioning some of their original work on LGR5 mRNA and protein), does 
not present the data to a scientifically acceptable standard. That is, it does 
not provide the details of methodology or information with respect to the 
exact antibody used (Gil-Sanchis, Cervello et al. 2013). Since the specificity 
of the available anti-human LGR5 antibodies are in a considerable doubt, 
this is a significant deficiency in this manuscript, which casts a huge doubt on 
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the credibility of claims made by the authors. The same group later published 
another study, xenografting isolated cells expressing LGR5 into a mouse 
model (Cervello, Gil-Sanchis et al. 2017). An anti-human LGR5 antibody was 
used to isolate positive cells from human endometrium to determine their 
functional relevance, with no attempt at locating the positive cells in the intact 
human endometrium pre-sorting. It is unclear if the authors used the same 
antibody (or not) that they had used in the IHC data presented in the review 
article (Gil-Sanchis, Cervello et al. 2013). Human LGR5+ epithelial and 
stromal cells from endometrial biopsies (not full thickness endometrium, thus 
we assume only containing functionalis including LE) were sorted, according 
to their surface expression of LGR5, using an antibody (of unconfirmed 
specificity) by FACs, and phenotypically characterised by flow cytometry with 
haematopoietic and mesenchymal markers. These cells were labelled and 
injected under the kidney capsule of immunocompromised mice. The authors 
reported LGR5+ cells in the human endometrium to constitute 1.08 ± 0.73%, 
and 0.82 ± 0.76% of the total cells in the epithelial and stromal compartments 
respectively. LGR5+ cells showed an abundant expression of CD45 (a 
hematopoietic marker), and no expression of surface markers CD31, CD34, 
CD133, CD73, and CD90. However, co-expression with the macrophage 
marker CD163 was detected. The tissue recapitulation resulted in a weak 
endometrial reconstitution, and transcriptomic profiling revealed new 
attributes for LGR5+ cells, related to their putative hematopoietic origin. The 
authors concluded that LGR5 was unlikely to be a universal stem cell 
marker, contradicting their proposal made in the previous review paper (Gil-
Sanchis, Cervello et al. 2013). They further stated that LGR5+ cells appeared 
to be recruited from blood to be part of the stem cell niche at the perivascular 
microenvironment, to activate the endogenous niche (Cervello, Gil-Sanchis 
et al. 2017). The conclusions, and main criticisms drawn from the current 
literature on all previous endometrial LGR5 expression studies therefore are: 
Mouse studies may not translate well to humans due to obvious species-
specific differences in their endometrial biology; the initial study examining 
LGR5 mRNA level did not attempt to ascertain the location of the 
endometrial LGR5 expression; the specificity of all presently available anti-
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human LGR5 antibodies to identify the protein are not confirmed, and are of 
considerable doubt (Munoz, Stange et al. 2012). 
Therefore, further work is necessary to ascertain the exact endometrial cell 
types that express LGR5, their location, phenotype and functional 
characterisation. Testing the utility of LGR5 as a marker of human 
endometrial epithelial progenitor cells will also require the development of 
high-quality antibodies to a surface epitope, to purify the cells for subsequent 
assessment of their ASC function. 
1.5.2.1.2.2 Basalis specific markers 
1.5.2.1.2.2.1 SSEA-1 
SSEA-1 is a cell surface glycan; an antigenic epitope; defined as Lewis X 
carbohydrate; and is expressed by preimplantation mouse embryos, 
teratocarcinoma stem cells, and mouse ESCs (Knowles, Aden et al. 1978, 
Solter and Knowles 1978, Knowles, Rappaport et al. 1982, Fox, Damjanov et 
al. 1983). Its presence signifies cells in an undifferentiated state, as 
expression is lost during stem cell differentiation.  
In the endometrium, immuno-reactivity to SSEA-1 was specific to epithelia 
only. Intensity was significantly greater in the proliferative over the secretory 
endometrial phase, and strongest in the basalis, and basalis like, PM 
endometrium, when compared to the functionalis epithelium. SSEA-1 
enriched cell populations have a greater propensity to produce gland-like 
structures in 3D culture, and also have higher telomerase activity and longer 
telomere lengths. The function of SSEA-1 in the endometrium remains 
unknown, but it is postulated to be associated with cell adhesion, migration, 
and capacity to differentiate (Valentijn, Palial et al. 2013).  
Fibroblast growth factor (FGF) and Wnt-1 are both involved in stem cell 
maintenance and differentiation, work has shown that SSEA-1 possibly 
functions to bind and modulate these growth factors (Capela and Temple 
2002), and when this is supplemented with the prominent expression of 
SSEA-1 in the basalis epithelium, it is conceivable that these cells are a 
component of the endometrial-epithelial stem/progenitor cell niche. 
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1.5.2.1.2.2.2  N-cadherin 
The first report of human endometrial expression of N-cadherin was in 2010, 
comparing the endometrium of infertility patients to fertile controls. N-
cadherin staining was at the epithelial apical and lateral membrane, but was 
very weak (H-score <1) in the endometrium, conversely to this, N-cadherin 
staining was strong in the tubal epithelium. N-cadherin expression did not 
change with the menstrual cycle, and the authors concluded that N-cadherin 
could have a role in the receptivity of the endometrium (Poncelet, Cornelis et 
al. 2010). N-cadherin was found to be one of the Wnt associated genes in a 
profiling study (Nguyen, Sprung et al. 2012) and, given the known 
importance of Wnt signalling in stem cell biology, N-cadherin was 
investigated to determine if it could be a potential marker of the endometrial 
epithelial progenitors (Nguyen, Xiao et al. 2017). N-cadhein protein was 
shown to be expressed in 16.7% (range 3.7-36.7%) of Epithelial cell 
adhesion molecule (EpCAM)+ sorted endometrial epithelial cells, similar to 
when magnetic beads were used to sort (20.2% N-cadherin positive, range 
8-35.5%). When colony forming assays were utilised to assess enrichment of 
epithelial progenitors, larger clones, and significantly higher median cloning 
efficiency, were observed in the N-cadherin+ cells. These clones were large 
and densely packed, with small cytokeratin-positive cells, and a high 
nuclear:cytoplasmic ratio. When serial cloning was undertaken, N-cadherin+ 
cells generated clones from freshly isolated suspensions, samples 
underwent up to three rounds of serial cloning, and also differentiated into 
cytokeratin+ glandlike epithelial structures with a lumen in 3D Matrigel. N-
cadherin was found, by IF, to be strongest in the basalis glands adjacent to 
the myometrium, and rarely co-localised with Ki-67, indicating a quiescent 
phenotype. SSEA-1 cells were described to be phenotypically distinct from 
N-cadherin, suggesting a potential epithelial hierarchy (Nguyen, Xiao et al. 
2017). Two further IHC studies were also published in the same year. The 
first compared infertile patients with fibroids, to fertile controls, using IHC and 
qRT-PCR (Makker, Goel et al. 2017). This showed that N-cadherin was 
lower in the LE in the mid secretory endometrium of infertile women when 
compared to fertile controls, but no significant change was demonstrated in 
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either the immunoexpression or the mRNA. The IHC staining demonstrated 
by Makker et al (LE expresses strongest levels) (Makker, Goel et al. 2017) is 
in stark contrast to the IF staining presented in the manuscript by Nguyen et 
al (basalis adjacent to the myometrium expresses strongest levels) (Nguyen, 
Xiao et al. 2017). Using purely IHC, Xie and colleagues compared N-
cadherin between patients with endometriod adenocarcinoma, and normal 
controls (Xie, Zheng et al. 2017). They showed that N-cadherin was positive 
when brown/yellow particles were seen in the cytoplasm of a cell (again 
contradictory to other published studies). For the 50 normal samples that 
were reported on in this study, the positive expression rate for N-cadherin 
protein was 40.0% (8 weak positive, 9 moderate positive, and 3 strong 
positive) and the positive N-cadherin protein expression rate was statistically 
higher in the endometriod adenocarcinoma group compared to the normal 
controls (p < 0.05). They also showed that E-cadherin is commonly not 
expressed in the cells with positive N-cadherin expression, therefore, a 
transition may exist between them (Xie, Zheng et al. 2017). 
The published studies on endometrial N-cadherin seem to report major 
conflicting differences. However, these studies have reported on N-cadherin 
expression in a variety of patient populations (healthy and pathological), 
using different techniques; the exact clones identified by different anti-N-
cadherin antibodies were inconsistent and this makes it difficult to draw 
conclusions from the available N-cadherin data. Although the N-cadherin 
expressing cells may have some progenitor activity, their exact position in 
the human endometrial epithelial differentiation hierarchy is yet to be 
confirmed.  
1.5.2.1.2.3 Stromal stem cell markers 
Stromal ASC work was initiated with identifying markers preferentially 
expressed in the cell populations demonstrating higher clonogenic properties 
in vitro, by Gargett and her colleagues.   
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1.5.2.1.2.3.1  Co-expression of CD146 and platelet derived growth factor–
receptor β  
The first markers proposed to identify an endometrial stromal ASC 
population were CD146, and platelet derived growth factor–receptor β 
(PDGF-Rβ) (2 perivascular cell markers). This is because their co-expression 
was detected in cells with higher clonogenic ability in vitro. These cells were 
located in the perivascular area in both the functionalis, and the basalis of 
the intact full thickness human endometrium (Schwab and Gargett 2007). In 
vitro FACS sorted CD146+/PDGF-Rβ+ cells had significantly greater colony-
forming capacities than CD146ˉ/PDGF-Rβˉ cell populations (7.7 ± 1.7% 
versus 0.7 ± 0.2% respectively) (p=0.0001) (Schwab and Gargett 2007). 
CD146+/ PDGF-Rβ+ cells produced more large colonies with densely packed 
cells and a high nuclear:cytoplasmic ratio. The CD146+PDGF-Rβ+ cells 
expressed typical MSC surface markers such as CD29, CD44, CD73, CD90 
and CD105, and were negative for haematopoietic (CD34, CD45), and 
endothelial markers (CD31) (Schwab and Gargett 2007). When cultured in 
appropriate induction media, the CD146+PDGF-Rβ+ cells underwent 
multilineage mesenchymal differentiation into adipogenic, myogenic, 
chondrogenic, and osteoblastic lineages (Schwab and Gargett 2007). These 
studies used pooled, clonally derived CD146+PDGF-Rβ+ cells (not singly 
expanded clones) as well as not using a positive control of known multi-
lineage differentiation (such as MSCs), thus making it difficult to determine 
their true differentiation ability. This study did not consider the CD146+PDGF-
Rβ+ cells any further after colony forming capacity, and multi-lineage 
differentiation ability, therefore, we are not able to comment on their capacity 
to produce endometrial stroma in 3D culture, or in vivo tissue reconstitution 
ability. Without this evidence, it is difficult to conclude that these isolated cells 
are in fact an ASC population. It is thought that the CD146+PDGF-
Rβ+ subpopulation are similar to bone marrow and adipose tissue MSCs in 
their differentiation potential, and in their perivascular location identified for 
MSC in many organs (Crisan, Yap et al. 2008).  
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1.5.2.1.2.3.2 W5C5/ SUSD2 
W5C5 was the next ASC marker reported in the endometrial stroma, and it 
was particularly successful in selecting endometrial MSC. W5C5+ cells 
represented 4.2 ± 0.6% of the freshly sorted endometrial stromal cells using 
flow cytometry, located peri-vascularly in the basalis, and functionalis, with a 
significantly greater clonogenicity (median 3.6: range, 0.7-6.9) than depleted 
counterparts (median 0.6: range, 0.1-3.8). W5C5+ cells were able to be 
differentiated into adipocytes, osteocytes, chondrocytes, myocytes, and 
endothelial cells; producing endometrial stromal-like tissue in vivo (no MSC 
were used as an external control). W5C5+ cells were transplanted under the 
kidney capsule of NOD scid gamma (NSG) mice, and white growths (small 
masses) were identified macroscopically on 2 out of 10 kidneys. When the 
mice were examined by histological and microscopic analyses, stromal-like 
connective tissue was revealed under all of the kidney capsules. The W5C5+ 
cells produced significantly greater numbers of CFUs and the study identified 
W5C5 as a single marker capable of purifying endometrial MSCs (Masuda, 
Anwar et al. 2012), thus negating the need to use two markers 
(CD146+/PDGF-Rβ+).  
1.5.2.1.2.3.3  MSCA-1 
MSCA-1, a bone marrow-derived MSC surface marker, has been identified to 
be identical to Tissue Non-specific Alkaline Phosphatase (TNAP) (Sobiesiak, 
Sivasubramaniyan et al. 2010), which belongs to a large family of dimeric 
enzymes common to all organisms and expressed in liver, bone, kidney, and 
endometrium (Bitensky and Cohen 1965, Wilson 1969, Wilson 1976, Hoshi, 
Amizuka et al. 1997) as well as in ESCs (O'Connor, Kardel et al. 2008) 
(when ESC differentiate the expression of TNAP decreases) (Sobiesiak, 
Sivasubramaniyan et al. 2010). TNAP is expressed on endometrial 
perivascular cells, the proposed endometrial MSC-like cell location (Schwab 
and Gargett 2007). The proportion of W8B2+CD146+ endometrial stromal 
cells was compared to the proportion of CD146+PDGFRβ+ MSC-like cells 
found in human endometrium, and these were very similar, leading to the 
conclusion that endometrial MSC-like cells express TNAP. Combined with 
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CD146, this ectoenzyme was proposed to be a suitable marker for the 
isolation from the EpCAMˉ endometrial stromal population. Due to TNAP 
being exclusively expressed in the CD146+ subset, but not on other MSC-
like/fibroblast-like cells, it would appear that TNAP is developmentally 
expressed on MSC/pericyte progenitor cells, and is down-regulated during 
further differentiation.  
Not only was TNAP expressed on the endometrial perivascular cells, but it 
also stained endometrial epithelial tissue on the apical luminal surface. This 
has led to TNAP also being proposed as a marker for the isolation of a 
subset of endometrial glandular epithelial cells. The fact that TNAP is found 
in two separate niches in the endometrium makes this potential MSC marker 
confusing, and if studies were to be completed showing that the TNAP cells 
could recapitulate endometrial tissue in animal models, and had multilineage 
potential, then the cells would need to be sorted on TNAP, and also EPCAM, 
therefore, TNAP is not suitable as a single marker isolation protocol for 
endometrial MSC. However, the fact it is expressed in cells of the stromal 
and epithelial compartment is interesting, and if further studies demonstrate 
that cells expressing TNAP from both fractions possess stem cell 
characteristics, it may be a common marker for cells involved in the 
endometrial regeneration process, and a good therapeutic target. 
Consequently, further studies are warranted in this area.  
1.5.2.1.2.4 Epithelial stem cell markers 
Unlike the stromal studies, the study of epithelial stem cell markers 
considered the hypothesis that the stem cells should reside in the basalis 
glands, or in the PM epithelium. The basalis markers described above 
(SSEA-1, nuclear SOX9) were the first basalis markers to be presented as 
epithelial ASC markers, in 2013. The recent work also suggests N-cadherin 
to be another basalis marker. These studies, however, are based on the 
presumption that human endometrial glandular architectural arrangement is 
a single blunt ended tube, which is yet to be confirmed in 3D reconstruction. 
Particularly the latter study suggests; the deeper in the glandular base the 
cells are, the more likely they are to be marking the more primitive cell, i.e. a 
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hierarchical arrangement depending on the location within the presumed 
single tubular, blind-ended structure (Nguyen, Xiao et al. 2017). Hence, the 
localisation of these need to be re-examined with the 3D architectural re-
modelling of the endometrial glands.      
1.5.2.2 In Vitro Functional studies 
1.5.2.2.1 Colony forming units, clonogenicity 
In 2004, clonogenicity (the ability of a single cell to form colonies, a key 
feature of stem cells) of endometrial derived cells was demonstrated, this 
suggested a definitive stem cell phenotype (Chan, Schwab et al. 2004). 
Epithelial and stromal cells from the endometrium were seeded at clonal 
density, and cloning efficiency (CE) was assessed in vitro. The resulting 
colonies of endometrial cells were of two types; one large tightly-packed, and 
one, more common, smaller dense type. Endometrial epithelial colony 
forming units (CFU) could be cultured in a serum-free medium, containing 
EGF, or transforming growth factor-α, this suggested that they express EGF 
receptors (Chan, Schwab et al. 2004, Schwab, Chan et al. 2005, Gargett 
2006). The stem cell niche was shown to be important to endometrial 
epithelial progenitor cell activity, as mouse fibroblast feeder layers were 
required for serum-free clonal culture. The CE of epithelia was 0.22 ± 0.07%, 
and stroma had an overall CE of 1.25 ± 0.18%. The smaller colonies were 
thought to represent transient amplifiers (TAs); they were more common and 
had limited self-renewal. The larger colonies were assumed to represent 
primitive ASCs; they were less common and more proliferative. This proposal 
is not fully consistent with progenitor cells having higher proliferative activity 
and primitive stem cells being more quiescent. Furthermore, stem cells 
(particularly epithelial) are likely to differentiate rapidly when removed from 
their niche, therefore, they may not necessarily produce larger colonies in in 
vitro culture after tissue disruption and isolation in to single cells.  
Follow-up studies on epithelial CFU indicated that individual large CFU had 
substantial self-renewal activity when seeded at very low density (10 
cells/cm2), compared to small CFUs (large CFU subcloning 2.9 times vs 
small CFU 0.5 times) (Gargett, Schwab et al. 2009). When cultured in 
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Matrigel the large epithelial CFU differentiated into large cytokeratin-
expressing gland-like structures, although the low power phase micrographs 
of these structures grown on 3D matrix presented in this particular 
manuscript is less persuasive of the claim (Gargett, Schwab et al. 2009).  
This work concluded that endometrial epithelial progenitors were represented 
in the large CFU with the ability to self-renew and differentiate in vitro, and 
the small CFU potentially to be initiated by more mature TA cells. 
1.5.2.2.2 Side population 
SP cells (0–5%) have been identified in fresh isolates (Tsuji, Yoshimoto et al. 
2008, Cervello and Simon 2009, Masuda, Matsuzaki et al. 2010) and short-
term cultures (Kato, Yoshimoto et al. 2007) of human endometrial cells. The 
percentage of SP cells in single cell endometrial suspensions derived from 
different patient samples were reported to be highly variable between 
individuals. However, higher numbers seemed to be found in the menstrual 
(Kato, Yoshimoto et al. 2007) and proliferative (Tsuji, Yoshimoto et al. 2008, 
Masuda, Matsuzaki et al. 2010) stages of the cycle. This percentage 
variability was also mirrored by CFU activity in human endometrium. There is 
no consensus as to whether the absolute number of SP cells are stable 
throughout the menstrual cycle or not, in agreement with the concept that 
ASCs, being a small, quiescent and static, resident population (Masuda, 
Matsuzaki et al. 2010), the decline of SPs in the secretory phase may result 
from dilution as the functionalis grows, and increases in thickness. When SP 
cells (freshly sorted) showed little growth in culture, the authors argued that 
this was secondary to them being quiescent (most of the cells (85%), being 
in G0 phase of the cell cycle). This is a proposed feature of ASCs, but, in 
contrast, the SP cells sorted from endometrial short-term cultures were, 
primarily, in G1 and G1/M/S phases (Tsuji, Yoshimoto et al. 2008). 
Endometrial SP cells sorted from short-term cultures did not express 
endometrial epithelial (CD9), or stromal (CD13) cell differentiation markers to 
start with, but these markers were re-expressed in subsequent long-term 
Matrigel cultures, indicating a capacity to differentiate into CD9+E-
cadherin+ gland-like organoids (suggesting epithelial differentiation), and 
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CD13+ stromal clusters, when cultured for a further 2 months on collagen 
coated dishes (Kato, Yoshimoto et al. 2007). However, even FACS, the most 
efficient sorting method available, does not have 100% efficiency. Therefore, 
particularly in long-term culture, the small percentage of both epithelial and 
stromal cells that are likely to have been contaminating the initial SP 
population (although the authors reported that they do not express 
epithelial/stromal markers) are likely to have expanded. The other reports 
examining the endometrial SP show SP cells in both the stromal, and 
epithelial population (Cervello, Gil-Sanchis et al. 2010, Masuda, Matsuzaki et 
al. 2010, Cervello, Mas et al. 2011). Furthermore, it is known that 
endometrial cells in 2D culture lose their phenotypical markers and undergo 
culture related changes, thus, cultured cells may have lost their markers, but 
regain them in the more physiologically relevant growth environment; the 3D 
matrix. Finally, the achievement of single cell suspension from the solid 
tissue samples that is necessary for cell sorting (e.g. enzymatic digestion) 
will remove the cell surface proteins, which will later be re-formed in cells 
with prolonged culture. All these issues needed to be considered when the 
current literature was interpreted. The sorted short-term cultured SP cells 
were able to be maintained in culture for 3 months, whereas the non-SP cells 
sorted from the short term cultured SP cells became senescent within 3 
months (Kato, Yoshimoto et al. 2007). This evidence agrees with the 
longevity associated with ASCs as opposed to differentiated cells. 
To demonstrate their functional potential, cultured endometrial SP cells were 
shown to decidualise after treating with oestradiol and progesterone, 
therefore confirming their ability to assume the morphologic, and functional, 
changes characteristic of the secretory endometrium (Tsuji, Yoshimoto et al. 
2008). 
Additionally, by differentiating into adipocytes and osteoblasts in vitro, 
endometrial epithelial SP cells have been demonstrated to be multipotent 
(Cervello, Gil-Sanchis et al. 2010). After 2 weeks in culture, the authors 
reported the presence of Oil Red O lipid vacuoles in adipogenic induction 
media (but the round morphology typical of adipocytes was not seen). 
Similarly, in osteogenic induction media, positive immuno-reactivity for bone 
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sialoprotein was reported. Once again, this evidence is intriguing, and needs 
to be considered with the possibility of contamination with stromal cells 
(which are known to have the ability to differentiate in the mesenchymal 
lineages). Further evidence has been produced by Kurita et al., with their 
elegant set of xenograft experiments, demonstrating the adult endometrial 
epithelium to be lineage specific (Kurita, Cooke et al. 2001).   
Masuda et al., demonstrated unipotency of the endometrial epithelial SP 
cells in vitro by injecting them under the mouse kidney capsule (mesodermal 
derivative), and generating endometrial tissue; those cells did not 
differentiate into kidney parenchyma (Masuda, Matsuzaki et al. 2010). This 
unipotency was echoed with work showing that SSEA-1 positive cells grown 
in a chimeric explant model, using kidney tissue isolated from CD1 neonatal 
mice, injected under the kidney capsule, produced endometrial gland like 
structures staining positive for endometrial differentiation markers (Matthew 
2013). 
Serum oestradiol levels have been shown to change in the same manner as 
the proportion of SP cells in postpartum mice, perhaps indicating that 
oestrogen is a prerequisite for increasing SP cells (Xu, Hu et al. 2011). This 
finding of increased oestrogen was confirmed within a mouse endometrial 
injury model, stromal SP cells significantly increased 6 hours after injury, but 
they were dependent on oestrogen, not progesterone or a combination of 
oestrogen and progesterone (Hyodo, Matsubara et al. 2011). 
1.5.2.3 In vitro studies utilising functional assays 
1.5.2.3.1  Differentiation 
Differentiation potential, the ability of a stem cell to produce differentiated 
progeny, is a stem cell property. Most work assessing multipotency of 
endometrial cells has focused on the stromal population, due to the greater 
abundance in endometrial tissue, and difficulties with epithelial culture. 
Furthermore, the tissue reconstruction studies have shown interesting data 
on endometrial cellular plasticity. The endometrial epithelial phenotype is 
driven by the stromal component in the neonatal mice (Cunha 1976, Kurita, 
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Cooke et al. 2001), but in tissue reconstruction experiments the authors have 
shown that uterine epithelial cells from adult mice, when transplanted with 
mesenchymal cells of adult vagina, did not change their original simple 
columnar uterine phenotype. After 1 month of in vivo growth, adult uterine 
epithelial cells, recombined with vaginal mesenchymal cells, remained simple 
columnar. Thus, differentiation of adult uterine epithelium was unresponsive 
to induction by vaginal mesenchyme (Kurita, Cooke et al. 2001).  
In adult tissue, epithelium drives the phenotype despite the stroma, 
suggesting that stroma retains the plasticity and epithelia does not. 
Therefore, the epithelium should be the driving force in endometrial 
regeneration.  
1.5.2.3.2 Menstrual blood stem cells 
In 2007, menstrual blood was used to obtain endometrial stromal ASCs, and 
these were capable of differentiation into adipocytes, osteoblasts, 
chondrocytes, cardiocytes, myocytes, and endothelia. These menstrual 
blood stromal ASCs were also capable of trans-differentiation into 
endodermal and ectodermal tissue, such as hepatocytes, pulmonary 
epithelia, and neurones. The ASCs were mononuclear, and demonstrated 
positive immuno-reactivity for CD90, CD73, and CD103, but were devoid of 
CD34, and CD45, suggesting the cells are of mesenchymal, not 
haematopoietic origin (Meng, Ichim et al. 2007). Menstrual blood derived 
stem cells are an attractive target as a treatment for many diseases, 
secondary to their ease of collection and autologous nature (Borlongan, 
Kaneko et al. 2010). The use of autologous cells for the subacute phase of 
stroke offers practical clinical application (Kaneko, Dailey et al. 2013). When 
grown in appropriate conditioned media, they express neuronal phenotypic 
markers (Nestin, MAP2), and in an in vitro stroke model of oxygen glucose 
deprivation, it was found that oxygen glucose deprived-exposed primary rat 
neurons, that were co-cultured with menstrual blood-derived stem cells, or 
exposed to the media collected from cultured menstrual blood, exhibited 
significantly reduced cell death. Transplantation of menstrual blood-derived 
stem cells (either intracerebrally, or intravenously, and without 
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immunosuppression) into a rat model of ischaemic stroke, significantly 
reduced behavioural and histological impairments, compared to vehicle-
infused rats, supporting the use of menstrual blood-derived cells as a stem 
cell source for cell therapy in stroke (Borlongan, Kaneko et al. 2010, 
Rodrigues, Glover et al. 2011, Kaneko, Dailey et al. 2013, Azedi, 
Kazemnejad et al. 2014) and other basal ganglia disorders, such as 
Parkinson`s and Huntington`s disease (Rodrigues, Voltarelli et al. 2012). 
Sepsis (in the cecal ligation and puncture mouse model) has also shown to 
have improved outcomes when menstrual derived stem cells are utilised in 
the treatment regime, alongside antibiotics. Menstrual derived stem cells, in 
synergy with antibiotics, improved the survival rate (95%) in comparison; with 
saline (6%); antibiotics alone (73%); and menstrual derived stem cells alone 
(48%); concluding that menstrual derived stem cells could constitute a 
feasible approach for the future clinical treatment of sepsis (Alcayaga-
Miranda, Cuenca et al. 2015). 
A mouse model of premature ovarian failure, treated with menstrual blood 
stem cells, expressed higher levels of ovarian markers (AMH, inhibin α/β and 
FSH receptor), and the proliferative marker Ki67. In addition, the overall 
weight, plasma oestrogen level, and number of normal follicles increased 
overtime compared with controls (Liu, Huang et al. 2014). 
Menstrual blood stem cells have been differentiated into hepatocyte-like 
cells, and demonstrated in vitro mature hepatocyte functions such as urea 
synthesis, glycogen storage, and indocyanine green uptake; leading to their 
potential to be used in chronic liver disease (Mou, Lin et al. 2013, Khanjani, 
Khanmohammadi et al. 2014, Khanjani, Khanmohammadi et al. 2015). 
The type 1 diabetes mellitus mouse model was used to show the therapeutic 
effects of menstrual blood stem cells on the mechanism of β-
cell regeneration after transplantation. The menstrual blood stem cells 
reversed hyperglycaemia and weight loss, prolonged lifespan, and increased 
insulin production in the diabetic mice. The mice recovered islet structures 
and increased their β-cell number, with the majority of the menstrual blood 
stem cells migrating into the damaged pancreas, and being located at the 
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islet, duct, and exocrine tissue. The menstrual blood derived stem cells were 
found to enhance neurogenin3 expression (represents endocrine 
progenitors), rather than differentiate into insulin-producing cells, concluding 
that they stimulated β-cell regeneration through promoting differentiation of 
endogenous progenitor cells (Wu, Luo et al. 2014). 
Menstrual blood derived stem cells have also been proposed to be used for; 
bone tissue-engineering purposes (taking advantage of their osteogenic 
driving potential) (Darzi, Zarnani et al. 2012); dermatological lesions and 
diseases (Faramarzi, Mehrabani et al. 2016); heart muscle repair (Hida, 
Nishiyama et al. 2008); limb ischaemia (Murphy, Wang et al. 2008); and 
muscular dystrophy (Cui, Uyama et al. 2007).   
More recently it has been shown that these MSCs derived from menstrual 
blood have the ability to secrete decidualisation markers (prolactin and 
insulin-like growth factor binding protein-1), and differentiate into 
decidualised cells, leading to the potential of a therapy for decidualisation 
insufficiency (Domnina, Novikova et al. 2015). When cultured in 
differentiation-inducing media supplemented with 20% human follicular fluid, 
the human menstrual blood stem cells form oocyte-like cells and express 
germ cell markers. Cells also expressed FSH and LH receptors, and 
produced oestrogen and progesterone regulated by gonadotrophin 
suggesting a potential to differentiate in to ovarian tissue (Lai, Guo et al. 
2016). The exact origin of these cells (endometrial or bone marrow derived) 
however, is not known. 
1.5.2.3.3  Differentiation potential of endometrial stromal stem cells 
In 2009, endometrial stromal ASCs were shown to be capable of multi-
lineage differentiation into fat, bone (confirmed with presence of osteopontin, 
ostenectin and alkaline phosphatase) (Azami, Ai et al. 2013), cartilage, 
skeletal muscle (Gargett, Schwab et al. 2009, Fayazi, Salehnia et al. 2015), 
and smooth muscle (expressing specific smooth muscle cell markers 
including α-smooth muscle actin, desmin, vinculin and calponin) (Shoae-
Hassani, Sharif et al. 2013). Plasticity has also been shown by the trans-
differentiation of endometrial stromal ASCs into neural (neural and glial 
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lineage markers such as Nestin, NF-L, MAP2, PDGFRa, CNP, Olig2, MBP 
and GFAP) (Ebrahimi-Barough, Hoveizi et al. 2015, Fayazi, Salehnia et al. 
2015), Schwann cells (expression of S100 and P75 noted) (Bayat, Ebrahimi-
Barough et al. 2016), Oligodendrocytes (Ebrahimi-Barough, Kouchesfahani 
et al. 2013), pancreatic cells (shown by secretion of insulin and markers of β 
cells such as PDX1, proinsulin and c-peptide) (Santamaria, Massasa et al. 
2011, Niknamasl, Ostad et al. 2014), urinary bladder epithelial cells 
(urothelium, as tested by urothelium-specific genes and proteins, uroplakin-
Ia/Ib, II, III and cytokeratin 20) (Shoae-Hassani, Mortazavi-Tabatabaei et al. 
2015), hepatocytes (biomarkers albumin and cytokeratin 8, reduced alpha-
fetoprotein and alpha smooth muscle actin expression, synthesised urea, 
and stored glycogen) (Snykers, De Kock et al. 2009, Yang, Wang et al. 
2014), and megakaryocytes (identified by expression of CD41a and CD42b 
and reduction of pluripotent transcription factors Oct4 and Sox2, platelets 
were seen and functional as evidenced by the up regulation of CD62p 
expression and fibrinogen binding following thrombin stimulation); both in 
vitro, and in animal models (Wang, Chen et al. 2012, Khademi, Soleimani et 
al. 2014). 
Animal models of Duchenne muscular disease (Toyoda, Cui et al. 2007), 
stroke (Allickson, Sanchez et al. 2011), diabetes (Wu, Luo et al. 2014), 
Parkinson`s disease (Wolff, Gao et al. 2011, Wolff, Mutlu et al. 2015), and 
critical limb ischemia (Murphy, Wang et al. 2008) suggest endometrial 
stromal ASCs improve outcomes. 
1.5.2.3.4 Differentiation potential of endometrial epithelial stem cells 
Unipotency was shown in epithelial cells in 2009 by differentiating 
endometrial epithelial ASCs into CK+ gland-like structures, in 3D Matrigel 
(Gargett, Schwab et al. 2009). An assessment of multipotency was not 
possible as epithelial cells were unable to grow to confluency. Intriguingly, as 
mentioned earlier, endometrial epithelial SP cells have been demonstrated to 
be multipotent by differentiating into adipocytes and osteoblasts in vitro 
(Cervello, Gil-Sanchis et al. 2010). Adult human endometrial epithelial cells 
are expected to be committed to an endometrial phenotype, therefore, they 
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are presumed to not have the potential for differentiating in to other lineages. 
In our laboratory, the kidney-endometrium human-mouse chimera, supported 
growth of kidney structures from mouse cells, and endometrial gland like 
structures by human endometrial epithelium demonstrated uni-potency of 
these cells (Mathew, Drury et al. 2016).   
1.5.2.3.5  Label retaining cells 
Locating LRC in animal subjects (as BrdU is a recognised health hazard, and 
the use of the LRC technique in humans is not permitted) is a method of 
identifying somatic stem/progenitor cells and their location in the stem cell 
niche when specific markers are unknown. This method relies on the 
infrequent cell turnover of most ASCs, in comparison to rapidly proliferating 
TA cells (Chan and Gargett 2006, Gargett 2007). Mouse endometrium was 
pulse labelled with BrdU and studied after an 8-week chase to identify 
endometrial LRC. 
1.5.2.3.5.1 Epithelial LRCs 
3% of the epithelial nuclei were BrdU+and were located in the LE. They were 
shown to be negative for ERα through dual labelling IF, providing evidence 
that LE stem/progenitor cells are responsible for the growth of glands during 
development and in cycling mice (Chan and Gargett 2006). In 
ovariectomised prepubertal mice the first cells to proliferate in oestrogen-
stimulated endometrial growth differed from ovariectomised cycling mice, in 
the first, the epithelial LRC proliferated, suggesting they function as 
stem/progenitor cells to initiate epithelial regeneration; while in the second 
epithelial LRC and non-LRC rapidly proliferated to regenerate LE and 
glandular epithelium (Chan and Gargett 2006). Using a mouse model with 
menstrual breakdown and repair, ERα negative glandular epithelial LRC 
contributed to repair of the LE, following menstruation, post progesterone 
withdrawal (Chan, Kaitu'u-Lino et al. 2012). Endometrial repair occurred in 
the absences of oestrogen (Chan, Kaitu'u-Lino et al. 2012). BrdU+ epithelia 
was lost soon into the chase period, leading to the thoughts that the epithelial 
regeneration could be relying on the self-duplication of a mature epithelial 
cell type, or that the LRC technique is not sensitive enough to label 
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endometrial epithelial cells with an ASC phenotype (Cervello, Martinez-
Conejero et al. 2007). 
1.5.2.3.5.2 Stromal LRCs 
Between 6-9% of the stroma were LRCs located just below the LE, at the 
endo-myometrial junctions, or near blood vessels (Chan and Gargett 2006, 
Cervello, Martinez-Conejero et al. 2007), with 84% of them being ERα 
negative. The cells were found to not be leucocytes (CD45 staining), or 
endothelia (CD31 staining) (Chan and Gargett 2006). BrdU+ cells 
surrounding blood vessels were positive for alpha smooth muscle actin (α-
SMA) making it probable that these cells represent pericytes. In some 
studies, 0.6% of stromal LRCs co-expressed OCT4 (a pluripotency marker) 
and c-kit (a haemopoietic stem cell marker) (Cervello, Martinez-Conejero et 
al. 2007), so they were potentially in an undifferentiated state; but in others 
neither Sca-1 (Chan and Gargett 2006) nor c-kit (Szotek, Chang et al. 2007) 
were expressed. 
Oestrogen was shown to drive epithelial LRC proliferation in juvenile 
development, but had a minimal role in epithelial and stromal LRC cyclical 
regeneration, perhaps indicating that BrdUˉ/ERα+ cells release paracrine 
factors to mediate a LRC response (Chan, Kaitu'u-Lino et al. 2012).  
A relationship between stromal and epithelial ASCs was seen when stromal 
SP cells were transplanted under the kidney capsule in mice. Only 
endometrial stroma was formed, and when epithelial SP cells were 
transplanted, only epithelia was formed. Endometrial-like tissue was only 
generated when both these populations were combined. This would suggest 
two distinct ASCs exist; a stromal and an epithelial ASC (Cervello, Mas et al. 
2011). 
1.5.2.3.6 Bone marrow as a source of endometrial ASCs 
Bone marrow, as a source of endometrial regeneration, is supported by the 
ability of bone marrow derived MSC to produce ‘decidua-like’ stroma, after 
activation of the PKA pathway in vitro (Aghajanova, Horcajadas et al. 2010); 
together with bone marrow derived cells being found in the decidua of normal 
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murine pregnancy (Lysiak and Lala 1992). Co-culture of bone marrow 
derived cells with endometrial stromal cells, and oestrogen stimulation, 
resulted in CK+ endometrial epithelial like cells (Zhang, Cheng et al. 2012).  
When male bone marrow derived cells were transplanted into female mice, 
and Fluorescence in situ hybridisation of the mice endometrium was 
completed, Y-chromosomes were present in a tiny 0.0002% of CD45-/F4/80- 
epithelial cells, and 0.0003% of CD45-/F4/80- stromal cells (Du and Taylor 
2007). In another set of experiments, samples from female mice harvested 
40 days after a haematological stem cell transplant, showed that 6% average 
donor-derived ECs were detected, concluding that bone marrow-derived 
endothelial progenitors contribute to the formation of new blood vessels in 
the endometrium (Mints, Jansson et al. 2008). 
In a study of Human leucocyte antigen mismatch transplant, donor-derived 
endometrial cells were detected in endometrial biopsy samples from all bone 
marrow recipients, and accounted for a wide range (0.2% to 48%) of 
epithelial (displaying CD9 marker), and stromal cells (0.3% to 52%) (vimentin 
positive) (Taylor 2004, Ikoma, Kyo et al. 2009, Cervello, Gil-Sanchis et al. 
2012). SP cells were not shown to be formed by XY donor-derived cells 
(Cervello, Gil-Sanchis et al. 2012). 
Therefore, the evidence presented above may suggest bone marrow to also 
be a source of endometrial regeneration, but its contribution seems to be 
low. It is likely that bone marrow could be implicated in endometrial repair 
after times of massive injury, such as ablation, and in the formation of the 
decidua; when the endometrium requires ‘extra-assistance’. 
In a much more recent study, authors were characterising bone marrow 
derived cells in the endometrium of mice transplant recipients, and found no 
evidence of bone marrow derived stroma, epithelium or endothelium. All of 
the cells that were detected in the endometrium were immune cells 
expressing the pan-leukocyte marker CD45, including CD3+ T cells and 
F4/80+ macrophages; immuno-stained weakly for CD45. The macrophages 
were abundant in the stroma, infiltrated the epithelial and vascular 
compartments, and were documented that they could easily be mistaken for 
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bone marrow derived endometrial cells. The authors concluded (in 
disagreement with previous studies) that bone marrow cells are unlikely to 
transdifferentiate into endometrial stroma, epithelium and endothelium. They 
warned of the massive implications, as expectations for bone marrow derived 
endometrial stem cells have been high, with numerous treatment strategies 
discussed previously (Ong, Cousins et al. 2018). 
1.5.2.4 Direct confirmation of the existence of endometrial 
epithelial progenitor cells inferred from gland methylation 
patterns 
Methylation patterns (to represent random replication errors) have been used 
to reconstruct endometrial epithelial cell lineages; with the hypothesis that all 
daughter cells are originating from a common ancestor, and cell divisions 
and ancestry may be surreptitiously recorded by identifying replication errors 
that naturally accumulate in a clock-like manner during aging (increased with 
age), parity (decreased by parity), or BMI (increased with increased BMI) 
(Pike, Pearce et al. 2004, Kim, Tavare et al. 2005).  
In 2003, Tanaka et al used a collagenase based method to isolate 
endometrial glands from the stroma, and extract DNA from individual 
endometrial glands; to examine them for chromosome inactivation patterns 
and determine the clonal constitution of glandular cells, and the LE, in order 
to discuss the presence of endometrial stem cells, as well as endometrial 
carcinogenesis (Tanaka, Kyo et al. 2003). PCR amplification of the CAG 
repeats in the androgen receptor (AR) gene were utilised to assess the 
clonality of the endometrial epithelial cells. The AR linked to the X 
chromosome has a polymorphic short tandem repeat of the trinucleotide 
[CAG]n. 90% of the general population are heterozygous for the length of 
CAG repeats (Allen, Zoghbi et al. 1992, Enomoto, Fujita et al. 1994). 
Methylation of the HhaI endonuclease sites near the CAG repeats correlates 
with X chromosome inactivation (Wolf and Migeon 1982, Allen, Zoghbi et al. 
1992). Digesting samples with the enzyme Hhal generated homogenous 
products derived from either the paternal, or maternal, inactive X 
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chromosome (Hhal can cut the unmethylated sites on an active X 
chromosome, but cannot cut the methylated sited on an inactive X 
chromosome) (Tanaka, Kyo et al. 2003). The results of this experiment, in 7 
of the 10 patients (3 were excluded as the size of the amplification products 
did not differ between the two alleles), showed that DNA recovered from 
almost all of the glands, from each patient, yielded two distinct PCR bands, 
in the absence of HhaI digestion. After Hhal digestion, the DNA yielded a 
single band, indicating the monoclonal cellular composition of the glands. To 
examine if the monoclonal composition is limited to a single gland, or 
extends to the surrounding glands, an endometrial surface area of 25 mm2 
was surgically extracted, subdivided, and glands were isolated from each 
piece for DNA extraction and analysis of clonality. In 15 of the 25 pieces, all 
10 glands isolated from each piece exhibited the same clonality, suggesting 
that glands within a 1mm2 area share clonality, and the monoclonal 
composition of endometrial glands is regionally defined. The remaining 10 
pieces contained glands that exhibited clonality of mixed parental origins. 
The authors are unsure if these pieces contained abutting areas of 
monoclonal groups or one field with both clones integrated. To test clonality 
further, a GFP labelled (on either the maternal or paternal X chromosome) 
mouse model was utilised. Mouse cells that have the transgene on the active 
X chromosome are fluorescent, whereas those that have the transgene on 
the inactive X chromosome are not (Hadjantonakis, Gertsenstein et al. 1998, 
Hadjantonakis, Cox et al. 2001). Individual mouse endometrial glands were 
either fluorescent or nonfluorescent, demonstrating the monoclonal 
composition of glandular cells. Interestingly, the LE had clear boundaries 
between fluorescent and nonfluorescent cell layers, indicating the boundaries 
where epithelial cells with different clonalities, converge (Tanaka, Kyo et al. 
2003). 
The authors concluded that the composition of epithelial cells in human 
endometrium is monoclonal, and monoclonal growth is a hallmark of cancer 
cells. Polyclonal growth is exhibited by normal cells, this signifies that 
endometrial glands must be an exception to the theory and poses the 
suggestion that maybe, secondary to the endometrium being continuously 
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renewing, the cells must be capable of long-term self-maintenance, with the 
properties of stem cells (Tanaka, Kyo et al. 2003). The authors postulated 
that it is likely that stem cells with the same clonality are located in the basal 
layers in each gland, and, therefore, when endometrial cancer develops, this 
would be from the stem cells at the base of the glands. They concluded that 
further analysis is needed to clarify the number of stem cells, and the 
existence of niches, in endometrial glands (Tanaka, Kyo et al. 2003). The 
main criticism of this work is that the method used to extract the epithelial 
glands from the stroma is a method developed for the colon, where the 
glands are blind ending tubes, and have a definitive end. The method, and 
authors, presume that human endometrial glandular architecture is the same 
as the intestine; single tubular architecture with a blind-ended tube. As 
described in the results section of this thesis, this presumption is erroneous. 
Therefore, the same method utilised on the human endometrium could have 
prevented the authors from extracting the whole endometrial glands, which 
are much more complex than the intestinal crypts (tortuous functionalis 
portion of the endometrial glands, and branching interconnecting basalis 
architecture of endometrial glands (Chapter 4) are rather differently 
arranged). This previous study is unlikely to have identified the contribution 
of the glandular bases to their clonality assessment.   
In 2005, Kim et al tracked methylation patterns to assess stem cell progeny. 
The glands were freed from the stroma again with an isolation procedure 
developed for the colon (Potten, Kellett et al. 1992), thus, for the 
aforementioned reasons, the method is unlikely to have isolated all portions 
of the endometrial epithelial fraction, gathering just the functionalis glandular 
portion. The authors proposed methylation patterns in the endometrium, to 
follow the hypothesis that methylation increased after menarche to 
menopause, thereafter, levels were relatively stable, indicating that the 
number of epigenetic marks was a reflection of the mitotic activity of 
endometrial stem/progenitor cells (Kim, Tavare et al. 2005). Different 
methylation patterns were found within the same uterus, this would be 
consistent with individual glands being maintained by distinct stem cell 
niches that evolve independently (Kim, Tavare et al. 2005). Mathematical 
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predictive analysis indicated that individual glands contain stem cell niches 
occupied by several long-lived stem cells. Symmetric and asymmetric cell 
divisions occurred in a stochastic manner, maintaining a constant number of 
ASCs in the endometrial gland niche (Kim, Tavare et al. 2005), and arguing 
against the monoclonality concept that had been previously proposed 
(Tanaka, Kyo et al. 2003). Once again, this method, utilised a gland 
extraction method that is not appropriate for the endometrial glands, but to 
the crypts of the colon, therefore it is not sufficient to conclude on clonality, or 
stem cell arrangement, of the human endometrial epithelium. 
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Chapter 2.  Methods 
2.1  Ethical Approval  
Ethical approval for the study was obtained from Liverpool Adult Research 
Ethics committee (LREC09/H1005/55). Tissue was collected from patients 
who attended Liverpool Women’s hospital (LWH) from 2009-2017 after 
patients gave written informed consent. 
2.2  Collection of human samples 
Human endometrial samples were obtained from 119 women undergoing 
surgery for benign gynaecological conditions (e.g.prolapse), without any 
evidence of endometrial pathology (Table 2.1).  
Sample 
no. Age BMI Smoker Parity 
1 21 25.9 No 0 
2 23 23.5 No 0 
3 24 23.8 No 3 
4 25 20.9 No 0 
5 26 33.4 Yes 2 
6 27 23 No 3 
7 27 33.7 No 2 
8 27 21.1 No 4 
9 27 23 No 5 
10 30 26.7 No 1 
11 31 25.8 Yes 2 
12 31 24.9 No 3 
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13 32 26.6 No 2 
14 32 27.8 Yes 2 
15 33 26.1 No 2 
16 33 27.4 Yes 3 
17 33 32.7 Yes 3 
18 33 25.9 No 5 
19 35 32 No 3 
20 35 24.4 No 1 
21 35 30.5 No 0 
22 35  No  
23 36 23.9 No 4 
24 37 22.8 Yes 2 
25 37 39.2 No 2 
26 37 21.7 No 4 
27 37 25.7 No 0 
28 39 36.9 No 4 
29 39 22.4 Yes 6 
30 37 41.5 No 3 
31 37 26.5 Yes 2 
32 37 30.8 No 2 
33 38 30.8 No 3 
34 38 27.9 No 4 
35 38 26.6 Yes 2 
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36 39 32 Yes 2 
37 39 27.9 No 1 
38 39 26.5 No 2 
39 40 34.7 Yes 3 
40 40 33 No 2 
41 40 33 No 2 
42 40 27.4 No  
43 41 30.7 No 1 
44 41 18.9 Yes 2 
45 41 26.7 Yes 4 
46 41 23.2 Yes 1 
47 42 23.5 No 2 
48 42 25.6 Yes 2 
49 42 22.3 No 2 
50 43 28.6 No 2 
51 43 24.5 No 0 
52 43 26.7 No 2 
53 43 40.5 No 3 
54 43 24.2 Yes 2 
55 43 25.4 No 2 
56 44 24.3 Yes 2 
57 44 30.7 Yes 2 
58 44 32.3 No 1 
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59 44 38 No 2 
60 44 29.6 No 1 
61 44 24.5 No 2 
62 44 30.7 No 0 
63 44 18.7 No 0 
64 44 29.4 No 2 
65 44 30.7 Yes 2 
66 45 36.4 No 3 
67 45 22.5 No 2 
68 45 31.6 No 0 
69 45 26.1 No 0 
70 45 21.7 Yes 4 
71 46 23.1 No 3 
72 46 25.4 Yes 1 
73 46 26.2 No 3 
74 46 26.8 No 5 
75 47 30.2 No 3 
76 47 21.6 No 2 
77 47 32.4 No 5 
78 47 22.6 No 0 
79 47 25 No 1 
80 47 23.4 No 1 
81 47 25.8 No 2 
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82 47 29.4 No 2 
83 47 24.2 Yes 0 
84 47 29.8 No 2 
85 48 28.6 No 2 
86 48 29.9 No 4 
87 48 37.3 No 2 
88 48 40.1 No 3 
89 49 24.4 No 2 
90 49 23.2 No 0 
91 49  Yes 2 
92 49 28.4 No 2 
93 49 27.6 No 3 
94 50 20.3 No 3 
95 50 21 No 4 
96 52 24.5 No 2 
97 52 26.3 No 2 
98 52 39.6 No 2 
99 58 20 No 2 
100 60 31 No 2 
101 60 26.9 Yes 5 
102 61 27.7 No 4 
103 62 28.3 No 3 
104 61 32.2 No 4 
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105 62 27.4 No 1 
106 65 28.8 Yes 3 
107 65 18.5 No 2 
108 66 24.9 No 3 
109 66 24.9 No 3 
110 67 32.8 No 4 
111 69 24.7 No 4 
112 69 26.8 No 3 
113 72 35.8 No 3 
114 74 32 No 3 
115 74 35.6 No 3 
116 75 29.6 No 2 
117 76 25.2 No 2 
118 77 26.6 No 2 
119 78 26.8 No 4 
 
Table 2.1 - Demographical details of the patients involved in the study. 
 
Endometrial and Fallopian tube biopsies were collected, in the theatre, by 
trained members of the clinical research team, immediately after completion 
of hysterectomy (full thickness sample), or following gynaecological surgery 
where the uterus was not removed (pipelle sample). Full thickness “wedge” 
biopsies from normal pre or post menopausal (PM) endometrium were 
obtained by cutting a thin slice of endometrium, attached to underlying 
myometrium, straight after opening the anterior aspect of the uterus, in the 
coronal plane. Pipelle biopsies were obtained with a suction pipelle 
(Laboratoire C.C.D., Paris, France) (Figure 2.1 A and B) placed into the 
endometrial cavity; after gentle scraping, the inner piston of the pipelle was 
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withdrawn, allowing tissue to be sucked into the pipelle under the effect of 
vacuum. Fallopian tube biopsies were obtained from the fimbrial end of the 
fallopian tube, by cutting a slice from the end of one of the Fallopian tubes. 
 
Figure 2.1 (A) – Photograph of Pipelle®, flexible polypropylene suction 
cannula packaging. (B) Photograph of pipelle suction cannula with an outer 
diameter of 3.1 mm. 
 
Collected samples were split into 3-4 containers, depending on the size of 
the sample and the experiments to be performed: 15 mL neutral buffered 
formalin (NBF; Sigma-Aldrich, Dorset, UK), to fix and preserve tissues for 
subsequent histology processing; 0.5 mL RNAlater (Sigma-Aldrich, Dorset, 
UK), to permeate the tissue in order to stabilise and protect cellular RNA for 
subsequent RNA extraction; 15 mL phosphate buffered saline (PBS) (Sigma-
Aldrich, Dorset, UK), to remove excess blood prior to snap freezing; and 15 
mL Dulbecco's Modified Eagle Medium (DMEMF12) culture medium (Sigma-
Aldrich, Dorset, UK), for explant culturing.  
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2.3  Tissue preparation 
2.3.1 Formalin fixed paraffin embedded sample 
preparations 
2.3.1.1 Tissue processing 
To avoid autolysis, all samples collected were preserved in 10% NBF directly 
after collection, and processed after 1-5 days at 4°C in an automated tissue 
processor (ShandonHistoCentre3, Thermo Fisher, Cheshire, UK). During 
processing, the tissue samples were dehydrated automatically inside the 
processor, through increasing concentrations of ethanol, before the 
cassettes were incubated in xylene (the clearing agent, replacing the 
dehydrant, with a substance miscible with the paraffin), and impregnated with 
paraffin (the embedding agent). 
2.3.1.2 Tissue embedding 
An embedding platform (ShandonHistoCentre3, Thermo Fisher, Cheshire, 
UK) was used to manually prepare paraffin tissue blocks for sectioning. 
Following tissue processing, the paraffin impregnated tissue samples were 
removed from the processing cassettes, orientated in pre-warmed metal 
block moulds, and fully immersed in paraffin. Any air bubbles trapped in the 
liquid paraffin were removed by gentle tapping. A fresh tissue cassette was 
placed on top of the paraffin and, after labelling (specimen number and 
date), the blocks were left on a cold plate until set, and kept in the freezer (-
20°C) overnight (or for at least 30 minutes) prior to sectioning. 
2.3.1.3 Tissue Sectioning 
The formalin fixed paraffin embedded sample (FFPE) sections (3-4 µm), 
were cut using a Microtome (Leica RM2255 Rotary Microtome, Leica, 
Wetziar, Germany), before being floated in a pre-warmed water bath (37°C), 
left for a few minutes (to remove wrinkles), and collected on 3-
Aminopropyltriethoxysilane (APES) coated glass slides (charged slides 
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provide adhesion for tissue sections), and left to dry at room temperature 
(RT) overnight. 
2.3.1.3.1 RNA free sectioning 
When undertaking In situ hybridisation (ISH) experiments, FFPE samples 
were cut in RNase-free conditions to maintain the signal, and decrease 
background. Prior to sectioning, the microtome and water bath were cleaned 
with RNASEZAP™ (Sigma-Aldrich, Dorset, UK), the water was changed in 
the water bath, and the slides were cut onto RNase-free slides (Superfrost, 
Fisher Scientific, Cheshire, UK). Samples were cut as per sectioning (see 
above), but dried in a box pre-treated with RNASEZAP™ to minimise 
contamination.  
2.3.2 Frozen tissue processing 
Tissue was snap frozen in liquid nitrogen, and stored at -80°C until 
sectioning was required.  
2.3.2.1 Cryo-sectioning 
The frozen samples were sectioned at 12 µm onto Membrane Slides 1.0 
PEN (D) (Carl Zeiss, Oberkochen, Germany) for enzyme histochemistry and 
laser capture micro dissection (LCM), in RNase-free conditions, on the 
Shandon Cryotome FE (Thermo Fisher Scientific, Cheshire, UK). The frozen 
sections cut for Hematoxylin and Eosin (H&E) staining were sectioned onto 
3-Aminopropyltriethoxysilane (APES) coated glass slides slide at 10 µm, 
before being stored at -80°C prior to staining.  
2.3.3 Cycle staging 
The premenopausal endometrial tissue specimens were phase typed 
according to: the patient`s reported last menstrual period (LMP); histological 
criteria (Noyes, Hertig et al. 1975, Dallenbach-Hellweg 2012) (the H&E 
section was examined); review of the official pathological report. 
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2.4  Messenger RNA (mRNA) expression and 
quantification 
2.4.1 RNA isolation 
Preliminary isolation of RNA is critical as it determines the reliability of all 
experimental results performed downstream. The TRIzol/chloroform 
extraction technique performed, is based on protein denaturation and RNase 
inactivation by guanidinium isothiocyanate, followed by an acid 
phenol/chloroform phase separation. Guanidine isothiocyanate was used 
because it is a chaotropic salt; it destabilises hydrogen bonds, van der Waals 
forces, and hydrophobic interactions. Proteins, including nucleases, are 
destabilised, and the association of nucleic acids with water is disrupted, 
thus allowing optimum conditions for the transfer to silica. The spin cartridges 
used to isolate RNA contained a clear silica-based membrane, and the RNA 
in the lysed sample is bound to this membrane. The chaotropic salts 
enhance and influence the nucleic acid, binding to silica, along with the 
alcohol. Extracted RNA should be bound to the membrane, and the 
impurities (protein and polysaccharides) pass through after centrifugation of 
the lysate. To release the pure RNA from the silica, water was added (the 
preferred dilutent), RNA readily dissolves in water.  
2.4.1.1 Extraction 
Total RNA was extracted from frozen and RNA-later endometrial and 
Fallopian tubes, using the Pure Link RNA mini Kit (Invitrogen LTD., Paisley, 
UK) following the manufacturer`s protocol. 
Firstly, the extraction hood, pipettes, and all other equipment were 
thoroughly cleaned with 1% Chemgene (Medimark Scientific, Kent, UK), 
followed by 70% ethanol, and finally RNASEZAP™. The Ultra-Turrax 
homogeniser (Sigma-Aldrich, Dorset, UK) was assembled, and washing 
tubes were readied to clean the homogeniser between each sample 
extraction (5 mL tubes each containing TRIzol or 70% ethanol, one is 
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required per sample). An RNA free 5 mL bijoux, and a 1.5 mL tube were pre 
labelled for each sample (sample, name, and date), and the Eppendorf 5424 
microcentrifuge (Thermo Fisher Scientific, Loughborough, UK) was pre-
cooled to 4°C. SHIELDskin CHEM gloves (Appleton Woods, Birmingham, 
UK) were worn and changed regularly to protect from the reagents (gloves 
were changed immediately after handling choloroform, or any spillage, as the 
break through time was only 4 minutes). The RNA-later samples were 
homogenised in 1 mL of TRIzol reagent (Thermo Fisher Scientific, 
Loughborough, UK ), with the resulting cell lysate being transferred to the pre 
labelled 1.5 mL tube, and incubated at RT for 5 minutes, before being placed 
on ice. Following homogenisation, 200 µL of chloroform (Sigma-Aldrich, 
Dorset, UK) was added to each sample, and the samples were shaken 
vigorously for 15 seconds before incubation at RT for 5 minutes. Samples 
were centrifuged at 12,000 g for 15 minutes at 4°C while spin columns and 
recovery tubes were appropriately labelled. The upper aqueous phase, 
containing RNA, was transferred to a new RNAse-free tube, and an equal 
volume of 70% (v/v) ethanol was added and vortexed.  
2.4.1.2 Purification 
Approximately 700 µL of the RNA/ethanol solution was transferred onto a 
Pure Link RNA mini Kit spin column (all was eventually transferred), and 
centrifuged at 12,000 g, at 18°C for 30 seconds. The flow through was 
discarded, and the rest of the sample was transferred into the column and 
spun again at 12,000 g at 18°C for 30 seconds. The RNA binds to the silica 
based membrane in the spin cartridge during purification. The bound RNA 
was washed by adding 700 μL of wash buffer I and centrifuging at 12,000 g 
for 15 seconds at 18°C; followed by two washes and centrifuge spins with 
500 μL of wash buffer II to dry the membrane with the attached RNA. The 
spin column was then transferred to a recovery tube and 30 μl of RNase-free 
water was added to the centre of the column and left for 1 minute. The 
sample was then centrifuged for 2 minutes at 18°C at 12,000g, and the 
column discarded as the RNA had been released from the column 
membrane and passed in to the recovery tube. 2 µL of the purified RNA was 
removed from each sample for NanoDrop ND-1000 (Thermo Fisher 
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Scientific, Loughborough, UK) quantification, and 8 µL was removed for 
DNase treatment, the remaining purified RNA was stored at -80°C. 
2.4.1.3 Quantification 
A NanoDrop ND-1000 was used to confirm RNA concentrations and purity 
spectrophotometrically at the 260/280nm ratio (2 was considered suitable for 
further experiments). 
2.4.1.4 DNase treatment 
Prior to transcriptase reactions, to remove any contaminating genomic DNA, 
8 μL of purified RNA was treated with 1 μL of DNase I enzyme (NEB, 
Hertfordshire, UK) in the presence of 1 μL (10×) DNase I reaction buffer 
(NEB, Hertfordshire, UK), this was incubated for 30 minutes at 42°C. 
Following this, 1 μL of EGTA (Promega, Hampshire, UK) was added, and a 
further incubation for 10 minutes at 65°C was performed to stop the reaction. 
2.4.1.5 First strand DNA synthesis 
RNA needs to be converted to cDNA before PCR can be undertaken. In 
order to remove secondary structures that could impede long cDNA 
synthesis, 0.3 -1 μg of purified total RNA was denatured at 70°C for 5 
minutes (with 2 μL Oligo (dT) and RNAase free water to make up to 8 μL) 
then immediately cooled on ice (to stop the reaction). 10 μL of 2x reaction 
mix and 2 μL of AMV reverse transcriptase RT (NEB, Hertfordshire, UK) was 
added to make the total volume 20 μL. The 20 µL mixture was incubated at 
25°C for 5 minutes, and 42°C for 60 minutes, for maximum yield and length, 
and then further heated to 80°C for 5 minutes to stop the reaction. Samples 
were diluted to 50 µL by adding 30 µL of RNase free water, and stored at -
20°C. 
2.4.1.6 Polymerase chain reaction 
Polymerase chain reaction (PCR) was used to amplify specific sequences of 
cDNA by million folds, using sequence specific oligonucleotides, heat stable 
DNA polymerase, and thermal cycling. PCR amplifies DNA exponentially; 
doubling the number of target molecules with each amplification cycle. 
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Thermal cycling is based on three major steps: Denaturation, high 
temperatures break the hydrogen bonds between complementary DNA 
strands to form single stranded DNA (the highest temperature the DNA can 
withstand is 95°C); Annealing, depending on the calculated melting 
temperature (Tm) of the primers (usually 5°C below Tm), short 
complementary sequences attach to the target DNA template; Elongation of 
the annealed primer by Taq polymerase to form a new strand of DNA, primer 
extension occurs at a rate of up to 100 bases per second at the optimum 
temperature (70-72°C).  
2.4.1.6.1  Reverse transcriptase quantitative polymerase chain reaction 
Reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) is 
used to simultaneously detect a specific DNA sequence in a sample, and 
determine the sequences copy number relative to a standard. SYBR green 
(a fluorescent dye) binds to double stranded DNA molecules non-specifically, 
emitting a fluorescent signal which increases with increasing cycles due to 
exponential increase in PCR product.  
The PCR reaction per sample constituted: 5 μL of iTaq SYBR Green 
supermix (Bio-Rad, Hertfordshire, UK); 0.25 μL forward (F) and reverse (R) 
primers (LGR5 was the target gene and GAPDH was the reference gene) 
LGR5 forward (5`-CCTGCTTGACTTTGAGGAAGACC), LGR5 reverse (5`-
CCAGCCATCAAGCAGGTGTTCA), GAPDH forward (5`-
AATCCCATCACCATCTTCCA) and GAPDH reverse (5`-
TGGACTCCACGACGTACTCA); 1 μL of cDNA; and nuclease free water, up 
to a final volume of 10 μl. The reaction was set following the conditions 
optimised for the target at 40 cycles. All samples and negative controls were 
amplified in triplicate, and the mean value was used for further analysis. 
A standard curve was generated so that the efficiency and reproducibility of 
the qPCR could be assessed. Ishikawa cells (ISK) were used to produce a 
dilution series of cDNA, spanning the concentration range for the 
experimental samples amplified. Results were plotted with input nucleic acid 
quantity on the x-axis, and cycle threshold (Ct) on the y-axis. The reaction 
efficiency had to be in the accepted range of 90-110%, and this was 
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determined by the slope of the curve. The R2 value of the standard curve 
was accepted at ≥0.996, confirming reproducibility of the experiment. 
2.4.1.6.2  Gene expression analysis 
Gene expression analysis was performed using Bio-Rad CFX Manager 
software (Hertfordshire, UK), and relative quantification. The expression level 
of a gene of interest is analysed for up- or down- regulation, looking at fold 
changes between the sample and the control. 
The ΔΔCt method was used to compare experimental sample results with 
the calibrator (untreated sample), and the normaliser (reference genes). For 
the gene of interest, the test sample and the calibrator are adjusted in 
relation to the mean of the normalisers Ct from the same samples. The 
resulting ΔΔCt value is incorporated to determine the fold difference in the 
expression. 
Fold differences = 2-ΔΔCt 
ΔC t sample- ΔC t calibrator = ΔΔCt 
C t target- C t reference= ΔC t sample 
C t target – C t reference = ΔC t calibrator  
2.5  In situ hybridisation 
In situ hybridisation (ISH) allowed for the localisation of a specific segment of 
nucleic acid within a histological specimen. If nucleic acids are preserved 
adequately within a specimen, they can be detected through the application 
of a complementary strand of nucleic acid, to which a reporter molecule is 
attached. The RNAscope 2.5 High Definition Brown assay was used 
(Advanced Cell Diagnostics, Hayward, CA) to locate the LGR5 mRNA in 
FFPE specimens.  
RNA free slides were firstly baked for 1 hour 30 minutes at 60°C to 
encourage adherence of the tissue to the slide. All 
containers/surfaces/implements used for the experiment (including the de-
paraffinisation steps) were washed in RNASEZAP™, and rinsed with distilled 
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RNAse free water to eliminate any external RNAs, keeping the appropriate 
signal as strong as possible. Dewaxing consisted of submerging the samples 
in fresh xylene (10 minutes) twice, followed by fresh 100% ethanol (2 
minutes) twice. Slides were allowed to air dry at RT for 5 minutes (during this 
time the oven was set to 40°C, and the humidified chamber was assembled 
following RNASEZAP™ treatment of all components). 1-2 drops of pretreat 1 
(to cover the entire section) were added to each sample, and these were 
incubated for 10 minutes at RT. After washing in distilled water twice, slides 
were submerged into boiling pretreat 2 (20 mL of pretreat 2 and 180 mL of 
RNase free water microwaved until gently boiling) for 15 minutes. The slides 
were washed in distilled water twice and placed in fresh 100% ethanol before 
air drying at RT. A hydrophobic barrier was drawn around each section and 
left to completely dry, before 1-2 drops of pretreat 3 were added to each 
sample, and the slides were placed into the hybridisation chamber in the 
oven for 30 minutes (during this time the LGR5 negative and positive probes 
were placed into an incubator at 40°C to dissolve any precipitation prior to 
use). Slides were washed in distilled water twice, before being placed back 
into the hybridisation chamber and adding 2 drops of the appropriate probe 
(LGR5 (NM_003667.2, region 560-1589 catalogue number 311021) POLR2A 
(positive control probe) (NM_000937.4, region 2514-3433 catalogue number 
310451) and dapB (negative control probe) (EF191515, region 414-862, 
catalogue number 310043) to the pre labelled sections. The hybridisation 
chamber was placed in the oven at 40°C degrees for 2 hours (during this 
time AMPs 1-6 were taken out of the fridge to acclimatise to RT, and 1 L of 
wash buffer was made (980 mL water and 20 mL wash buffer, warm 50x 
wash buffer to 40°C degrees for 20 minutes before making, to remove any 
precipitation)). Following incubation the slides were placed in 1x wash buffer 
for 2 minutes (twice), and then 2 drops of AMP 1 were added to each 
section. The slides were placed in the hybridisation chamber in the oven for 
30 minutes and the wash step repeated, before 2 drops of AMP 2 are added. 
Slides were then placed in the hybridisation chamber in the oven for 15 
minutes. The wash step was repeated following each AMP application; 
AMPs 3 and 5 were left for 30 minutes, and AMPs 4 and 6 were left for 15 
minutes. Following AMP 4 the hybridisation oven was no longer utilised, and 
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all steps were performed at RT. DAB substrate was used following the 6 
AMP steps in order to detect the signal (equal volumes of Brown A and 
Brown B were mixed together in a microcentrifuge tube). The slides were 
incubated with the DAB substrate for 20 minutes at RT before being washed 
in distilled water twice and counterstained with 50% hematoxylin for 30 
seconds. The slides were again washed in distilled water before being 
submerged in 0.02% ammonia water (33 µL of 30% ammonia and 50 mL 
water) (Sigma-Aldrich, Dorset, UK) for 30 seconds. After washing in distilled 
water the slides were dehydrated through 70% ethanol (2 minutes), 100% 
ethanol (2 minutes twice), and xylene (5 minutes), before being mounted 
using 1-2 drops of Consul-Mount (Thermo Scientific, Runcorn, UK).  
2.5.1 Quantification of In situ hybridisation data 
LGR5 expression was quantified according to the five-grade scoring system 
recommended by the manufacturer and previously described (Baker, 
Graham et al. 2015) (0 = No staining or less than 1 dot to every 10 cells (40× 
magnification), 1 = 1–3 dots/cell (visible at 20–40× magnification), 2 = 4–10 
dots/cell, very few dot clusters (visible at 20–40× magnification), 3 = > 10 
dots/cell, less than 10% positive cells have dot clusters (visible at 20× 
magnification), 4 = > 10 dots/cell, more than 10% positive cells have dot 
clusters (visible at 20× magnification)).   
2.6  Immunohistochemistry 
The protein expression of numerous immunohistochemistry (IHC) antibodies 
were investigated using IHC.  
2.6.1 IHC protocol 
Tissue sections were baked for one hour at 60°C, prior to commencing the 
protocol, to encourage adherence of the tissue sections to the slide. The 
sections were deparaffinised in xylene, and rehydrated through graded 
alcohol. To enhance immunostaining, antigen retrieval, which involved 
heating the sections in a pressure cooker for an appropriate time with the 
appropriate optimised buffer (Table 2.2), was performed. Following antigen 
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retrieval the sections were incubated in 0.3% hydrogen peroxide/TBS 
(Sigma-Aldrich, Dorset, UK) for 10 minutes (to block endogenous 
peroxidase). After blocking unspecific binding with horse serum for 20 
minutes (if necessary, see Table 2.2), the primary antibody was added and 
the sections were incubated in a humidified chamber for the appropriate 
length of time at the appropriate temperature (Table 2.2). One drop of Vector 
ImmPRESS labelled polymer-HRP matching the primary antibody (Vector 
Laboratories, Peterborough, UK) (Table 2.2) was then added to each 
sample, and they were incubated for 30 minutes, followed by incubation with 
DAB-substrate for 10 minutes, and immersion in distilled water. 
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Primary 
Antibody 
Type Clone Supplier Antigen 
Retrieval 
Dilution Incubation Secondary 
SSEA-1 Monoclonal MC-480 Biolegend Tris 3 
mins 
pH=9 
1:800 Overnight at 
4oC 
Mouse 
Pancytokeratin Monoclonal C2562 Sigma Citrate 2 
mins 
pH=6 
1:4000 Overnight at 
4oC 
Mouse 
N Cadherin 
  
Monoclonal 8C11 Abcam Citrate 2 
mins 
pH=6 
1:200 Overnight at 
4oC 
Mouse 
SOX 9 Polyclonal SOX 9 R&D Citrate 4 
mins 
pH=6 
1:400 Overnight at 
4oC 
Mouse 
CK5/6 
 
Monoclonal D5/16B4 Merck Tris 3 
mins 
pH=9 
1:250 Overnight at 
4oC 
Mouse 
MUC 1 Monoclonal BC-2 Serotec Citrate 2 
mins 
pH=6 
1:400 Overnight at 
4oC 
Mouse 
BCAM Monoclonal EPR4164 Abcam Citrate 2 
mins 
pH=6 
1:100 Overnight at 
4oC 
Rabbit 
CCO 
 
Monoclonal 1D6E1A8 Invitrogen Citrate 2 
mins 
pH=6 
1:1000 30mins 
room 
temperature 
Mouse 
Ki67 Monoclonal Ki67 Dako Citrate 4 
mins 
pH=6 
1:200 Overnight at 
4oC 
Mouse 
LGR5-N Polyclonal AP2745a Abgent Citrate 2 
mins 
pH=6 
1:100 Overnight at 
4oC 
Rabbit 
LGR5-C Polyclonal AP2745f Abgent Citrate 2 
mins 
pH=6 
1:100 Overnight at 
4oC 
Rabbit 
 
Table 2.2 – IHC antibodies and conditions of use. 
 
In order to hold the reaction and remove any unbound material (that could 
potentially interfere with subsequent steps), sections were rinsed in Tris-
buffered saline (TBS) at the end of each step. 
Lastly, the sections were counterstained with Gill haematoxylin (Thermo 
Scientific, Runcorn, UK) and mounted in Consul-Mount (Thermo Scientific, 
Runcorn, UK), after being dehydrated through graded alcohol. 
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To assess the specificity of the primary antibody, a negative control was 
included in each run. For this, the primary antibody was substituted with a 
matched type, and concentration of immunoglobulin. An internal positive 
control was also included in each run to identify any staining variation. 
All slides were scanned using an Aperio CS2 scanner 
(http://www.leicabiosystems.com/digital-pathology/aperio-digital-pathology-
slide-scanners/products/aperio-cs2/. Leica, Wetziar, Germany) and analysed 
using spectrum, ScanScope® (Leica, Wetziar, Germany).  
2.6.2 Analysis of IHC data 
Entire sections were evaluated at ×400 magnification for analysis. The 
proportion of positive staining was used to determine the proliferation index 
(Ki67); the scanned sections were analysed, and positive staining of any 
intensity was estimated as a percent. Quick score was used to assess SOX9 
and SSEA-1 immunostaining. The whole section was analysed and the 
proportion of positive cells (0=no staining, 1=25%, 2=50%, 3=75% and 
4=100%) was multiplied by the staining intensity (0=no staining, 1=weak, 
2=moderate and 3=strong), giving a final score between 0 and 12. All slides 
were scored by two independent observers who were blinded to the sample 
identity.  
All other IHC protein expression was analysed descriptively with no formal 
statistical analysis.  
2.6.3 Dual staining with In situ hybridisation and 
Immunofluorescence  
After performing the aforementioned ISH protocol, slides were washed in 
PBS, and blocked with horse serum for 30 minutes at RT. SSEA-1 (1:100 
Biolegend, San Diego, USA) was added to the samples, and they were left 
overnight at 4°C in a humidified chamber, before being washed and 
incubated with the secondary antibody (Alexa FluorR 488 (anti-mouse) 
Thermo Fisher, Cheshire, UK) for 30 minutes at RT in the dark. Slides were 
mounted in Vectashield with DAPI (Vector laboratories, Peterborough, UK). 
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Immunofluorescence (IF) was visualised on a Nikon Eclipse 50i microscope 
(Nikon, Surrey, UK), using NIS Elements F (Nikon, Surrey, UK) for image 
capture.  
2.7  Explant culture 
The endometrial explant cultures were kindly prepared by Dr Sofia 
Makrydima at our laboratory. Freshly collected endometrial biopsies were 
firstly washed several times in Dulbecco`s modified Eagle`s medium 
(DMEM)/F12 (Phenol red free, Life technologies, Paisley, UK) to remove 
blood. The tissue was cut into 1-2 mm3 pieces and placed into 24 well plates 
with medium [DMEM/F12, 5% charcoal-stripped fetal bovine serum (FBS, 
Sigma-Aldrich, Dorset, UK), Primocin (Source Bioscience, Nottingham, UK)] 
containing 1 µM medroxyprogesterone acetate (MPA) (Sigma-Aldrich, 
Dorset, UK), or ethanol (vehicle control), for 24 hours (as previously 
described) (Valentijn, Saretzki et al. 2015). Harvested tissue, after treatment, 
was washed with PBS, immersed in RNAlater, and frozen at -80°C for qRT-
PCR (Valentijn, Saretzki et al. 2015).  
2.8  Three dimensional epithelial cell cultures in 
Matrigel  
The epithelial cells grown in three dimensional (3D) culture, used for 
assessing LGR5 expression, were kindly provided by Mr Anthony Valentijn at 
our laboratory; and the methodology was as previously described (Valentijn, 
Palial et al. 2013). Short-term cultured (16–36 hours post-plating) epithelial 
cells, from predominantly proliferative phase samples, were trypsinized and 
re-suspended to single-cell suspensions at 100,000 cells/200 mL in undiluted 
Matrigel (BD Biosciences, Oxford, UK), and diluted serially 2-fold up to 
approximately 3000 cells/100 mL; 50 mL of the resulting mixture was plated 
in duplicate in 24-well tissue culture plates. After allowing the Matrigel to set 
at 37°C for 15–20 minutes, DMEM/F12 medium supplemented with insulin-
transferrin-selenite (Invitrogen, Paisley, UK), and 50 ng/mL Epidermal growth 
factor (EGF) (Sigma-Aldrich, Dorset, UK) was added. The medium was 
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replaced every 3 days, and cultures were monitored over 14 days. Short-
term cultured epithelial cells were sorted into SSEA-1+ and SSEA1ˉ using 
magnetic activated cell sorting (MACS), the 2 fractions were embedded in 
Matrigel as described above. For ISH, the 3D cultures were fixed in 10% 
neutral-buffered formalin (NBF) (Sigma-Aldrich, Dorset, UK) for 30 minutes, 
harvested into 1% agarose in PBS, and placed in NBF overnight at 48°C 
then processed to paraffin wax for sectioning (see RNA free sectioning 
above).  
2.9  Histochemistry 
Slides were baked for one hour at 60°C, prior to commencing the protocol, to 
encourage adherence of the tissue to the slide. The sections were 
deparaffinised in xylene and rehydrated through graded alcohol. Slides were 
immersed in Gills 2 Haematoxylin (Thermo Scientific, Runcorn, UK) for 4 
minutes, before being rinsed in tap water, dipped in acid alcohol, and 
returned to tap water for 5 minutes. The slides were then placed in 70% 
ethanol, followed by 95% ethanol, for one minute each, before 
counterstaining with Eosin Y (Thermo Fisher Scientific, Runcorn, UK) for 4 
minutes. Subsequently, they were rinsed in water before dehydrating, 
clearing, and mounting with Consul-Mount (Thermo Fisher Scientific, 
Runcorn, UK).  
2.10 Model generation 
100 consecutively cut and stained sections of full thickness endometrium 
were scanned using an Aperio ScanScope slide scanner (Aperio 
Technologies, Vista, CA, USA) at x400 magnification, creating virtual slides. 
The slides were sent to the Leeds Institute of Cancer and Pathology where 
they underwent the process of `registration,` aligning in stacks, so that the 
two dimensional (2D) features were aligned to form smooth 3D topographies. 
This registration resulted in a stack of images which had been aligned, thus 
could be rendered in 3D as a 3D ‘volume’. This ‘volume’ was a 3D image, 
which was analogous to a cube of glass containing the stained tissue. The 
virtual slides were registered using Slice Registration Application 
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(SliceRegApp) program, [version 11.1.1 (64 bit OpenMP build), University of 
Leeds, Leeds, UK]. For this, a reference image was selected in the middle of 
the image stack, and was used to align subsequent images proceeding out 
from the centre, aligning all images to their neighbours. This aligned each 
virtual slide to adjacent slides within the dataset, before the images were 
uploaded into FreeD16 240 software program (Andrey and Maurin 2005) for 
3D reconstruction. The method of which was as follows; serial images (TIFF 
file format) were imported into FreeD software v 1.10 image stack files. 
Endometrial gland boundaries, in a specific area on the individual sections of 
full thickness endometrium, were drawn manually in each 2D serial image, 
and connected along the third dimension, between adjacent slides, 
producing 3D models. 
The different anatomical areas of the full thickness endometrial samples (the 
basalis and the functionalis) were examined in greater detail, relating to the 
architecture of the glands, and the gland interactions.  
2.11 Enzyme histochemistry 
A dual histochemical assay was used to determine the cytochrome C 
oxidase (CCO) status of the glands. In order to identify mutations in the CCO 
enzyme, dual enzyme histochemistry with succinate dehydrogenase (SDH) 
was used (the blue SDH staining highlights where the wild type brown 
staining is absent). Frozen sections were thawed for 1 hour at RT in a moist 
chamber to prevent drying out and contamination (these samples were 
subsequently used for laser capture micro dissection (LCM) and DNA 
extraction). The CCO (500 µm cytochrome C Sigma-Aldrich, Dorset, UK) and 
DAB (light sensitive) (5 mM DAB in phosphate buffer pH 7.0 Sigma-Aldrich, 
Dorset, UK) frozen aliquots were initially thawed at 37°C (one pre mixed tube 
was adequate to do 20 slides), and mixed together with a match head of 
catalase (20 µg /mL Sigma-Aldrich, Dorset, UK), before vortexing and 
filtering with a 2 mL syringe. 50-200 µL of the medium was added to each 
sample (to cover the tissue), before the slides were incubated at 37°C for 55 
minutes. Following incubation, the slides were washed 3 times in PBS, and 
incubated in succinate dehydrogenase (SDH) (1.875 mM NBT in phosphate 
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buffer pH 7.0 (Sigma-Aldrich, Dorset, UK), 1.3 M sodium succinate in 
phosphate buffer pH 7.0 (Sigma-Aldrich, Dorset, UK), 2 mM PMS in 
phosphate buffer pH 7.0 (Sigma-Aldrich, Dorset, UK), 100 mM sodium azide 
in phosphate buffer pH 7.0 )Sigma-Aldrich, Dorset, UK)) at 37°C for 1 hour 
20 minutes. The slides were, again, washed in PBS 3 times, before 
dehydrating in graded ethanol, and air drying for 1 hour prior to LCM. When 
the slides were for normal tissue processing, they were cleared with `histo 
clear` (National Diagnostics, Atlanta, Georgia, USA), and mounted in DPX 
(BDH Laboratory Supplies, Poole, United Kingdom).  
2.12 Laser Capture Micro dissection 
All equipment to be used with the LCM underwent 10 minutes of ultraviolet 
(UV) treatment in the hood (LCM tubes, tube holder, pipette tips and ATL 
buffer), in order to remove as much contaminating DNA as possible pre 
micro dissection, and DNA extraction of the samples.  
Single endometrial epithelial cells of interest (mutated and wild type), and 
stroma for control, were cut into sterile 0.5 mL AdhesiveCap PCR tubes (Carl 
Zeiss, Oberkochen, Germany) using a PALM Microbeam laser capture 
system (Carl Zeiss, Oberkochen, Germany). Following LCM, 15 µL of ATL 
buffer (QIAamp DNA micro kit, Qiagen, Manchester, UK) was added to each 
sample, to commence cell lysis, and the samples were stored at -20°C 
overnight, prior to DNA extraction. 
2.13 Isolation of genomic DNA from LCM tissue 
The Qiagen QIAamp DNA micro kit (Qiagen, Manchester, UK) was utilised to 
extract the DNA from the single epithelial cells.10 µL of proteinase K was 
added to each sample of epithelial cell and ATL mixture, and the samples 
were mixed by pulse vortexing for 15 seconds. This was followed by a 3 hour 
incubation at 56°C (with occasional agitation), before 25 µL of buffer ATL, 
and 50 µL of buffer AL were added, and the sample was pulse vortexed 
again for 15 seconds. To ensure efficient cell lysis, the sample and buffer AL 
were thoroughly mixed to yield a homogenous solution. 50 µL of 100% 
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ethanol was added to each sample before they were pulse vortexed for 15 
seconds, and incubated at RT for 5 minutes. Samples were briefly 
centrifuged (to remove any residual drops from inside the lid), and carefully 
transferred to the QIAamp MinElute column (QIAamp DNA micro kit, Qiagen, 
Manchester, UK) (in a 2 mL collection tube), without wetting the rim. The 
samples were centrifuged at 6000g for 1 minute before discarding the flow 
through, and collection tube. This was repeated after adding 500 µL of buffer 
AW1, and 500 µL of buffer AW2, before the samples were centrifuged at full 
speed (20,000g) for 3 minutes to dry the membrane completely (this step is 
necessary as ethanol carryover into the eluate may interfere with 
downstream applications). The QIAamp MinElute columns were placed in 
clean 1.5 mL microcentrifuge tubes, and 20 µL of distilled water was added 
to the centre of the membrane. The samples were then incubated at RT for 5 
minutes, spun at maximum for 1 minute, before a further 20 µL of water was 
added, and the samples were incubated at RT for 5 minutes and spun on 
maximum for a further minute. The DNA, now in the collection tube was 
stored at -20°C prior to PCR.  
2.14 Sequencing of mtDNA from individual 
endometrial epithelia cells   
The entire sequence of the mitochondrial genome from microdissected 
individual epithelial cells was determined using the single-cell lysate as the 
DNA template, and a two-stage amplification protocol. 
The primary PCR reactions involved amplification of the mitochondrial 
genome in 9 fragments of approximately 2 kb, using a series of overlapping 
primer pairs. These initial large PCR reaction products decrease the risk of 
amplifying pseudogenes when extracting DNA from small quantities of 
tissue. All PCR amplifications were performed in a 50 μL volume, containing 
1× PCR buffer (10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, 50 mM KCl, 0.001% 
wt/vol gelatin), 0.2 mM dNTPs, 0.6 μM primers, 1 U AmpliTaq Gold DNA 
polymerase (Applied Biosystems), and 1 μL single-cell lysate. PCR 
conditions were 94°C for 12 minutes, and 38 cycles of 94°C for 1 minute; 
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60°C for 1 minute, and 72°C for 2 minutes. The final extension was for 8 
minutes. 
The secondary PCR reactions involved amplification of the primary PCR 
products with 28 primer pairs, specifically to generate overlapping fragments 
of between 600–700 base pairs that span the entire sequence of the human 
mitochondrial genome. To facilitate the direct sequencing of PCR-amplified 
products, all primer pairs were tagged with M13 sequence, and designed to 
anneal optimally at 58°C. All reactions proceeded for 30 cycles, and used 2 
μL of primary reaction product as the DNA template.  
2.15 Agarose Gel 
Following PCR, before sequencing, a gel electrophoresis was used to 
confirm that PCR products were present in the sample. Agarose 1.5 g 
(Bioline, Essex, UK) and 100 mL of TAE buffer (4.9 L water and 100 mL TAE 
50x tris acetate EDTA 10x solution (Severn Biotech, Worcestershire, UK)) 
were heated in the microwave for 2 minutes, before 5 µL per 100 mL of gel 
red (nucleic acid gel stain 10,000x in water 0.5 mL (Biotium, Fremonet, 
USA)) (light sensitive) was added. The hot agarose mixture was poured into 
the gel tray and allowed to set for 20 minutes. 1.5 µL of loading dye (glycerol, 
(Thermo Fisher Scientific, Loughborough, UK) and bromophenol blue 6x 
(Thermo Fisher Scientific, Loughborough, UK), 3 mL glycerol (30%), 25 mg 
bromophenol blue (0.25%), water to 10 mL) was added to 5 µL of each 
sample, and the ladder (100bp hyperladder (Bioline, Essex, UK)) was placed 
into the 1st well of each row. Samples mixed with loading dye were 
transferred to the gel, and this was run at 135V for 45 minutes, before 
viewing under UV light (Figure 2.2). 
 
Figure 2.2 – Representative photograph of identified PCR products on a gel.  
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2.16 ExoSAP 
If the gel showed that DNA was present, then these samples were treated 
with ExoSAP (Thermo Fisher Scientific, Loughborough, UK); an enzyme that 
removes single strand DNA and unused dNTPs, to leave just double 
stranded DNA. 5 µL of DNA and 2 µL of ExoSAP (kept on ice as it is an 
enzyme) were added to each well, and the plate underwent the ExoSAP 
programme in the thermocycler (37°C for 15 minutes, 80°C for 15 minutes, 
followed by storing at 12°C).  
2.17 Big Dye Terminator reaction 
The Big Dye Terminator (BDT) reaction is necessary to incorporate 
fluorescent labels into the reaction prior to sequencing (it contains a mixture 
of fluorescent and non-fluorescent dNTPS). When the PCR incorporates a 
fluorescent dNTP, the extension of the strand stops leaving a mixture of 
products of different lengths ending in a fluorescent dye (different colours for 
Guanine (G), Thymine (T), Adenine (A), Cytosine (C)). The sequencer 
separates the products by size, and reads the tag on the end.  
 Following the ExoSAP reaction, 20 µL of water was added to each sample, 
and 2 µL of this diluted sample was added to the BDT reaction (5 µL BDT, 
2.5 µL water, 0.5 µL M13 primer, forward or reverse as universal primer 
(Sigma primer, F =5`GTAAAACGACGGCCAGT, 
R=5`CAGGAAACAGCTATGAC)). These samples were run on the PCR 
‘mitoseq’ programme (96°C for 1 minute, 96°C 10 seconds, 50°C for 5 
seconds, 60°C for 4 minutes, repeat for 24 cycles before holding at 10°C). 
2.18 EDTA-Ethanol cleaning protocol  
Following the BDT reactions, prior to sequencing, the samples were cleaned 
to remove unincorporated primers. This was done with the EDTA-ethanol 
cleaning protocol. 10 µL of the sequencing product from the BDT was added 
to a plate compatible with the sequencer (barcoded). 2.5 µL of 125 mM 
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EDTA (Thermo Fisher Scientific, Loughborough, UK) was added to each 
sample, before gentle vortexing, to ensure that the EDTA was not sitting on 
top of the sample (if this happens, the sample will precipitate on contact with 
the ethanol). 30 µL of 100% ethanol was added to each sample before 
vortexing briefly again, and incubating at RT for 20 minutes (minimum) 
before the plate containing the samples was centrifuged at 4000 rpm for 30 
minutes. The supernatant was removed by inverting the plate and spinning at 
800 rpm for 20 seconds, before adding 100 µL of 70% ethanol (to wash the 
pellet), and spinning the plate for 10 minutes at 4000 rpm. The supernatant 
was removed, as previously described, and the plate was ready to be stored 
at -20°C to await sequencing; or 10 µL of formamide was added to each 
sample, and the plate had the denature PCR program run (95°C for 3 
minutes), before placing on ice and delivering straight to the sequencer.   
2.19 Sequencing 
The sequencing was completed on a Sanger sequencing reaction, using 
BigDye 3.1 terminator cycle-sequencing chemistries (Applied Biosystems, 
Thermo Fisher Scientific, Loughborough, UK) on an ABI 3730XL automated 
DNA sequencer, by the staff at Barts cancer Institute.  
The sequences obtained were analysed using 4Peaks software 
(www.mekentosj.com), together with Clustal W2 software (EMBL-EBI), and 
compared to the revised Cambridge reference sequence (Andrews, Kubacka 
et al. 1999) with sequences from stromal controls and CCO normal 
specimens to identify polymorphisms and somatic mutations from the CCO-
deficient sequences. Individual mutations were confirmed, in all instances, by 
repeating the first and second-round PCRs, and resequencing the products.  
2.20 Statistical analyses 
Statistical differences between groups were calculated by non-parametric 
tests, using graph pad prism (GraphPad Software, California, USA). 
Descriptive values were presented as median and range. The correlations 
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between immuno-expression scores were examined with Spearman Rank 
test. P <0.05 was considered significant.
126 
 
 
Chapter 3. LGR5 as a stem cell marker in 
the human endometrium  
3.1 Introduction  
The human endometrium is a highly regenerative tissue which undergoes 
over 400 cycles of menstrual shedding and re-growth in a woman’s life time. 
It is composed of two functionally distinct layers: the superficial functionalis, 
and the deeper basalis.  
The functionalis layer is completely shed with menstruation, and fully 
regenerated within 2 weeks, up to a thickness of 16 mm (Fleischer 1999). 
This impressive regeneration implies that a stem cell population may reside 
within the endometrial glands. The location of stem/progenitor cells of the 
endometrium is postulated to be within the basalis layer (which remains after 
the menstrual shedding of the functionalis layer) (Prianishnikov 1978, 
Gargett, Schwab et al. 2016).  
Of the two main endometrial specific cell types, the mesenchymal stem cells 
(MSC) that give rise to stromal cells are well described and studied (Gargett, 
Schwab et al. 2016). However, the evidence for an endometrial epithelial 
stem cell population is sparse. Previous work suggests that SSEA-1, nuclear 
SOX9, and N-cadherin expressing epithelial cell subpopulations have some 
ability to generate gland-like structures in vitro (Valentijn, Palial et al. 2013, 
Nguyen, Xiao et al. 2017, Turco, Gardner et al. 2017), but, as yet, there are 
no other epithelial markers with the location, or functional characterisation, 
suggestive of stem cells specificity described in the endometrium. 
Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5) is a 
transmembrane receptor (Barker, van Es et al. 2007), which belongs to a 
family of glycoprotein hormone receptors (Sun, Jackson et al. 2009). LGR5 is 
a marker of stem cells in various epithelia, such as the intestinal mucosa 
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(Schuijers and Clevers 2012), gastric mucosa (Barker, Huch et al. 2010), hair 
follicles (Jaks, Barker et al. 2008), and kidneys (Barker, Rookmaaker et al. 
2012). In mammary epithelium, Lgr5+ cells contribute to both luminal, and 
basal epithelia (de Visser, Ciampricotti et al. 2012), and are essential to 
reconstitute mammary glands from single cells (Plaks, Brenot et al. 2013). In 
the intestine, LGR5 was shown to be a Wnt target gene, regulating epithelial 
regeneration with a restricted expression (visualised by in situ hybridisation 
(ISH)) in the intestinal crypt base (Barker, van Es et al. 2007, Schuijers and 
Clevers 2012). These basal crypt cells were previously proposed to be an 
adult intestinal stem cell population, but their formal functional confirmation 
awaited the discovery of a specific marker (Leushacke and Barker 2012). 
Subsequent work on Lgr5+  cells from the intestine, using in vivo lineage 
tracing and a heritable-inducible lacZ reporter gene, showed that Lgr5+  cells 
are long-lived, multi-potent stem cells (Gerbe, van Es et al. 2011), and a 
single Lgr5+ stem cell can form organoids with a gut-like architecture 
containing all epithelial cell types (Schuijers and Clevers 2012). 
LGR5 is expressed in the female reproductive organs. Lgr5 marks 
stem/progenitor cells of the rodent ovary, and the oviduct (Flesken-Nikitin, 
Hwang et al. 2013, Ng, Tan et al. 2014), where it is critical for the 
maintenance of a functional corpus luteum and, therefore, for successful 
pregnancy (Sun, Terakawa et al. 2014). In immature, and in ovarian 
hormone deprived mice, Lgr5 is highly expressed in the single layer of 
epithelia lining the uterine cavity, and progesterone treatment down-
regulated Lgr5, suggesting an ovarian hormonal regulation (Sun, Jackson et 
al. 2009, Boretto, Cox et al. 2017). However, mice do not menstruate, their 
oestrous cycle is characterised by complete reabsorption of the endometrial 
lining and, therefore, their epithelial regeneration pattern is proposed to be 
distinct from women (Gargett, Schwab et al. 2016). In the human ovary and 
distal Fallopian tube (fimbriae), LGR5 expression was confirmed by 
quantitative reverse transcription PCR (qRT-PCR) (Ng, Tan et al. 2014), with 
constitutive LGR5 mRNA expression reported in healthy human endometrial 
epithelium throughout the menstrual cycle (Krusche, Kroll et al. 2007, 
Schuijers and Clevers 2012).  
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The specificity of the available anti-human-LGR5 antibodies is disputed and, 
in general, the antibody based protein expression data does not correlate 
with RNA data (Munoz, Stange et al. 2012). Thus, ISH is considered as the 
gold standard to detect LGR5 expressing cells in a solid tissue (Munoz, 
Stange et al. 2012). An antibody-based approach has been previously 
reported to locate LGR5 expressing cells in the human endometrium by a 
single group, in two recent manuscripts. The first manuscript, which was a 
review article, presented original data of LGR5 expressing cells being in the 
perivascular region of the stromal and epithelial compartments, with one 
Figure depicting 4 immunohistochemistry (IHC) pictures. The authors 
claimed that the staining intensity, and amount of LGR5, did not alter across 
the menstrual cycle, but due to the type of article (review), the basic 
methodological information required to assess the scientific robustness of the 
data, such as the information on the antibody used (origin, clone, type of, 
etc.) or the number/type (full thickness/pipelle, pathological/non pathological 
etc.) of samples, was not documented. The authors, however, concluded that 
LGR5 could be a universal stem cell marker, despite not providing any 
supporting evidence to that end (Gil-Sanchis, Cervello et al. 2013). The 
same group, subsequently, published a second manuscript, in which they 
isolated epithelial and stromal LGR5 cells with fluorescence activated cell 
sorting (FACS), using a polyclonal rabbit antibody (Novus 28904) without 
confirmed specificity, to further characterise these cells. They did not show 
any confirmation of high LGR5 expression in the sorted cells with PCR, or 
other methods. The characterisation work confirmed the sorted cells to be of 
haemopoietic origin, leading the authors to suggest that LGR5 was not a 
universal stem cell marker, and the endometrial cells isolated using the 
LGR5 antibody were recruited from blood to be part of the stem cell niche, 
proposed at the perivascular microenvironment (Cervello, Gil-Sanchis et al. 
2017). Therefore, in the human endometrium, these antibody-based studies 
need further validation (Gil-Sanchis, Cervello et al. 2013, Cervello, Gil-
Sanchis et al. 2017) in order to confirm the exact LGR5 expressing cell 
population, and to elucidate the function and regulation of the LGR5 gene in 
those cells.  
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The overall aim of the work described in this chapter was to examine if the 
expression of the proposed universal epithelial stem cell marker (LGR5) is 
suggestive of demarcating a stem cell population in the human endometrium. 
We examined the cellular localisation of LGR5 in all epithelial compartments 
of the human endometrium by ISH. As the human Fallopian tube shares the 
same embryological origin, and exists as a continuum with the endometrium, 
we compared the expression of LGR5 in the epithelial mucosa of the 
endometrium, with that of the fimbrial end of the Fallopian tube (due to its 
known stem cell enrichment (Auersperg 2013) and Lgr5 expression (Ng, Tan 
et al. 2014)). The hormone regulation of LGR5 in the endometrium was also 
studied in vitro and in vivo.  
3.1.1 The Research Questions that were addressed 
1. Are there spatio-temporal differences in LGR5 expression, in pre-, and 
post-menopausal (PM) full thickness endometrium, and Fallopian 
tube?  
2. Does endometrial LGR5 expression correlate with epithelial 
proliferative activity?  
3. Does endometrial LGR5 expression correlate with the previously 
known epithelia progenitor markers SSEA-1 and SOX9?  
4. Does progesterone alter the expression of LGR5 in vitro or in vivo?  
5. Does LGR5 expression alteration, seen within the progesterone 
treated human endometrial samples, correlate with cell proliferation?  
6. Do isolated SSEA-1 enriched epithelial cells grown in 3D culture, to 
simulate epithelial glandular regeneration, contain LGR5 expressing 
cells? 
3.2  Methods 
3.2.1 Patient population 
Human endometrium and tubal fimbriae was obtained from 57 women 
undergoing benign gynaecological surgery with no endometrial pathology, at 
the Liverpool Women’s Hospital (Table 3.1) from 2009-2017. The cycle 
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phase of the endometrium was assigned according to the last menstrual 
period (LMP), and histological criteria (Noyes, Hertig et al. 1975, Dallenbach-
Hellweg 2012). Endometrium and the distal (fimbrial) end of the Fallopian 
tube samples were divided in to two pieces: one was fixed (⩾24 hours in 4% 
(v/v) buffered formalin) and paraffin-embedded for ISH and IHC staining; the 
other piece was immediately placed in to RNAlater (Sigma, Dorset, UK) for 
RNA extraction and qRT-PCR. A further 13 endometrial samples were 
collected in reduced serum (1%) Dulbecco's modified Eagle's medium 
(DMEM)/F12 media, for short-term explant culture or cell sorting, and three 
dimensional (3D) culture. ISH and IHC staining for all antibodies was 
analysed with specific reference to the three different endometrial epithelial 
compartments in full-thickness endometrial tissue sections: the luminal 
epithelium (LE) (the single layer of cells that forms the luminal surface, or 
lining of the uterine cavity); the functionalis (glands in the upper two-thirds of 
the endometrium below the LE, surrounded by sparse stroma); and the 
basalis (glands in the lower one-third of the endometrium, adjacent to the 
endo-myometrial junction, surrounded by densely packed stroma). 
Sequential sections were stained with pancytokeratin to confirm the 
assignment of the epithelial compartment.  
Sample 
no. 
Stage of 
cycle/treatment Age BMI Smoker Parity 
1 Proliferative 37 22.8 Yes 2 
2 Proliferative 31 43.9 No 1 
3 Proliferative 57 22 No 3 
4 Proliferative 42 25.6 Yes 2 
5 Proliferative 39 36.9 No 4 
6 Proliferative 50 21 No 4 
7 Proliferative 32 27.8 Yes 2 
8 Proliferative 45 36.4 No 3 
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9 Proliferative 43 40.5 No 3 
10 Proliferative 48 37.3 No 2 
11 Proliferative 37 39.2 No 2 
12 Proliferative 44 29.6 No 1 
13 Proliferative 44 24.5 No 2 
14 Secretory 32 26.6 No 2 
15 Secretory 45 31.6 No 0 
16 Secretory 35 32 No 3 
17 Secretory 45 26.1 No 0 
18 Secretory 47 22.6 No 0 
19 Secretory 44 30.7 Yes 2 
20 Secretory 37 21.7 No 4 
21 Secretory 41 18.9 Yes 2 
22 Secretory 39 22.4 Yes 6 
23 Secretory 21 25.9 No 0 
24 Secretory 46 25.4 Yes 1 
25 Secretory 33 26.1 No 2 
26 Secretory 40 33 No 2 
27 POP 36 23.9 No 4 
28 POP 33 27.4 Yes 3 
29 POP 25 20.9 No 0 
30 POP 31 25.8 Yes 2 
31 POP 37 25.7 No 0 
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32 POP 43 24.2 Yes 2 
33 LNG-IUS 46 26.2 No 3 
34 LNG-IUS 45 22.5 No 2 
35 LNG-IUS 35 24.4 No 1 
36 LNG-IUS 33 32.7 Yes 3 
37 LNG-IUS 33 25.9 No 5 
38 Explant 26 33.4 Yes 2 
39 Explant 44 30.7 Yes 2 
40 Explant 27 33.7 No 2 
41 Explant 40 33 No 2 
42 Explant 43 25.4 No 2 
43 Explant 47 24.2 Yes 0 
44 Explant 48 28.6 No 2 
45 PM 69 24.7 No 4 
46 PM 69 26.8 No 3 
47 PM 67 32.8 No 4 
48 PM 66 24.9 No 3 
49 PM 52 39.6 No 2 
50 PM 74 35.6 No 3 
51 SSEA1 sorted 30 26.7 No 1 
52 SSEA1 sorted 27 21.1 No 4 
53 SSEA1 sorted 40 27.4 No  
54  SSEA1 sorted 38 26.6 Yes 2 
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55 SSEA1 sorted 27 23 No 5 
56 SSEA1 sorted 39 24.8 No 0 
57 SSEA1 sorted 31 18.7 No 0 
 
Table 3.1 - Demographical details of the patients included in the study. 
(Abbreviations POP - Progesterone only pill, LNG-IUS - levonorgestrel-
releasing intrauterine system, PM – postmenopausal). 
 
3.2.2 qRT-PCR  
Total RNA from tissue samples was extracted using TRIzol Plus RNA 
Purification System (Life Technologies, Paisley, UK), and quantified by 
NanoDrop ND-1000 (Thermo Fisher Scientific, Loughborough, UK). Total 
RNA was reverse transcribed using AMV First Strand cDNA synthesis kit 
(New England Bio Labs, Hertfordshire, UK) after DNase treatment (DNase I, 
New England Bio Labs, Hertfordshire, UK), using the manufacturer's protocol 
as previously described (Kamal, Bulmer et al. 2016). cDNA was amplified by 
qPCR using iTaq SYBR Green supermix (Bio-Rad, Hertfordshire, UK), with 
the Bio-Rad connect (Hertfordshire, UK), and the following primers: LGR5 
forward (5`-CCTGCTTGACTTTGAGGAAGACC); LGR5 reverse (5`-
CCAGCCATCAAGCAGGTGTTCA); GAPDH forward (5`-
AATCCCATCACCATCTTCCA); and GAPDH reverse (5`-
TGGACTCCACGACGTACTCA). Relative transcript expression was 
calculated using the ΔΔCT method and normalised to the reference gene, 
GAPDH, using Bio-Rad CFX manager (Hertfordshire, UK). 
3.2.3 In situ hybridisation 
ISH for LGR5 expression was performed as previously described (Baker, 
Graham et al. 2015) on 4 μm sections using the RNAscope 2.5 High 
Definition Brown assay, according to the manufacturer’s instructions 
(Advanced Cell Diagnostics, Hayward, CA). Formalin-fixed paraffin-
embedded (FFPE) tissue sections were baked at 60°C for 1 hour 30 minutes, 
followed by de-paraffinization, and incubation with Pretreat 1 buffer, for 10 
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minutes, at room temperature (RT). These slides were subsequently boiled 
in Pretreat 2 buffer for 15 minutes, followed by incubation with Pretreat 3 
buffer for 15 minutes at 40°C. The sections were then incubated with the 
relevant probes for 2 hours at 40°C, followed by successive incubations with 
AMPs 1 to 6 reagents. Staining was visualized with 3,3′-diaminobenzine 
(DAB) for 20 minutes, then lightly counterstained with Gill's haemotoxylin. 
RNAscope probes used were LGR5 (NM_003667.2, region 560-1589 
catalogue number 311021), POLR2A (positive control probe) (NM_000937.4, 
region 2514-3433 catalogue number 310451), and dapB (negative control 
probe) (EF191515, region 414-862, catalogue number 310043) (Figure 3.1). 
 
Figure 3.1 - Representative LGR5 ISH images of secretory endometrium 
showing (A) LGR5 Probe (B) Positive control (C) Negative control (All 
images x400, scale bar = 60µm). 
 
LGR5 expression was quantified according to the five-grade scoring system 
recommended by the manufacturer previously described (Baker, Graham et 
al. 2015) (0 = No staining or less than 1 dot to every 10 cells (400× 
magnification), 1 = 1–3 dots/cell (visible at 200–400× magnification), 2 = 4–
10 dots/cell, very few dot clusters (visible at 200–400× magnification), 3 = > 
10 dots/cell, less than 10% positive cells have dot clusters (visible at 200× 
magnification), 4 = > 10 dots/cell, more than 10% positive cells have dot 
clusters (visible at 200× magnification)).   
3.2.4 Immunohistochemistry 
After antigen retrieval in citrate, or TRIS buffer (see antibody conditions, 
Table 3.2), (as described in chapter 2), 4 µm FFPE sections were blocked 
with 3% hydrogen peroxide for 10 minutes, then immunostained with the 
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appropriate antibody for the given time, and dilution in Table 3.2. This was 
followed by incubation for 30 minutes at RT in the appropriate secondary 
antibody. Detection was with ImmPRESS polymer based system, and 
visualisation was with ImmPACT DAB (Vector Labarotories, Peterborough, 
UK), used as per manufacturer’s instructions. Sections were counter stained 
in Gill 2 Haemotoylin (Thermo Scientific, Runcorn, UK), dehydrated, cleared, 
and mounted in synthetic resin. Matching isotype replaced the primary 
antibody as a negative control, with internal positive control in each staining 
run.  
 
Primary 
Antibody 
Type Clone Supplier Antigen 
Retrieval 
Dilution Incubation Secondary 
SSEA-1 Monoclonal 125601/2 Biolegend Tris 3 
mins 
1:800 Overnight 
at 4oC 
Mouse 
Pancytokeratin Monoclonal C2562 Sigma Citrate 2 
mins 
1:4000 Overnight 
at 4oC 
Mouse 
SOX 9 Polyclonal Af3075 R&D Citrate 4 
mins 
1:400 Overnight 
at 4oC 
Goat 
Ki67 Monoclonal NCL-
Ki67-
MM1 
Novocastra Citrate 4 
mins 
1:200 Overnight 
at 4oC 
Mouse 
LGR5-N Polyclonal AP2745a Abgent Citrate 2 
mins 
1:100 Overnight 
at 4oC 
Rabbit 
LGR5-C Polyclonal AP2745f Abgent Citrate 2 
mins 
1:100 Overnight 
at 4oC 
Rabbit 
Table 3.2 - Primary antibodies and their immunohistochemistry conditions. 
All slides were scanned using an Aperio CS2 scanner 
(http://www.leicabiosystems.com/digital-pathology/aperio-digital-pathology-
slide-scanners/products/aperio-cs2/), and analysed using spectrum, 
ScanScope®.  
3.2.5 Analysis of IHC  
Percentage of nuclear Ki67 immuno-positive cells, of any intensity, was 
evaluated as the Ki67-labelling index (Ki67-LI). The entire section was 
evaluated at ×400 magnification (minimum 25 fields) (as  described 
previously) (Al Kushi, Lim et al. 2002), and the 3 epithelial compartments 
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were scored separately. SOX9 and SSEA-1 immunostaining was assessed 
by multiplying the proportion of positive cells (0=no staining, 1=25%, 2=50%, 
3=75% and 4=100%) by the staining intensity (0=no staining, 1=weak, 
2=moderate and 3=strong), giving a final score between 0 and 12 (Valentijn, 
Palial et al. 2013). All slides were scored by two independent observers who 
were masked to the sample identity.  
3.2.6 In situ hybridisation with Immunofluorescence  
Following on from the ISH protocol, three specimens were used for 
immunofluorescence (IF) SSEA-1 co localisation. The slides were washed in 
PBS, rather than mounted, and incubated in horse serum block for 30mins, 
at RT. SSEA-1 (1:100 Biolegend) was added to the samples, and they were 
left overnight at 4oC, before being washed and incubated with the secondary 
antibody, Alexa FluorR 488 (anti-mouse), for 30 minutes at RT, in the dark. 
Slides were mounted in Vectashield with DAPI (Vector laboratories, 
Peterborough, UK). IF was visualised on a Nikon Eclipse 50i microscope, 
using NIS Elements F for image capture.  
3.2.7 Explant culture 
The endometrial explant cultures were performed, and kindly provided, by Dr 
Sofia Makrydima at our laboratory. In vitro, short-term endometrial explant 
cultures were prepared from freshly collected endometrial biopsies, which 
were firstly washed several time in Dulbecco`s modified Eagle`s medium 
(DMEM)/F12 (Phenol red free, Life technologies, Paisley, UK) to remove 
blood. The tissue was cut into 1-2mm3 pieces, and placed into 24 well plates 
with medium [DMEM/F12, 5% charcoal-stripped fetal bovine serum (FBS, 
Sigma-Aldrich, Dorset, UK), Primocin (Source Bioscience, Nottingham, UK)], 
containing 1 µM medroxyprogesterone acetate (MPA) (Sigma-Aldrich, 
Dorset, UK), or ethanol (vehicle control), for 24 hours as previously 
described (Valentijn, Saretzki et al. 2015). Harvested tissue, after treatment, 
was washed with PBS, immersed in RNAlater, and frozen for qRT-PCR 
(Valentijn, Saretzki et al. 2015).  
137 
 
3.2.8 3D epithelial cell cultures in Matrigel  
The epithelial cells, grown in 3D culture, used for assessing LGR5 
expression, were kindly provided by Mr Anthony Valentijn at our laboratory, 
and the methodology was as previously described (Valentijn, Palial et al. 
2013). Briefly, short-term cultured (16–36 hours post-plating) epithelial cells, 
from predominantly proliferative phase samples, were trypsinized and re-
suspended, to single-cell suspensions at 100 000 cells/200 mL undiluted 
Matrigel (BD Biosciences, Oxford, UK), and diluted serially 2-fold up to 
approximately 3000 cells/100 mL; 50 mL of the resulting mixture was plated 
in duplicate in 24-well tissue culture plates. After allowing the Matrigel to set 
at 37°C for 15–20 minutes, DMEM/F12 medium, supplemented with insulin-
transferrin-selenite (Invitrogen) and 50 ng/mL Epidermal growth factor (EGF) 
(Sigma-Aldrich), was added. The medium was replaced every 3 days and 
cultures monitored over 14 days. Short-term cultured epithelial cells were 
sorted into SSEA-1+ and SSEA1ˉ, the 2 fractions were embedded in Matrigel. 
For ISH, the 3D cultures were fixed in 10% NBF for 30 minutes, harvested 
into 1% agarose in Phosphate buffered saline (PBS), and placed in NBF 
overnight at 48°C, then processed to paraffin wax; 4 µm sections were cut.  
3.2.9 Statistical methods 
All statistical analyses were performed using GraphPad Prism software 
(Mann Whitney U and one-way ANOVA was used to assess differences 
between groups). Spearman rank correlation was used to determine the 
association between pairs of variables. The criterion for significance was 
p≤0.05. 
3.3 Results 
Healthy human pre-menopausal endometrium demonstrated dynamic 
spatio-temporal regulation of LGR5 expression, with high LGR5 
expressing cells in the luminal, and in the basalis epithelium. 
Full thickness, whole endometrial tissue samples, containing all endometrial 
layers and cell types from the oestrogen dominant proliferative phase of the 
138 
 
cycle, showed a trend of higher LGR5 mRNA expression levels (as 
measured by qRT-PCR); compared with the samples from the progesterone 
dominant secretory phase of the menstrual cycle (p=0.5, Figure 3.2A). LGR5 
mRNA levels were significantly higher in the stem cell rich distal Fallopian 
tubes, than in the corresponding eutopic endometrium (p<0.01, Figure 3.2B). 
The cell type expressing LGR5 was identified with ISH, demonstrating that 
LGR5 expression was limited to the epithelial compartment in both 
endometrium and tube. Semi-quantitative scoring of LGR5 expression 
revealed that the LE cells expressed significantly higher levels of LGR5 than 
all other epithelial compartments in the endometrium (p<0.05, Figures 3.2C 
and 3.2D), including the endometrial basalis. The reduction in LGR5 
expression in the secretory phase was confirmed with ISH in the LE 
(p=0.03), and functionalis epithelium (p=0.04) respectively (Figures 2C and 
2D).  
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Figure 3.2 - LGR5 gene expression appears to decrease in the eutopic 
endometrium and Fallopian tube in the secretory phase of the 
menstrual cycle. (A) The eutopic endometrial samples and matched 
Fallopian tube express apparently decreased levels of LGR5 mRNA in the 
secretory phase of the menstrual cycle when compared with the proliferative 
phase (n=21). (B) Fallopian tube (at any stage of the cycle) demonstrate 
significantly higher levels of LGR5 mRNA than matched eutopic 
endometrium (p<0.01) (n=20). (C) Representative LGR5 ISH images of 
Fallopian tube and luminal, functionalis and basalis eutopic endometrium in 
140 
 
the proliferative and secretory stages of the menstrual cycle (All images 
x1000, scale bar = 20 µm, (n=15). (D) Graphical representation of semi-
quantitative scoring of LGR5 ISH In the proliferative stage of the cycle, the 
LE demonstrated significantly higher LGR5 ISH staining scores than the 
functionalis (p<0.05), basalis epithelium (p<0.01) and Fallopian tube (p<0.02 
as well as the LE of the secretory phase (p<0.03); the proliferative 
functionalis had significantly higher LGR5 scores than the secretory 
functionalis (p<0.04); the secretory LE showed significantly higher LGR5 
scores than the epithelia of secretory functionalis (p<0.03), secretory basalis 
(p<0.05) and Fallopian tube (p<0.02) (n=7 per group). (Prol=Proliferative, 
Sec=Secretory, Funct= Functionalis, Bas=Basalis).  
 
LGR5 expression correlated with endometrial epithelial cell 
proliferation in the functionalis epithelial compartment. 
The differences in the cellular proliferative activity in the three endometrial 
epithelial compartments across the menstrual cycle, were demonstrated by 
the dynamic changes in the expression of the proliferative marker Ki67 
(Figures 3.3A and 3.3B) in sequential tissue sections. Epithelial Ki67-LI was 
highest in the proliferative phase, with the maximum Ki67-LI observed in the 
cells of functionalis glands (median 70%, range 10-100%), and the lowest 
Ki67-LI seen in the basalis epithelium (median 30%, range 0-85%). Ki67-LI 
was higher in the functionalis and in LE, compared with the basalis glands in 
all phases of the cycle. In the secretory phase Ki67-LI, in all epithelial 
compartments, decreased, with the LE compartment demonstrating the 
highest Ki67-LI (median 1%, range 0-90%); and Ki67-LI was absent in the 
basalis glands. Ki67-LI and LGR5 expression levels only correlated 
significantly (r=0.74, p=0.01) in the functionalis epithelium. The basalis LGR5 
expression persisted in the secretory phase (Figure 3.2D), while the 
corresponding Ki67-LI reactivity decreased significantly (p=0.03) (Figure 
3.3B). The quiescent (absent Ki67-LI) atrophic PM endometrial epithelium 
also expressed LGR5 (particularly the LE) (Figure 3.4).   
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Epithelial proliferation (Ki67-LI) in the Fallopian tube was consistently very 
low throughout the cycle, contrasting with the dynamic tubal LGR5 
expression pattern (r=0.23, p=0.55). 
 
Figure 3.3 - Ki67-LI correlated with endometrial epithelial cell 
proliferation only in the epithelial compartment of the functionalis. 
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Epithelial LGR5 expression scores also correlated with the expression 
of the previously known progenitor markers SOX9 and SSEA-1 in 
sequential tissue sections across the cycle. (A) Representative images of 
Ki67, SOX9 and SSEA-1 IHC in luminal, functionalis, basalis epithelial 
compartments of the eutopic endometrium and Fallopian tubes in the 
proliferative and secretory stages of the menstrual cycle (all images x400, 
scale bar 10 µm). (B) Quantification of percentage Ki67-positive cells (Ki-67 
LI) throughout the cycle. A minimum of 25 fields of cells were counted at 
x400 magnification (n=7 per group). The functionalis in the proliferative 
phase has the highest Ki67-LI and is statistically higher than the functionalis 
epithelium in the secretory phase (p<0.05). Ki67-LI decreased dramatically in 
the secretory phase of the cycle in all epithelial compartments. 
(Prol=Proliferative, Sec=Secretory Funct= Functionalis, Bas= Basalis).  
 
 
Figure 3.4 - Representative LGR5 ISH images of PM luminal and glandular 
epithelium (All images x1000, scale bar = 20 µm). 
 
In the human endometrium, luminal and basalis epithelia share distinct 
patterns of co-expression of LGR5, and the previously known 
progenitor markers SSEA-1 and SOX9. 
Sequential tissue sections were employed to examine if the cellular location 
of LGR5 mRNA (by ISH) was consistent with the expression of, previously 
described, endometrial basalis progenitor markers SSEA-1 and nuclear 
SOX9 (by IHC, Figure 3.3A). In general, SOX9 and SSEA-1 expression 
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followed the same cyclical pattern of expression as LGR5: levels decreased 
in all 3 endometrial epithelial compartments, and also in the tubal epithelium, 
in the secretory phase, when compared with the samples from the 
proliferative phase (Figure 3.3A). However, out of all 3 endometrial epithelial 
compartments, the strongest LGR5 expression was seen in the LE (Figures 
3.2C and 3.2D), whereas the strongest SSEA-1 and SOX9 staining was 
observed in the basalis glands, agreeing with previous reports (Valentijn, 
Palial et al. 2013) (Figure 3.3A). It is noteworthy that the luminal staining for 
both SSEA-1 and SOX9 was consistently high throughout the cycle, even 
when their expression decreased in the functionalis epithelium in the 
secretory phase (Figure 3.3A).   
In the Fallopian tube, SOX9 staining scores and LGR5 ISH scores, were high 
throughout the menstrual cycle, similar to the basalis glands of the 
endometrium, with only an apparent reduction in the intensity during the 
secretory phase (Figure 3.2D). In contrast, SSEA-1 scores were very low in 
the tubal epithelium in all phases of the cycle. The co-expression of SSEA-1 
protein and LGR5 mRNA by ISH was further confirmed with 
immunofluorescence staining (Figure 3.5). 
 
Figure 3.5 – Representative co-localisation LGR5 ISH probe (red)/anti-
human SSEA-1 antibody immunofluorescence (green), images of luminal 
and basalis epithelium of healthy human full thickness endometrium (All 
images x400). 
Progestogens regulate LGR5 expression in vitro and in vivo.  
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The progestogenic regulation of LGR5 expression was examined by treating 
endometrial explants in vitro with the synthetic progestogen MPA in short-
term culture, and MPA treatment decreased LGR5 levels by 1.5 fold (Figure 
3.6A). 
The in vivo effect of progestogens on the endometrial expression of LGR5 
was tested in endometrial samples from women taking synthetic progestogen 
treatment (progesterone only pill, ‘POP’, or levonorgestrel-releasing 
intrauterine system, ‘LNG-IUS’) and a significant reduction of LGR5 mRNA 
levels were observed with progestogen treatment, compared with the normal 
eutopic endometrium of women not on hormonal treatments (p<0.01, Figure 
3.6B). Even with these very low levels, the LE continued to retain higher 
LGR5 expression than the glands, following progestogen treatment (Figures 
3.6C and 3.6D). 
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Figure 3.6 - Progestagens regulate LGR5 expression in vitro and in vivo. 
(A) LGR5 mRNA expression levels analysed by qRT-PCR. Explants treated 
with MPA (‘+MPA’) expressed lower LGR5 levels relative to GAPDH when 
compared with the same of vehicle-treated explants (‘-MPA’) (n=6 per 
group). (B) LGR5 mRNA expression by qRT-PCR. Patients taking the oral 
progesterone only pill (POP) or having the levonorgestrel-releasing 
intrauterine system (LNG-IUS) have significantly less LGR5 mRNA 
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expression relative to GAPDH when compared with normal eutopic 
proliferative and secretory endometrium (p<0.01 and p<0.04 respectively). (n 
= 6 per group). (C) Representative LGR5 ISH images of POP treated and 
LNG-IUS treated luminal and glandular eutopic endometrium (All images 
x1000, scale bar = 20 µm). (D) Graphical representation of semi-quantitative 
scoring of LGR5 ISH. The LE has more LGR5 when compared with the 
glandular epithelium in the POP and LNG-IUS treated samples (n=6 per 
group). 
  
LGR5 expression did not correlate with epithelial cell proliferation in 
progesterone treated human endometrial samples. 
The luminal and glandular epithelial Ki67-LI was much higher in the POP 
samples when compared to the LNG-IUS treated endometrium (POP luminal 
median 50%, range 40-75%, glands median 70%, range 50-85%, LNG-IUS 
luminal median 1%, range 0-1%, glands median 2% range 0-2%, Figures 
3.7A and 3.7B). Therefore, the Ki67-LI levels in the POP treated samples did 
not correlate with the levels of LGR5 expression, whereas, in the atrophic 
glandular and LE cells of the LNG-IUS samples, there were low levels of 
both LGR5 and Ki67-LI.   
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Figure 3.7 - LGR5 expression did not correlate with epithelial cell 
proliferation in progesterone treated human endometrial samples. (A) 
Ki67-LI IHC data, in the progesterone only pill (POP) group, the glandular 
and LE showed high Ki67-LI but the levonorgestrel-releasing intrauterine 
system (LNG-IUS) group endometrial Ki67-LI was very low. (B) 
Representative Ki67 images of luminal and glandular eutopic endometrium 
from patients treated with either POP or LNG-IUS (all images x400, scale bar 
=10 µm, n=6 per group). 
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Sorted SSEA1+ epithelial cells grown in 3D culture do not express 
LGR5. 
Organoids grown from single isolated SSEA1+ epithelial cells, developed in 
to gland-like spheroid structures after 10-14 days in 3D culture (as previously 
published) (Valentijn, Palial et al. 2013). The mature epithelial cells, forming 
these well-organised glandular structures, lost SSEA-1 expression we 
presumed to be associated with cellular differentiation, as described in the 
previous publication (Valentijn, Palial et al. 2013), and similarly, we could not 
identify any LGR5 expression in any of the seven 3D cultures forming 
detectable organoid-structures studies (Figure 3.8). 
 
Figure 3.8 – Epithelial organoids grown in 3D culture from SSEA1+ cells 
did not express LGR5. Representative LGR5 ISH images of paraffin 
embedded 3D cultures of sorted SSEA1+ epithelial cells grown for 14 days in 
Matrigel, clearly demonstrating gland-like organoid formation (All images 
x400). 
 
3.4 Discussion 
This is the first comprehensive study employing the gold standard method 
(ISH) in order to examine the cellular location of LGR5 expression in full 
thickness normal human endometrium. High LGR5 expressing cells were 
seen in the endometrial LE, and in the basalis. Healthy human endometrium 
shows a dynamic, spatiotemporal, pattern of LGR5 expression, suggesting 
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hormonal regulation. Endogenous and exogenous progestogens appear to 
inhibit LGR5 expression in the endometrium, both in vitro and in vivo.  
Previous evidence from other epithelial tissues proposes LGR5 expression to 
be limited to stem cells and, thus, for LGR5 to be an epithelial stem cell 
marker (Kumar, Burgess et al. 2014). We have shown that LGR5 was not 
localised to a small number of cells in the adult endometrial basalis 
epithelium, which was the proposed location of the stem cell niche (Valentijn, 
Palial et al. 2013, Gargett, Schwab et al. 2016). The LGR5 expression we 
observed in the human adult endometrium, unlike in the small intestine, 
mimics the Lgr5 expression pattern seen in mouse uteri (Sun, Jackson et al. 
2009). A uniform expression of Lgr5 was seen in the ovariectomised uterine 
epithelium, and it is suggested that most of these remaining epithelial cells 
have the potential to proliferate, when necessary, for uterine glandular 
growth (Sun, Jackson et al. 2009). A mouse endometrial epithelial organoid 
system, which allowed long-term expansion of epithelium, also showed Lgr5 
gene expression (Boretto, Cox et al. 2017). In contrast, in humans, the whole 
of the endometrial functional layer is regularly shed with menstruation, a 
phenomenon not relevant to most mammals, including rodents. The initial 
step of embryo attachment and implantation occurs at the LE, which exists at 
a relatively distant location, in cellular terms, from the basalis (up to 16 mm in 
the mid-secretory phase). Due to external assaults, such as mechanical 
friction or infection, cells are continually lost and replaced from the surface of 
any epithelial tissue, including the skin, and intestine (Barker 2014); 
therefore, a similar daily cellular loss is likely to happen at the endometrial 
LE, which is exposed to the uterine cavity, and external environment. The 
daily maintenance of the LE may require locally positioned cells with 
progenitor ability. Supporting this hypothesis, rapid Lgr5+ epithelial cell 
proliferation can be observed in many other organs upon tissue damage (Ng, 
Tan et al. 2014, Beumer and Clevers 2016). 
We, therefore, hypothesise that it is possible for the human endometrium to 
have more than one epithelial stem/progenitor cell pool; one residing in the 
basalis (SSEA-1++  SOX9+ + LGR5+), supporting the massive regeneration of 
the functionalis after menstrual shedding or parturition; while the other 
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(LGR5+ + SSEA-1+ SOX9+) supports the embryo-implantation process, and 
maintains the LE cells that are likely to be lost on a daily basis (Figure 3.9). 
This is in agreement with the scanning electron microscopy (SEM) studies of 
human endometrium, the endometrial injury model of the rabbit (Ferenczy 
and Richart 1974), and neo-natal endometrial glandular development in 
humans (Cooke, Spencer et al. 2013). The persistent expression of the 
progenitor cell markers SOX9 and SSEA-1 in the LE, with concomitant high 
LGR5 expression, corroborate further with the above hypothesis (Barker and 
Clevers 2010, Valentijn, Palial et al. 2013). Future work examining the 
functional properties of endometrial epithelial cell subpopulations that are 
isolated from the two anatomical regions within the human endometrium, 
which express either high or low LGR5, SOX9 and SSEA-1, is warranted. 
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Figure 3.9 – Putative model of endometrial epithelial regeneration. A) 
The secretory phase endometrial epithelial configuration; LE contains 
LGR5++ SOX9+ SSEA-1+ cells, functional glands contain LGR5ˉSOX9ˉSSEA-
1ˉ epithelial cells and basalis glandular cells with SOX9++  SSEA-1++  LGR5+  
phenotype. B) Luminal and functional layers are shed at menstruation, LE 
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regenerated from the basalis epithelium (SOX9+ + SSEA-1++  LGR5+) after 
menstrual shedding, subsequently, the LE (LGR5+ + SOX9+ SSEA-1+) 
throughout the cycle regenerates itself and possibly also contributes to the 
regeneration of functional glands in the proliferative phase (LGR5+ SOX9+ 
SSEA-1+) whilst basalis glands are responsible for the regeneration of 
all/most of the epithelia of the functionalis in the proliferative phase. 
 
N-cadherin has recently been identified as a possible endometrial epithelial 
stem cell marker, highlighting a sub set of epithelial cells at the 
basalis/myometrial junction (Nguyen, Xiao et al. 2017). Sorted N-cadherin+ 
epithelial cells were more clonogenic, underwent more population doublings 
(showing greater capacity for serial cloning), and differentiated into 
cytokeratin+ gland like organoids, when compared to the N-cadherin- 
population (Nguyen, Xiao et al. 2017). During this work, I have not co-
localised LGR5 with N-cadherin, however, with no evidence of N-cadherin in 
the LE, a high correlation between the two markers is unlikely.    
The two antibody based studies examining LGR5 in the human endometrium 
(Gil-Sanchis, Cervello et al. 2013, Cervello, Gil-Sanchis et al. 2017) are in 
contrast to our work. We did not detect LGR5 expression in the stroma, but 
only in the pancytokeratin expressing epithelial cells, and the observed 
proportion of epithelial cells expressing LGR5 exceeded 1%. It should be 
noted that mRNA and protein levels may not necessarily correlate, and in our 
hands, the endometrial LGR5 protein expression, using two commercially 
available antibodies, demonstrated non-specific staining (Figure 3.10). 
Therefore, in agreement with the general consensus, we concluded that the 
reliability of antibodies against LGR5 remains in considerable doubt.  
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Figure 3.10 - Representative micrographs of the staining pattern 
demonstrated with 2 commercially available IHC LGR5 antibodies, in the 
luminal, functionalis and basalis of the human endometrium (all images x400, 
scale bar =10 µm).   
 
Suppression of glandular regeneration and progenitor activity is postulated to 
occur within the progesterone-dominant, non-proliferative, secretory 
functional epithelium, where the lowest LGR5 expression levels were 
observed.  
The SSEA1+ epithelial cells grown in 3D culture have the architecture of 
functionalis epithelial glands, not primitive basalis-like glands. We postulate 
that this is the reason that they lose SSEA1 staining, and LGR5 is also not 
expressed. The 3D organoid structures are formed from SSEA1 sorted 
epithelial cells, suggesting that these cells, possibly, do not contain many LE 
cells (SSEA1 low) to commence with, but mainly containing SSEA1+ + (high) 
basalis cells.  
In the absence of validated lineage markers for the various epithelial 
populations that are likely to exist within the endometrium, we cannot 
formally characterise the resident LGR5+ cells as multipotent. Lineage 
tracing studies need to be completed in the human endometrial epithelium to 
identify the location of stem cells, this will further complement the in vitro 
functional studies, to confirm if LGR5 expressing epithelial cells, indeed, 
represent the epithelial stem cell population (see Chapter 5). 
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Chapter 4. 3D Architecture of endometrial 
glands  
4.1 Introduction 
The current dogma is that endometrial epithelial stem cells residing in the 
terminal end of the basalis glands, at the endometrial/myometrial interface, 
are responsible for epithelial regeneration (Kim, Tavare et al. 2005, Valentijn, 
Palial et al. 2013, Gargett, Schwab et al. 2016). However, previous scanning 
electron microscopy (SEM) studies have suggested that endometrial re-
epithelialisation occurs from remaining gland stumps and the luminal 
epithelium (LE) that is not shed in the cornual region, rather than the 
glandular bases (Ferenczy 1976). Although provision of transient amplifying 
(TA) cells to regenerate the functionalis glands at the gland stumps of the 
basalis/functionalis junctional region of the endometrium could be a direct 
function of the postulated stem cells residing in the gland bases, the theory 
cannot easily explain the cornual regeneration. Furthermore, this theory 
presumes endometrial glands to possess a single, blind-ended, linear, 
tubular architecture, where the terminal portion ends abutting the sub-
endometrial myometrium junction (Figure 4.1). However, the precise three 
dimensional (3D) anatomical features, and micro-architectural organisation, 
of the human endometrial glandular epithelium is fundamentally unknown. In 
the context of conventional two dimensional (2D) histo-architecture, many 
have alluded to functionally different epithelial sub-compartments, located in 
luminal, functionalis, and basalis regions (Hild-Petito, Fazleabas et al. 1996, 
Nguyen, Sprung et al. 2012, Valentijn, Palial et al. 2013, Khan, Fujishita et al. 
2016); yet distinct validated lineage markers for these various epithelial sub-
populations do not exist. Traditional in vivo lineage tracing studies, in rodent 
models, that confirm the existence of an adult epithelial stem cell, are less 
relevant to the human endometrium because of its unique regeneration 
pattern (dissimilar to most other mammals) (Chan and Gargett 2006, 
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Cervello, Martinez-Conejero et al. 2007, Cervello, Gil-Sanchis et al. 2010, 
Cervello, Mas et al. 2011, Wang, Sacchetti et al. 2012).  
 
Figure 4.1 – Schematic demonstrating the current presumed endometrial 
glandular epithelial architecture, at different times of the menstrual cycle, a 
single blunt ended tube abutting the myometrium.  
 
Attempts have been made to reconstruct endometrial epithelial cell lineages 
utilising two methods: Firstly, by analysing the non-random X chromosome 
inactivation with an X-linked androgen receptor gene, with DNA extracted 
from individual endometrial glands, the clonal constitution of glandular cells 
and luminal epithelium (LE) were examined to determine clonality of 
epithelial cells (Tanaka, Kyo et al. 2003); Secondly, by using methylation 
patterns to represent random replication errors, with the hypothesis that all 
daughter cells originate from a common ancestor, and cell divisions and 
ancestry may be surreptitiously recorded by identifying replication errors that 
naturally accumulate in a clock-like manner during aging (Tanaka, Kyo et al. 
2003, Kim, Tavare et al. 2005). However, the methodology for these studies 
assumed a single, blunt-ended, tubular, 3D architecture for the glandular 
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epithelium, which is yet to be confirmed. Moreover, the sensitivity of the X-
chromosome inactivation technique depends on the size, and tessellation, of 
X-inactivated patches, which in many tissues confounds the analysis of 
clonality (Novelli, Cossu et al. 2003).  
3D tissue reconstruction, and examination of tissue at microscopic resolution 
from the digital images of serial sections, has significant potential to improve 
the understanding of the growth patterns, and the spatial arrangement, of 
diseased cells, and enhance the study of biomechanical behaviour of the 
tissue structures, towards better treatments (e.g. tissue-engineering 
applications) (Song, Treanor et al. 2013). Inparticular, diseases involving 
structural changes, or those in which the spatial relationship of disease 
features are important (Roberts, Magee et al. 2012). Its application to, or 
combination with, techniques, such as immunohistochemistry (IHC) or in situ 
hybridisation (ISH), adds further value by allowing understanding of 
additional phenotypic, or functional information (Roberts, Magee et al. 2012). 
The information is obtained by successively applying 2D image-to-image 
registrations, and then concatenating the set of aligned images, to form a 3D 
volumetric dataset (Song, Treanor et al. 2013).  
Early 3D studies were performed by Wellings et al. in the late 1960s and 70s 
(Marcum and Wellings 1969, Wellings and Jensen 1973, Wellings, Jensen et 
al. 1975). Their methodology involved sectioning 50 to 150 consecutive 2 
mm wide slices, staining them with hematoxylin and eosin (H&E), and 
sealing the sections in heavy polyethene bags in order to read the slices in 
the bags under the dissecting microscope, and mark the lesions on the 
overlying plastic. The lesions were cut out of the slices and subgross 
photographs were taken, before confirming findings with conventional 
histology. This method made selection and quantification of solitary lesions in 
whole mounts, possible for the first time, allowing the number of conventional 
paraffin embedded blocks needed to be examined to be reduced. 
It is now possible to generate image stacks of serially sectioned tissues 
(Sun, Wang et al. 2009, Onozato, Klepeis et al. 2012), and in studies of 
pathological tissues. Such reconstructions have demonstrated previously 
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unknown architectural patterns, for example, showing that tubulo-lobular 
carcinomas are very similar to tubular carcinomas of the breast (Marchio, 
Sapino et al. 2006).  
3D reconstruction has been undertaken of ductal carcinoma in situ (DCIS) of 
the breast, where it was anticipated that this would provide additional insight 
in to the natural course of the disease, and pathogenesis, on top of the 
normal 2D evaluation routinely performed. For example, if the disease is truly 
continuous in affected areas, or whether there is coexistent invasive disease; 
and whether multiple origins of invasion are the normal, or whether invasion 
usually occurs from a single point (Booth, Treanor et al. 2015). Initial 
applications of this technique have been mainly concerned with the 
investigations of the anatomical features, and microarchitecture of normal 
tissue (Kaufman, Brune et al. 1997), tumour invasion, growth factor 
expression, localisation of therapeutic targets in relation to microvasculature, 
and studying gene expression (for example, in developing mouse embryos 
(Han, van Hemert et al. 2011), and the developing human brain) (Wang, 
Lindsay et al. 2010). 
There are competing alternative techniques to 3D tissue reconstruction using 
individually stained serial sections, and these include: Alternative non-
destructive 3D imaging techniques, consisting of; optical projection 
tomography (Quintana and Sharpe 2011); 3D imaging with ultrasonography 
(Prager, Ijaz et al. 2010); microscopic magnetic resonance imaging or X-ray 
microcomputed tomography; confocal laser scanning or multiphoton 
microscopy, and serial block face imaging (e.g., episcopic fluorescence 
image capture and high-resolution episcopic microscopy) (Denk and 
Horstmann 2004). These methods are still in the process of being optomised, 
so could potentially have benefits over 3D tissue reconstruction with serial 
sections. Conventional histopathological staining and interpretation 
techniques have significant, and obvious, advantages over other techniques 
(Roberts, Magee et al. 2012).The Leeds Institute of Cancer and Pathology 
has previously employed 3D histopathological techniques to reconstruct a 
variety of tissues (including liver and kidney), providing detailed visualisation 
of structural features, and spatial relationships (Roberts, Magee et al. 2012). 
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We aimed to test the current hypothesis that the endometrial epithelial 
glands are blind ending, singular tubes, running from the LE to the 
endometrial/ myometrial junction.  
4.1.1 The Research Questions that were addressed 
Main research question: What is the 3D histo-architectural 
arrangement of the human premenopausal endometrial epithelial 
compartment? 
We aimed to answer the above question in 2 steps: 
1. What is the 3D structural organisation of the premenopausal 
endometrial functionalis glands? 
2. What is the 3D structural organisation of the premenopausal 
basalis glands? 
4.2  Methods 
4.2.1 Patient population 
Patients who donated endometrial tissue are detailed in Table 4.1. Three, full 
thickness, endometrial samples were collected from patients undergoing 
hysterectomy for benign conditions at Liverpool Women’s Hospital, from 
2009-2017. The hysterectomy specimens were opened immediately after 
surgical excision, and full thickness wedge biopsies, containing all 
endometrial layers and subendometrial myometrium were taken. These 
tissue sections were fixed for 24 hours in 4% (v/v) buffered formalin, then 
paraffin embedded for histochemical staining. The patient demographic 
details were documented at the time of sample collection. None of the 
patients received hormonal treatments for 3 months prior to surgery, and 
they did not have known endometrial pathology. 
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Sample 
Number 
Age BMI Parity Smoker Stage of 
Cycle 
1 42 22.3 2 N Proliferative 
2 44 18.7 0 N Secretory 
3 44 29.4 2 N Proliferative 
 
Table 4.1 - Demographical details of the patients involved in the study. 
 
4.2.2 Histochemistry 
From each block, one hundred sequential 4 µm thick serial sections were cut 
and numbered with the same orientation throughout. The slides were H&E 
stained as follows: dewaxed (as per chapter 2), followed by staining firstly in 
Gills 2 Haematoxylin (Thermo Scientific, Runcorn, UK) for four minutes, 
rinsing in tap water, and dipping in acid alcohol, before returning to tap water 
for five minutes. Slides are then placed in 70% alcohol, followed by 95% 
alcohol for one minute each. Counterstain with Eosin Y (Thermo Fisher 
Scientific, Runcorn, UK) for four minutes, and rinse in water, before 
dehydrating, clearing, and mounting in synthetic resin.  
4.2.3 Model generation 
The 100 consecutive stained slides (H&E), of full thickness endometrium, 
were scanned using an Aperio ScanScope slide scanner (Aperio 
Technologies, Vista, CA, USA) at x400 magnification, creating virtual slides. 
The slides were sent to the Leeds Institute of Cancer and Pathology where 
they underwent the process of `registration` aligning in stacks, so that the 2D 
features were aligned, to form smooth 3D topographies. This registration 
resulted in a stack of images which had been aligned, thus, could be 
rendered in 3D as a 3D ‘volume’. This ‘volume’ was a 3D image, which was 
analogous to a cube of glass containing the H&E stained tissue. The virtual 
slides were registered using Slice Registration Application (SliceRegApp) 
program, [version 11.1.1 (64 bit OpenMP build), University of Leeds, Leeds, 
UK]. For this, a reference image was selected in the middle of the image 
160 
 
stack, and was used to align subsequent images, proceeding out from the 
centre, aligning all images to their neighbours (Video 4.1). This aligned each 
virtual slide to adjacent slides within the dataset, before we uploaded the 
images into the FreeD16 240 software program (Andrey and Maurin 2005) 
for 3D reconstruction, as follows: Serial images (TIFF file format) were 
imported into FreeD software v 1.10 image stack files; Endometrial gland 
boundaries in a specific area on the individual sections of full thickness 
endometrium were drawn manually in each 2D serial image, and connected 
along the third dimension between adjacent slides, producing 3D models. 
Video 4.1 – Representative video of one of the 100 consecutively sectioned, 
H&E stained aligned, endometrial tissue blocks.   
 
The different anatomical areas of the full thickness endometrial samples (the 
basalis and the functionalis) were examined in greater detail, relating to the 
architecture of the glands, and the gland interactions.  
4.3 Results 
3D reconstructions of full thickness endometrial samples did not show 
a single, tubular, blunt-ended architecture for the human endometrial 
glands. 
We were able to create 3D reconstructions from all 3 full thickness 
endometrial samples using the 100 consecutive 2D sections (Figure 4.2). 
This, therefore, provided the basis for progression on to further work in order 
to analyse the samples, examining their regional specific 3D configuration. 
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Figure 4.2 – Representative images of one of the full thickness endometrial 
samples formed into a 3D block.  
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Premenopausal functionalis glands are non-branching and run a 
parallel, vertical course through the superficial human endometrium. 
The endometrial functionalis glands could be tracked from the 
functionalis/basalis junction to the LE, running parallel to each other (Figure 
4.3 A and B, 4.4 A and B and 4.5 A and B, and videos 4.2, 4.3 and 4.4). The 
proliferative glands were thinner, straighter, and easier to trace (Figure 4.3 A 
and B and 4.4 A and B) than the much longer, coiled secretory glands, with 
wider lumens (Figure 4.5 A and B). 
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Figure 4.3 – Demonstration of premenopausal early-proliferative 
functionalis glands are non-branching and run a parallel, vertical 
course through the superficial human endometrium. (A) Representative 
micrographs of full thickness proliferative endometrium showing functionalis 
glands running parallel to each other. (B) 3D schematic of vertical non 
branching functionalis glands.  
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Figure 4.4 - Demonstration of premenopausal mid-proliferative 
functionalis glandular 3D-architecture. (A) Representative micrographs of 
full thickness proliferative endometrium showing functionalis glands run a 
parallel, vertical course through the superficial functionalis human 
endometrium (B) 3D schematic of vertical non branching functionalis glands. 
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Figure 4.5 – Demonstration of premenopausal secretory functionalis 
glands are also non-branching and run a parallel, vertical course 
through the superficial human endometrium. (A) Representative 
micrographs of full thickness proliferative endometrium showing functionalis 
glands running parallel to each other. (B) 3D schematic of vertical non 
branching functionalis glands. 
Video 4.2 – Non-branching vertical early proliferative functionalis glands. 3D 
video documenting the non-branching vertical early-proliferative phase functionalis 
glands.  
Video 4.3 - Non-branching vertical mid-proliferative functionalis glands. 3D 
video documenting the non-branching vertical mid-proliferative phase functionalis 
glands. 
Video 4.4 - Non-branching vertical secretory functionalis glands. 3D video 
documenting the non-branching vertical secretory phase functionalis glands 
 
Premenopausal endometrial basalis glands form a complex and 
branching configuration, proceeding in a horizontal course to the 
myometrium. 
The endometrial basalis glands were similarly traced from the sub-
endometrial myometrium, up to the endometrial functionalis/basalis junction. 
These basalis glands demonstrated a more complex, and a dissimilar, 
structural organisation when compared with the parallel, singular vertical 
functionalis glands. They often branched, as well as enveloping around one 
another horizontally in a root –like “stolon” configuration, giving rise to single 
lumen functionalis glands arranged at 90 degree angles to them (Figure 4.6 
A and B, 4.7 A and B and 4.8 A and B, and videos 4.5, 4.6 and 4.7). Since 
the stem cells are postulated to reside in them, this basalis glandular 
organisation is likely to provide an effective glandular propagation strategy to 
maintain continuous endometrial covering of the uterine cavity, and its scar-
less regeneration. 
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Figure 4.6 – Demonstration of premenopausal endometrial basalis 
glands forming a complex and branching configuration, proceeding in 
a horizontal course to the myometrium. (A) Representative micrographs 
of full thickness early-proliferative endometrium showing branching basalis 
glands running at a horizontal course to the myometrium. (B) 3D schematic 
of branching horizontal basalis glands. 
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Figure 4.7 – Demonstration of premenopausal endometrial basalis 
glands forming a complex and branching configuration, proceeding in 
a horizontal course to the myometrium. (A) Representative micrographs 
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of full thickness mid-proliferative endometrium showing branching basalis 
glands running at a horizontal course to the myometrium and enveloping 
around one another. (B) 3D schematic of branching basalis glands and a non 
branching functionalis gland rising vertically from the basalis.  
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Figure 4.8 – Demonstration of premenopausal endometrial basalis 
glands forming a complex and branching configuration, proceeding in 
a horizontal course to the myometrium. (A) Representative micrographs 
of full thickness secretory endometrium showing branching basalis glands 
running at a horizontal course to the myometrium and enveloping around one 
another. (B) 3D schematic of branching basalis glands and non branching 
functionalis glands rising vertically from the basalis. 
Video 4.5 – Horizontal branching basalis glands. 3D video documenting the 
branching early-proliferative basalis glands. 
Video 4.6 - Horizontal branching basalis glands. 3D video documenting the 
branching mid-proliferative basalis glands. 
Video 4.7 - Horizontal branching basalis glands and vertical non branching 
functionalis glands. 3D video documenting the branching secretory basalis glands 
and non branching functionalis glands. 
 
4.4  Discussion 
The 3D architecture of the human adult endometrial glands was previously 
uncharacterised until now, and 3D reconstruction work has not been 
previously attempted on full thickness endometrial samples containing the 
whole glandular element. The current consensus had been that the 
endometrial glandular arrangement is similar to intestinal glandular crypts, 
assuming a single, blunt ended, ductular design. The novel work presented 
in this chapter gives a whole new insight into the complex, previously 
unknown, intricate, 3D histoarchitectural organisation of the human 
endometrial glands, replacing the existing, obsolete, schematics of the 
endometrial glandular organisation (Figure 4.9 A and B). 
173 
 
 
Figure 4.9 – Endometrial premenopausal secretory functionalis glands 
are non-branching and run a parallel, vertical course through the 
superficial human endometrium whereas the basalis glands form a 
complex and branching configuration, proceeding in a horizontal 
course to the myometrium. (A) Old schematic of endometrial glands. (B) 
Proposed new schematic of endometrial glands with complex basalis 
architecture. 
 
The functionalis glands, which are shed on a monthly basis, were found to 
run parallel to each other, without branching in their course, from the LE to 
the functionalis/basalis junction. Although these glands assumed a single 
tubular configuration, like the straight colonic crypts (Henrikson R 1997), their 
spiralling and coiling rendered them to be more structurally complex than the 
straight intestinal crypts. Furthermore, the spiralling increased with 
advancing phase, and associated cellular differentiation, of the menstrual 
cycle (from proliferative to secretory) in the functionalis glands.  
Based on observations made on 2D tissue sections, others have reported 
the basalis glands of the human endometrium to run a horizontal course 
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alongside the myometrium (Ferenczy and Richart 1973, Cooke, Spencer et 
al. 2013), but their suggestions have been overlooked in all recent 
manuscripts, and frequent schematics have adopted the intestinal crypt-like 
basalis gland configuration, with blind ending tubes resting into the 
myometrium (Gargett, Schwab et al. 2016). This work, the first 3D 
reconstructions of the human pre-menopausal endometrial glandular 
compartment, agrees with previous studies (Ferenczy and Richart 1973, 
Cooke, Spencer et al. 2013) and offers an alternative schematic (Figure 4.9). 
The glands have a more complex/intricate course than a blind ending tube, 
likely to be assisting in the self-preserving, self-renewing, scar-less nature of 
the human endometrial regeneration. The regular endometrial regeneration 
on a monthly basis is well known (Hapangama, Kamal et al. 2015), and it 
also regenerates following parturition, iatrogenic destruction after surgical 
ablation, and curettage. Therefore, relying on a single blind ending tube may 
not be the most efficacious arrangement, as the stem cell rich, basalis, 
glandular ends could potentially be easily lost/artificially removed during one 
of the above situations, leading to the loss of the regenerative ability of the 
endometrium in the near vicinity. Therefore, the preservation of the potential 
endometrial epithelial stem cell niche, the basalis glands, is vital. The 
complex, root-like stolen configuration, therefore, provides the ideal rapid 
replenishment of the stem cell niche, in any area of the basalis glandular 
element.  
This work forms the basis for a new avenue of study, to understand many 
unanswered questions relevant to human embryo-implantation, utilising the 
3D architecture (similar to the recent mouse studies) which demonstrated 
previously unknown information in murine embryo-implantation. Yuan et al 
recently showed, using 3D reconstruction, a previously unknown event in 
implantation biology; that LE invaginates to form a crypt with the existing 
glands, setting up a direct communication between the blastocyst and glands 
within the crypt (Yuan, Deng et al. 2018). Aberrations of these events were 
captured in a 3D context in the Vangl2-deleted epithelia, providing 
compounding evidence for the role of epithelial Vangl2/PCP signalling in 
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implantation (Yuan, Deng et al. 2018). Similarly, the work presented in this 
chapter paves the way for further 3D studies.  
Further modelling of different human endometrial samples needs to be 
completed, scrutinising closely the LE, postmenopausal (PM) endometrium, 
and endometrial pathologies; such as pre-cancerous endometrial 
hyperplasia, endometrial cancer, and endometriosis. The LE, as previously 
discussed, should be seen as a separate entity to the functionalis and 
basalis epithelium. With the current 3D modelling data presented in this 
chapter, the dynamic architecture of the LE is difficult to discern. Further 
work to tease out the relationship between the LE and the functionalis glands 
in the superficial functionalis layer needs to be completed; potentially, 
digitally re-slicing the re-constructed tissue blocks, or forming models utilising 
different markers of different epithelial areas to distinguish interactions in 
more detail, would be future avenues to explore. PM samples are obviously 
required to be interrogated, to confirm, or dispute, the current consensus that 
these glands are similar to the basalis glands of the premenopausal 
endometrium in their nature, and architecture. This method could also be 
utilised to allow us a better understanding of the interplay between normal 
endometrium, hyperplasia, and cancer; and to distinguish if women with 
particular endometrial pathologies (such as recurrent miscarriage, 
endometriosis, subfertility, or heavy menstrual bleeding) carry an altered 
architectural arrangement to women without endometriosis.  
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Chapter 5. In vivo lineage tracing using 
mitochondrial DNA mutations 
5.1 Introduction 
All adult organs have stem cells that are responsible for their maintenance 
and repair. The characteristics, behaviour, and ‘undifferentiated’ status of a 
stem cell changes when it is removed from its niche. The identification of 
these long-lived adult stem cells (ASCs) in a solid organ is, therefore, 
particularly challenging, and only certain techniques are suitable for 
isolating/identifying stem cells of human organs. This chapter describes in 
vivo lineage tracing, the “gold standard” method of stem cell identification.   
Lineage analysis is a technique originally developed to study early embryos, 
and represents, by far, the most powerful and reliable tool for identifying and 
confirming stem cells; and for deciphering other aspects of tissue behaviour 
(Fox DT 2009). The methods employed for lineage tracing in animals are 
very different to the methods that can be used for lineage tracing in humans, 
due to the obvious unacceptability/unsuitability for studies using genetic 
modification, and ingestion of fluorescent probes to be undertaken in human 
subjects. However, in vivo lineage tracing where the progeny of a stem cell is 
directly tracked/identified in intact tissue is the ultimate confirmation of the 
existence of a stem cell. The method used in the experiments described in 
this chapter enables lineage tracing in vivo in the intact human endometrial 
tissue, without potential harm to the participating subjects. This method 
involves tracing mitochondrial DNA (mtDNA) mutations in the epithelial 
compartment, and is deemed a natural experiment since genetic changes 
occur spontaneously, allowing lineages to be tracked and, in several 
instances, the stem cell niche to be identified (Wright 2012). 
Taylor and colleagues, in Newcastle-upon-Tyne (Taylor, Barron et al. 2003), 
initially used this method of tracing mtDNA mutations in human colon tissue. 
Subsequently, it was generalised by Fellous et al for the identification of 
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human epithelial stem cell niches in solid organs, to study liver (Fellous, 
Islam et al. 2009), intestine, pancreas, and skin (Fellous, McDonald et al. 
2009). We have employed this method, for the first time, to prove the 
existence of human endometrial epithelial stem cells. The added value of this 
method is that the analysis of passenger mutations has proven to be more 
useful than the analysis of driver mutations, because maintenance of 
passenger mutations is presumably not subject to selective pressure (Fearon 
and Bommer 2011).  
Mitochondria are essential intracellular organelles that are required for 
oxidative phosphorylation, and are found in all nucleated human cells. They 
contain the only non-chromosomal DNA in human cells, their own mtDNA 
(Taylor and Turnbull 2005). The mitochondria are, therefore, under the dual 
control of nuclear and mtDNA (Taylor, Barron et al. 2003). High levels of 
reactive oxygen species (ROS) production (Richter, Park et al. 1988), lack of 
protective histones, and the absence of DNA repair mechanisms to protect 
mtDNA, renders the mitochondrial genome more prone to mutations than 
nuclear DNA (Taylor, Taylor et al. 2001, He, Chinnery et al. 2002, Fellous, 
McDonald et al. 2009). Therefore, mtDNA displays elevated levels of 
spontaneous, non-pathogenic, passenger mutations, and it is through these 
that the visualisation and following of the progeny of an individual stem cell in 
a tissue section has been realised, as these passenger mutations act as 
clonal markers (Walther and Alison 2016). The passenger mutations are 
passed on to daughter cells during cell division, providing a platform for 
studying cell lineage in human tissues.  
Mitochondrially-encoded cytochrome C oxidase (CCO) is an enzyme forming 
the last step of the electron transport chain in respiratory complex IV 
(Mootha, Lepage et al. 2003, Taylor, Barron et al. 2003, Greaves, Preston et 
al. 2006, Li, Park et al. 2006, McDonald, Greaves et al. 2008). It is a major 
regulatory site for oxidative phosphorylation and is essential for the assembly 
and respiratory function of the enzyme complex (Li, Park et al. 2006). 
Spontaneous passenger, non-pathogenic, mutations can occur in the CCO 
gene, and they confer little or no selective growth advantage to normal cells 
(Nooteboom, Johnson et al. 2010). Importantly, such mutations are readily 
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detectable in tissue sections, using dual-colour enzyme histochemistry 
(Fellous, McDonald et al. 2009), or immunohistochemistry (IHC) (Greaves, 
Preston et al. 2006). 
When CCO mutations occur, they can affect all copies of the mitochondrial 
genome within a cell, homoplasmy, or there may be a mixture of mutated 
and wild-type genomes in the same cell, heteroplasmy (Lightowlers, 
Chinnery et al. 1997, Taylor and Turnbull 2005). In the presence of 
heteroplasmy, identification of a detectable deficiency in the CCO enzyme 
requires at least 80% of the CCO genes in a cell to be mutated (Sciacco, 
Bonilla et al. 1994, Taylor, Barron et al. 2003).  
The expansion of a mutation within a cell can follow a stochastic course, 
which, over time, can evolve from a heteroplasmic state to a homoplasmic, 
or near homoplasmic, state. This process is termed `genetic drift` (Elson, 
Samuels et al. 2001, Wright 2012). The mutation spreads, firstly, within the 
individual mitochondrial genome, and then in the mitochondria of the stem 
cell, to a level of homoplasmy. Therefore, due to this lengthy process, wholly-
mutant crypts are rarely seen before the age of 40 (Greaves, Preston et al. 
2006), indicating the time required for near-homoplasmy to be reached 
(Greaves, Preston et al. 2006, Wright 2012). For the same reason, it is 
assumed that only stem cells live long enough to acquire the near-
homoplasmic state, enabling their detection of a biochemical deficiency 
(Fellous, McDonald et al. 2009).  
In mucosal tissues, such as the small intestinal crypt and the gastric gland, 
CCOˉ crypts and glands were shown to contain cells of all lineages, 
demonstrating that all of the cells in these glands originated from a CCOˉ 
common ancestor, a stem cell (Wright 2012). This method has, 
subsequently, been utilised to confirm the existence of epithelial stem cells in 
the colon (Taylor, Barron et al. 2003), pancreas (Fellous, McDonald et al. 
2009), bladder (Gaisa, Graham et al. 2011), and prostate (Gaisa, Graham et 
al. 2011), but has not yet been utilised in the human endometrium. The work 
described in this chapter is, therefore, intended to extend the method to, 
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conclusively, examine the existence of a human endometrial epithelial stem 
cell. 
5.1.1 The research questions that were addressed 
1. Do CCO mutations occur in the human endometrium? 
2. What is the natural history of endometrial CCO mutations in the 
human endometrium with advancing age? 
3. Do all epithelial cells from a CCO negative patch contain the same 
mtDNA mutation, confirming clonality, and proving the existence of 
endometrial epithelial stem cells? 
4. Does more than one stem cell contribute to functionalis 
endometrial gland regeneration?  
5. Do CCO-deficient clonal patches incorporate cells of all epithelial 
regions (basal, functional and luminal), therefore demonstrating 
multipotency? 
6. Can 3D modelling of CCO-deficient clonal patches identify the 
location of the endometrial epithelial stem cell niche?  
5.2  Methods 
5.2.1 Patient population 
Patient groups who donated endometrial tissue are detailed in Table 5.1. 78 
full thickness endometrial samples were collected from patients undergoing 
hysterectomy for benign conditions at Liverpool Women’s Hospital, from 
2009-2017. The hysterectomy specimens were either opened immediately 
after surgical excision (70/78), or transported straightaway on ice to the 
pathology laboratory at the Royal Liverpool University Hospital, to be 
opened, and sectioned, by the pathologist (8/78) (allowing a larger sample); 
and full thickness wedge biopsies containing all endometrial layers, and 
subendometrial myometrium were taken. These tissue sections were 
processed in two ways: fixed for 24 hours in 4% (v/v) buffered formalin, then 
paraffin embedded for IHC staining; flash frozen with liquid nitrogen, and 
stored at -80°C for enzyme histochemistry, laser capture micro dissection 
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(LCM), polymerase chain reaction (PCR), and Sanger sequencing of the 
CCO gene. The patient demographic details were documented at the time of 
sample collection. None of the patients received hormonal treatments for 3 
months prior to surgery, and they did not have known endometrial pathology.  
Age BMI Parity Smoking 
21 25.9 0 N 
23 23.5 0 N 
25 20.2 0 Y 
27 23 3 N 
31 24.9 3 N 
32 27.8 2 Y 
32 26.6 2 N 
34 23.8 3 N 
35 30.5 0 N 
35   N 
37 41.5 3 N 
37 26.5 2 Y 
37 21.7 4 Y 
38 30.8 3 N 
38 27.9 4 N 
39 32 2 Y 
39 27.9 1 N 
39 26.5 2 N 
40 34.7 3 Y 
41 30.7 1 N 
41 26.7 4 Y 
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41 23.2 1 Y 
42 23.5 2 N 
42 22.3 2 N 
43 40.5 3 N 
43 28.6 2 N 
43 24.5 0 N 
43 26.7 2 N 
44 29.4 2 N 
44 29.6 1 N 
44 24.3 2 Y 
44 32.3 1 N 
44 38 2 N 
44 30.7 0 N 
44 24.5 2 N 
44 18.7 0 N 
45 21.7 4 Y 
46 23.1 3 N 
46 26.8 5 N 
47 29.8 2 N 
47 30.2 3 N 
47 21.6 2 N 
47 32.4 5 N 
47 25 1 N 
47 23.4 1 N 
47 25.8 2 N 
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47 29.4 2 N 
48 29.9 4 N 
48 40.1 3 N 
49 24.4 2 N 
49 23.2 0 N 
49  2 Y 
49 28.4 2 N 
49 27.6 3 N 
50 20.3 3 N 
52 24.5 2 N 
52 26.3 2 N 
57 30.8 2 N 
58 20 2 N 
60 31 2 N 
60 26.9 5 Y 
61 27.7 4 N 
62 28.3 3 N 
62 32.2 4 N 
62 27.4 1 N 
65 28.8 3 Y 
65 18.5 2 N 
66 24.9 3 N 
69 24.7 4 N 
69 26.8 3 N 
72 35.8 3 N 
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74 35.6 3 N 
74 32 3 N 
75 29.6 2 N 
75 29.6  N 
76 25.2 2 N 
77 26.6 2 N 
78 26.8 4 N 
 
Table 5.1 – Demographical details of the patients involved in the study. 
 
5.2.2 Immunohistochemistry 
After antigen retrieval in citrate or TRIS buffer (see antibody conditions, 
Table 5.2) (as previously described in chapter 2), 4 µm formalin fixed paraffin 
embedded (FFPE) sections were blocked with 3% hydrogen peroxide for 10 
minutes, then immunostained with the appropriate antibody for the given 
time, and dilution in Table 5.2. This was followed by incubation for 30 
minutes at RT in the appropriate secondary antibody. Detection was with 
ImmPRESS polymer based system, and visualisation was with ImmPACT 
DAB (Vector Labarotories, Peterborough, UK) (used as per manufacturer’s 
instructions). Sections were counter stained in Gill 2 Haemotoylin (Thermo 
Scientific, Runcorn, UK), dehydrated, cleared, and mounted in Consul-
Mount. Matching isotype replaced the primary antibody as a negative control, 
with internal positive control in each staining run.  
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Primary 
Antibody 
Type Clone Supplier Antigen 
Retrieval 
Dilution Incubation Secondary 
SSEA-1 Monoclonal MC-480 Biolegend Tris 3 
mins 
1:800 Overnight 
at 4oC 
Mouse 
Pancytokeratin Monoclonal C2562 Sigma Citrate 2 
mins 
1:4000 Overnight 
at 4oC 
Mouse 
N Cadherin 
  
Monoclonal 8C11 Abcam Citrate 2 
mins 
1:200 Overnight 
at 4oC 
Mouse 
SOX 9 Polyclonal SOX 9 R&D Citrate 4 
mins 
1:400 Overnight 
at 4oC 
Mouse 
CK5/6 
 
Monoclonal D5/16B4 Merck Tris 3 
mins 
1:250 Overnight 
at 4oC 
Mouse 
MUC 1 Monoclonal BC-2 Serotec Citrate 2 
mins 
1:400 Overnight 
at 4oC 
Mouse 
BCAM 
 
 
Monoclonal EPR4164 Abcam Citrate 2 
mins 
1:100 Overnight 
at 4oC 
Rabbit 
CCO 
 
Monoclonal 1D6E1A8 Invitrogen Citrate 2 
mins 
1:1000 30mins 
room 
temperature 
Mouse 
Ki67 Monoclonal Ki67 Dako Citrate 4 
mins 
1:200 Overnight 
at 4oC 
Mouse 
 
Table 5.2 – IHC Antibody details.  
 
Immunostaining was analysed with specific reference to CCO presence in 
the luminal epithelium (LE), the functionalis (glands in the upper two-thirds of 
the endometrium below the LE), and the basalis (glands in the lower one-
third of the endometrium adjacent to the endo-myometrial junction), in 
numbers of wild type vs partial gland vs complete gland mutations.  
5.2.3 In situ hybridisation  
ISH for LGR5 expression was performed as, previously described (Baker, 
Graham et al. 2015), on 4 μm sections using the RNAscope 2.5 High 
Definition Brown assay, according to the manufacturer’s instructions 
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(Advanced Cell Diagnostics, Hayward, CA). Samples were baked at 60°C for 
1 hour 30 minutes, followed by de-paraffinisation and incubation with 
Pretreat 1 buffer, for 10 minutes at RT. Slides were boiled in Pretreat 2 buffer 
for 15 minutes, followed by incubation with Pretreat 3 buffer, for 15 minutes 
at 40°C. Slides were incubated with the relevant probes for 2 hours at 40°C, 
followed by successive incubations with Amp 1 to 6 reagents. Staining was 
visualized with DAB for 20 minutes, then lightly counterstained with Gill's 
haemotoxylin. RNAscope probes used were LGR5 (NM_003667.2, region 
560-1589 catalogue number 311021), POLR2A (positive control probe) 
(NM_000937.4, region 2514-3433 catalogue number 310451), and dapB 
(negative control probe) (EF191515, region 414-862, catalogue number 
310043). 
LGR5 expression was quantified according to the five-grade scoring system 
recommended by the manufacturer, previously described (Baker, Graham et 
al. 2015) (0 = No staining or less than 1 dot to every 10 cells (40× 
magnification), 1 = 1–3 dots/cell (visible at 20–40× magnification), 2 = 4–10 
dots/cell, very few dot clusters (visible at 20–40× magnification), 3 = > 10 
dots/cell, less than 10% positive cells have dot clusters (visible at 20× 
magnification), 4 = > 10 dots/cell, more than 10% positive cells have dot 
clusters (visible at 20× magnification)).   
5.2.4 Enzyme histochemistry 
12 µm sections of frozen full thickness endometrium were cut with the 
cryostat and incubated, firstly in CCO medium (100 mM cytochrome c, 4 mM 
diaminobenzidine tetrahydrochloride, and 20 µg/mL catalase in 0.2 M 
phosphate buffer, pH 7.0 all from Sigma Aldrich, Poole, UK) at 37°C for 50 
minutes to allow for detection of CCO activity in brown, followed by washes 
in PBS pH7.4 (3 × 5 minutes). Succinate dehydrogenase (SDH) medium 
incubation followed (130 mM sodium succinate, 200 µM phenazine 
methosulphate, 1 mM sodium azide, 1.5 mM nitroblue tetrazolium in 0.2 M 
phosphate buffer, pH 7.0) at 37°C for 40 minutes before further PBS washes 
(3x 5 minutes). Following this, the sections were allowed to air dry for LCM, 
or dehydrated in a graded ethanol series (70%, 95%, 2 × 100%), cleared in 
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Histoclear (Fisher Scientific, Leicestershire, UK), and mounted in DPX (BDH 
Laboratory Supplies, Poole, United Kingdom). This method, therefore, 
allowed CCO-positive cells (wild type) to be stained brown, and CCO-
deficient areas to be highlighted, and recognised, using a second stain 
detecting the activity of a nuclear encoded enzyme, succinate 
dehydrogenase (SDH, blue, a component of complex II of the respiratory 
chain). 
5.2.5 Isolation of total DNA from micro-dissected 
endometrium 
Fresh frozen sections (12 µm) of endometrium were mounted on PALM 
membrane slides (Carl Zeiss, Oberkochen, Germany), underwent dual 
enzymatic histochemistry (as described above) and were air-dried for one 
hour. Single endometrial epithelial cells of interest (mutated and wild type) 
and stroma (for control) were cut into sterile 0.5 mL AdhesiveCap PCR tubes 
(Carl Zeiss, Oberkochen, Germany) (previously ultraviolet (UV) treated) 
using a PALM Microbeam laser capture system (Carl Zeiss, Oberkochen, 
Germany). After LCM, 15 µL of ATL buffer was added to each sample to 
commence cell lysis (RNA extraction of the samples was done immediately 
after LCM, or after storing at -20°C overnight). 
5.2.6 DNA extraction 
DNA was extracted using Qiagen QIAamp DNA Micro kits. 10 µL of 
proteinase K and 15 µL of ATL buffer was added to the tubes already 
containing the tissue, and this was mixed by pulse vortexing for 15 seconds, 
before incubating for 3 hours at 56°C, with occasional agitation. 25 µL of 
buffer ATL was added, and 50 µL of buffer AL, before mixing by pulse 
vortexing for 15 seconds. To ensure efficient lysis it is essential that the 
sample and buffer AL are thoroughly mixed to yield a homogenous solution. 
50 µL of 100% ethanol was added, and this was mixed thoroughly by pulse 
vortexing for 15 seconds, before incubating for 5 minutes at RT. The mixture 
was briefly centrifuged to remove drops from inside the lid, and the entire 
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lysate was transferred to the QIAamp MinElute column (in a 2 mL collection 
tube) without wetting the rim. The tube was centrifuged at 6000g for 1 
minute, and the QIAamp MinElute column was placed in a clean collection 
tube (discarding the collection tube and flow through). 500 µL of buffer AW1 
was added, and the mixture was centrifuged at 6000g for 1 minute. The 
QIAamp MinElute column was placed in a clean collection tube, and 500 µL 
of buffer AW2 was added. Centrifuge was performed at 6000g for 1 minute, 
again, and the MinElute column was placed in a clean 2 mL collection tube 
before centrifuging at full speed (20,000g) for 3 minutes to dry the membrane 
completely (this step is necessary as ethanol carryover may interfere with 
some downstream applications). 
The QIAamp MinElute column was placed in a clean 1.5 mL microcentrifuge 
tube, and 20 µL of distilled water was applied. The mixture was incubated for 
5 minutes before spinning on maximum for 1 minute, and adding a further 20 
µL of water, incubating for a second 5 minutes, and spinning at maximum for 
1 minute.  
5.2.7 Mitochondrial DNA sequencing of individual 
endometrial epithelial cells 
The entire sequence of the mitochondrial genome from micro-dissected 
endometrial cells was determined using the single cell lysate as the DNA 
template, and a two stage nested PCR amplification protocol. The primary 
PCR reactions involved amplification of the mitochondrial genome in 9 
fragments, of approximately 2 kb, using a series of overlapping primer pairs. 
These initial large PCR reaction products decrease the risk of amplifying 
pseudogenes when extracting DNA from small quantities of DNA. All PCR 
amplifications were performed in a 25 µL volume containing 1× PCR buffer 
(10 mM Tris-HCl, pH 8.3, 1.5 mM MgCl2, 50 mM KCl, 0.001% wt/vol gelatin), 
0.2 mM dNTPs, 0.6 µM primers, 1 U AmpliTaq Gold DNA polymerase 
(Applied Biosystems), and 1 µL single-cell lysate. Reaction conditions were 
95°C for 10 minutes, and 38 cycles of 94°C for 45 seconds; 58°C for 45 
seconds and 72°C for 2 minutes. The final extension was for 8 minutes, 
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followed by incubation at 4°C indefinitely. The secondary PCR reactions 
involved amplification of the primary PCR products with 28 primer pairs, 
specifically to generate overlapping fragments of between 600–700 base 
pairs that span the entire sequence of the human mitochondrial genome. 
Reaction conditions were 95°C for 10 minutes, and 30 cycles of 94°C for 45 
seconds; 58°C for 45 seconds and 72°C for 1 minute. The final extension 
was for 8 minutes, followed by incubation at 4°C indefinitely. To facilitate the 
direct sequencing of PCR-amplified products, all primer pairs are tagged with 
M13 sequence and designed to anneal optimally at 58°C. All reactions 
proceeded for 30 cycles and used 2 µL of primary reaction product as DNA 
template. PCR products were treated with ExoSaP-IT according to the 
manufacturer’s protocol, before EDTA-ethanol cleaning, then Sanger 
sequencing reaction using BigDye 3.1 terminator cycle-sequencing 
chemistries (Applied Biosystems) on an ABI 3730XL automated DNA 
sequencer.  
The sequences obtained were analysed using 4Peaks software 
(www.mekentosj.com), together with Clustal W2 software (EMBL-EBI), and 
compared to the revised Cambridge reference sequence (Andrews, Kubacka 
et al. 1999), with sequences from stromal controls and CCO normal 
specimens, to identify polymorphisms and somatic mutations from the CCO-
deficient sequences. Individual mutations were confirmed in all instances by 
repeating the first and second-round PCRs, and resequencing the products.  
5.2.8 CCO model generation 
The 100 consecutive CCO stained slides of full thickness endometrium were 
scanned using an Aperio ScanScope slide scanner (Aperio Technologies, 
Vista, CA, USA) at ×400 magnification, creating virtual slides. The slides 
were sent to the Leeds Institute of Cancer and Pathology where they 
underwent the process of `registration` aligning in stacks, so that the 2D 
features in them are aligned to form smooth 3D topographies. This 
registration resulted in a stack of images which had been aligned, thus, could 
be rendered in 3D as a 3D ‘volume’. This ‘volume’ was a 3D image, which 
was analogous to a cube of glass, containing the H&E stained tissue. The 
189 
 
virtual slides were registered using Slice Registration Application 
(SliceRegApp) program, [version 11.1.1 (64 bit OpenMP build), University of 
Leeds, Leeds, UK]. For this, a reference image was selected in the middle of 
the image stack, and was used to align subsequent images proceeding out 
from the centre, aligning all images to their neighbours. This aligned each 
virtual slide to adjacent slides within the dataset, before we uploaded the 
images into FreeD16 240 software program (Andrey and Maurin 2005) for 
3D reconstruction, as follows: Serial images (TIFF file format) were imported 
into FreeD software v 1.10 image stack files; The mutations were manually 
annotated in every section; and these were super imposed onto one of the 
pictures to visualise the location of the mutant clones. 
5.3 Results 
CCO-deficient epithelial patches exist in the endometrium. 
The screening of human tissues for CCO-deficient cells can initially be 
performed on FFPE tissue sections using a mouse monoclonal, anti-Oxphos 
complex IV subunit 1 antibody, and IHC, clearly identifying cases of interest 
which contain CCO-deficient areas.  
The presence of cells with common ancestry in the human endometrium was 
determined by screening the endometrial tissue sections with IHC for CCO 
activity (brown), which confirmed the presence of blue CCO-deficient glands 
(Figure 5.1). 75 FFPE endometrial samples from women aged 21-78 years 
were screened using IHC, and CCO-deficient patches (defined as any CCO-
negative gland, partial, or complete) were observed in 58 of the samples 
(77.3%). 
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Figure 5.1 - CCO-deficient epithelial patches exist in the human 
endometrium (A,B and C) Representative micrographs of pre menopausal 
functionalis epithelium with CCO deficiency. (D,E and F) Representative 
micrographs of premenopausal basalis epithelium with CCO deficiency. (G,H 
and I) Representative micrographs of PM epithelium with CCO deficiency. 
(J,K and L) Representative micrographs of PM LE with CCO deficiency. 
(Images A,D,G and J x40 magnification , images B,E,H and K x100, C,F,I 
and L x400, all scale bars = 10 µm).  
 
Incidence of CCO-deficient epithelial patches increases across the 
reproductive years, up to the age of menopause. 
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The presence of CCO-deficient clonal patches in the endometrial samples 
examined appeared to increase up to menopausal age, but plateaued after 
that (figure 5.2A). The lowest prevalence of clonal patches was observed in 
the endometrium from 20-29 year old women (50% (2/4)), and all 
endometrial samples examined from women aged 60-69 years contained 
CCO-deficient glands (100% (10/10)). However, beyond that age, the 
prevalence of these patches remained stable, despite advancing age in the 
endometrium of PM women.  
The percentage of partially-deficient, and wholly-deficient, glands as a 
percentage of the total glands present in the sample, also increases with age 
(Figure 5.2B and 5.2C), as does the percentage of the partially-deficient 
glands in the basalis layer (Figure 5.2D). 
When the pre-menopausal functionalis layer of the endometrium (only 
present in premenopausal women, and regenerated monthly) was 
considered, the presence of wholly-deficient functionalis glands (Figure 
5.2E), and partially-deficient functionalis glands (Figure 5.2F) increased 
across the decades, with none being present in the 20-30 year olds (neither 
partial nor complete). The earliest appearance of a CCO-negative clonal 
patch was observed in the basalis glands of a 25 year old, suggesting the 
long lived epithelial cells (likely stem cells) to be located in the basalis.  
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Figure 5.2 – The incidence of CCO-deficient epithelial patches increases 
across the reproductive years up to the age of menopause. (A) The 
presence of CCO-deficient clonal patches in the endometrium increases up 
until the age of menopause (n=78). (B) The percentage of wholly CCO-
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deficient clonal patches increased with age until menopause (n=78). (C) The 
percentage of partially CCO-deficient glands increases with age (n=78). (D) 
The percentage of partially CCO-deficient glands in the endometrial basalis 
glands increases with age (n=78). (E) The percentage of wholly CCO-
deficient glands in the pre-menopausal functionalis glands increases with 
age (n=52). (F) The percentage of partially CCO-deficient pre-menopausal 
functionalis glands increases with age (n=52). 
When all samples were considered, age, or BMI, did not correlate 
significantly with the prevalence of clonal patches.  
When all endometrial samples derived from the nulliparous women were 
considered against all multiparous women (any ages), nulliparous women 
had more (although not significantly) CCO-deficient patches.  
Unique mitochondrial mutations confirm the existence of endometrial 
epithelial stem cells in the endometrium. 
Eight frozen full thickness endometrial samples were screened with enzyme 
histochemistry for their suitability for isolating mtDNA from single cells using 
LCM and sequencing of the mtDNA. In order to prove the clonality of 
endometrial glands, we selected an endometrial sample containing both 
CCO-deficient glands (Figure 5.3 A&B), as well as partially mutated glands 
(Figure 5.3 C&D) (Taylor, Barron et al. 2003).  
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Figure 5.3 – Dual enzyme histochemistry demonstrates CCO deficiency 
and partially mutated glands in the endometrium. (A and B) 
Representative micrographs showing a wholly CCO-deficient endometrial 
basalis gland. (C and D) Representative micrographs showing a partially 
CCO-deficient endometrial functionalis gland. (Image A x200, scale bar = 
150 µm, Image B x400, scale bar = 150 µm, Image C x40, scale bar = 300 
µm, Image D x200, scale bar = 150 µm). 
 
To demonstrate that patches of CCO-deficient cells represent bona fide 
clonal expansions (similar to the previous studies in other solid organs), 
multiple CCO-deficient (blue) cells were isolated using LCM alongside 
isolating multiple wild type (brown) cells and stroma (as control tissue) 
(Figure 5.4). Their entire mtDNA genome was sequenced to reveal common 
somatic mutations that would indicate a common cell-of-origin. Figure 5.5 
shows that all of the micro dissected cells from the CCO-deficient area of a 
partially mutated gland contained the same mtDNA mutation (6667 C to T), 
which was not present in the surrounding CCO-proficient cells, 
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demonstrating a clonal expansion. Previous work has informed us that the 
chance of the same mutation occurring separately in two neighbouring cells 
(if they are not from the same progenitor cell) is calculated to be 2.48x109 
(Lin, Lim et al. 2010). Therefore, this data conclusively confirms the 
existence of an endometrial epithelial stem cell, whilst the existence of 
partially mutated glands suggest that at least some endometrial glands are 
regenerated by more than one epithelial stem cell (polyclonal origin). 
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Figure 5.4 – Representative micrographs showing multiple CCO-deficient 
(blue) cells and adjacent CCO-proficient (brown) cells isolated from the same 
endometrial gland using LCM. The single epithelial cells can be seen in the 
adhesive lid of the PCR tube following removal from the tissue.  
 
 
Figure 5.5 – A Unique mitochondrial mutation confirms the existence of 
endometrial epithelial stem cells in the endometrium. Representative 
images showing all wild type brown CCO-proficient cells with `C` on Sanger 
sequencing at position 6667 and all blue CCO-deficient cells with `T` on 
Sanger sequencing at position 6667, demonstrating a clonal expansion.  
 
Endometrial epithelial stem cells are multipotent. 
As previously discussed, markers deciphering the different endometrial 
epithelial cell subpopulations are yet to be confirmed. Therefore, in order to 
prove that the CCO-deficient epithelial cell progeny contain all endometrial 
epithelial cell subtypes, we examined the co-expression of markers proposed 
for the 3 different anatomical regions (luminal, functionalis, and basalis 
epithelial glands), and of proliferation and epithelium in 2 proliferative and 1 
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secretory phase endometrial samples. This included LGR5, MUC1, BCAM, 
CK5/6 for LE; SSEA-1, N-Cadherin, and SOX9 for basalis glands; and 
absence of SSEA-1, LGR5, N-Cadherin, SOX9, BCAM, and CK5/6 for the 
secretory functionalis glands (Figures 5.6, 5.7 and 5.8). The clonal patch 
containing CCO-deficient epithelial cells contained markers specific to all 3 
endometrial regions, suggesting the different cell subtypes comprising the 
human endometrial glandular compartment has a common ancestral origin, 
i.e. the existence of a multipotent epithelial stem cell. 
199 
 
 
200 
 
 
Figure 5.6 - Endometrial epithelial stem cells are multipotent. 
Representative micrographs of consecutive sections of full thickness 
endometrium depicting CCO-deficient epithelial cells contain markers in all 3 
endometrial regions. (All images x400 and scale bars = 10 µm). 
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Figure 5.7 - Endometrial epithelial stem cells are multipotent. 
Representative micrographs of the consecutive sections of full thickness 
endometrium depicting CCO-deficient epithelial cells contain markers in all 3 
endometrial regions (All images x400 and scale bars = 10 µm). 
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Figure 5.8 - Endometrial epithelial stem cells are multipotent. 
Representative micrographs of consecutive sections of full thickness 
endometrium depicting CCO-deficient epithelial cells contain markers in all 3 
endometrial regions (All images x400 and scale bars = 10 µm). 
 
A 3D-model of endometrial epithelium incorporating CCO negative 
clonal patches of full thickness endometrium suggests the basalis 
glands to be the location of the human endometrial epithelial stem cell 
niche. 
The model of CCO staining clearly demonstrates an abundance of mutated 
glands residing in the basalis glands, which appear to communicate with the 
functionalis/luminal CCO-deficient epithelial areas in the premenopausal 
secretory phase endometrial sample (Figure 5.9). Since the 
functionalis/luminal layers are lost with the menstrual shedding, the clonal 
patch can be assumed to have arisen from the stem cells located in the 
basalis glands.   
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Figure 5.9 – The extent of the CCO-deficient clonal patches suggests 
the basalis glands to be the location of the human endometrial 
epithelial stem cell niche. Representative image showing the CCO-
deficient epithelial cells that occurred across the 100 sections, superimposed 
onto one section (scale bar = 2 mm). 
 
5.4 Discussion 
We identified and traced a clonal mtDNA CCO mutation in single cells of 
human endometrial epithelium, thereby confirming the existence of an 
endometrial epithelial stem cell for the first time. The observation of partially 
mutated glands demonstrated the polyclonal nature of some endometrial 
glands (i.e. more than one stem cell contributes to the gland). CCO-deficient 
clonal patches also contained cells of all epithelial regions of the 
endometrium, demonstrating their common origin from a multipotent 
epithelial stem cell. 3D reconstruction of CCO-deficient patches suggested 
the epithelial stem cell niche to be located in the basalis region. 
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CCO–deficient patches appeared in basalis glands of a 25 year old patient, 
relatively earlier than the reported age when mutations were observed in 
other mucosal tissue, such as the colon (Greaves, Preston et al. 2006). 
Previous authors have suggested these patches to be a rare occurrence 
before the age of 40 years in other mucosal organs. However, this 
assumption may be at least partly due to the lack of access to human 
samples from those organs, before that age, for study, rather than a true lack 
of CCO-deficiency. Nevertheless, the younger women in our cohort did have 
less CCO-deficient clonal patches than the older age groups, and the 
location of the mutations were in the basalis, but not the functionalis. This 
may indicate the origin of these clonal patches also to be the basalis. 
Interestingly, the prevalence of the CCO-deficient clonal patches increased 
with age only in the pre-menopausal period. During the reproductive years, 
due to the repetitive regeneration requirement with the monthly menstrual 
shedding, endometrial epithelial stem cells are likely to be in an active state. 
This will promote oxidative stress and, together with advancing age, the 
active stem cells will accumulate mtDNA mutations. After menopause, in the 
non-regenerating quiescent endometrium, the clonal patch prevalence 
remained static. This may be explained by the accumulation of mutations 
relevant to stem cell activation during the pre-menopausal years. This data 
agrees with previous work tracking methylation patterns to assess stem cell 
progeny (Kim, Tavare et al. 2005). The authors proposed methylation 
patterns in the endometrium to follow the hypothesis that methylation 
increased after menarche to menopause, but were relatively stable 
thereafter, indicating that the number of epigenetic marks was a reflection of 
the mitotic activity of endometrial stem/progenitor cells (Kim, Tavare et al. 
2005).   
The endometrial samples from nulliparous women had a higher number of 
CCO-deficient clonal patches (either partial/complete) than the multiparous 
women. It is already known that nulliparous women are at a higher risk of 
endometrial cancer due to them having a higher number of ovulatory 
menstrual cycles (likely because the parous women do not have ovulatory 
cycles whilst being pregnant or when breast feeding) (Britt and Short 2012), 
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thus, an increased number of cycles of endometrial regeneration. This may 
not be an easy hypothesis to test in our patient cohort since many of the 
nulliparous women may not have undergone more cycles of menstrual 
regeneration, due to their use of many hormonal contraceptives. This, 
possible confounding, factor (we are unaware of the complete contraceptive 
history of our donors) means that the effect of regenerative cycles is difficult 
to interpret in our patient group (Gleicher 2013).  
The cells of CCO-deficient patches were confirmed to harbour the same 
mtDNA mutation, confirming their common origin, and the existence of an 
epithelial stem cell. The presence of unique mtDNA mutations in all cells of 
CCO-deficient areas, but their absence in adjacent CCO-proficient areas, in 
a partially mutated gland, confirms the contribution from more than one stem 
cell for the regeneration of such glands, therefore, glandular polyclonality.  
Previous studies on glandular clonality are contradictory, with one study 
using X chromosome inactivation suggesting endometrial glands to be 
monoclonal in origin (Tanaka, Kyo et al. 2003), whilst another study, which 
employed tracking of methylation patterns to examine cell progeny, 
concluded endometrial glands to be of polyclonal origin (Kim, Tavare et al. 
2005). Both studies utilised a gland extraction method that is not appropriate 
for the complex endometrial glands, but to the crypts of the colon, with the 
presumption that endometrial glandular histo-architecture is a single blunt 
ended tube. Therefore, both studies are likely only to have considered the 
functionalis glandular portion. Furthermore, they both examined less than 
250 glands in total, which is far less than the number examined in our study, 
which examined intact undisturbed full thickness human endometrium from a 
large number of patients, and thousands of individual glands. Additionally, it 
is notable that the large patch size of X-chromosome inactivation could be a 
potential confounding factor. 
Since endometrial epithelial subtypes are yet to be fully characterised, we 
examined the expression of regional specific markers according to previous 
publications, and considered data generated in house from our laboratory.  
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Here, I have demonstrated the LE to express high levels of LGR5 gene, 
BCAM, SSEA-1, SOX9 (Tempest, Baker et al. 2018), CK5/6 (Maclean A 
2017), and MUC1 (Hild-Petito, Fazleabas et al. 1996, DeLoia, Krasnow et al. 
1998, Dharmaraj, Chapela et al. 2014); the basalis epithelial markers utilised 
were SSEA-1, SOX9 (Valentijn, Palial et al. 2013), and N-cadherin (Nguyen, 
Xiao et al. 2017). Ki67 and pancytokeratin were used to confirm that the 
CCO deficient clonal patches maintained normal proliferation levels, and 
markers of an epithelial cell. The CCO-deficient clonal patch contained cells 
stained for all of these markers, as well as cells that do not express LE and 
basalis markers. Therefore, clonal patches containing cells with 
characteristic markers of all endometrial regions is indicative of the 
multipotency of the ancestral epithelial stem cell, capable of contributing to 
all cells of the whole endometrial epithelial compartment. Finally the 3D 
gland reconstruction confirms the basalis layer to be the location of at least 
one epithelial stem cell niche of the human endometrium. We have 
demonstrated the existence of a basal glandular CCO-deficient clonal patch, 
extending to the functionalis gland in premenopausal endometrium, thus, our 
data provides evidence for the existence of an epithelial stem cell niche in 
the basalis, agreeing with the current dogma. However, we cannot rule out 
further endometrial epithelial niches, since, even with this model of the 
secretory phase endometrium, we can see CCO-deficient clonal patches in 
the LE and functionalis glands that do not appear to communicate directly 
with a clonal population in the basalis region. Furthermore, this method does 
not allow visualisation of dynamic spread of the mutation within the model, 
thus, we cannot comment on if the mutation has arisen from the basalis or 
descended from the LE. These aspects require further investigation with 
alternative methods in the future. 
Although the existence of an epithelial stem cell in the human endometrium 
has been postulated for a long time, this is the first direct in vivo confirmation 
of the existence of a human adult endometrial epithelial stem cell. We, for the 
first time, demonstrated that the human endometrium harbours unique 
mtDNA mutations, proving the existence of endometrial epithelial stem cells, 
and that endometrial glandular regeneration is polyclonal. Non-pathogenic 
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mtDNA mutations present in single CCO-deficient (blue) cells that are not 
present in single adjacent CCO-proficient (brown) cells indicate that long 
lived clonal populations exist in the endometrium. Although the method only 
allows for a single snapshot in time, the technique does demonstrate the two 
major aspects of stemness: multipotency and self-renewal.     
This method could be utilised in the future to investigate the clonality of 
endometrial hyperplasia and endometrial cancer and, therefore, to examine 
the role of ASCs in endometrial carcinogenesis, and to discover if stem cells 
play a role in the pathogenesis of endometriosis or if ectopic lesions are 
derived from the eutopic endometrium. 
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Chapter 6. General Discussion 
Overview of research findings 
During the reproductive years of a woman’s life, the human endometrium is 
one of the most regenerative organs in humans. The endometrium, 
secondary to its regenerative capacity, was always thought to have a stem 
cell basis and, subsequently, from the initial studies that identified 
endometrial cells with some stem cell activity, endometrial stromal stem cells 
have been thoroughly researched, albeit predominantly, using in vitro 
methods. However, up until now, the existence of endometrial epithelial stem 
cells has not been conclusively proven. The main difficulty may have been 
the incompatibility of most in vitro analyses for the human endometrial 
epithelial cells, which are challenging to culture in the laboratory. The work 
presented in this thesis utilises a method that has not previously been 
employed in the human endometrium (in vivo lineage tracing) to confirm the 
existence of endometrial epithelial stem cells, as well as illuminating the 
location of expression, proposing a role for LGR5 (a presumed universal 
epithelial stem cell marker) in the endometrial epithelial compartment and, 
finally, the previously unknown, complex three dimensional (3D) 
histoarchitecture of the endometrial glands.  
Leucine-rich repeat-containing G-protein-coupled receptor-5 emphases 
future research efforts to define and characterise the endometrial 
luminal epithelium.   
Chapter 3 documents the first comprehensive study employing the gold 
standard method (in situ hybridisation (ISH)) in order to examine the cellular 
location of LGR5 expression in full thickness normal human endometrium. 
The results of this study were unanticipated. Instead of depicting a small 
number of endometrial epithelial cells in the gland bases (the proposed 
endometrial epithelial stem cell location) (Valentijn, Palial et al. 2013, 
Gargett, Schwab et al. 2016), the strongest LGR5 expression were seen in 
the endometrial luminal epithelium (LE). The previously proposed 
endometrial epithelial stem cell niche, the basalis, also contained cells 
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expressing LGR5, but the expression was weaker than the LE. Previous 
studies have highlighted the need for the LE to be scrutinised as a separate 
entity to the functionalis epithelium (Evans, Martinez-Conejero et al. 2014), 
but despite this, the whole of the glandular epithelium (LE, functionalis, and 
basalis epithelium together) is regularly discussed in many manuscripts. The 
LE is, obviously, the first point of contact for an embryo that attaches, 
invades, and implants in the window of implantation in the secretory phase of 
the cycle. Endometrium is thickest at this time point (up to 16 mm) and, 
therefore, LE, in cellular terms, exists at a relatively distant location from the 
basalis. Due to the surprising finding of high LGR5 expression in LE, we 
speculated that the LE could, in fact, regenerate itself, with its own pool of 
progenitor cells. It is known that other epithelial tissues such as the skin, and 
the intestine (Barker 2014), react to external assaults on a daily basis 
(mechanical friction or infection), continually replacing cells that are lost. A 
similar daily cellular loss is likely to be happening at the endometrial surface. 
The LE (exposed to the uterine cavity and external environment) requiring its 
daily maintenance by locally positioned cells with progenitor ability. 
Supporting this hypothesis, rapid Lgr5+ epithelial cell proliferation can be 
observed in many other organs upon tissue damage (Ng, Tan et al. 2014, 
Beumer and Clevers 2016). We merged the LGR5 data generated with the 
new hypothesis and proposed Figure 3.9, illustrating that it would be possible 
that the human endometrium could have more than one epithelial 
stem/progenitor cell pool. The persistent expression of the progenitor cell 
markers SOX9 and SSEA-1 in the LE, with concomitant high LGR5 
expression, corroborate further with the above hypothesis (Barker and 
Clevers 2010, Valentijn, Palial et al. 2013).  
A hormonal regulation of LGR5 expression was observed, examining 
samples of endometrium taken across the menstrual cycle (oestrogen 
dominant proliferative phase, and progesterone dominant secretory phase) 
from healthy women, not on hormonal therapy, and from women who are on 
progestogens; by quantitative polymerase chain reaction (qPCR) and ISH, 
and also through in vitro experiments.  
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If LGR5 was a universal epithelial stem cell marker, one would postulate that 
the expression be limited to a relatively small number of epithelial cells in a 
stem cell niche. If they mark the stem/progenitor cells responsible for 
regeneration of the endometrial functionalis, their numbers may be expected 
to change at the time of regeneration, or if they mark the more primitive 
quiescent stem cells producing the progenitor or transient amplifiers (TAs), 
they would be static throughout the menstrual cycle. This being said, the 
endometrium is unique in its regenerative ability and its exquisite response to 
hormones, this may result in a different pattern of LGR5 expression in the 
endometrium when compared with other regenerative epithelial tissues.    
Future work examining the functional properties of different endometrial 
epithelial cell subpopulations that are isolated from the three anatomical 
regions within the human endometrium (which express either high, low, or 
absent LGR5, SOX9 and SSEA-1), is warranted. Identifying the exact ligand 
for LGR5 receptor in the human endometrium may also shed light on the 
functional regulation of these epithelial cells. 
The newly found complex 3D Architecture of endometrial glands 
highlights a potential mechanism for the observed endometrial 
epithelium self-preservation. 
To date, it has been assumed that the endometrial glandular architecture is 
similar to the intestinal crypt, with blind ending single tubes. These were 
thought to commence at the LE, and were to extend through the functionalis 
layer, to end as the basalis glands at the basalis-myometrial junction. 
Although there are a lot of similarities between the endometrial epithelium 
and the intestinal crypts, striking differences are also present; for example, 
the monthly shedding of the functionalis. The endometrial glands have a 
much more complex coiling architecture, which changes progressively 
through the menstrual cycle, under the influence of oestrogen and 
progesterone. The current consensus of considering the endometrial glands 
as blind ending tubes has ignored some previous studies, suggesting an 
alternative architecture of the endometrial glands (Ferenczy and Richart 
1973, Cooke, Spencer et al. 2013); although only two dimensional (2D) 
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tissue sections were considered. The work undertaken, as presented in 
Chapter 4, proposes a new glandular architectural arrangement (Figure 4.9), 
after developing 3D models from 3 full thickness tissue samples of human 
endometrium. This newly constructed endometrial glandular layout 
demonstrated non-branching vertical parallel functionalis glands, and 
branching, intricate basalis networks running horizontal to the myometrium. 
The purpose of this complex glandular architecture generates the hypothesis 
that it is required for efficient endometrial regeneration. For example, the 
current presumed single tubular architecture of the glands may be an 
ineffective way of ensuring regeneration, since, if a basal-end of the gland is 
lost by iatrogenic curettage, it will be detrimental to endometrial regeneration 
in that area, and will result in endometrial scarring. However, with root-like, 
complex basalis glands running at a horizontal course, a damaged basalis 
glandular zone can be efficiently repaired by the adjacent, stem-cell rich, 
basalis glands. The basalis glands are more likely to be preserved, covering 
the myometrial surface, to assist in scar-less endometrial self-renewal, not 
just on a monthly basis, but also following parturition, iatrogenic destruction 
(after surgical ablation), and curettage. It is tempting to assume that relying 
on the previously proposed architecture may not be the most efficacious 
arrangement, as the basalis glandular ends could potentially be easily 
lost/artificially removed during one of the above situations, leading to the loss 
of the regenerative ability of the endometrium in the near vicinity. The 
complex root-like stolen configuration provides the ideal rapid replenishment 
of the stem cell niche for the entire basalis glandular element.  
The work presented in this chapter commences a novel avenue of 
endometrial 3D architectural work, and needs to be expanded to study 
normal endometrium, i.e. the postmenopausal (PM) endometrium, many 
human endometrial pathologies such as endometrial hyperplasia, and 
endometrial cancer. Further work is warranted to examine if the normal 3D 
architecture is altered in common recurrent endometrial pathologies that 
interfere with the normal function of human embryo-implantation, such as 
subfertility and recurrent miscarriage.  
214 
 
The existence of endometrial epithelial stem cells instigates 
endometrial pathology research.  
Chapter 5 provides confirmation of the existence of endometrial epithelial 
stem cells. Using the gold standard method (in vivo cell lineage tracing), a 
unique mitochondrial DNA (mtDNA) cytochrome C oxidase (CCO) mutation 
in single cells from a clonal population of human endometrial epithelium, was 
identified; confirming the existence of endometrial epithelial stem cells for the 
first time. This work further demonstrated partially mutated glands, producing 
evidence for the polyclonal nature of at least some endometrial glands (i.e. 
more than one stem cell contributes to the gland). The CCO-deficient clonal 
patches incorporated cells of the LE, functionalis, and basalis epithelium, 
demonstrating their common origin. 3D reconstruction of CCO-deficient 
patches suggested the location of at least one epithelial stem cell niche to be 
in the basalis region. This method of natural lineage tracing allows only for a 
single snapshot in time, but, the technique does demonstrate the two major 
aspects of stemness: multipotency and self-renewal.     
The finding that endometrial epithelial stem cells exist is only the start of this 
work, in order to extend our current understanding of the endometrial 
regeneration, and to eventually help women suffering with endometrial 
proliferative disorders, more work is to be done investigating the clonal 
nature of endometrial hyperplasia and endometrial cancer; and also in the 
benign, chronic condition (currently without adequate treatment) 
endometriosis. Since stem cells are likely to be abnormal in these conditions, 
(thus, regenerating an abnormal endometrium each month), treating stem 
cell abnormalities will potentially cure the disease. Understanding how 
endometriosis develops, if it is originating from the eutopic endometrium, will 
allow us to classify, treat, and potentially cure women suffering with this 
condition. Furthermore, by determining if stem cells play a role in endometrial 
cancer, and knowing their exact location, will aid in the development of 
targeted treatment options. 
Strengths and limitations of this research 
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Immunoscoring of IHC and ISH analysis was open to observer subjectivity. 
We controlled for this bias by at least two observers scoring the sections 
independently, in a set of randomly selected samples (assessing the inter-
observer reproducibility), and by revisiting the samples and scoring them 
again personally (assessing intra-observer reproducibility). The LGR5 ISH 
scores were analysed using a scoring system that was optimised, and 
recommended, by the manufacturers of the ISH kit (Advanced Cell 
Diagnostics, Hayward, CA), and by previous publications (Baker, Graham et 
al. 2015).  
Although a larger sample set is always preferable when undertaking 
experiments, to account for patient related heterogeneity, there are obvious 
limitations to the numbers that can be realistically included. For example, the 
challenges encountered included: collecting appropriately dated, matched, 
eutopic and Fallopian tube samples from women who are not on hormonal 
treatment, without known endometrial pathologies for paraffin embedding, 
frozen sectioning, and extraction of RNA; Identifying full thickness 
endometrial blocks that can provide 100 consecutive sections. Appropriate 
numbers of samples were collected in order to produce data that can be 
interrogated with statistical testing for significance, and to provide 
conclusions. The methodology required to produce the data presented in the 
thesis was time consuming to master (e.g. single cell DNA extraction and 
sequencing), and to perform (3D reconstruction). Producing 3D models with 
100 consecutive sections from a PM sample, stained with CCO would have 
been ideal, unfortunately, the technical challenges with the collected PM 
samples, and time pressures, precluded that. Co-localising the known 
epithelial region specific markers, such as SSEA-1, SOX9, N-cadherin, 
LGR5 etc, with CCO staining, using alternative methods such as IF, would 
further confirm the data presented using IHC in the consecutive tissue 
sections. 
Conclusion, impact and future direction 
The work described in this thesis presents three novel findings in the area of 
endometrial research that represent `stepping stones` in order to develop 
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new ways of thinking about research in the field of endometrial epithelial 
regeneration. They encourage development of new theories and hypothesis 
regarding the different epithelial compartments, the 3D architecture of the 
glands, and the stem cell makeup of the endometrium; for the enhancement 
of our current understanding of the human endometrium. LGR5 expression in 
the human endometrial epithelium has presented a new conundrum 
regarding the location of the stem cell niche in the human endometrial 
epithelium. The 3D reconstruction of the endometrial epithelium has shown 
that, previously proposed, non-branching, vertical and parallel glandular 
architecture, is limited only to the functionalis glands but intricate, branching, 
horizontal basalis glands, form a previously unknown root-like ‘stolen’ 
architecture, which instigates many further queries regarding the glandular 
architectural changes in various pathologies. The direct confirmation of the 
existence of endometrial epithelial stem cells, utilising non-pathogenic 
mtDNA mutations and lineage tracing for the first time, will re-ignite the race 
to find markers to further examine them in the future. For those reasons, the 
work presented in here is envisaged to pave the way to enhance the field of 
endometrial and gynaecology research in general in the future.   
217 
 
References 
Aghajanova, L., J. A. Horcajadas, F. J. Esteban and L. C. Giudice (2010). 
"The bone marrow-derived human mesenchymal stem cell: potential 
progenitor of the endometrial stromal fibroblast." Biol Reprod 82(6): 1076-
1087. 
Ahuja, N., Q. Li, A. L. Mohan, S. B. Baylin and J. P. Issa (1998). "Aging and 
DNA methylation in colorectal mucosa and cancer." Cancer Res 58(23): 
5489-5494. 
Ahuja, N., A. L. Mohan, Q. Li, J. M. Stolker, J. G. Herman, S. R. Hamilton, S. 
B. Baylin and J. P. Issa (1997). "Association between CpG island methylation 
and microsatellite instability in colorectal cancer." Cancer Res 57(16): 3370-
3374. 
Akasaka, Y., Y. Saikawa, K. Fujita, T. Kubota, Y. Ishikawa, A. Fujimoto, T. 
Ishii, H. Okano and M. Kitajima (2005). "Expression of a candidate marker for 
progenitor cells, Musashi-1, in the proliferative regions of human antrum and 
its decreased expression in intestinal metaplasia." Histopathology 47(4): 348-
356. 
Al Kushi, A., P. Lim, C. Aquino-Parsons and C. B. Gilks (2002). "Markers of 
proliferative activity are predictors of patient outcome for low-grade 
endometrioid adenocarcinoma but not papillary serous carcinoma of 
endometrium." Mod Pathol 15(4): 365-371. 
Alcayaga-Miranda, F., J. Cuenca, A. Martin, L. Contreras, F. E. Figueroa and 
M. Khoury (2015). "Combination therapy of menstrual derived mesenchymal 
stem cells and antibiotics ameliorates survival in sepsis." Stem Cell Res Ther 
6: 199. 
Alfer, J., L. Happel, R. Dittrich, M. W. Beckmann, A. Hartmann, A. Gaumann, 
V. U. Buck and I. Classen-Linke (2017). "Insufficient Angiogenesis: Cause of 
Abnormally Thin Endometrium in Subfertile Patients?" Geburtshilfe 
Frauenheilkd 77(7): 756-764. 
Allen, R. C., H. Y. Zoghbi, A. B. Moseley, H. M. Rosenblatt and J. W. 
Belmont (1992). "Methylation of HpaII and HhaI sites near the polymorphic 
218 
 
CAG repeat in the human androgen-receptor gene correlates with X 
chromosome inactivation." Am J Hum Genet 51(6): 1229-1239. 
Allickson, J. G., A. Sanchez, N. Yefimenko, C. V. Borlongan and P. R. 
Sanberg (2011). "Recent Studies Assessing the Proliferative Capability of a 
Novel Adult Stem Cell Identified in Menstrual Blood." Open Stem Cell J 
3(2011): 4-10. 
Anderson, S., A. T. Bankier, B. G. Barrell, M. H. de Bruijn, A. R. Coulson, J. 
Drouin, I. C. Eperon, D. P. Nierlich, B. A. Roe, F. Sanger, P. H. Schreier, A. 
J. Smith, R. Staden and I. G. Young (1981). "Sequence and organization of 
the human mitochondrial genome." Nature 290(5806): 457-465. 
Andrews, R. M., I. Kubacka, P. F. Chinnery, R. N. Lightowlers, D. M. Turnbull 
and N. Howell (1999). "Reanalysis and revision of the Cambridge reference 
sequence for human mitochondrial DNA." Nat Genet 23(2): 147. 
Andrey, P. and Y. Maurin (2005). "Free-D: an integrated environment for 
three-dimensional reconstruction from serial sections." J Neurosci Methods 
145(1-2): 233-244. 
Aplin, J. D. (2006). "Embryo implantation: the molecular mechanism remains 
elusive." Reprod Biomed Online 13(6): 833-839. 
Auersperg, N. (2013). "The stem-cell profile of ovarian surface epithelium is 
reproduced in the oviductal fimbriae, with increased stem-cell marker density 
in distal parts of the fimbriae." Int J Gynecol Pathol 32(5): 444-453. 
Azami, M., J. Ai, S. Ebrahimi-Barough, M. Farokhi and S. E. Fard (2013). "In 
vitro evaluation of biomimetic nanocomposite scaffold using endometrial 
stem cell derived osteoblast-like cells." Tissue Cell 45(5): 328-337. 
Azedi, F., S. Kazemnejad, A. H. Zarnani, G. Behzadi, M. Vasei, M. 
Khanmohammadi, S. Khanjani, H. Edalatkhah and N. Lakpour (2014). 
"Differentiation potential of menstrual blood- versus bone marrow-stem cells 
into glial-like cells." Cell Biol Int 38(5): 615-624. 
Baggish, M. S., C. J. Pauerstein and J. D. Woodruff (1967). "Role of stroma 
in regeneration of endometrial epithelium." Am J Obstet Gynecol 99(4): 459-
465. 
Baker, A. M., T. A. Graham, G. Elia, N. A. Wright and M. Rodriguez-Justo 
(2015). "Characterization of LGR5 stem cells in colorectal adenomas and 
carcinomas." Sci Rep 5: 8654. 
219 
 
Baraggino, E., S. Dalla Pria, C. Cuberli and S. Bortolotti (1980). "Scanning 
electron microscopy of the human normal endometrium." Clin Exp Obstet 
Gynecol 7(1): 66-70. 
Barker, N. (2014). "Adult intestinal stem cells: critical drivers of epithelial 
homeostasis and regeneration." Nat Rev Mol Cell Biol 15(1): 19-33. 
Barker, N. and H. Clevers (2010). "Leucine-rich repeat-containing G-protein-
coupled receptors as markers of adult stem cells." Gastroenterology 138(5): 
1681-1696. 
Barker, N., M. Huch, P. Kujala, M. van de Wetering, H. J. Snippert, J. H. van 
Es, T. Sato, D. E. Stange, H. Begthel, M. van den Born, E. Danenberg, S. 
van den Brink, J. Korving, A. Abo, P. J. Peters, N. Wright, R. Poulsom and H. 
Clevers (2010). "Lgr5(+ve) stem cells drive self-renewal in the stomach and 
build long-lived gastric units in vitro." Cell Stem Cell 6(1): 25-36. 
Barker, N., M. B. Rookmaaker, P. Kujala, A. Ng, M. Leushacke, H. Snippert, 
M. van de Wetering, S. Tan, J. H. Van Es, M. Huch, R. Poulsom, M. C. 
Verhaar, P. J. Peters and H. Clevers (2012). "Lgr5(+ve) stem/progenitor cells 
contribute to nephron formation during kidney development." Cell Rep 2(3): 
540-552. 
Barker, N., S. Tan and H. Clevers (2013). "Lgr proteins in epithelial stem cell 
biology." Development 140(12): 2484-2494. 
Barker, N., J. H. van Es, J. Kuipers, P. Kujala, M. van den Born, M. 
Cozijnsen, A. Haegebarth, J. Korving, H. Begthel, P. J. Peters and H. 
Clevers (2007). "Identification of stem cells in small intestine and colon by 
marker gene Lgr5." Nature 449(7165): 1003-1007. 
Barrandon, Y. and H. Green (1987). "Three clonal types of keratinocyte with 
different capacities for multiplication." Proc Natl Acad Sci U S A 84(8): 2302-
2306. 
Bartlemez G, C. G., Hartman C (1951). "Cyclic changes of the rhesus 
monkey (Macaca mulatta)." Contrib Embryol 34: 99-146. 
Bastide, P., C. Darido, J. Pannequin, R. Kist, S. Robine, C. Marty-Double, F. 
Bibeau, G. Scherer, D. Joubert, F. Hollande, P. Blache and P. Jay (2007). 
"Sox9 regulates cell proliferation and is required for Paneth cell differentiation 
in the intestinal epithelium." J Cell Biol 178(4): 635-648. 
220 
 
Bayat, N., S. Ebrahimi-Barough, M. M. Ardakan, A. Ai, A. Kamyab, N. 
Babaloo and J. Ai (2016). "Differentiation of Human Endometrial Stem Cells 
into Schwann Cells in Fibrin Hydrogel as 3D Culture." Mol Neurobiol 53(10): 
7170-7176. 
Bazer, F. W. and O. D. Slayden (2008). "Progesterone-induced gene 
expression in uterine epithelia: a myth perpetuated by conventional wisdom." 
Biol Reprod 79(5): 1008-1009. 
Bentz, E. K., M. Kenning, C. Schneeberger, A. Kolbus, J. C. Huber, L. A. 
Hefler and C. B. Tempfer (2010). "OCT-4 expression in follicular and luteal 
phase endometrium: a pilot study." Reprod Biol Endocrinol 8: 38. 
Bertoncello, I. and B. Williams (2004). "Hematopoietic stem cell 
characterization by Hoechst 33342 and rhodamine 123 staining." Methods 
Mol Biol 263: 181-200. 
Beumer, J. and H. Clevers (2016). "Regulation and plasticity of intestinal 
stem cells during homeostasis and regeneration." Development 143(20): 
3639-3649. 
Bieczynski, F., W. D. Torres, J. C. Painefilu, J. M. Castro, V. A. Bianchi, J. L. 
Frontera, D. A. Paz, C. Gonzalez, A. Martin, S. S. Villanueva and C. M. 
Luquet (2016). "Alterations in the intestine of Patagonian silverside 
(Odontesthes hatcheri) exposed to microcystin-LR: Changes in the 
glycosylation pattern of the intestinal wall and inhibition of multidrug 
resistance proteins efflux activity." Aquat Toxicol 178: 106-117. 
Bird, A. (2002). "DNA methylation patterns and epigenetic memory." Genes 
Dev 16(1): 6-21. 
Biswas Shivhare, S., J. N. Bulmer, B. A. Innes, D. K. Hapangama and G. E. 
Lash (2018). "Endometrial vascular development in heavy menstrual 
bleeding: altered spatio-temporal expression of endothelial cell markers and 
extracellular matrix components." Hum Reprod. 
Bitensky, L. and S. Cohen (1965). "The histochemical demonstration of 
alkaline phosphatase in unfixed frozen sections." Q J Microsc Sci 106(2): 
193-196. 
Bjerknes, M. and H. Cheng (1981). "Methods for the isolation of intact 
epithelium from the mouse intestine." Anat Rec 199(4): 565-574. 
221 
 
Blache, P., M. van de Wetering, I. Duluc, C. Domon, P. Berta, J. N. Freund, 
H. Clevers and P. Jay (2004). "SOX9 is an intestine crypt transcription factor, 
is regulated by the Wnt pathway, and represses the CDX2 and MUC2 
genes." J Cell Biol 166(1): 37-47. 
Booth, M. E., D. Treanor, N. Roberts, D. R. Magee, V. Speirs and A. M. 
Hanby (2015). "Three-dimensional reconstruction of ductal carcinoma in situ 
with virtual slides." Histopathology 66(7): 966-973. 
Boretto, M., B. Cox, M. Noben, N. Hendriks, A. Fassbender, H. Roose, F. 
Amant, D. Timmerman, C. Tomassetti, A. Vanhie, C. Meuleman, M. Ferrante 
and H. Vankelecom (2017). "Development of organoids from mouse and 
human endometrium showing endometrial epithelium physiology and long-
term expandability." Development. 
Borlongan, C. V., Y. Kaneko, M. Maki, S. J. Yu, M. Ali, J. G. Allickson, C. D. 
Sanberg, N. Kuzmin-Nichols and P. R. Sanberg (2010). "Menstrual blood 
cells display stem cell-like phenotypic markers and exert neuroprotection 
following transplantation in experimental stroke." Stem Cells Dev 19(4): 439-
452. 
Brenner, R. M. and O. D. Slayden (2012). "Molecular and functional aspects 
of menstruation in the macaque." Rev Endocr Metab Disord 13(4): 309-318. 
Britt, K. and R. Short (2012). "The plight of nuns: hazards of nulliparity." 
Lancet 379(9834): 2322-2323. 
Bruce Lessey, S. Y. (2013). The Structure, Function and Evaluation of the 
Female Reproductive Tract. Yen and Jaffe`s Reproductive Endocrinology, 
Elsevier Inc.: 192-235. 
Buckingham, M. E. and S. M. Meilhac (2011). "Tracing cells for tracking cell 
lineage and clonal behavior." Dev Cell 21(3): 394-409. 
Burton, G. J., E. Jauniaux and D. S. Charnock-Jones (2007). "Human early 
placental development: potential roles of the endometrial glands." Placenta 
28 Suppl A: S64-69. 
Capela, A. and S. Temple (2002). "LeX/ssea-1 is expressed by adult mouse 
CNS stem cells, identifying them as nonependymal." Neuron 35(5): 865-875. 
Carmon, K. S., X. Gong, Q. Lin, A. Thomas and Q. Liu (2011). "R-spondins 
function as ligands of the orphan receptors LGR4 and LGR5 to regulate 
222 
 
Wnt/beta-catenin signaling." Proc Natl Acad Sci U S A 108(28): 11452-
11457. 
Cervello, I., C. Gil-Sanchis, A. Mas, F. Delgado-Rosas, J. A. Martinez-
Conejero, A. Galan, A. Martinez-Romero, S. Martinez, I. Navarro, J. Ferro, J. 
A. Horcajadas, F. J. Esteban, J. E. O'Connor, A. Pellicer and C. Simon 
(2010). "Human endometrial side population cells exhibit genotypic, 
phenotypic and functional features of somatic stem cells." PLoS One 5(6): 
e10964. 
Cervello, I., C. Gil-Sanchis, A. Mas, A. Faus, J. Sanz, F. Moscardo, G. 
Higueras, M. A. Sanz, A. Pellicer and C. Simon (2012). "Bone marrow-
derived cells from male donors do not contribute to the endometrial side 
population of the recipient." PLoS One 7(1): e30260. 
Cervello, I., C. Gil-Sanchis, X. Santamaria, A. Faus, J. Vallve-Juanico, P. 
Diaz-Gimeno, O. Genolet, A. Pellicer and C. Simon (2017). "Leucine-rich 
repeat-containing G-protein-coupled receptor 5-positive cells in the 
endometrial stem cell niche." Fertil Steril 107(2): 510-519 e513. 
Cervello, I., J. A. Martinez-Conejero, J. A. Horcajadas, A. Pellicer and C. 
Simon (2007). "Identification, characterization and co-localization of label-
retaining cell population in mouse endometrium with typical undifferentiated 
markers." Hum Reprod 22(1): 45-51. 
Cervello, I., A. Mas, C. Gil-Sanchis, L. Peris, A. Faus, P. T. Saunders, H. O. 
Critchley and C. Simon (2011). "Reconstruction of endometrium from human 
endometrial side population cell lines." PLoS One 6(6): e21221. 
Cervello, I. and C. Simon (2009). "Somatic stem cells in the endometrium." 
Reprod Sci 16(2): 200-205. 
Chambers, S. M., C. A. Shaw, C. Gatza, C. J. Fisk, L. A. Donehower and M. 
A. Goodell (2007). "Aging hematopoietic stem cells decline in function and 
exhibit epigenetic dysregulation." PLoS Biol 5(8): e201. 
Chan, R. W. and C. E. Gargett (2006). "Identification of label-retaining cells 
in mouse endometrium." Stem Cells 24(6): 1529-1538. 
Chan, R. W., T. Kaitu'u-Lino and C. E. Gargett (2012). "Role of label-
retaining cells in estrogen-induced endometrial regeneration." Reprod Sci 
19(1): 102-114. 
223 
 
Chan, R. W., K. E. Schwab and C. E. Gargett (2004). "Clonogenicity of 
human endometrial epithelial and stromal cells." Biol Reprod 70(6): 1738-
1750. 
Charruyer, A., L. R. Strachan, L. Yue, A. S. Toth, G. Cecchini, M. L. 
Mancianti and R. Ghadially (2012). "CD133 is a marker for long-term 
repopulating murine epidermal stem cells." J Invest Dermatol 132(11): 2522-
2533. 
Chen, X., J. Liu, B. He, Y. Li, S. Liu, B. Wu, S. Wang, S. Zhang, X. Xu and J. 
Wang (2015). "Vascular endothelial growth factor (VEGF) regulation by 
hypoxia inducible factor-1 alpha (HIF1A) starts and peaks during endometrial 
breakdown, not repair, in a mouse menstrual-like model." Hum Reprod 30(9): 
2160-2170. 
Cheng, H. and C. P. Leblond (1974). "Origin, differentiation and renewal of 
the four main epithelial cell types in the mouse small intestine. I. Columnar 
cell." Am J Anat 141(4): 461-479. 
Cheng, H. and C. P. Leblond (1974). "Origin, differentiation and renewal of 
the four main epithelial cell types in the mouse small intestine. V. Unitarian 
Theory of the origin of the four epithelial cell types." Am J Anat 141(4): 537-
561. 
Choi, J. and J. Smitz (2014). "Luteinizing hormone and human chorionic 
gonadotropin: origins of difference." Mol Cell Endocrinol 383(1-2): 203-213. 
Clarke, R. B., K. Spence, E. Anderson, A. Howell, H. Okano and C. S. Potten 
(2005). "A putative human breast stem cell population is enriched for steroid 
receptor-positive cells." Dev Biol 277(2): 443-456. 
Cooke, P. S., T. E. Spencer, F. F. Bartol and K. Hayashi (2013). "Uterine 
glands: development, function and experimental model systems." Mol Hum 
Reprod 19(9): 547-558. 
Cornillie, F. J., J. M. Lauweryns and I. A. Brosens (1985). "Normal human 
endometrium. An ultrastructural survey." Gynecol Obstet Invest 20(3): 113-
129. 
Cotsarelis, G., S. Z. Cheng, G. Dong, T. T. Sun and R. M. Lavker (1989). 
"Existence of slow-cycling limbal epithelial basal cells that can be 
preferentially stimulated to proliferate: implications on epithelial stem cells." 
Cell 57(2): 201-209. 
224 
 
Cotsarelis, G., T. T. Sun and R. M. Lavker (1990). "Label-retaining cells 
reside in the bulge area of pilosebaceous unit: implications for follicular stem 
cells, hair cycle, and skin carcinogenesis." Cell 61(7): 1329-1337. 
Crisan, M., S. Yap, L. Casteilla, C. W. Chen, M. Corselli, T. S. Park, G. 
Andriolo, B. Sun, B. Zheng, L. Zhang, C. Norotte, P. N. Teng, J. Traas, R. 
Schugar, B. M. Deasy, S. Badylak, H. J. Buhring, J. P. Giacobino, L. Lazzari, 
J. Huard and B. Peault (2008). "A perivascular origin for mesenchymal stem 
cells in multiple human organs." Cell Stem Cell 3(3): 301-313. 
Crow, J., N. N. Amso, J. Lewin and R. W. Shaw (1994). "Morphology and 
ultrastructure of fallopian tube epithelium at different stages of the menstrual 
cycle and menopause." Hum Reprod 9(12): 2224-2233. 
Cui, C. H., T. Uyama, K. Miyado, M. Terai, S. Kyo, T. Kiyono and A. 
Umezawa (2007). "Menstrual blood-derived cells confer human dystrophin 
expression in the murine model of Duchenne muscular dystrophy via cell 
fusion and myogenic transdifferentiation." Mol Biol Cell 18(5): 1586-1594. 
Cunha, G. R. (1976). "Epithelial-stromal interactions in development of the 
urogenital tract." Int Rev Cytol 47: 137-194. 
Dallenbach-Hellweg, G. (2012). Histopathology of the endometrium. Berlin 
Heidelberg, Springer. 
Dallenbach-Hellweg Gisela, S. D., Dallenbach Friederike (2010). Atlas of 
Endometrial Histopathology, Springer-Verlag Berlin Heidelberg. 
Dallenbach, F. D. and D. Vonderlin (1973). "The innervation of the human 
endometrium." Arch Gynakol 215(4): 365-376. 
Darzi, S., A. H. Zarnani, M. Jeddi-Tehrani, K. Entezami, E. Mirzadegan, M. 
M. Akhondi, S. Talebi, M. Khanmohammadi and S. Kazemnejad (2012). 
"Osteogenic differentiation of stem cells derived from menstrual blood versus 
bone marrow in the presence of human platelet releasate." Tissue Eng Part 
A 18(15-16): 1720-1728. 
de Lau, W., N. Barker, T. Y. Low, B. K. Koo, V. S. Li, H. Teunissen, P. 
Kujala, A. Haegebarth, P. J. Peters, M. van de Wetering, D. E. Stange, J. E. 
van Es, D. Guardavaccaro, R. B. Schasfoort, Y. Mohri, K. Nishimori, S. 
Mohammed, A. J. Heck and H. Clevers (2011). "Lgr5 homologues associate 
with Wnt receptors and mediate R-spondin signalling." Nature 476(7360): 
293-297. 
225 
 
de Lazaro, I., A. Yilmazer and K. Kostarelos (2014). "Induced pluripotent 
stem (iPS) cells: a new source for cell-based therapeutics?" J Control 
Release 185: 37-44. 
de Visser, K. E., M. Ciampricotti, E. M. Michalak, D. W. Tan, E. N. 
Speksnijder, C. S. Hau, H. Clevers, N. Barker and J. Jonkers (2012). 
"Developmental stage-specific contribution of LGR5(+) cells to basal and 
luminal epithelial lineages in the postnatal mammary gland." J Pathol 228(3): 
300-309. 
Deligdisch, L. (2000). "Hormonal pathology of the endometrium." Mod Pathol 
13(3): 285-294. 
Deligdisch, L. (2000). "Hormonal Pathology of the Endometrium." Modern 
Pathology 13(3): 285-294. 
DeLoia, J. A., J. S. Krasnow, J. Brekosky, A. Babaknia, J. Julian and D. D. 
Carson (1998). "Regional specialization of the cell membrane-associated, 
polymorphic mucin (MUC1) in human uterine epithelia." Hum Reprod 13(1O): 
2902-2909. 
Demir, R., U. A. Kayisli, C. Celik-Ozenci, E. T. Korgun, A. Y. Demir-Weusten 
and A. Arici (2002). "Structural differentiation of human uterine luminal and 
glandular epithelium during early pregnancy: an ultrastructural and 
immunohistochemical study." Placenta 23(8-9): 672-684. 
Demir, R., A. Yaba and B. Huppertz (2010). "Vasculogenesis and 
angiogenesis in the endometrium during menstrual cycle and implantation." 
Acta Histochem 112(3): 203-214. 
Denk, W. and H. Horstmann (2004). "Serial block-face scanning electron 
microscopy to reconstruct three-dimensional tissue nanostructure." PLoS 
Biol 2(11): e329. 
Derycke, L. D. and M. E. Bracke (2004). "N-cadherin in the spotlight of cell-
cell adhesion, differentiation, embryogenesis, invasion and signalling." Int J 
Dev Biol 48(5-6): 463-476. 
Dharmaraj, N., P. J. Chapela, M. Morgado, S. M. Hawkins, B. A. Lessey, S. 
L. Young and D. D. Carson (2014). "Expression of the transmembrane 
mucins, MUC1, MUC4 and MUC16, in normal endometrium and in 
endometriosis." Hum Reprod 29(8): 1730-1738. 
226 
 
Diao, H., B. C. Paria, S. Xiao and X. Ye (2011). "Temporal expression 
pattern of progesterone receptor in the uterine luminal epithelium suggests 
its requirement during early events of implantation." Fertil Steril 95(6): 2087-
2093. 
Dimitriadis, E., C. Stoikos, M. Stafford-Bell, I. Clark, P. Paiva, G. Kovacs and 
L. A. Salamonsen (2006). "Interleukin-11, IL-11 receptoralpha and leukemia 
inhibitory factor are dysregulated in endometrium of infertile women with 
endometriosis during the implantation window." J Reprod Immunol 69(1): 53-
64. 
Domnina, A. P., P. V. Novikova, Fridlyanskaya, II, M. A. Shilina, V. V. Zenin 
and N. N. Nikolsky (2015). "[Induction of Decidual Differentiation of 
Endometrial Mesenchymal Stem Cells]." Tsitologiia 57(12): 880-884. 
Donoghue, J. F., F. L. Lederman, B. J. Susil and P. A. Rogers (2007). 
"Lymphangiogenesis of normal endometrium and endometrial 
adenocarcinoma." Hum Reprod 22(6): 1705-1713. 
Du, H. and H. S. Taylor (2007). "Contribution of bone marrow-derived stem 
cells to endometrium and endometriosis." Stem Cells 25(8): 2082-2086. 
Ebrahimi-Barough, S., E. Hoveizi, A. Norouzi Javidan and J. Ai (2015). 
"Investigating the neuroglial differentiation effect of neuroblastoma 
conditioned medium in human endometrial stem cells cultured on 3D 
nanofibrous scaffold." J Biomed Mater Res A 103(8): 2621-2627. 
Ebrahimi-Barough, S., H. M. Kouchesfahani, J. Ai and M. Massumi (2013). 
"Differentiation of human endometrial stromal cells into oligodendrocyte 
progenitor cells (OPCs)." J Mol Neurosci 51(2): 265-273. 
Eckfeldt, C. E., E. M. Mendenhall and C. M. Verfaillie (2005). "The molecular 
repertoire of the 'almighty' stem cell." Nat Rev Mol Cell Biol 6(9): 726-737. 
Eddy, C. A. and C. J. Pauerstein (1980). "Anatomy and physiology of the 
fallopian tube." Clin Obstet Gynecol 23(4): 1177-1193. 
Edgar, R., Y. Mazor, A. Rinon, J. Blumenthal, Y. Golan, E. Buzhor, I. Livnat, 
S. Ben-Ari, I. Lieder, A. Shitrit, Y. Gilboa, A. Ben-Yehudah, O. Edri, N. 
Shraga, Y. Bogoch, L. Leshansky, S. Aharoni, M. D. West, D. Warshawsky 
and R. Shtrichman (2013). "LifeMap Discovery: the embryonic development, 
stem cells, and regenerative medicine research portal." PLoS One 8(7): 
e66629. 
227 
 
El-Mowafi DM, D. M. (2017). "Fallopian Tube."   Retrieved 26.2.18, 2018, 
from 
https://www.gfmer.ch/internation_activities_En/El_mowafi/fallopian_tube.htm. 
Elkilani, O. A. and M. A. Soliman (2017). "Angiogenesis mediators in women 
with idiopathic heavy menstrual bleeding." Int J Gynaecol Obstet 136(3): 
280-284. 
Ellett, L., E. Readman, M. Newman, K. McIlwaine, R. Villegas, N. Jagasia 
and P. Maher (2015). "Are endometrial nerve fibres unique to endometriosis? 
A prospective case-control study of endometrial biopsy as a diagnostic test 
for endometriosis in women with pelvic pain." Hum Reprod 30(12): 2808-
2815. 
Elson, J. L., D. C. Samuels, D. M. Turnbull and P. F. Chinnery (2001). 
"Random intracellular drift explains the clonal expansion of mitochondrial 
DNA mutations with age." Am J Hum Genet 68(3): 802-806. 
Enomoto, T., M. Fujita, M. Inoue, O. Tanizawa, T. Nomura and K. R. Shroyer 
(1994). "Analysis of clonality by amplification of short tandem repeats. 
Carcinomas of the female reproductive tract." Diagn Mol Pathol 3(4): 292-
297. 
Ernst LM, R. E., Huff DS (2011). Color Atlas of Fetal and Neonatal Histology, 
Springer-Verlag New York. 1. 
Evans, G. E., J. A. Martinez-Conejero, G. T. Phillipson, P. H. Sykes, I. L. Sin, 
E. Y. Lam, C. G. Print, J. A. Horcajadas and J. J. Evans (2014). "In the 
secretory endometria of women, luminal epithelia exhibit gene and protein 
expressions that differ from those of glandular epithelia." Fertil Steril 102(1): 
307-317 e307. 
Faramarzi, H., D. Mehrabani, M. Fard, M. Akhavan, S. Zare, S. 
Bakhshalizadeh, A. Manafi, S. Kazemnejad and R. Shirazi (2016). "The 
Potential of Menstrual Blood-Derived Stem Cells in Differentiation to 
Epidermal Lineage: A Preliminary Report." World J Plast Surg 5(1): 26-31. 
Fayazi, M., M. Salehnia and S. Ziaei (2015). "Differentiation of human 
CD146-positive endometrial stem cells to adipogenic-, osteogenic-, neural 
progenitor-, and glial-like cells." In Vitro Cell Dev Biol Anim 51(4): 408-414. 
228 
 
Fayazi, M., M. Salehnia and S. Ziaei (2016). "Characteristics of Human 
Endometrial Stem Cells in Tissue and Isolated Cultured Cells: An 
Immunohistochemical Aspect." Iran Biomed J 20(2): 109-116. 
Fearon, E. R. and G. T. Bommer (2011). "Ancestries hidden in plain sight: 
methylation patterns for clonal analysis." Gastroenterology 140(4): 1139-
1143. 
Feil, R., M. D. Boyano, N. D. Allen and G. Kelsey (1997). "Parental 
chromosome-specific chromatin conformation in the imprinted U2af1-rs1 
gene in the mouse." J Biol Chem 272(33): 20893-20900. 
Fellous, T. G., S. Islam, P. J. Tadrous, G. Elia, H. M. Kocher, S. 
Bhattacharya, L. Mears, D. M. Turnbull, R. W. Taylor, L. C. Greaves, P. F. 
Chinnery, G. Taylor, S. A. McDonald, N. A. Wright and M. R. Alison (2009). 
"Locating the stem cell niche and tracing hepatocyte lineages in human 
liver." Hepatology 49(5): 1655-1663. 
Fellous, T. G., S. A. McDonald, J. Burkert, A. Humphries, S. Islam, N. M. De-
Alwis, L. Gutierrez-Gonzalez, P. J. Tadrous, G. Elia, H. M. Kocher, S. 
Bhattacharya, L. Mears, M. El-Bahrawy, D. M. Turnbull, R. W. Taylor, L. C. 
Greaves, P. F. Chinnery, C. P. Day, N. A. Wright and M. R. Alison (2009). "A 
methodological approach to tracing cell lineage in human epithelial tissues." 
Stem Cells 27(6): 1410-1420. 
Ferenczy, A. (1976). "Studies on the cytodynamics of human endometrial 
regeneration. I. Scanning electron microscopy." Am J Obstet Gynecol 124(1): 
64-74. 
Ferenczy, A. (1976). "Studies on the cytodynamics of human endometrial 
regeneration. II. Transmission electron microscopy and histochemistry." Am 
J Obstet Gynecol 124(6): 582-595. 
Ferenczy, A. and C. Bergeron (1991). "Histology of the human endometrium: 
from birth to senescence." Ann N Y Acad Sci 622: 6-27. 
Ferenczy, A. and R. M. Richart (1973). "Scanning and transmission electron 
microscopy of the human endometrial surface epithelium." J Clin Endocrinol 
Metab 36(5): 999-1008. 
Ferenczy, A. and R. M. Richart (1974). "Scanning electron microscopy of 
human female genital tract." N Y State J Med 74(5): 794-802. 
229 
 
Filant, J. and T. E. Spencer (2013). "Endometrial glands are essential for 
blastocyst implantation and decidualization in the mouse uterus." Biol Reprod 
88(4): 93. 
Fleischer, A. C. (1999). "Sonographic assessment of endometrial disorders." 
Semin Ultrasound CT MR 20(4): 259-266. 
Flesken-Nikitin, A., C. I. Hwang, C. Y. Cheng, T. V. Michurina, G. Enikolopov 
and A. Y. Nikitin (2013). "Ovarian surface epithelium at the junction area 
contains a cancer-prone stem cell niche." Nature 495(7440): 241-245. 
Foster, J. W., M. A. Dominguez-Steglich, S. Guioli, C. Kwok, P. A. Weller, M. 
Stevanovic, J. Weissenbach, S. Mansour, I. D. Young, P. N. Goodfellow and 
et al. (1994). "Campomelic dysplasia and autosomal sex reversal caused by 
mutations in an SRY-related gene." Nature 372(6506): 525-530. 
Fox DT, M. L., Nystul T, Spradling AC (2009). Lineage Analysis of Stem 
cells. StemBook. G. L. 
Fox, N., I. Damjanov, B. B. Knowles and D. Solter (1983). 
"Immunohistochemical localization of the mouse stage-specific embryonic 
antigen 1 in human tissues and tumors." Cancer Res 43(2): 669-678. 
Fromm, M. F. (2000). "P-glycoprotein: a defense mechanism limiting oral 
bioavailability and CNS accumulation of drugs." Int J Clin Pharmacol Ther 
38(2): 69-74. 
Fuchs, E. (2009). "The tortoise and the hair: slow-cycling cells in the stem 
cell race." Cell 137(5): 811-819. 
Fuchs, E. and V. Horsley (2011). "Ferreting out stem cells from their niches." 
Nat Cell Biol 13(5): 513-518. 
Gaisa, N. T., T. A. Graham, S. A. McDonald, S. Canadillas-Lopez, R. 
Poulsom, A. Heidenreich, G. Jakse, P. J. Tadrous, R. Knuechel and N. A. 
Wright (2011). "The human urothelium consists of multiple clonal units, each 
maintained by a stem cell." J Pathol 225(2): 163-171. 
Gaisa, N. T., T. A. Graham, S. A. McDonald, R. Poulsom, A. Heidenreich, G. 
Jakse, R. Knuechel and N. A. Wright (2011). "Clonal architecture of human 
prostatic epithelium in benign and malignant conditions." J Pathol 225(2): 
172-180. 
230 
 
Garcia, M. I., M. Ghiani, A. Lefort, F. Libert, S. Strollo and G. Vassart (2009). 
"LGR5 deficiency deregulates Wnt signaling and leads to precocious Paneth 
cell differentiation in the fetal intestine." Dev Biol 331(1): 58-67. 
Gargett, C. E. (2006). "Identification and characterisation of human 
endometrial stem/progenitor cells." Aust N Z J Obstet Gynaecol 46(3): 250-
253. 
Gargett, C. E. (2007). "Uterine stem cells: what is the evidence?" Hum 
Reprod Update 13(1): 87-101. 
Gargett, C. E., R. W. Chan and K. E. Schwab (2007). "Endometrial stem 
cells." Curr Opin Obstet Gynecol 19(4): 377-383. 
Gargett, C. E. and H. Masuda (2010). "Adult stem cells in the endometrium." 
Mol Hum Reprod 16(11): 818-834. 
Gargett, C. E. and P. A. Rogers (2001). "Human endometrial angiogenesis." 
Reproduction 121(2): 181-186. 
Gargett, C. E., K. E. Schwab and J. A. Deane (2016). "Endometrial 
stem/progenitor cells: the first 10 years." Hum Reprod Update 22(2): 137-
163. 
Gargett, C. E., K. E. Schwab, R. M. Zillwood, H. P. Nguyen and D. Wu 
(2009). "Isolation and culture of epithelial progenitors and mesenchymal 
stem cells from human endometrium." Biol Reprod 80(6): 1136-1145. 
Garry, R., R. Hart, K. A. Karthigasu and C. Burke (2010). "Structural changes 
in endometrial basal glands during menstruation." BJOG 117(10): 1175-
1185. 
Gerbe, F., J. H. van Es, L. Makrini, B. Brulin, G. Mellitzer, S. Robine, B. 
Romagnolo, N. F. Shroyer, J. F. Bourgaux, C. Pignodel, H. Clevers and P. 
Jay (2011). "Distinct ATOH1 and Neurog3 requirements define tuft cells as a 
new secretory cell type in the intestinal epithelium." J Cell Biol 192(5): 767-
780. 
Gil-Sanchis, C., I. Cervello, A. Mas, A. Faus, A. Pellicer and C. Simon 
(2013). "Leucine-rich repeat-containing G-protein-coupled receptor 5 (Lgr5) 
as a putative human endometrial stem cell marker." Mol Hum Reprod 19(7): 
407-414. 
Gimpelson, R. J. (2014). "Ten-year literature review of global endometrial 
ablation with the NovaSure(R) device." Int J Womens Health 6: 269-280. 
231 
 
Gisina, A. M., A. Y. Lupatov, P. A. Karalkin, O. A. Mainovskaya, L. O. Petrov, 
D. V. Sidorov, G. A. Frank and K. N. Yarygin (2014). "CD133+ human 
colorectal adenocarcinoma cells are resistant to staining with fluorescent 
dyes used for analysis of ABC transporter activities." Bull Exp Biol Med 
158(1): 80-83. 
Gleicher, N. (2013). "Why are reproductive cancers more common in 
nulliparous women?" Reprod Biomed Online 26(5): 416-419. 
Glinka, A., C. Dolde, N. Kirsch, Y. L. Huang, O. Kazanskaya, D. Ingelfinger, 
M. Boutros, C. M. Cruciat and C. Niehrs (2011). "LGR4 and LGR5 are R-
spondin receptors mediating Wnt/beta-catenin and Wnt/PCP signalling." 
EMBO Rep 12(10): 1055-1061. 
Golebiewska, A., N. H. Brons, R. Bjerkvig and S. P. Niclou (2011). "Critical 
appraisal of the side population assay in stem cell and cancer stem cell 
research." Cell Stem Cell 8(2): 136-147. 
Goodell, M. A., M. Rosenzweig, H. Kim, D. F. Marks, M. DeMaria, G. 
Paradis, S. A. Grupp, C. A. Sieff, R. C. Mulligan and R. P. Johnson (1997). 
"Dye efflux studies suggest that hematopoietic stem cells expressing low or 
undetectable levels of CD34 antigen exist in multiple species." Nat Med 
3(12): 1337-1345. 
Gossen, M. and H. Bujard (1992). "Tight control of gene expression in 
mammalian cells by tetracycline-responsive promoters." Proc Natl Acad Sci 
U S A 89(12): 5547-5551. 
Gotte, M., M. Wolf, A. Staebler, O. Buchweitz, R. Kelsch, A. N. Schuring and 
L. Kiesel (2008). "Increased expression of the adult stem cell marker 
Musashi-1 in endometriosis and endometrial carcinoma." J Pathol 215(3): 
317-329. 
Gray, C. A., F. F. Bartol, B. J. Tarleton, A. A. Wiley, G. A. Johnson, F. W. 
Bazer and T. E. Spencer (2001). "Developmental biology of uterine glands." 
Biol Reprod 65(5): 1311-1323. 
Gray, C. A., R. C. Burghardt, G. A. Johnson, F. W. Bazer and T. E. Spencer 
(2002). "Evidence that absence of endometrial gland secretions in uterine 
gland knockout ewes compromises conceptus survival and elongation." 
Reproduction 124(2): 289-300. 
232 
 
Gray, C. A., K. M. Taylor, W. S. Ramsey, J. R. Hill, F. W. Bazer, F. F. Bartol 
and T. E. Spencer (2001). "Endometrial glands are required for 
preimplantation conceptus elongation and survival." Biol Reprod 64(6): 1608-
1613. 
Greaves, L. C., S. L. Preston, P. J. Tadrous, R. W. Taylor, M. J. Barron, D. 
Oukrif, S. J. Leedham, M. Deheragoda, P. Sasieni, M. R. Novelli, J. A. 
Jankowski, D. M. Turnbull, N. A. Wright and S. A. McDonald (2006). 
"Mitochondrial DNA mutations are established in human colonic stem cells, 
and mutated clones expand by crypt fission." Proc Natl Acad Sci U S A 
103(3): 714-719. 
Guzeloglu Kayisli, O., U. A. Kayisli, M. Basar, N. Semerci, F. Schatz and C. 
J. Lockwood (2015). "Progestins Upregulate FKBP51 Expression in Human 
Endometrial Stromal Cells to Induce Functional Progesterone and 
Glucocorticoid Withdrawal: Implications for Contraceptive- Associated 
Abnormal Uterine Bleeding." PLoS One 10(10): e0137855. 
Hadjantonakis, A. K., L. L. Cox, P. P. Tam and A. Nagy (2001). "An X-linked 
GFP transgene reveals unexpected paternal X-chromosome activity in 
trophoblastic giant cells of the mouse placenta." Genesis 29(3): 133-140. 
Hadjantonakis, A. K., M. Gertsenstein, M. Ikawa, M. Okabe and A. Nagy 
(1998). "Non-invasive sexing of preimplantation stage mammalian embryos." 
Nat Genet 19(3): 220-222. 
Han, L., J. I. van Hemert and R. A. Baldock (2011). "Automatically identifying 
and annotating mouse embryo gene expression patterns." Bioinformatics 
27(8): 1101-1107. 
Hapangama, D. K., A. M. Kamal and J. N. Bulmer (2015). "Estrogen receptor 
β: the guardian of the endometrium." Hum Reprod Update 21(2): 174-193. 
Harrison, D. A. and N. Perrimon (1993). "Simple and efficient generation of 
marked clones in Drosophila." Curr Biol 3(7): 424-433. 
Hayashi, S. and A. P. McMahon (2002). "Efficient recombination in diverse 
tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated 
gene activation/inactivation in the mouse." Dev Biol 244(2): 305-318. 
He, L., P. F. Chinnery, S. E. Durham, E. L. Blakely, T. M. Wardell, G. M. 
Borthwick, R. W. Taylor and D. M. Turnbull (2002). "Detection and 
233 
 
quantification of mitochondrial DNA deletions in individual cells by real-time 
PCR." Nucleic Acids Res 30(14): e68. 
Healey, A. (2012). Embryology of the Female Reproductive Tract. Imaging of 
Gynecological disorder in Infants and Children, Springer. 
Hendrickson, M. (2007). Histology for Pathologists. S. Mills. 
Hennen, E. and A. Faissner (2012). "LewisX: a neural stem cell specific 
glycan?" Int J Biochem Cell Biol 44(6): 830-833. 
Henrikson R, K. G., Mazurkiewicz J (1997). The National Medical Series for 
Independent Study - Histology, Lippincott Williams and Wilkins. 
Hickey, M., G. Krikun, P. Kodaman, F. Schatz, C. Carati and C. J. Lockwood 
(2006). "Long-term progestin-only contraceptives result in reduced 
endometrial blood flow and oxidative stress." J Clin Endocrinol Metab 91(9): 
3633-3638. 
Hida, N., N. Nishiyama, S. Miyoshi, S. Kira, K. Segawa, T. Uyama, T. Mori, 
K. Miyado, Y. Ikegami, C. Cui, T. Kiyono, S. Kyo, T. Shimizu, T. Okano, M. 
Sakamoto, S. Ogawa and A. Umezawa (2008). "Novel cardiac precursor-like 
cells from human menstrual blood-derived mesenchymal cells." Stem Cells 
26(7): 1695-1704. 
Hild-Petito, S., A. T. Fazleabas, J. Julian and D. D. Carson (1996). "Mucin 
(Muc-1) expression is differentially regulated in uterine luminal and glandular 
epithelia of the baboon (Papio anubis)." Biol Reprod 54(5): 939-947. 
Horisawa, K., T. Imai, H. Okano and H. Yanagawa (2010). "The Musashi 
family RNA-binding proteins in stem cells." Biomol Concepts 1(1): 59-66. 
Hoshi, K., N. Amizuka, K. Oda, Y. Ikehara and H. Ozawa (1997). 
"Immunolocalization of tissue non-specific alkaline phosphatase in mice." 
Histochem Cell Biol 107(3): 183-191. 
Hsu, Y. C., H. A. Pasolli and E. Fuchs (2011). "Dynamics between stem 
cells, niche, and progeny in the hair follicle." Cell 144(1): 92-105. 
Hyodo, S., K. Matsubara, K. Kameda and Y. Matsubara (2011). "Endometrial 
injury increases side population cells in the uterine endometrium: a decisive 
role of estrogen." Tohoku J Exp Med 224(1): 47-55. 
Ikoma, T., S. Kyo, Y. Maida, S. Ozaki, M. Takakura, S. Nakao and M. Inoue 
(2009). "Bone marrow-derived cells from male donors can compose 
234 
 
endometrial glands in female transplant recipients." Am J Obstet Gynecol 
201(6): 608 e601-608. 
Jabbour, H. N., R. W. Kelly, H. M. Fraser and H. O. Critchley (2006). 
"Endocrine regulation of menstruation." Endocr Rev 27(1): 17-46. 
Jaks, V., N. Barker, M. Kasper, J. H. van Es, H. J. Snippert, H. Clevers and 
R. Toftgard (2008). "Lgr5 marks cycling, yet long-lived, hair follicle stem 
cells." Nat Genet 40(11): 1291-1299. 
Jeong, J. W., I. Kwak, K. Y. Lee, T. H. Kim, M. J. Large, C. L. Stewart, K. H. 
Kaestner, J. P. Lydon and F. J. DeMayo (2010). "Foxa2 is essential for 
mouse endometrial gland development and fertility." Biol Reprod 83(3): 396-
403. 
Jo, A., S. Denduluri, B. Zhang, Z. Wang, L. Yin, Z. Yan, R. Kang, L. L. Shi, J. 
Mok, M. J. Lee and R. C. Haydon (2014). "The versatile functions of Sox9 in 
development, stem cells, and human diseases." Genes Dis 1(2): 149-161. 
Jost, A., B. Vigier, J. Prepin and J. P. Perchellet (1973). "Studies on sex 
differentiation in mammals." Recent Prog Horm Res 29: 1-41. 
Kaaij, L. T., M. van de Wetering, F. Fang, B. Decato, A. Molaro, H. J. van de 
Werken, J. H. van Es, J. Schuijers, E. de Wit, W. de Laat, G. J. Hannon, H. 
C. Clevers, A. D. Smith and R. F. Ketting (2013). "DNA methylation dynamics 
during intestinal stem cell differentiation reveals enhancers driving gene 
expression in the villus." Genome Biol 14(5): R50. 
Kamal, A. (2016). Endometrial cancer: involvement of androgens and 
metastasis inducing proteins., University of Liverpool. 
Kamal, A., N. Tempest, C. Parkes, R. Alnafakh, S. Makrydima, M. Adishesh 
and D. K. Hapangama (2016). "Hormones and endometrial carcinogenesis." 
Horm Mol Biol Clin Investig 25(2): 129-148. 
Kamal, A. M., J. N. Bulmer, S. B. DeCruze, H. F. Stringfellow, P. Martin-
Hirsch and D. K. Hapangama (2016). "Androgen receptors are acquired by 
healthy postmenopausal endometrial epithelium and their subsequent loss in 
endometrial cancer is associated with poor survival." Br J Cancer 114(6): 
688-696. 
Kaneko, Y., T. Dailey, N. L. Weinbren, J. Rizzi, C. Tamboli, J. G. Allickson, 
N. Kuzmin-Nichols, P. R. Sanberg, D. J. Eve, N. Tajiri and C. V. Borlongan 
235 
 
(2013). "The battle of the sexes for stroke therapy: female- versus male-
derived stem cells." CNS Neurol Disord Drug Targets 12(3): 405-412. 
Kasius, A., J. G. Smit, H. L. Torrance, M. J. Eijkemans, B. W. Mol, B. C. 
Opmeer and F. J. Broekmans (2014). "Endometrial thickness and pregnancy 
rates after IVF: a systematic review and meta-analysis." Hum Reprod Update 
20(4): 530-541. 
Kato, K., M. Yoshimoto, K. Kato, S. Adachi, A. Yamayoshi, T. Arima, K. 
Asanoma, S. Kyo, T. Nakahata and N. Wake (2007). "Characterization of 
side-population cells in human normal endometrium." Hum Reprod 22(5): 
1214-1223. 
Kaufman, M. H., R. M. Brune, R. A. Baldock, J. B. Bard and D. Davidson 
(1997). "Computer-aided 3-D reconstruction of serially sectioned mouse 
embryos: its use in integrating anatomical organization." Int J Dev Biol 41(2): 
223-233. 
Khademi, F., M. Soleimani, J. Verdi, S. M. Tavangar, E. Sadroddiny, M. 
Massumi and J. Ai (2014). "Human endometrial stem cells differentiation into 
functional hepatocyte-like cells." Cell Biol Int 38(7): 825-834. 
Khan, K. N., A. Fujishita, M. Kitajima, H. Masuzaki, M. Nakashima and J. 
Kitawaki (2016). "Biological differences between functionalis and basalis 
endometria in women with and without adenomyosis." Eur J Obstet Gynecol 
Reprod Biol 203: 49-55. 
Khanjani, S., M. Khanmohammadi, A. H. Zarnani, M. M. Akhondi, A. Ahani, 
Z. Ghaempanah, M. M. Naderi, S. Eghtesad and S. Kazemnejad (2014). 
"Comparative evaluation of differentiation potential of menstrual blood- 
versus bone marrow-derived stem cells into hepatocyte-like cells." PLoS One 
9(2): e86075. 
Khanjani, S., M. Khanmohammadi, A. H. Zarnani, S. Talebi, H. Edalatkhah, 
S. Eghtesad, I. Nikokar and S. Kazemnejad (2015). "Efficient generation of 
functional hepatocyte-like cells from menstrual blood-derived stem cells." J 
Tissue Eng Regen Med 9(11): E124-134. 
Kim, J. Y., S. Tavare and D. Shibata (2005). "Counting human somatic cell 
replications: methylation mirrors endometrial stem cell divisions." Proc Natl 
Acad Sci U S A 102(49): 17739-17744. 
236 
 
Kim, T. H., S. Escudero and R. A. Shivdasani (2012). "Intact function of Lgr5 
receptor-expressing intestinal stem cells in the absence of Paneth cells." 
Proc Natl Acad Sci U S A 109(10): 3932-3937. 
Klein, A. M. and B. D. Simons (2011). "Universal patterns of stem cell fate in 
cycling adult tissues." Development 138(15): 3103-3111. 
Knowles, B. B., D. P. Aden and D. Solter (1978). "Monoclonal antibody 
detecting a stage-specific embryonic antigen (SSEA-1) on preimplantation 
mouse embryos and teratocarcinoma cells." Curr Top Microbiol Immunol 81: 
51-53. 
Knowles, B. B., J. Rappaport and D. Solter (1982). "Murine embryonic 
antigen (SSEA-1) is expressed on human cells and structurally related 
human blood group antigen I is expressed on mouse embryos." Dev Biol 
93(1): 54-58. 
Kooy, J., N. H. Taylor, D. L. Healy and P. A. Rogers (1996). "Endothelial cell 
proliferation in the endometrium of women with menorrhagia and in women 
following endometrial ablation." Hum Reprod 11(5): 1067-1072. 
Krusche, C. A., T. Kroll, H. M. Beier and I. Classen-Linke (2007). "Expression 
of leucine-rich repeat-containing G-protein-coupled receptors in the human 
cyclic endometrium." Fertil Steril 87(6): 1428-1437. 
Kumar, K. K., A. W. Burgess and J. M. Gulbis (2014). "Structure and function 
of LGR5: an enigmatic G-protein coupled receptor marking stem cells." 
Protein Sci 23(5): 551-565. 
Kurita, T., P. S. Cooke and G. R. Cunha (2001). "Epithelial-stromal tissue 
interaction in paramesonephric (Mullerian) epithelial differentiation." Dev Biol 
240(1): 194-211. 
Lagadec, C., E. Vlashi, P. Frohnen, Y. Alhiyari, M. Chan and F. Pajonk 
(2014). "The RNA-binding protein Musashi-1 regulates proteasome subunit 
expression in breast cancer- and glioma-initiating cells." Stem Cells 32(1): 
135-144. 
Lai, D., Y. Guo, Q. Zhang, Y. Chen and C. Xiang (2016). "Differentiation of 
human menstrual blood-derived endometrial mesenchymal stem cells into 
oocyte-like cells." Acta Biochim Biophys Sin (Shanghai) 48(11): 998-1005. 
Lan, S. Y., T. Yu, Z. S. Xia, Y. H. Yuan, L. Shi, Y. Lin, K. H. Huang and Q. K. 
Chen (2010). "Musashi 1-positive cells derived from mouse embryonic stem 
237 
 
cells can differentiate into neural and intestinal epithelial-like cells in vivo." 
Cell Biol Int 34(12): 1171-1180. 
Lankas, G. R., L. D. Wise, M. E. Cartwright, T. Pippert and D. R. 
Umbenhauer (1998). "Placental P-glycoprotein deficiency enhances 
susceptibility to chemically induced birth defects in mice." Reprod Toxicol 
12(4): 457-463. 
Lash, G. E., H. Pitman, H. L. Morgan, B. A. Innes, C. N. Agwu and J. N. 
Bulmer (2016). "Decidual macrophages: key regulators of vascular 
remodeling in human pregnancy." J Leukoc Biol 100(2): 315-325. 
Lebovitz, O. and R. Orvieto (2014). "Treating patients with "thin" 
endometrium - an ongoing challenge." Gynecol Endocrinol 30(6): 409-414. 
Lessey, B. A., A. O. Ilesanmi, M. A. Lessey, M. Riben, J. E. Harris and K. 
Chwalisz (1996). "Luminal and glandular endometrial epithelium express 
integrins differentially throughout the menstrual cycle: implications for 
implantation, contraception, and infertility." Am J Reprod Immunol 35(3): 195-
204. 
Leushacke, M. and N. Barker (2012). "Lgr5 and Lgr6 as markers to study 
adult stem cell roles in self-renewal and cancer." Oncogene 31(25): 3009-
3022. 
Li, L. and T. Xie (2005). "Stem cell niche: structure and function." Annu Rev 
Cell Dev Biol 21: 605-631. 
Li, Y., J. S. Park, J. H. Deng and Y. Bai (2006). "Cytochrome c oxidase 
subunit IV is essential for assembly and respiratory function of the enzyme 
complex." J Bioenerg Biomembr 38(5-6): 283-291. 
Lightowlers, R. N., P. F. Chinnery, D. M. Turnbull and N. Howell (1997). 
"Mammalian mitochondrial genetics: heredity, heteroplasmy and disease." 
Trends Genet 13(11): 450-455. 
Lin, W. R., S. N. Lim, S. A. McDonald, T. Graham, V. L. Wright, C. L. 
Peplow, A. Humphries, H. M. Kocher, N. A. Wright, A. P. Dhillon and M. R. 
Alison (2010). "The histogenesis of regenerative nodules in human liver 
cirrhosis." Hepatology 51(3): 1017-1026. 
Liu, J., H. Zhang, Y. Zhang, N. Li, Y. Wen, F. Cao, H. Ai and X. Xue (2014). 
"Homing and restorative effects of bone marrow-derived mesenchymal stem 
cells on cisplatin injured ovaries in rats." Mol Cells 37(12): 865-872. 
238 
 
Liu, T., Y. Huang, J. Zhang, W. Qin, H. Chi, J. Chen, Z. Yu and C. Chen 
(2014). "Transplantation of human menstrual blood stem cells to treat 
premature ovarian failure in mouse model." Stem Cells Dev 23(13): 1548-
1557. 
Livet, J. (2007). "[The brain in color: transgenic "Brainbow" mice for 
visualizing neuronal circuits]." Med Sci (Paris) 23(12): 1173-1176. 
Lockwood, C. J. (2011). "Mechanisms of normal and abnormal endometrial 
bleeding." Menopause 18(4): 408-411. 
Lu, X., F. Lin, H. Fang, X. Yang and L. Qin (2011). "Expression of a putative 
stem cell marker Musashi-1 in endometrium." Histol Histopathol 26(9): 1127-
1133. 
Lysiak, J. J. and P. K. Lala (1992). "In situ localization and characterization of 
bone marrow-derived cells in the decidua of normal murine pregnancy." Biol 
Reprod 47(4): 603-613. 
Maclean A, D. J., Hapangama DK (2017). "Identification of epithelial cell 
markers contribute towards the characterisation of endometrial epithelial cell 
subtypes." Human Reproduction 32(Supp1): 1-539`. 
Makker, A., M. M. Goel, D. Nigam, V. Bhatia, A. A. Mahdi, V. Das and A. 
Pandey (2017). "Endometrial Expression of Homeobox Genes and Cell 
Adhesion Molecules in Infertile Women With Intramural Fibroids During 
Window of Implantation." Reprod Sci 24(3): 435-444. 
Marchio, C., A. Sapino, R. Arisio and G. Bussolati (2006). "A new vision of 
tubular and tubulo-lobular carcinomas of the breast, as revealed by 3-D 
modelling." Histopathology 48(5): 556-562. 
Marcum, R. G. and S. R. Wellings (1969). "Subgross pathology of the human 
breast: method and initial observations." J Natl Cancer Inst 42(1): 115-121. 
Markee, J. E. (1946). "The morphological basis for menstrual bleeding." Anat 
Rec 94: 481. 
Masuda, H., S. S. Anwar, H. J. Buhring, J. R. Rao and C. E. Gargett (2012). 
"A novel marker of human endometrial mesenchymal stem-like cells." Cell 
Transplant 21(10): 2201-2214. 
Masuda, H., T. Maruyama, E. Hiratsu, J. Yamane, A. Iwanami, T. 
Nagashima, M. Ono, H. Miyoshi, H. J. Okano, M. Ito, N. Tamaoki, T. 
Nomura, H. Okano, Y. Matsuzaki and Y. Yoshimura (2007). "Noninvasive 
239 
 
and real-time assessment of reconstructed functional human endometrium in 
NOD/SCID/gamma c(null) immunodeficient mice." Proc Natl Acad Sci U S A 
104(6): 1925-1930. 
Masuda, H., Y. Matsuzaki, E. Hiratsu, M. Ono, T. Nagashima, T. Kajitani, T. 
Arase, H. Oda, H. Uchida, H. Asada, M. Ito, Y. Yoshimura, T. Maruyama and 
H. Okano (2010). "Stem cell-like properties of the endometrial side 
population: implication in endometrial regeneration." PLoS One 5(4): e10387. 
Mathew, D., J. A. Drury, A. J. Valentijn, O. Vasieva and D. K. Hapangama 
(2016). "In silico, in vitro and in vivo analysis identifies a potential role for 
steroid hormone regulation of FOXD3 in endometriosis-associated genes." 
Hum Reprod 31(2): 345-354. 
Matthai, C., R. Horvat, M. Noe, F. Nagele, A. Radjabi, M. van Trotsenburg, J. 
Huber and A. Kolbus (2006). "Oct-4 expression in human endometrium." Mol 
Hum Reprod 12(1): 7-10. 
Matthew, D. (2013). Investigation of neonatal mouse kidney and endometrial 
cell populations in explant culture combined with an in silico approach to the 
endometrium. . Master of Philosophy, University of Liverpool. 
Maybin, J. A. and H. O. Critchley (2015). "Menstrual physiology: implications 
for endometrial pathology and beyond." Hum Reprod Update 21(6): 748-761. 
Mayer, U., E. Wagenaar, J. H. Beijnen, J. W. Smit, D. K. Meijer, J. van 
Asperen, P. Borst and A. H. Schinkel (1996). "Substantial excretion of 
digoxin via the intestinal mucosa and prevention of long-term digoxin 
accumulation in the brain by the mdr 1a P-glycoprotein." Br J Pharmacol 
119(5): 1038-1044. 
McDonald, S. A., L. C. Greaves, L. Gutierrez-Gonzalez, M. Rodriguez-Justo, 
M. Deheragoda, S. J. Leedham, R. W. Taylor, C. Y. Lee, S. L. Preston, M. 
Lovell, T. Hunt, G. Elia, D. Oukrif, R. Harrison, M. R. Novelli, I. Mitchell, D. L. 
Stoker, D. M. Turnbull, J. A. Jankowski and N. A. Wright (2008). 
"Mechanisms of field cancerization in the human stomach: the expansion 
and spread of mutated gastric stem cells." Gastroenterology 134(2): 500-
510. 
McGuire, S. E., P. T. Le, A. J. Osborn, K. Matsumoto and R. L. Davis (2003). 
"Spatiotemporal rescue of memory dysfunction in Drosophila." Science 
302(5651): 1765-1768. 
240 
 
Medvedev, S. P., A. I. Shevchenko and S. M. Zakian (2010). "Induced 
Pluripotent Stem Cells: Problems and Advantages when Applying them in 
Regenerative Medicine." Acta Naturae 2(2): 18-28. 
Meng, X., T. E. Ichim, J. Zhong, A. Rogers, Z. Yin, J. Jackson, H. Wang, W. 
Ge, V. Bogin, K. W. Chan, B. Thebaud and N. H. Riordan (2007). 
"Endometrial regenerative cells: a novel stem cell population." J Transl Med 
5: 57. 
Meseguer, M., J. D. Aplin, P. Caballero-Campo, J. E. O'Connor, J. C. Martin, 
J. Remohi, A. Pellicer and C. Simon (2001). "Human endometrial mucin 
MUC1 is up-regulated by progesterone and down-regulated in vitro by the 
human blastocyst." Biol Reprod 64(2): 590-601. 
Miller, E. J. and I. S. Fraser (2015). "The importance of pelvic nerve fibers in 
endometriosis." Womens Health (Lond) 11(5): 611-618. 
Mints, M., M. Jansson, B. Sadeghi, M. Westgren, M. Uzunel, M. Hassan and 
J. Palmblad (2008). "Endometrial endothelial cells are derived from donor 
stem cells in a bone marrow transplant recipient." Hum Reprod 23(1): 139-
143. 
Mootha, V. K., P. Lepage, K. Miller, J. Bunkenborg, M. Reich, M. Hjerrild, T. 
Delmonte, A. Villeneuve, R. Sladek, F. Xu, G. A. Mitchell, C. Morin, M. Mann, 
T. J. Hudson, B. Robinson, J. D. Rioux and E. S. Lander (2003). 
"Identification of a gene causing human cytochrome c oxidase deficiency by 
integrative genomics." Proc Natl Acad Sci U S A 100(2): 605-610. 
Morrison, S. J. and D. T. Scadden (2014). "The bone marrow niche for 
haematopoietic stem cells." Nature 505(7483): 327-334. 
Mou, X. Z., J. Lin, J. Y. Chen, Y. F. Li, X. X. Wu, B. Y. Xiang, C. Y. Li, J. M. 
Ma and C. Xiang (2013). "Menstrual blood-derived mesenchymal stem cells 
differentiate into functional hepatocyte-like cells." J Zhejiang Univ Sci B 
14(11): 961-972. 
Mulac-Jericevic, B. and O. M. Conneely (2004). "Reproductive tissue 
selective actions of progesterone receptors." Reproduction 128(2): 139-146. 
Muller I, V. d. P. J., Massop-Kelmink D, Vos-de Bruni R, Sikkema JM (2015). 
"Patient satisfaction and amenorrhea rate after endometrial ablation by 
Thermachoice III or NovaSure: a retrospective cohort study." Gynecological 
Surgery 12(2): 81-87. 
241 
 
Munoz, J., D. E. Stange, A. G. Schepers, M. van de Wetering, B. K. Koo, S. 
Itzkovitz, R. Volckmann, K. S. Kung, J. Koster, S. Radulescu, K. Myant, R. 
Versteeg, O. J. Sansom, J. H. van Es, N. Barker, A. van Oudenaarden, S. 
Mohammed, A. J. Heck and H. Clevers (2012). "The Lgr5 intestinal stem cell 
signature: robust expression of proposed quiescent '+4' cell markers." EMBO 
J 31(14): 3079-3091. 
Murayama, M., R. Okamoto, K. Tsuchiya, J. Akiyama, T. Nakamura, N. 
Sakamoto, T. Kanai and M. Watanabe (2009). "Musashi-1 suppresses 
expression of Paneth cell-specific genes in human intestinal epithelial cells." 
J Gastroenterol 44(3): 173-182. 
Murphy, M. P., H. Wang, A. N. Patel, S. Kambhampati, N. Angle, K. Chan, A. 
M. Marleau, A. Pyszniak, E. Carrier, T. E. Ichim and N. H. Riordan (2008). 
"Allogeneic endometrial regenerative cells: an "Off the shelf solution" for 
critical limb ischemia?" J Transl Med 6: 45. 
Naiche, L. A. and V. E. Papaioannou (2007). "Tbx4 is not required for 
hindlimb identity or post-bud hindlimb outgrowth." Development 134(1): 93-
103. 
Nakamura, M., H. Okano, J. A. Blendy and C. Montell (1994). "Musashi, a 
neural RNA-binding protein required for Drosophila adult external sensory 
organ development." Neuron 13(1): 67-81. 
Nelson, E. D., E. T. Kavalali and L. M. Monteggia (2008). "Activity-dependent 
suppression of miniature neurotransmission through the regulation of DNA 
methylation." J Neurosci 28(2): 395-406. 
Nemeth, K. and S. Karpati (2014). "Identifying the stem cell." J Invest 
Dermatol 134(11): e26. 
Ng, A., S. Tan, G. Singh, P. Rizk, Y. Swathi, T. Z. Tan, R. Y. Huang, M. 
Leushacke and N. Barker (2014). "Lgr5 marks stem/progenitor cells in ovary 
and tubal epithelia." Nat Cell Biol 16(8): 745-757. 
Nguyen, H. P., C. N. Sprung and C. E. Gargett (2012). "Differential 
expression of Wnt signaling molecules between pre- and postmenopausal 
endometrial epithelial cells suggests a population of putative epithelial 
stem/progenitor cells reside in the basalis layer." Endocrinology 153(6): 
2870-2883. 
242 
 
Nguyen, H. P. T., L. Xiao, J. A. Deane, K. S. Tan, F. L. Cousins, H. Masuda, 
C. N. Sprung, A. Rosamilia and C. E. Gargett (2017). "N-cadherin identifies 
human endometrial epithelial progenitor cells by in vitro stem cell assays." 
Hum Reprod 32(11): 2254-2268. 
Niknamasl, A., S. N. Ostad, M. Soleimani, M. Azami, M. K. Salmani, N. 
Lotfibakhshaiesh, S. Ebrahimi-Barough, R. Karimi, R. Roozafzoon and J. Ai 
(2014). "A new approach for pancreatic tissue engineering: human 
endometrial stem cells encapsulated in fibrin gel can differentiate to 
pancreatic islet beta-cell." Cell Biol Int 38(10): 1174-1182. 
Nikpour, P., S. J. Mowla, M. Forouzandeh-Moghaddam and S. A. Ziaee 
(2013). "The stem cell self-renewal gene, Musashi 1, is highly expressed in 
tumor and non-tumor samples of human bladder." Indian J Cancer 50(3): 
214-218. 
Nilsson, O., D. Englund, E. Weiner and A. Victor (1980). "Endometrial effects 
of levonorgestrel and estradiol: A Scanning electron microscopic study of the 
luminal epithelium." Contraception 22(1): 71-83. 
Nishimura, S., N. Wakabayashi, K. Toyoda, K. Kashima and S. Mitsufuji 
(2003). "Expression of Musashi-1 in human normal colon crypt cells: a 
possible stem cell marker of human colon epithelium." Dig Dis Sci 48(8): 
1523-1529. 
Nooteboom, M., R. Johnson, R. W. Taylor, N. A. Wright, R. N. Lightowlers, T. 
B. Kirkwood, J. C. Mathers, D. M. Turnbull and L. C. Greaves (2010). "Age-
associated mitochondrial DNA mutations lead to small but significant 
changes in cell proliferation and apoptosis in human colonic crypts." Aging 
Cell 9(1): 96-99. 
Novak E, E. H. (1928). "Cyclical and other variations in the tubal epithelium." 
American Journal of obstetrics and Gyanecology 16: 499-530. 
Novelli, M., A. Cossu, D. Oukrif, A. Quaglia, S. Lakhani, R. Poulsom, P. 
Sasieni, P. Carta, M. Contini, A. Pasca, G. Palmieri, W. Bodmer, F. Tanda 
and N. Wright (2003). "X-inactivation patch size in human female tissue 
confounds the assessment of tumor clonality." Proc Natl Acad Sci U S A 
100(6): 3311-3314. 
Noyes, R. W., A. T. Hertig and J. Rock (1975). "Dating the endometrial 
biopsy." Am J Obstet Gynecol 122(2): 262-263. 
243 
 
O'Connor, M. D., M. D. Kardel, I. Iosfina, D. Youssef, M. Lu, M. M. Li, S. 
Vercauteren, A. Nagy and C. J. Eaves (2008). "Alkaline phosphatase-
positive colony formation is a sensitive, specific, and quantitative indicator of 
undifferentiated human embryonic stem cells." Stem Cells 26(5): 1109-1116. 
Ong, Y. R., F. L. Cousins, X. Yang, A. Mushafi, D. T. Breault, C. E. Gargett 
and J. A. Deane (2018). "Bone Marrow Stem Cells Do Not Contribute to 
Endometrial Cell Lineages in Chimeric Mouse Models." Stem Cells 36(1): 91-
102. 
Ono, M. and T. Maruyama (2015). "Stem Cells in Myometrial Physiology." 
Semin Reprod Med 33(5): 350-356. 
Onozato, M. L., V. E. Klepeis, Y. Yagi and M. Mino-Kenudson (2012). "A role 
of three-dimensional (3D)-reconstruction in the classification of lung 
adenocarcinoma." Anal Cell Pathol (Amst) 35(2): 79-84. 
Paik, D. Y., D. M. Janzen, A. M. Schafenacker, V. S. Velasco, M. S. Shung, 
D. Cheng, J. Huang, O. N. Witte and S. Memarzadeh (2012). "Stem-like 
epithelial cells are concentrated in the distal end of the fallopian tube: a site 
for injury and serous cancer initiation." Stem Cells 30(11): 2487-2497. 
Pike, M. C., C. L. Pearce and A. H. Wu (2004). "Prevention of cancers of the 
breast, endometrium and ovary." Oncogene 23(38): 6379-6391. 
Plaks, V., A. Brenot, D. A. Lawson, J. R. Linnemann, E. C. Van Kappel, K. C. 
Wong, F. de Sauvage, O. D. Klein and Z. Werb (2013). "Lgr5-expressing 
cells are sufficient and necessary for postnatal mammary gland 
organogenesis." Cell Rep 3(1): 70-78. 
Poncelet, C., F. Cornelis, M. Tepper, E. Sauce, N. Magan, J. P. Wolf and M. 
Ziol (2010). "Expression of E- and N-cadherin and CD44 in endometrium and 
hydrosalpinges from infertile women." Fertil Steril 94(7): 2909-2912. 
Potten, C. S. (2004). "Keratinocyte stem cells, label-retaining cells and 
possible genome protection mechanisms." J Investig Dermatol Symp Proc 
9(3): 183-195. 
Potten, C. S., C. Booth, G. L. Tudor, D. Booth, G. Brady, P. Hurley, G. 
Ashton, R. Clarke, S. Sakakibara and H. Okano (2003). "Identification of a 
putative intestinal stem cell and early lineage marker; musashi-1." 
Differentiation 71(1): 28-41. 
244 
 
Potten, C. S., M. Kellett, D. A. Rew and S. A. Roberts (1992). "Proliferation in 
human gastrointestinal epithelium using bromodeoxyuridine in vivo: data for 
different sites, proximity to a tumour, and polyposis coli." Gut 33(4): 524-529. 
Prager, R. W., U. Z. Ijaz, A. H. Gee and G. M. Treece (2010). "Three-
dimensional ultrasound imaging." Proc Inst Mech Eng H 224(2): 193-223. 
Prianishnikov, V. A. (1978). "A functional model of the structure of the 
epithelium of normal, hyperplastic and malignant human endometrium: a 
review." Gynecologic oncology 6(5): 420-428. 
Prianishnikov, V. A. (1978). "A functional model of the structure of the 
epithelium of normal, hyperplastic and malignant human endometrium: a 
review." Gynecol Oncol 6(5): 420-428. 
Punzel, M. and A. D. Ho (2001). "Divisional history and pluripotency of 
human hematopoietic stem cells." Ann N Y Acad Sci 938: 72-81; discussion 
81-72. 
Quintana, L. and J. Sharpe (2011). "Optical projection tomography of 
vertebrate embryo development." Cold Spring Harb Protoc 2011(6): 586-594. 
Rae, M., A. Mohamad, D. Price, P. W. Hadoke, B. R. Walker, J. I. Mason, S. 
G. Hillier and H. O. Critchley (2009). "Cortisol inactivation by 11beta-
hydroxysteroid dehydrogenase-2 may enhance endometrial angiogenesis via 
reduced thrombospondin-1 in heavy menstruation." J Clin Endocrinol Metab 
94(4): 1443-1450. 
Raji, B., A. Dansault, J. Leemput, G. de la Houssaye, V. Vieira, A. Kobetz, L. 
Arbogast, C. Masson, M. Menasche and M. Abitbol (2007). "The RNA-
binding protein Musashi-1 is produced in the developing and adult mouse 
eye." Mol Vis 13: 1412-1427. 
Ramsey, E. M. (1989). History. Biology of the Uterus. . R. M. Wynn, Plenum 
Publishing Corp. : 1-17. 
Richter, C., J. W. Park and B. N. Ames (1988). "Normal oxidative damage to 
mitochondrial and nuclear DNA is extensive." Proc Natl Acad Sci U S A 
85(17): 6465-6467. 
Ro, S. and B. Rannala (2001). "Methylation patterns and mathematical 
models reveal dynamics of stem cell turnover in the human colon." Proc Natl 
Acad Sci U S A 98(19): 10519-10521. 
245 
 
Roberts, N., D. Magee, Y. Song, K. Brabazon, M. Shires, D. Crellin, N. M. 
Orsi, R. Quirke, P. Quirke and D. Treanor (2012). "Toward routine use of 3D 
histopathology as a research tool." Am J Pathol 180(5): 1835-1842. 
Robson, A., L. K. Harris, B. A. Innes, G. E. Lash, M. M. Aljunaidy, J. D. Aplin, 
P. N. Baker, S. C. Robson and J. N. Bulmer (2012). "Uterine natural killer 
cells initiate spiral artery remodeling in human pregnancy." FASEB J 26(12): 
4876-4885. 
Rodrigues, M. C., L. E. Glover, N. Weinbren, J. A. Rizzi, H. Ishikawa, K. 
Shinozuka, N. Tajiri, Y. Kaneko, P. R. Sanberg, J. G. Allickson, N. Kuzmin-
Nichols, S. Garbuzova-Davis, J. C. Voltarelli, E. Cruz and C. V. Borlongan 
(2011). "Toward personalized cell therapies: autologous menstrual blood 
cells for stroke." J Biomed Biotechnol 2011: 194720. 
Rodrigues, M. C., J. Voltarelli, P. R. Sanberg, J. G. Allickson, N. Kuzmin-
Nichols, S. Garbuzova-Davis and C. V. Borlongan (2012). "Recent progress 
in cell therapy for basal ganglia disorders with emphasis on menstrual blood 
transplantation in stroke." Neurosci Biobehav Rev 36(1): 177-190. 
Rogers, P. A., J. F. Donoghue, L. M. Walter and J. E. Girling (2009). 
"Endometrial angiogenesis, vascular maturation, and lymphangiogenesis." 
Reprod Sci 16(2): 147-151. 
Sacchetti, B., A. Funari, S. Michienzi, S. Di Cesare, S. Piersanti, I. Saggio, E. 
Tagliafico, S. Ferrari, P. G. Robey, M. Riminucci and P. Bianco (2007). "Self-
renewing osteoprogenitors in bone marrow sinusoids can organize a 
hematopoietic microenvironment." Cell 131(2): 324-336. 
Saegusa, M., M. Hashimura, E. Suzuki, T. Yoshida and T. Kuwata (2012). 
"Transcriptional up-regulation of Sox9 by NF-kappaB in endometrial 
carcinoma cells, modulating cell proliferation through alteration in the 
p14(ARF)/p53/p21(WAF1) pathway." Am J Pathol 181(2): 684-692. 
Santamaria, X., S. Cabanillas, I. Cervello, C. Arbona, F. Raga, J. Ferro, J. 
Palmero, J. Remohi, A. Pellicer and C. Simon (2016). "Autologous cell 
therapy with CD133+ bone marrow-derived stem cells for refractory 
Asherman's syndrome and endometrial atrophy: a pilot cohort study." Hum 
Reprod 31(5): 1087-1096. 
Santamaria, X., E. E. Massasa, Y. Feng, E. Wolff and H. S. Taylor (2011). 
"Derivation of insulin producing cells from human endometrial stromal stem 
246 
 
cells and use in the treatment of murine diabetes." Mol Ther 19(11): 2065-
2071. 
Satake, T. and M. Matsuyama (1987). "Argyrophil cells in normal endometrial 
glands." Virchows Arch A Pathol Anat Histopathol 410(5): 449-454. 
Sato, T., J. H. van Es, H. J. Snippert, D. E. Stange, R. G. Vries, M. van den 
Born, N. Barker, N. F. Shroyer, M. van de Wetering and H. Clevers (2011). 
"Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts." 
Nature 469(7330): 415-418. 
Sato, T., R. G. Vries, H. J. Snippert, M. van de Wetering, N. Barker, D. E. 
Stange, J. H. van Es, A. Abo, P. Kujala, P. J. Peters and H. Clevers (2009). 
"Single Lgr5 stem cells build crypt-villus structures in vitro without a 
mesenchymal niche." Nature 459(7244): 262-265. 
Satoh, A., K. Sakamaki, H. Ide and K. Tamura (2005). "Characteristics of 
initiation and early events for muscle development in the Xenopus limb bud." 
Dev Dyn 234(4): 846-857. 
Schenker, J. G., M. I. Sacks and W. Z. Polischuk (1971). "I. Regeneration of 
rabbit endometrium following curettage." Am J Obstet Gynecol 111(7): 970-
978. 
Schieke, S. M., M. Ma, L. Cao, J. P. McCoy, Jr., C. Liu, N. F. Hensel, A. J. 
Barrett, M. Boehm and T. Finkel (2008). "Mitochondrial metabolism 
modulates differentiation and teratoma formation capacity in mouse 
embryonic stem cells." J Biol Chem 283(42): 28506-28512. 
Schuijers, J. and H. Clevers (2012). "Adult mammalian stem cells: the role of 
Wnt, Lgr5 and R-spondins." Embo j 31(12): 2685-2696. 
Schwab, K. E., R. W. Chan and C. E. Gargett (2005). "Putative stem cell 
activity of human endometrial epithelial and stromal cells during the 
menstrual cycle." Fertil Steril 84 Suppl 2: 1124-1130. 
Schwab, K. E. and C. E. Gargett (2007). "Co-expression of two perivascular 
cell markers isolates mesenchymal stem-like cells from human 
endometrium." Hum Reprod 22(11): 2903-2911. 
Sciacco, M., E. Bonilla, E. A. Schon, S. DiMauro and C. T. Moraes (1994). 
"Distribution of wild-type and common deletion forms of mtDNA in normal 
and respiration-deficient muscle fibers from patients with mitochondrial 
myopathy." Hum Mol Genet 3(1): 13-19. 
247 
 
Shoae-Hassani, A., S. A. Mortazavi-Tabatabaei, S. Sharif, A. M. Seifalian, A. 
Azimi, A. Samadikuchaksaraei and J. Verdi (2015). "Differentiation of human 
endometrial stem cells into urothelial cells on a three-dimensional 
nanofibrous silk-collagen scaffold: an autologous cell resource for 
reconstruction of the urinary bladder wall." J Tissue Eng Regen Med 9(11): 
1268-1276. 
Shoae-Hassani, A., S. Sharif, A. M. Seifalian, S. A. Mortazavi-Tabatabaei, S. 
Rezaie and J. Verdi (2013). "Endometrial stem cell differentiation into smooth 
muscle cell: a novel approach for bladder tissue engineering in women." BJU 
Int 112(6): 854-863. 
Singer, A., B. Reid and M. Coppleson (1968). "The role of peritoneal 
mononuclear cells in the regeneration of the uterine epithelium of the rat." 
Aust N Z J Obstet Gynaecol 8(4): 163-170. 
Singh, S. R., M. K. Mishra, M. Kango-Singh and S. X. Hou (2012). 
"Generation and staining of intestinal stem cell lineage in adult midgut." 
Methods Mol Biol 879: 47-69. 
Singh, V. K., N. Kumar, M. Kalsan, A. Saini and R. Chandra (2015). 
"Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs)." J Stem 
Cells 10(1): 43-62. 
Slayden, O. D. and R. M. Brenner (2006). "A critical period of progesterone 
withdrawal precedes menstruation in macaques." Reprod Biol Endocrinol 4 
Suppl 1: S6. 
Slayden, O. D. and C. S. Keator (2007). "Role of progesterone in nonhuman 
primate implantation." Semin Reprod Med 25(6): 418-430. 
Smit, J. W., A. H. Schinkel, B. Weert and D. K. Meijer (1998). "Hepatobiliary 
and intestinal clearance of amphiphilic cationic drugs in mice in which both 
mdr1a and mdr1b genes have been disrupted." Br J Pharmacol 124(2): 416-
424. 
Smith, O. P. and H. O. Critchley (2005). "Progestogen only contraception 
and endometrial break through bleeding." Angiogenesis 8(2): 117-126. 
Snippert, H. J., L. G. van der Flier, T. Sato, J. H. van Es, M. van den Born, C. 
Kroon-Veenboer, N. Barker, A. M. Klein, J. van Rheenen, B. D. Simons and 
H. Clevers (2010). "Intestinal crypt homeostasis results from neutral 
248 
 
competition between symmetrically dividing Lgr5 stem cells." Cell 143(1): 
134-144. 
Snykers, S., J. De Kock, V. Rogiers and T. Vanhaecke (2009). "In vitro 
differentiation of embryonic and adult stem cells into hepatocytes: state of 
the art." Stem Cells 27(3): 577-605. 
Sobiesiak, M., K. Sivasubramaniyan, C. Hermann, C. Tan, M. Orgel, S. 
Treml, F. Cerabona, P. de Zwart, U. Ochs, C. A. Muller, C. E. Gargett, H. 
Kalbacher and H. J. Buhring (2010). "The mesenchymal stem cell antigen 
MSCA-1 is identical to tissue non-specific alkaline phosphatase." Stem Cells 
Dev 19(5): 669-677. 
Society, T. A. F. (1988). "The American Fertility Society classifications of 
adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal 
ligation, tubal pregnancies, mullerian anomalies and intrauterine adhesions." 
Fertil Steril 49(6): 944-955. 
Solter, D. and B. B. Knowles (1978). "Monoclonal antibody defining a stage-
specific mouse embryonic antigen (SSEA-1)." Proc Natl Acad Sci U S A 
75(11): 5565-5569. 
Solter, D. and B. B. Knowles (1979). "Developmental stage-specific antigens 
during mouse embryogenesis." Curr Top Dev Biol 13 Pt 1: 139-165. 
Song, J. (1964). The human uterus; Morphogenesis and embryological basis 
for cancer., Thomas. 
Song, Y., D. Treanor, A. J. Bulpitt and D. R. Magee (2013). "3D 
reconstruction of multiple stained histology images." J Pathol Inform 
4(Suppl): S7. 
Sosa-Stanley, J. N. and S. S. Bhimji (2017). Anatomy, Pelvis, Uterus. 
StatPearls. Treasure Island (FL). 
Spencer, T. E. (2014). "Biological roles of uterine glands in pregnancy." 
Semin Reprod Med 32(5): 346-357. 
Spokony, R. F., Y. Aoki, N. Saint-Germain, E. Magner-Fink and J. P. Saint-
Jeannet (2002). "The transcription factor Sox9 is required for cranial neural 
crest development in Xenopus." Development 129(2): 421-432. 
Spradling, A., D. Drummond-Barbosa and T. Kai (2001). "Stem cells find 
their niche." Nature 414(6859): 98-104. 
249 
 
Spradling, A. C. (2011). "The living-tissue microscope: the importance of 
studying stem cells in their natural, undisturbed microenvironment." J Pathol 
225(2): 161-162. 
Stewart, C. L., P. Kaspar, L. J. Brunet, H. Bhatt, I. Gadi, F. Kontgen and S. J. 
Abbondanzo (1992). "Blastocyst implantation depends on maternal 
expression of leukaemia inhibitory factor." Nature 359(6390): 76-79. 
Sturgis SH, M. J. (1936). "Endometrial cycle and mechanism of normal 
menstruation." Obstet Gynecol 33: 369. 
Su, T., D. M. Turnbull and L. C. Greaves (2018). "Roles of Mitochondrial 
DNA Mutations in Stem Cell Ageing." Genes (Basel) 9(4). 
Sudbeck, P., M. L. Schmitz, P. A. Baeuerle and G. Scherer (1996). "Sex 
reversal by loss of the C-terminal transactivation domain of human SOX9." 
Nat Genet 13(2): 230-232. 
Sugiyama-Nakagiri, Y., M. Akiyama, S. Shibata, H. Okano and H. Shimizu 
(2006). "Expression of RNA-binding protein Musashi in hair follicle 
development and hair cycle progression." Am J Pathol 168(1): 80-92. 
Sun, L., D. Wang, J. T. Zubovits, M. J. Yaffe and G. M. Clarke (2009). "An 
improved processing method for breast whole-mount serial sections for 
three-dimensional histopathology imaging." Am J Clin Pathol 131(3): 383-
392. 
Sun, X., L. Jackson, S. K. Dey and T. Daikoku (2009). "In pursuit of leucine-
rich repeat-containing G protein-coupled receptor-5 regulation and function in 
the uterus." Endocrinology 150(11): 5065-5073. 
Sun, X., J. Terakawa, H. Clevers, N. Barker, T. Daikoku and S. K. Dey 
(2014). "Ovarian LGR5 is critical for successful pregnancy." FASEB J 28(5): 
2380-2389. 
Surveyor, G. A., S. J. Gendler, L. Pemberton, S. K. Das, I. Chakraborty, J. 
Julian, R. A. Pimental, C. C. Wegner, S. K. Dey and D. D. Carson (1995). 
"Expression and steroid hormonal control of Muc-1 in the mouse uterus." 
Endocrinology 136(8): 3639-3647. 
Swartz, M. A., J. A. Hubbell and S. T. Reddy (2008). "Lymphatic drainage 
function and its immunological implications: from dendritic cell homing to 
vaccine design." Semin Immunol 20(2): 147-156. 
250 
 
Szotek, P. P., H. L. Chang, L. Zhang, F. Preffer, D. Dombkowski, P. K. 
Donahoe and J. Teixeira (2007). "Adult mouse myometrial label-retaining 
cells divide in response to gonadotropin stimulation." Stem Cells 25(5): 1317-
1325. 
Tabibzadeh, S. and A. Babaknia (1995). "The signals and molecular 
pathways involved in implantation, a symbiotic interaction between blastocyst 
and endometrium involving adhesion and tissue invasion." Hum Reprod 
10(6): 1579-1602. 
Tanaka, M., S. Kyo, T. Kanaya, N. Yatabe, M. Nakamura, Y. Maida, M. 
Okabe and M. Inoue (2003). "Evidence of the monoclonal composition of 
human endometrial epithelial glands and mosaic pattern of clonal distribution 
in luminal epithelium." Am J Pathol 163(1): 295-301. 
Taraborrelli, S. (2015). "Physiology, production and action of progesterone." 
Acta Obstet Gynecol Scand 94 Suppl 161: 8-16. 
Taylor, H. S. (2004). "Endometrial cells derived from donor stem cells in 
bone marrow transplant recipients." JAMA 292(1): 81-85. 
Taylor, R. W., M. J. Barron, G. M. Borthwick, A. Gospel, P. F. Chinnery, D. 
C. Samuels, G. A. Taylor, S. M. Plusa, S. J. Needham, L. C. Greaves, T. B. 
Kirkwood and D. M. Turnbull (2003). "Mitochondrial DNA mutations in human 
colonic crypt stem cells." J Clin Invest 112(9): 1351-1360. 
Taylor, R. W., G. A. Taylor, S. E. Durham and D. M. Turnbull (2001). "The 
determination of complete human mitochondrial DNA sequences in single 
cells: implications for the study of somatic mitochondrial DNA point 
mutations." Nucleic Acids Res 29(15): E74-74. 
Taylor, R. W. and D. M. Turnbull (2005). "Mitochondrial DNA mutations in 
human disease." Nat Rev Genet 6(5): 389-402. 
Telford, W. G., J. Bradford, W. Godfrey, R. W. Robey and S. E. Bates 
(2007). "Side population analysis using a violet-excited cell-permeable DNA 
binding dye." Stem Cells 25(4): 1029-1036. 
Tempest, N., A. M. Baker, N. A. Wright and D. K. Hapangama (2018). "Does 
human endometrial LGR5 gene expression suggest the existence of another 
hormonally regulated epithelial stem cell niche?" Hum Reprod. 
251 
 
Terunuma, A., J. W. Cross, M. Dyke, V. Kapoor, W. G. Telford and J. C. 
Vogel (2008). "Behavior of human foreskin keratinocytes expressing a hair 
follicle stem cell marker CD200." J Invest Dermatol 128(5): 1332-1334. 
Terunuma, A., K. L. Jackson, V. Kapoor, W. G. Telford and J. C. Vogel 
(2003). "Side population keratinocytes resembling bone marrow side 
population stem cells are distinct from label-retaining keratinocyte stem 
cells." J Invest Dermatol 121(5): 1095-1103. 
Tokushige, N., R. Markham, P. Russell and I. S. Fraser (2006). "High density 
of small nerve fibres in the functional layer of the endometrium in women 
with endometriosis." Hum Reprod 21(3): 782-787. 
Tokushige, N., R. Markham, P. Russell and I. S. Fraser (2007). "Different 
types of small nerve fibers in eutopic endometrium and myometrium in 
women with endometriosis." Fertil Steril 88(4): 795-803. 
Tomiyasu, S., T. Miyamoto, M. Mori, T. Yaguchi, H. Yakushiji, S. Ohno, Y. 
Miyake, T. Sakaguchi, M. Ueda and E. Ohno (2014). "Isolation of side 
population cells from endometrial cancer cells using a violet laser diode." 
Hum Cell 27(1): 36-42. 
Toyoda, M., C. Cui and A. Umezawa (2007). "Myogenic transdifferentiation 
of menstrual blood-derived cells." Acta Myol 26(3): 176-178. 
Tresserra, F., P. Grases, A. Ubeda, M. A. Pascual, P. J. Grases and R. 
Labastida (1999). "Morphological changes in hysterectomies after 
endometrial ablation." Hum Reprod 14(6): 1473-1477. 
Triel, C., M. E. Vestergaard, L. Bolund, T. G. Jensen and U. B. Jensen 
(2004). "Side population cells in human and mouse epidermis lack stem cell 
characteristics." Exp Cell Res 295(1): 79-90. 
Tsuji, S., M. Yoshimoto, K. Takahashi, Y. Noda, T. Nakahata and T. Heike 
(2008). "Side population cells contribute to the genesis of human 
endometrium." Fertil Steril 90(4 Suppl): 1528-1537. 
Tumbar, T., G. Guasch, V. Greco, C. Blanpain, W. E. Lowry, M. Rendl and E. 
Fuchs (2004). "Defining the epithelial stem cell niche in skin." Science 
303(5656): 359-363. 
Turan, S., M. Galla, E. Ernst, J. Qiao, C. Voelkel, B. Schiedlmeier, C. Zehe 
and J. Bode (2011). "Recombinase-mediated cassette exchange (RMCE): 
traditional concepts and current challenges." J Mol Biol 407(2): 193-221. 
252 
 
Turco, M. Y., L. Gardner, J. Hughes, T. Cindrova-Davies, M. J. Gomez, L. 
Farrell, M. Hollinshead, S. G. E. Marsh, J. J. Brosens, H. O. Critchley, B. D. 
Simons, M. Hemberger, B. K. Koo, A. Moffett and G. J. Burton (2017). "Long-
term, hormone-responsive organoid cultures of human endometrium in a 
chemically defined medium." Nat Cell Biol 19(5): 568-577. 
Valdes-Dapena, M. (1973). The development of the uterus in late fetal life, 
infancy and childhood. , Williams and Wilkins. 
Valentijn, A. J., K. Palial, H. Al-Lamee, N. Tempest, J. Drury, T. Von 
Zglinicki, G. Saretzki, P. Murray, C. E. Gargett and D. K. Hapangama (2013). 
"SSEA-1 isolates human endometrial basal glandular epithelial cells: 
phenotypic and functional characterization and implications in the 
pathogenesis of endometriosis." Hum Reprod 28(10): 2695-2708. 
Valentijn, A. J., G. Saretzki, N. Tempest, H. O. Critchley and D. K. 
Hapangama (2015). "Human endometrial epithelial telomerase is important 
for epithelial proliferation and glandular formation with potential implications 
in endometriosis." Hum Reprod 30(12): 2816-2828. 
Van der Flier, L. G., J. Sabates-Bellver, I. Oving, A. Haegebarth, M. De Palo, 
M. Anti, M. E. Van Gijn, S. Suijkerbuijk, M. Van de Wetering, G. Marra and H. 
Clevers (2007). "The Intestinal Wnt/TCF Signature." Gastroenterology 
132(2): 628-632. 
van Es, J. H., T. Sato, M. van de Wetering, A. Lyubimova, A. N. Yee Nee, A. 
Gregorieff, N. Sasaki, L. Zeinstra, M. van den Born, J. Korving, A. C. M. 
Martens, N. Barker, A. van Oudenaarden and H. Clevers (2012). "Dll1+ 
secretory progenitor cells revert to stem cells upon crypt damage." Nat Cell 
Biol 14(10): 1099-1104. 
Van Keymeulen, A., A. S. Rocha, M. Ousset, B. Beck, G. Bouvencourt, J. 
Rock, N. Sharma, S. Dekoninck and C. Blanpain (2011). "Distinct stem cells 
contribute to mammary gland development and maintenance." Nature 
479(7372): 189-193. 
van Mourik, M. S., N. S. Macklon and C. J. Heijnen (2009). "Embryonic 
implantation: cytokines, adhesion molecules, and immune cells in 
establishing an implantation environment." J Leukoc Biol 85(1): 4-19. 
253 
 
Volchek, M., J. E. Girling, G. E. Lash, L. Cann, B. Kumar, S. C. Robson, J. N. 
Bulmer and P. A. Rogers (2010). "Lymphatics in the human endometrium 
disappear during decidualization." Hum Reprod 25(10): 2455-2464. 
Wagner, T., J. Wirth, J. Meyer, B. Zabel, M. Held, J. Zimmer, J. Pasantes, F. 
D. Bricarelli, J. Keutel, E. Hustert, U. Wolf, N. Tommerup, W. Schempp and 
G. Scherer (1994). "Autosomal sex reversal and campomelic dysplasia are 
caused by mutations in and around the SRY-related gene SOX9." Cell 79(6): 
1111-1120. 
Wallace, D. C. (2005). "A mitochondrial paradigm of metabolic and 
degenerative diseases, aging, and cancer: a dawn for evolutionary 
medicine." Annu Rev Genet 39: 359-407. 
Walther, V. and M. R. Alison (2016). "Cell lineage tracing in human epithelial 
tissues using mitochondrial DNA mutations as clonal markers." Wiley 
Interdiscip Rev Dev Biol 5(1): 103-117. 
Wang, J., S. Chen, C. Zhang, S. Stegeman, T. Pfaff-Amesse, Y. Zhang, W. 
Zhang, L. Amesse and Y. Chen (2012). "Human endometrial stromal stem 
cells differentiate into megakaryocytes with the ability to produce functional 
platelets." PLoS One 7(8): e44300. 
Wang, T. (1989). "Human fetal endometrium--light and electron microscopic 
study." Arch Gynecol Obstet 246(3): 169-179. 
Wang, X., S. Lindsay and R. Baldock (2010). "From spatial-data to 3D 
models of the developing human brain." Methods 50(2): 96-104. 
Wang, Y., A. Sacchetti, M. R. van Dijk, M. van der Zee, P. H. van der Horst, 
R. Joosten, C. W. Burger, J. A. Grootegoed, L. J. Blok and R. Fodde (2012). 
"Identification of quiescent, stem-like cells in the distal female reproductive 
tract." PLoS One 7(7): e40691. 
Wellings, S. R. and H. M. Jensen (1973). "On the origin and progression of 
ductal carcinoma in the human breast." J Natl Cancer Inst 50(5): 1111-1118. 
Wellings, S. R., H. M. Jensen and R. G. Marcum (1975). "An atlas of 
subgross pathology of the human breast with special reference to possible 
precancerous lesions." J Natl Cancer Inst 55(2): 231-273. 
Wilson, E. W. (1969). "Alkaline phosphatase in pre-decidual cells of the 
human endometrium." J Reprod Fertil 19(3): 567-568. 
254 
 
Wilson, E. W. (1976). "Some properties of human endometrial alkaline 
phosphatase." Fertil Steril 27(3): 299-303. 
Windsperger, K., S. Dekan, S. Pils, C. Golletz, V. Kunihs, C. Fiala, G. 
Kristiansen, M. Knofler and J. Pollheimer (2017). "Extravillous trophoblast 
invasion of venous as well as lymphatic vessels is altered in idiopathic, 
recurrent, spontaneous abortions." Hum Reprod 32(6): 1208-1217. 
Wolf, S. F. and B. R. Migeon (1982). "Studies of X chromosome DNA 
methylation in normal human cells." Nature 295(5851): 667-671. 
Wolff, E. F., X. B. Gao, K. V. Yao, Z. B. Andrews, H. Du, J. D. Elsworth and 
H. S. Taylor (2011). "Endometrial stem cell transplantation restores 
dopamine production in a Parkinson's disease model." J Cell Mol Med 15(4): 
747-755. 
Wolff, E. F., L. Mutlu, E. E. Massasa, J. D. Elsworth, D. Eugene Redmond, 
Jr. and H. S. Taylor (2015). "Endometrial stem cell transplantation in MPTP- 
exposed primates: an alternative cell source for treatment of Parkinson's 
disease." J Cell Mol Med 19(1): 249-256. 
Woodruff JD, P. C. (1969). The fallopian Tube: Structure, Function, 
Pathology and Management., Williams and Wilkins Co. 
Wright, A. J. and P. W. Andrews (2009). "Surface marker antigens in the 
characterization of human embryonic stem cells." Stem Cell Res 3(1): 3-11. 
Wright, N. A. (2012). "Stem cell identification--in vivo lineage analysis versus 
in vitro isolation and clonal expansion." J Pathol 227(3): 255-266. 
Wu, X., Y. Luo, J. Chen, R. Pan, B. Xiang, X. Du, L. Xiang, J. Shao and C. 
Xiang (2014). "Transplantation of human menstrual blood progenitor cells 
improves hyperglycemia by promoting endogenous progenitor differentiation 
in type 1 diabetic mice." Stem Cells Dev 23(11): 1245-1257. 
Xie, X., X. Zheng, J. Wang and L. Chen (2017). "Clinical significance of 
Twist, E-cadherin, and N-cadherin protein expression in endometrioid 
adenocarcinoma." J Cancer Res Ther 13(5): 817-822. 
Xu, J., H. Hardin, R. Zhang, K. Sundling, D. Buehler and R. V. Lloyd (2016). 
"Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid 
Tissues." Endocr Pathol 27(4): 271-275. 
Xu, J., F. F. Hu, Y. G. Cui, J. Luo, C. Y. Jiang, L. Gao, X. Q. Qian, Y. D. Mao 
and J. Y. Liu (2011). "Effect of estradiol on proliferation and differentiation of 
255 
 
side population stem/progenitor cells from murine endometrium." Reprod Biol 
Endocrinol 9: 103. 
Yang, X. Y., W. Wang and X. Li (2014). "In vitro hepatic differentiation of 
human endometrial stromal stem cells." In Vitro Cell Dev Biol Anim 50(2): 
162-170. 
Yatabe, Y., S. Tavare and D. Shibata (2001). "Investigating stem cells in 
human colon by using methylation patterns." Proc Natl Acad Sci U S A 
98(19): 10839-10844. 
Yuan, J., W. Deng, J. Cha, X. Sun, J. P. Borg and S. K. Dey (2018). 
"Tridimensional visualization reveals direct communication between the 
embryo and glands critical for implantation." Nat Commun 9(1): 603. 
Zeng, H., J. W. Park, M. Guo, G. Lin, L. Crandall, T. Compton, X. Wang, X. 
J. Li, F. P. Chen and R. H. Xu (2009). "Lack of ABCG2 expression and side 
population properties in human pluripotent stem cells." Stem Cells 27(10): 
2435-2445. 
Zhang, W. B., M. J. Cheng, Y. T. Huang, W. Jiang, Q. Cong, Y. F. Zheng and 
C. J. Xu (2012). "A study in vitro on differentiation of bone marrow 
mesenchymal stem cells into endometrial epithelial cells in mice." Eur J 
Obstet Gynecol Reprod Biol 160(2): 185-190. 
Zoubina, E. V., Q. Fan and P. G. Smith (1998). "Variations in uterine 
innervation during the estrous cycle in rat." J Comp Neurol 397(4): 561-571. 
  
256 
 
List of published papers 
Tempest N, Baker AM, Wright NA, Hapangama DK (2018) Does human 
endometrial LGR5 gene expression suggest the existence of another 
hormonally regulated epithelial stem cell niche? Hum Repro;Apr 10 [Epub 
ahead of print] 
Tempest N, Baker AM, Jensen M, Wright N, Hapangama D (2018) 3D 
Architecture of endometrial glands in relation to stem cell organisation. 
Reproductive Sciences;25(s1)57A 
Tempest N, Baker AM, Wright N, Hapangama D (2017) LGR5, the proposed 
universal stem cell marker is hormonally regulated in the human 
endometrium (2017) BJOG;124(s5)8-9 
Tempest N, Hapangama D (2017) LGR5 is expressed by human 
endometrial epithelial cells and regulated by progesterone. Reproductive 
Sciences;24(s1)90A 
Kamal A, Tempest N, Maclean A, Adishesh M, Bhullar J, Makrydima S, 
Hapangama D. Chapter 4, Hormone receptor expression in healthy 
endometrium and in endometrial cancer in Advances in Experimental 
Medicine and Biology (AEMB) by Springer. 
Kamal A, Tempest N, Maclean A, Adishesh M, Bhullar J, Makrydima S, 
Hapangama D. Chapter 4, Hormonal interactions in endometrial cancer. In: 
Endometrial cancer management, Edited by MR Mirza (on behalf of ENITEC 
consortium) by Springer.   
Kamal A, Tempest N, Parkes C, Alnafakh R, Makrydima S, Adishesh M, 
Hapangama D (2016) Hormones and endometrial carcinogenesis. Horm Mol 
Biol Clin Investig;1;25(2):129-48 
Manuscripts under preparation 
Tempest N, Baker AM, Jensen M, Wright N, Hapangama D (2018) 3D 
Architecture of endometrial glands in relation to stem cell organisation.   
257 
 
Published papers 
 
 
258 
 
259 
 
260 
 
261 
 
262 
 
263 
 
264 
 
265 
 
266 
 
267 
 
 
 
268 
 
269 
 
270 
 
271 
 
272 
 
273 
 
274 
 
275 
 
 
276 
 
 
277 
 
278 
 
 
279 
 
280 
 
281 
 
282 
 
283 
 
284 
 
285 
 
286 
 
287 
 
  
288 
 
National and International 
conference presentations 
Tempest N, Baker AM, Jensen M, Wright N, Hapangama D. 3D Architecture 
of endometrial glands in relation to stem cell organisation. Society for 
Gynaecologic Investigation, San Diego, March 2018. (Oral presentation - SRI 
President’s Plenary Award) 
Tempest N, Baker AM, Wright N, Hapangama D. LGR5, the proposed 
universal stem cell marker is hormonally regulated in the human 
endometrium. RCOG National Training Conference, Leeds, Nov 2017. 
(Poster presentation) 
Tempest N, Baker AM, Jensen M, Wright N, Hapangama D. 3D 
Architecture of endometrial glands in relation to stem cell organisation. 
North of England Obstetrics and Gynaecology society, Liverpool, Oct 2017. 
(Oral presentation – Second prize) 
Tempest N, Baker AM, Wright N, Hapangama D. LGR5 is expressed by 
human endometrial epithelial cells and regulated by progesterone. 
Society for Gynaecologic Investigation, Florida, March 2017. (Oral 
presentation) 
Tempest N, Hapangama D. LGR5 is expressed by human endometrial 
epithelial cells and regulated by progesterone. North West Cancer Research, 
Liverpool, March 2017. (Poster presentation) 
Tempest N, Hapangama D. LGR5 is expressed by human endometrial 
epithelial cells and regulated by progesterone. RCOG Academic meeting, 
London, Feb 2017. (Poster presentation) 
Tempest N, Hapangama D. LGR5 is expressed by human endometrial 
epithelial cells and regulated by progesterone. National RCOG Trainee 
Conference, Newcastle, Nov 2016. (Poster presentation)  
289 
 
Tempest N, Hapangama D. LGR5 is expressed by human endometrial 
epithelial cells and regulated by progesterone. Gordon Research 
Conference, Hong Kong, Aug 2016. (Poster presentation) 
 
